# EDGAR Filing Document

**Accession Number:** 0001418135
**File Stem:** 0001418135-26-000016
**Filing Date:** 2026-2
**Character Count:** 711550
**Document Hash:** b97bf58222b2acf0391c0439fa5e8e2b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001418135-26-000016.hdr.sgml**: 20260224

**ACCESSION NUMBER**: 0001418135-26-000016

**CONFORMED SUBMISSION TYPE**: 10-K

**PUBLIC DOCUMENT COUNT**: 139

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260224

**DATE AS OF CHANGE**: 20260224

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Keurig Dr Pepper Inc.
- **CENTRAL INDEX KEY:** 0001418135
- **STANDARD INDUSTRIAL CLASSIFICATION:** BEVERAGES [2080]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 753258232
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-33829
- **FILM NUMBER:** 26672658

**BUSINESS ADDRESS:**
- **STREET 1:** 53 SOUTH AVENUE
- **CITY:** BURLINGTON
- **STATE:** MA
- **ZIP:** 01803
- **BUSINESS PHONE:** 877-208-9991

**MAIL ADDRESS:**
- **STREET 1:** 53 SOUTH AVENUE
- **CITY:** BURLINGTON
- **STATE:** MA
- **ZIP:** 01803

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dr Pepper Snapple Group, Inc.
- **DATE OF NAME CHANGE:** 20080108

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CSAB Inc.
- **DATE OF NAME CHANGE:** 20071109

?xml version='1.0' encoding='ASCII'? kdp-20251231

 **UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 10-K** 

☒ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** 

**FOR THE FISCAL YEAR ENDED DECEMBER 31, 2025** 

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**FOR THE TRANSITION PERIOD FROM&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TO**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**COMMISSION FILE NUMBER 001-33829**![KDP_LOGO_Full_Color.jpg](kdp-20251231_g1.jpg)

---

| |
|:---|
| **Keurig Dr Pepper Inc.** |
| *(Exact name of registrant as specified in its charter)* |

---

---

| | |
|:---|:---|
| **Delaware** | **98-0517725** |
| *(State or other jurisdiction of incorporation or organization)* | *(I.R.S. employer identification number)* |

---

**6425 Hall of Fame Lane** 

**Frisco, Texas 75034**

*(Address of principal executive offices)*

**(800) 527-7096**

*(Registrant's telephone number, including area code)*

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol** | **Name of each exchange on which registered** |
| Common stock | KDP | The Nasdaq Stock Market LLC |

---

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Securities Exchange Act of 1934.

Large Accelerated Filer ☒ Accelerated Filer ☐ Non-Accelerated Filer ☐ Smaller Reporting Company ☐ Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934).Yes ☐ No ☒

As of June 30, 2025, the aggregate market value of the registrant's common equity held by non-affiliates of the registrant was approximately $44.8 billion (based on the closing sales price of the registrant's common stock on that date). As of February 20, 2026, there were 1,358,666,059 shares of the registrant's common stock, par value $0.01 per share, outstanding.

**DOCUMENTS INCORPORATED BY REFERENCE**

Portions of the registrant's definitive proxy statement to be filed with the Securities and Exchange Commission in connection with the registrant's Annual Meeting of Stockholders are incorporated by reference in Part III.

------

**KEURIG DR PEPPER INC.**

**FORM 10-K**

**FOR THE YEAR ENDED DECEMBER 31, 2025**

---

| | | |
|:---|:---|:---|
| | **<u>[PART I](#ic5c36f045fc7456185fd61e2116f03f7_13)</u>** | |
| <u>[Item 1](#ic5c36f045fc7456185fd61e2116f03f7_16)</u> | <u>[Business](#ic5c36f045fc7456185fd61e2116f03f7_16)</u> | <u>[1](#ic5c36f045fc7456185fd61e2116f03f7_16)</u> |
| <u>[Item 1A](#ic5c36f045fc7456185fd61e2116f03f7_55)</u> | <u>[Risk Factors](#ic5c36f045fc7456185fd61e2116f03f7_55)</u> | <u>[9](#ic5c36f045fc7456185fd61e2116f03f7_55)</u> |
| <u>[Item 1B](#ic5c36f045fc7456185fd61e2116f03f7_70)</u> | <u>[Unresolved Staff Comments](#ic5c36f045fc7456185fd61e2116f03f7_70)</u> | <u>[31](#ic5c36f045fc7456185fd61e2116f03f7_70)</u> |
| <u>[Item 1C](#ic5c36f045fc7456185fd61e2116f03f7_73)</u> | <u>[Cybersecurity](#ic5c36f045fc7456185fd61e2116f03f7_73)</u> | <u>[31](#ic5c36f045fc7456185fd61e2116f03f7_73)</u> |
| <u>[Item 2](#ic5c36f045fc7456185fd61e2116f03f7_76)</u> | <u>[Properties](#ic5c36f045fc7456185fd61e2116f03f7_76)</u> | <u>[32](#ic5c36f045fc7456185fd61e2116f03f7_76)</u> |
| <u>[Item 3](#ic5c36f045fc7456185fd61e2116f03f7_79)</u> | <u>[Legal Proceedings](#ic5c36f045fc7456185fd61e2116f03f7_79)</u> | <u>[32](#ic5c36f045fc7456185fd61e2116f03f7_79)</u> |
| <u>[Item 4](#ic5c36f045fc7456185fd61e2116f03f7_82)</u> | <u>[Mine Safety Disclosures](#ic5c36f045fc7456185fd61e2116f03f7_82)</u> | <u>[32](#ic5c36f045fc7456185fd61e2116f03f7_82)</u> |
|  | **<u>[PART II](#ic5c36f045fc7456185fd61e2116f03f7_85)</u>** |  |
| <u>[Item 5](#ic5c36f045fc7456185fd61e2116f03f7_88)</u> | <u>[Market for Registrant's Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities](#ic5c36f045fc7456185fd61e2116f03f7_88)</u> | <u>[33](#ic5c36f045fc7456185fd61e2116f03f7_88)</u> |
| <u>[Item 6](#ic5c36f045fc7456185fd61e2116f03f7_94)</u> | <u>[\[Reserved\]](#ic5c36f045fc7456185fd61e2116f03f7_94)</u> | <u>[33](#ic5c36f045fc7456185fd61e2116f03f7_94)</u> |
| <u>[Item 7](#ic5c36f045fc7456185fd61e2116f03f7_97)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#ic5c36f045fc7456185fd61e2116f03f7_97)</u> | <u>[34](#ic5c36f045fc7456185fd61e2116f03f7_97)</u> |
| <u>[Item 7A](#ic5c36f045fc7456185fd61e2116f03f7_166)</u> | <u>[Quantitative and Qualitative Disclosures About Market Risk](#ic5c36f045fc7456185fd61e2116f03f7_166)</u> | <u>[49](#ic5c36f045fc7456185fd61e2116f03f7_166)</u> |
| <u>[Item 8](#ic5c36f045fc7456185fd61e2116f03f7_169)</u> | <u>[Financial Statements and Supplementary Data](#ic5c36f045fc7456185fd61e2116f03f7_169)</u> | <u>[50](#ic5c36f045fc7456185fd61e2116f03f7_169)</u> |
| <u>[Item 9](#ic5c36f045fc7456185fd61e2116f03f7_286)</u> | <u>[Changes in and Disagreements with Accountants on Accounting and Financial Disclosures](#ic5c36f045fc7456185fd61e2116f03f7_286)</u> | <u>[111](#ic5c36f045fc7456185fd61e2116f03f7_286)</u> |
| <u>[Item 9A](#ic5c36f045fc7456185fd61e2116f03f7_289)</u> | <u>[Controls and Procedures](#ic5c36f045fc7456185fd61e2116f03f7_289)</u> | <u>[111](#ic5c36f045fc7456185fd61e2116f03f7_289)</u> |
| <u>[Item 9B](#ic5c36f045fc7456185fd61e2116f03f7_292)</u> | <u>[Other Information](#ic5c36f045fc7456185fd61e2116f03f7_292)</u> | <u>[111](#ic5c36f045fc7456185fd61e2116f03f7_292)</u> |
| <u>[Item 9C](#ic5c36f045fc7456185fd61e2116f03f7_304)</u> | <u>[Disclosure Regarding Foreign Jurisdictions that Prevent Inspections](#ic5c36f045fc7456185fd61e2116f03f7_304)</u> | <u>[112](#ic5c36f045fc7456185fd61e2116f03f7_304)</u> |
|  | **<u>[PART III](#ic5c36f045fc7456185fd61e2116f03f7_307)</u>** |  |
| <u>[Item 10](#ic5c36f045fc7456185fd61e2116f03f7_307)</u> | <u>[Directors, Executive Officers, and Corporate Governance](#ic5c36f045fc7456185fd61e2116f03f7_307)</u> | <u>[113](#ic5c36f045fc7456185fd61e2116f03f7_307)</u> |
| <u>[Item 11](#ic5c36f045fc7456185fd61e2116f03f7_307)</u> | <u>[Executive Compensation](#ic5c36f045fc7456185fd61e2116f03f7_307)</u> | <u>[113](#ic5c36f045fc7456185fd61e2116f03f7_307)</u> |
| <u>[Item 12](#ic5c36f045fc7456185fd61e2116f03f7_307)</u> | <u>[Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters](#ic5c36f045fc7456185fd61e2116f03f7_307)</u> | <u>[113](#ic5c36f045fc7456185fd61e2116f03f7_307)</u> |
| <u>[Item 13](#ic5c36f045fc7456185fd61e2116f03f7_307)</u> | <u>[Certain Relationships and Related Transactions and Director Independence](#ic5c36f045fc7456185fd61e2116f03f7_307)</u> | <u>[113](#ic5c36f045fc7456185fd61e2116f03f7_307)</u> |
| <u>[Item 14](#ic5c36f045fc7456185fd61e2116f03f7_307)</u> | <u>[Principal Accountant Fees and Services](#ic5c36f045fc7456185fd61e2116f03f7_307)</u> | <u>[113](#ic5c36f045fc7456185fd61e2116f03f7_307)</u> |
|  | **<u>[PART IV](#ic5c36f045fc7456185fd61e2116f03f7_310)</u>** |  |
| <u>Item 15</u> | <u>Exhibits and Financial Statement Schedules</u> | <u>[114](#ic5c36f045fc7456185fd61e2116f03f7_549755816411)</u> |
| <u>[Item 16](#ic5c36f045fc7456185fd61e2116f03f7_316)</u> | <u>[Form 10-K Summary](#ic5c36f045fc7456185fd61e2116f03f7_316)</u> | <u>[118](#ic5c36f045fc7456185fd61e2116f03f7_316)</u> |
|  | <u>[Signatures](#ic5c36f045fc7456185fd61e2116f03f7_319)</u> | <u>[119](#ic5c36f045fc7456185fd61e2116f03f7_319)</u> |

---

------

**KEURIG DR PEPPER INC.**

**FORM 10-K**

**FOR THE YEAR ENDED DECEMBER 31, 2025**

**MASTER GLOSSARY**

---

| | |
|:---|:---|
| **Term** | **Definition** |
| 2019 Incentive Plan | Keurig Dr Pepper Inc. Omnibus Incentive Plan of 2019 |
| 2025 Revolving Credit Agreement | KDP's revolving credit agreement, which was executed in March 2025 and amended in September 2025 |
| ABC | The American Bottling Company, a wholly-owned subsidiary of KDP |
| ABI | Anheuser-Busch InBev SA/NV |
| AOCI | Accumulated other comprehensive income or loss |
| Apollo Investor | One or more affiliated investment funds of Apollo Management Holdings, L.P. who are party to the Preferred Investment Agreement |
| ASU | Accounting Standards Update |
| Athletic Brewing | Athletic Brewing Holding Company, LLC, an equity method investment of KDP |
| Board | The Board of Directors of KDP |
| bps | basis points |
| Bridge Credit Agreement | Bridge credit agreement entered into on August 24, 2025 and amended on December 18, 2025 |
| Central States | The Central States, Southeast, and Southwest Areas Pension Fund |
| CEO | Chief Executive Officer |
| CFO | Chief Financial Officer |
| Chobani | FHU US Holdings LLC, an equity method investment of KDP |
| CISO | Chief Information Security Officer |
| Coca-Cola | The Coca-Cola Company |
| CODM | Chief Operating Decision Maker |
| Coffee Production Assets | Certain assets located in the United States that are used for the production, roasting, and grinding of single serve un-brewed beverage products (including K-Cup pods and K-Rounds) |
| Convertible Preferred Stock | KDP's Series A Convertible Perpetual Preferred Stock |
| CSD | Carbonated soft drink |
| Delayed Draw Term Loan Agreement | The delayed draw term loan agreement entered into by KDP on December 18, 2025 |
| DPS | Dr Pepper Snapple Group, Inc. |
| DPS Merger | The combination of the business operations of Keurig and DPS as of July 9, 2018 |
| DSD | Direct Store Delivery, KDP's route-to-market whereby finished beverages are delivered directly to retailers |
| EPS | Earnings per share |
| EURIBOR | Euro Interbank Offered Rate |
| Exchange Act | Securities Exchange Act of 1934, as amended |
| FASB | Financial Accounting Standards Board |
| FX | Foreign exchange |
| GHOST | GHOST Lifestyle LLC |
| GHOST Transactions | The series of transactions by which KDP acquired 60% of the interests in GHOST effective December 31, 2024, agreed to purchase the remaining 40% of the interests in GHOST in 2028, and obtained the rights to distribute GHOST products effective March 3, 2025 |
| IT | Information technology |
| IRS | Internal Revenue Service |
| JAB | JAB Holding Company S.a.r.l., and affiliates |
| JDE Peet's | JDE Peet's N.V. |
| JDE Peet's Acquisition | The planned acquisition of JDE Peet's, which was announced on August 25, 2025 |

---

------

**KEURIG DR PEPPER INC.**

**FORM 10-K**

**FOR THE YEAR ENDED DECEMBER 31, 2025**

---

| | |
|:---|:---|
| **Term** | **Definition** |
| JDE Peet's Acquisition Agreement | The merger protocol between KDP and JDE Peet's, whereby KDP agreed to commence a tender offer to acquire all of the issued ordinary shares, excluding ordinary shares held in treasury, of JDE Peet's |
| JV Commitment Letter | The commitment letter between KDP and each of the JV Investors, dated as of October 26, 2025 |
| JV Investment | The minority investment to be made by the JV Investor Partner into the Pod Manufacturing JV |
| JV Investor Partner | The holding company through which the JV Investors will contribute cash to the Pod Manufacturing JV |
| JV Investors | Apollo Capital Management L.P., certain funds or accounts managed, advised, or sub-advised by Kohlberg Kravis Roberts & Co., L.P., and Goldman Sachs Asset Management, L.P. and its affiliates |
| JV Transaction Agreement | The agreement between KDP, the Pod Manufacturing JV, and the JV Investor Partner to complete the JV Investment, dated as of February 23, 2026 |
| Kalil | Kalil Bottling Company |
| Kalil Acquisition | The acquisition of all production, sales, and distribution assets of Kalil by KDP on August 9, 2024 |
| KDP | Keurig Dr Pepper Inc. |
| Keurig | Keurig Green Mountain, Inc., a wholly-owned subsidiary of KDP, and the brand of our brewers |
| KKR Investor | One or more funds or accounts managed, advised, or sub-advised by Kohlberg Kravis Roberts & Co., L.P. who are party to the Preferred Investment Agreement |
| LRB | Liquid refreshment beverages |
| Nasdaq | The Nasdaq Stock Market LLC |
| Notes | Collectively, KDP's senior unsecured notes |
| Nutrabolt | Woodbolt Holdings LLC, d/b/a Nutrabolt, an equity method investment of KDP |
| OBBB | U.S. legislation formally titled "An Act to Provide for Reconciliation Pursuant to Title II of H. Con. Res. 14" and commonly referred to as the One Big Beautiful Bill |
| PepsiCo | PepsiCo, Inc. |
| PET | Polyethylene terephthalate, which is used to make KDP's plastic bottles |
| PFAS | Per- and polyfluoroalkyl substances |
| Pod Manufacturing JV | Keurig JV, LP |
| Pod Manufacturing JV Agreement | The amended and restated limited partnership agreement for the Pod Manufacturing JV |
| Preferred Investment | The issuance and sale of KDP's Convertible Preferred Stock under the Preferred Investment Agreement |
| Preferred Investment Agreement | The investment agreement, dated as of October 27, 2025, and amended on February 23, 2026, by and among KDP, the KKR Investor, the Apollo Investor, and any other investor that becomes a party thereto |
| Preferred Investors | Holders of our Convertible Preferred Stock |
| PRMB | Post-retirement medical benefit |
| Proxy Statement | The definitive proxy statement for the Annual Meeting of Stockholders to be filed with the SEC within 120 days of December 31, 2025, pursuant to Regulation 14A under the Exchange Act |
| PSU | Performance share unit |
| Qualified IPO | Initial public offering of our refreshment beverage portfolio, meeting certain criteria |
| rPET | Post-consumer recycled PET |
| RSU | Restricted share unit |
| RTD | Ready to drink |
| RVG | Residual value guarantee |

---

------

**KEURIG DR PEPPER INC.**

**FORM 10-K**

**FOR THE YEAR ENDED DECEMBER 31, 2025**

---

| | |
|:---|:---|
| **Term** | **Definition** |
| S&P | Standard & Poor's |
| SEC | Securities and Exchange Commission |
| Separation | The intended separation of KDP's beverage and coffee portfolios into two independent, publicly traded companies, as announced on August 25, 2025 |
| SG&A | Selling, general, and administrative |
| SOFR | Secured Overnight Financing Rate |
| Term Loan Agreement | Term loan agreement entered into on October 25, 2024 and terminated on May 7, 2025 |
| Tractor | Tractor Beverages, Inc., an equity method investment of KDP |
| U.S. GAAP | Accounting principles generally accepted in the U.S. |
| Veyron SPEs | Special purpose entities with a single sponsor, Veyron Global |
| VIE | Variable interest entity |
| Vita Coco | The Vita Coco Company, Inc. |
| Walmart | Walmart Inc. |
| WD | Warehouse Direct, KDP's route-to-market whereby finished beverages are shipped to retailer warehouses, and then delivered by the retailer through its own delivery system to its stores |
| WIP | Work-in-process |

---

------

**KEURIG DR PEPPER INC.**

**FORM 10-K**

**FOR THE YEAR ENDED DECEMBER 31, 2025**

*References in this Annual Report on Form 10-K to "KDP", "we", "us", and "our", refer to Keurig Dr Pepper Inc. and all wholly-owned subsidiaries included in our Consolidated Financial Statements.*

*This Annual Report on Form 10-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act, including, in particular, statements about the impact of future events, future financial performance, plans, strategies, business combinations, expectations, prospects, competitive environment, regulation, labor matters, supply chain issues, tariffs or trade wars and related uncertainty, inflation, and availability of raw materials. Forward-looking statements include all statements that are not historical facts and can be identified by the use of forward-looking terminology such as "outlook," "guidance," "anticipate," "enable," "expect," "believe," "could," "confident," "estimate," "feel," "continue," "ongoing," "forecast," "intend," "may," "on track," "plan," "positioned," "potential," "project," "should," "target," "will," "would," and similar words, phrases, or expressions and variations or negatives of these words in this Annual Report on Form 10-K. We have based these forward-looking statements on our current views with respect to future events and financial performance.*

*The following discussions should be read in conjunction with our Consolidated Financial Statements and the related Notes thereto included elsewhere in this Annual Report on Form 10-K. Our actual results may differ materially from those currently anticipated and expressed in the forward-looking statements as a result of various factors, including the inherent uncertainty of estimates, forecasts, and projections; global economic uncertainty or economic downturns; tariffs or the imposition of new tariffs, trade wars, barriers, or restrictions, or threats of such actions and related uncertainty; the risk that our financial performance may be better or worse than anticipated; the possibility that we are unable to successfully integrate GHOST into our business; risks related to the completion of the JDE Peet's Acquisition, the Preferred Investment, the JV Investment, or the Separation in the anticipated timeframe, or at all; risks relating to the receipt of regulatory approvals without unexpected delays or conditions; risks relating to our incurrence of significant debt or our entry into other funding alternatives, in each case, to fund the JDE Peet's Acquisition, which may result in increased indebtedness, dilution to our stockholders, and/or additional complexity to our capital structure; additional risks associated with the JDE Peet's Acquisition and those geographies where JDE Peet's currently operates; our ability to successfully integrate JDE Peet's into our business, or that such integration may be more difficult, time-consuming, or costly than expected; constraints on management's attention to operating and growing our business during the execution of the JDE Peet's Acquisition and the Separation; the potential downgrade of our credit ratings as a result of debt incurred and/or assumed in connection with the JDE Peet's Acquisition; the possibility of negative impacts on business relationships in connection with the JDE Peet's Acquisition and the Separation; the risk that the JDE Peet's Acquisition and the Separation incur significant additional costs; the risk of potential litigation; negative effects of the announcement and pendency of the JDE Peet's Acquisition and the Separation on our share price; the ability to achieve the anticipated strategic and financial benefits from the Separation; and the factors described under "Risk Factors" within Part I, Item 1A and elsewhere in this Annual Report on Form 10-K and subsequent filings with the SEC.*

*Given these uncertainties, you should not put undue reliance on any forward-looking statements. Forward-looking statements represent our estimates and assumptions only as of the date that they were made. We do not undertake any duty to update the forward-looking statements, and the estimates and assumptions associated with them, after the date of this Annual Report on Form 10-K, except to the extent required by applicable securities laws.*

*This Annual Report does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities in JDE Peet's. Any offer will be made only by means of an offer memorandum approved by the Dutch Authority for the Financial Markets. This Annual Report is not for release, publication, or distribution, in whole or in part, in or into, directly or indirectly, in any jurisdiction in which such release, publication, or distribution would be unlawful.*

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

**PART I**

**ITEM 1. BUSINESS**

**OUR COMPANY**

Keurig Dr Pepper Inc. is a leading beverage company in North America that manufactures, markets, distributes, and sells hot and cold beverages and single serve brewing systems. We have a broad portfolio of iconic beverage brands, including Dr Pepper, Canada Dry, Mott's, A&W, Peñafiel, GHOST, 7UP, Snapple, Green Mountain Coffee Roasters, Clamato, The Original Donut Shop, and Core Hydration, as well as the Keurig brewing system. Our beverage brands are some of the most recognized beverage brands in North America, with significant consumer awareness levels and long histories that evoke strong emotional connections with consumers. We offer more than 125 owned, licensed, and partner brands, supported by powerful distribution capabilities.

KDP was created on July 9, 2018, through the combination of the business operations of Keurig, a leading producer of innovative single serve brewing systems and specialty coffee in the U.S. and Canada, and DPS, a company built over time through a series of strategic acquisitions that brought together iconic beverage brands in North America. Today, we trade on Nasdaq under the symbol KDP.

**OUR STRENGTHS AND STRATEGY**

Our strategic framework starts with our purpose to *Drink Well. Do Good.* We aim to enhance the experience of every beverage occasion and to make a positive impact for people, communities, and the planet. Our vision is to be a total beverage leader, offering a beverage for every need, anytime, anywhere. We support our purpose and vision with five key strategies:

*Champion consumer-obsessed brand building.* We own a diverse portfolio of well-known beverage brands. Many of our brands enjoy high levels of consumer awareness, preference, and loyalty rooted in their rich heritage. This portfolio provides our customers with a wide variety of products to meet consumers' needs and provides us with a platform for growth and profitability. We drive growth in our business through investments in innovation, renovation, and marketing to support our portfolio of owned brands and partnerships with other leading beverage brands. We lead with deep consumer insights that inform our brand positioning and surface opportunities to address unmet needs. We have a robust innovation program, which is designed to meet consumers' changing flavor and beverage preferences and to grow our share of beverage occasions.

*Shape our now and next beverage portfolio.* We continually evaluate organic and inorganic investments that allow us to more fully meet evolving consumer preferences. Where appropriate, we leverage and extend our existing brands. We also cultivate strong relationships with leading beverage brands that enable us to form long-term, capital-efficient partnerships. In certain cases, we may add complementary brands to our owned portfolio through acquisitions. This flexible approach allows us to optimally address whitespace growth opportunities in our portfolio.

*Amplify our route-to-market advantage.* In our DSD network, we have strategically located distribution capabilities that enable us to better align our operations with our customers and sales channels, ensure our products are available to meet consumer demand, reduce transportation costs, and have greater control over the timing and coordination of new product launches. We actively manage transportation of our products using our fleet (owned and leased) of approximately 8,100 vehicles in the U.S. and 2,200 in Mexico, as well as third-party logistics providers.

With our Keurig.com website, we have a leading direct-to-consumer e-commerce platform which provides us insights and expertise in the e-commerce channel. We continually invest in digital tools and capabilities as part of our route-to-market strategy, and as one element of a holistic digital transformation across KDP.

*Generate fuel for growth.* We focus on critical transformational investments that drive continuous productivity and network optimization. We also maintain emphasis on lean overheads to drive operating leverage and fund investments in our growth opportunities.

*Dynamically allocate capital.* Our highly efficient business model, focused on an optimized capital structure, gives us optionality to invest internally and pursue investments, partnerships, acquisitions, or other opportunities to continue to drive growth and create value, while remaining committed to a strong balance sheet with investment grade ratings.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

**PROPOSED JDE PEET'S ACQUISITION AND SUBSEQUENT SEPARATION**

On August 24, 2025, we entered into an agreement to acquire JDE Peet's, a global pure-play coffee company with a portfolio of leading brands including Jacobs, L'OR, and Peet's. The JDE Peet's Acquisition is expected to occur early in the second quarter of 2026 and is subject to the satisfaction or waiver of the closing conditions, including the acceptance of the offer by the shareholders of JDE Peet's. We've also entered into a series of transactions to fund the JDE Peet's Acquisition. Refer to Note 3 of the Notes to our Consolidated Financial Statements for additional information on the JDE Peet's Acquisition and related transactions.

On August 25, 2025, we announced our intention to separate our beverage and coffee portfolios into two independent, publicly traded companies, which will allow for more tailored growth strategies, operating models, and approaches to capital allocation. The Separation is expected to occur subsequent to the closure of the JDE Peet's Acquisition.

**OUR PRODUCTS AND OPERATING STRUCTURE**

We are a leading integrated brand owner, manufacturer, and distributor of beverages in the U.S., Canada, Mexico, the Caribbean, and other international markets.

***Operating and Reportable Segments***

As of December 31, 2025, our operating structure consists of three operating and reportable segments: U.S. Refreshment Beverages, U.S. Coffee, and International. Segment financial data, including financial information about foreign and domestic operations, is included in Note 9 of the Notes to our Consolidated Financial Statements.

U.S. Refreshment Beverages

Our U.S. Refreshment Beverages segment is a brand owner, manufacturer, and distributor of LRBs in the U.S. In this segment, we manufacture and distribute beverage concentrates, syrups, finished beverages, and other consumables to third-party bottlers, distributors, retailers, and, ultimately, the end consumer.

We manufacture beverage concentrates and syrups, which we then sell throughout the U.S. to third-party bottlers or use them in our own manufacturing systems. Beverage concentrates, which are highly concentrated proprietary flavors, are combined with carbonation, water, sweeteners, and other ingredients, packaged in cans, bottles, or other packaging, and sold as a packaged beverage to retailers and, ultimately, the end consumer. Beverage concentrates are also manufactured into syrup, which is shipped to fountain customers, such as fast food restaurants, who mix the syrup with water and carbonation to create a finished beverage at the point of sale to consumers. Dr Pepper represents most of our fountain channel volume.

We manufacture and distribute finished beverages of our own beverage brands. Additionally, in order to maximize the size and scale of our manufacturing and distribution operations, we also distribute finished beverages for our partner brands and manufacture finished beverages for other third parties, including partners and private labels. We partner with other brands seeking effective route-to-market capabilities, including national selling and distribution scale. These brands can also give us exposure in certain markets to fast-growing segments of the beverage industry in a capital-efficient manner. We sell finished beverages through our DSD and our WD systems, both of which include sales to all major retail channels.

Key brands in this segment include Dr Pepper, Canada Dry, Mott's, A&W, GHOST, 7UP, Snapple, Squirt, Electrolit, Sunkist soda, C4 Energy, Hawaiian Punch, Bloom, Vita Coco, Core Hydration, Bai, Evian, Clamato, Yoo-Hoo, Big Red, and RC Cola.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

U.S. Coffee

Our U.S. Coffee segment is primarily a brand owner, manufacturer, and distributor of innovative single serve brewers, specialty coffee (including hot and iced varieties), and RTD coffee in the U.S. Our Keurig single serve brewers are aimed at changing the way consumers prepare and enjoy coffee and other beverages both at home and away from home in places such as offices, hotels, restaurants, cafeterias, and convenience stores. We create value by developing and selling our Keurig single serve brewers and by expanding Keurig brewer household adoption, which enables sales of specialty coffee and a variety of other specialty beverages in K-Cup pods (including hot and iced teas, hot cocoa, and other beverages) for use with Keurig brewers. We also compete in the broader coffee category through traditional whole bean and ground coffee in other package types, including bags, fractional packages, and cans, as well as RTD coffee beverages. We, together with our partners, are able to bring consumers high-quality coffee and other beverage experiences from the brands they love, all through the one-touch simplicity and convenience of Keurig brewers.

We manufacture and sell 100% of the K-Cup pods of our owned and licensed brands, including Green Mountain Coffee Roasters, McCafé, and The Original Donut Shop, to retailers, away from home channel participants, and end-use consumers. We manufacture K-Cup pods for our partner brands, who in turn sell them to retailers and consumers. Our partner brands include Starbucks, Dunkin', Folgers, and Peet's, among others. We have agreements for manufacturing, distributing, and selling K-Cup pods for tea under brands such as Celestial Seasonings and Bigelow. We produce and sell K-Cup pods for cocoa, including through a licensing agreement for the Swiss Miss brand, and hot apple cider, including under our own brand, Mott's. Generally, we are able to sell these partner brands to our away from home channel participants and directly to consumers through our website at www.keurig.com. We also participate in private label manufacturing arrangements.

Our U.S. Coffee segment manufactures K-Cup pods using freshly roasted and ground coffee as well as tea, cocoa, and other products. We offer high-quality, responsibly sourced coffee, including certified single-origin, organic, flavored, limited edition, and proprietary blends. We carefully select our coffee beans and roast them to optimize their taste and flavor differences. We engineer and design most of our single serve brewers and utilize third-party contract manufacturers located in various countries in Asia for brewer appliance manufacturing. We distribute our brewers using third-party distributors and retail partners, as well as directly to consumers through our website at www.keurig.com.

International

Our International segment includes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Sales in Canada, Mexico, the Caribbean, and other international markets from the manufacture and distribution of branded concentrates, syrup, and finished beverages, including sales of our own brands and third-party brands, to third-party bottlers, distributors, and retailers. Key beverage brands include Peñafiel, Clamato, Canada Dry, Squirt, Dr Pepper, Mott's, Schweppes, and Crush.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Sales in Canada from the manufacture and distribution of finished goods relating to our single serve brewers, K-Cup pods, and other coffee products to partners and retailers, as well as directly to consumer through our website at www.keurig.ca. Key K-Cup pod brands include McCafé, Tim Hortons, and Van Houtte, as well as other partner and private label brands.

***Product Innovation and New Partnerships***

We are focused on a robust innovation pipeline within our portfolio of products to expand our consumer base and grow market share. We regularly launch new brewers with new features and benefits, technological advances, sustainable attributes, and changes in aesthetics to provide a variety of options to suit individual consumer preferences. We also continuously innovate and renovate our portfolio of K-Cup pods and beverages to provide an expansive array of flavors.

In 2025, we released new flavor innovations, including Dr Pepper Blackberry and 7UP Tropical. Additionally, through our partnership with Bloom, we entered the prebiotic CSD market during the year with the distribution of Bloom Pop.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

We launched our Keurig K-Mini Mate brewer, with a compact design that saves space without compromising on coffee quality. Additionally, we released the Keurig K-Crema brewer, which allows users to brew crema-topped coffees from traditional K-Cup pods. We have also continued to progress in the development of our Keurig Alta brewer and K-Rounds plastic- and aluminum-free pods. We began in-home consumer beta testing during the year and expect to launch these products in late 2026.

In the fourth quarter of 2025, we debuted the first-ever coffee line under the Keurig brand, the Keurig Coffee Collective. This collection showcases the new Refined Grind manufacturing technique, which grinds premium beans to a high density and allows for more coffee in each K-Cup pod.

**CUSTOMERS**

We primarily serve the following types of customers:

***Retailers***

Retailers include supermarkets, hypermarkets, mass merchandisers, club stores, e-commerce retailers, office superstores, vending machines, fountains, grocery and drug stores, convenience stores, and other small outlets. Retailers purchase finished beverages, K-Cup pods, appliances, and accessories directly from us. Our portfolio of strong brands, operational scale, and experience in the beverage industry has enabled us to maintain strong relationships with major retailers throughout the U.S., Canada, and Mexico. Our largest retailer, Walmart, represented approximately 16% of our consolidated net sales in 2025. Net sales to Walmart are included in all reportable segments.

***Bottlers and Distributors***

In the U.S. and Canada, we generally grant manufacturing and distribution licenses for our CSDs to bottlers for specific geographic areas that are typically exclusive and long-term. These bottlers may be affiliated with Coca-Cola or with PepsiCo, or they may be independent. These agreements prohibit bottlers and distributors from selling the licensed products outside their exclusive territory and from selling any imitative products in that territory. Generally, we may terminate bottling and distribution agreements only for cause or change in control, and the bottler or distributor may terminate without cause upon giving certain specified notice and complying with other applicable conditions. These bottlers and distributor agreements may also contain provisions for fountain distribution rights, which are not exclusive for a territory, but generally do restrict bottlers from carrying imitative product in the territory.

Certain other brands, such as Snapple and Core, are licensed for distribution in various territories to bottlers and a number of smaller distributors such as beer wholesalers, wine and spirit distributors, independent distributors, and retail brokers.

***Partners***

We have differentiated ourselves and the Keurig brand through our ability to create and sustain partnerships with other leading coffee, tea, and beverage brand companies through multi-year licensing and manufacturing agreements that best suit each brand's interests and strengths. Typically, we manufacture K-Cup pods on behalf of our partners, who in turn sell them to retailers.

***Away from Home Channel Participants***

We distribute brewers, accessories, and K-Cup pods (owned, licensed, and partner brands) to away from home channel participants, which include office coffee distributors and hotel chains.

***End-use Consumers***

We have robust e-commerce platforms at www.keurig.com and www.keurig.ca where end-use consumers can purchase brewers, accessories, K-Cup pods, and other coffee products, such as bagged traditional coffee and cold brew.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

**COMPETITORS**

The beverage industry is highly competitive and continues to evolve in response to changing consumer preferences. Competition is generally based on brand recognition, taste, quality, price, availability, selection, and convenience, among other factors. We compete with multinational corporations with significant financial resources. In our bottling and manufacturing operations, we also compete with a number of smaller bottlers and distributors and a variety of smaller, regional, and private label manufacturers.

Our primary competitors include Coca-Cola, PepsiCo, Starbucks Corporation, The J.M. Smucker Company, The Kraft Heinz Company, and Nestlé S.A. Although these companies offer competing brands in categories we participate in, many are also our partners or customers, as they purchase products directly from us.

**MATERIAL RESOURCES** 

***Raw Materials***

The principal raw materials we use in our business, which we commonly refer to as ingredients and materials, represent approximately 55% of our cost of sales and include green coffee, water, aluminum cans and ends, PET bottles and caps, including both virgin and rPET, CO2, sweeteners, paper products, K-Cup pod packaging materials, fruit, glass bottles and enclosures, cocoa, teas, juices, and other ingredients. We also use post-consumer recycled materials in the manufacturing of our single serve brewers.

The availability, quality, and costs of many of these materials have fluctuated, and may continue to fluctuate, over time. Additionally, under many of our supply arrangements for these raw materials, the price we pay fluctuates along with certain changes in indirect commodity costs, such as aluminum in the case of cans and ends, natural gas in the case of glass bottles, resin in the case of K-Cup pods, PET bottles and caps, corn in the case of sweeteners, and pulp in the case of paperboard packaging.

When appropriate, we mitigate the exposure to volatility in the prices of certain commodities used in our production process and transportation to our customers through the use of various commodity derivative contracts or supplier pricing agreements. The intent of the contracts and agreements is to provide a certain level of predictability in our operating margins and our overall cost structure, while remaining in what we believe to be a competitive cost position.

Green Coffee

We develop and pursue direct relationships with farms, estates, cooperatives, cooperative groups, and exporters in order to purchase green coffee and to support our broader traceability and sustainable supply chain initiatives. We also purchase green coffee through outside brokers.

Energy and Transportation Costs

In addition to ingredients and packaging costs, we are significantly impacted by changes in fuel costs, which can also fluctuate substantially, due to the large truck fleet we operate in our distribution operations (reflected within SG&A expenses) and the energy costs consumed in the production process (reflected within cost of sales).

We are also significantly impacted by changes in other transportation costs, such as ocean freight and tariffs. Transportation costs associated with the transportation and import of certain raw materials and finished goods to our manufacturing and distribution facilities are reflected within cost of sales.

***Intellectual Property***

Trademarks and Patents

We possess a variety of intellectual property rights that are important to our business. We rely on a combination of trademarks, copyrights, patents, and trade secrets to safeguard our proprietary rights, including our brands, our technologies, and ingredient and production formulas for our products.

We own numerous trademarks in our portfolio within the U.S., Canada, Mexico, and other countries. Depending upon the jurisdiction, trademarks are valid as long as they are in use and/or their registrations are properly maintained.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

In many countries outside the U.S., Canada, and Mexico, the manufacturing and distribution rights to many of our CSD brands, including our Dr Pepper trademark and formula, are owned by third parties, including, in certain cases, competitors such as Coca-Cola.

We hold U.S. and international patents related to Keurig brewers and coffee pod technology. Of these, a majority are utility patents and the remainder are design patents. We view these patents as valuable assets but we do not view any single patent as critical to our success. We also have pending patent applications associated with our brewers and with coffee pod technology. We take steps that we believe are appropriate to protect such innovation.

Licensing Arrangements

We license various trade names from our partners in order to manufacture and distribute K-Cup pods. Although these licenses vary in length and other terms, they generally are long-term, cover the entire U.S. and/or Canada, and may include royalty payments, upfront payments, or some combination of the two, to the partner in order to use their trade names to manufacture and/or distribute the K-Cup pods.

We license various trademarks from third parties, which generally allow us to manufacture and distribute certain products or brands throughout the U.S. and/or Canada and Mexico. For example, we license trademarks for Sunkist soda and Rose's from third parties. Although these licenses vary in length and other terms, they generally are long-term, cover the entire U.S. and/or Canada and Mexico and generally include a royalty payment to the licensor.

For beverages in emerging and fast growing categories where we may not currently have a brand presence, we license various trademarks from third-party partners, which generally allow us to sell and distribute certain products or brands throughout the U.S., Canada, or Mexico. These partners view us as a distributor with strong route-to-market resources to grow their brands. Although these licenses vary in length and other terms, they generally are long-term and require a payment from the partner if the licensing agreement is terminated. In some instances, we make investments in these companies, which may include a path to acquire the company. As of December 31, 2025, our portfolio of partner brands included C4 energy drinks, Electrolit instant hydration beverages, Vita Coco coconut water, Bloom energy drinks and prebiotic sodas, evian water, Polar Beverages seltzer water, La Colombe shelf-stable RTD coffee, and Black Rifle Coffee Company energy drinks.

**SEASONALITY**

The beverage market is subject to some seasonal variations. Our cold beverage sales are generally higher during the warmer months, while hot beverage sales are generally higher during the cooler months. Overall beverage sales can also be influenced by the timing of holidays and weather fluctuations. Sales of brewers and related accessories are generally higher during the second half of the year due to the holiday shopping season.

**HUMAN CAPITAL RESOURCES**

***Our Employees***

We have approximately 30,600 employees, primarily located in North America. In the U.S., we have approximately 23,200 employees, of which approximately 5,700 employees are covered by union collective bargaining agreements. In Mexico, we have approximately 5,700 employees, of which approximately 4,200 are covered by union collective bargaining agreements. In Canada, we have approximately 1,400 employees, with approximately 400 covered by union collective bargaining agreements. We also have approximately 300 employees outside of North America.

Our collective bargaining agreements generally address working conditions, as well as wage rates and benefits, and expire over varying terms over the next several years. We generally believe that these agreements can be renegotiated on terms satisfactory to us as they expire and that we have good relationships with our employees and any representative organizations for our unionized employees.

Our compensation programs are designed to ensure that we attract and retain the right talent. We generally review and consider median market pay levels when assessing total compensation, but pay decisions are based on a more comprehensive set of considerations such as company performance, individual performance, experience, and internal equity. We continually monitor key talent metrics including employee engagement and employee turnover.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

Our employee benefits programs strive to deliver competitive benefits that are effective in attracting and retaining talent, and that create a culture of well-being and inclusiveness, designed to support each team member's unique needs. Our total package of benefits is designed to support the physical, mental, and financial health of our employees, and we currently provide access to medical, dental, vision, life insurance, retirement benefits, and disability benefits, as well as assistance with major life activities such as adoption, childbirth, and eldercare, among other benefits.

***Our Culture***

Together with our employees, we created a set of core values that define how we work together and are the cornerstone of our culture. We embrace a challenger mindset, which, together with our strategy and core values, are the unifying force for our team and guide our actions, each and every day. Our four core values are:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Team First. Win together. Be the kind of person you want on your team.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Deliver Big. Achieve our commitments. Then push beyond the expected.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Think Bold. Challenge the usual. Dare to try something new.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Be Fearless and Fair. Tell the truth with courage. Listen and act with respect.

Additionally, we have adopted a corporate code of conduct that applies to all of our employees, officers, and our Board, which lays the foundation for ethical behavior for our team. Our code of conduct is available on our website at http://www.keurigdrpepper.com.

Just as each of our brands brings its own personality to our product portfolio, each of our employees brings their own unique set of experiences, perspectives, and flavor to our business. We believe that to best innovate and deliver for our consumers and customers, our workforce should represent them.

***Employee Health and Safety***

We use a wide variety of strategies and programs to support the health and safety of our employees. Our Environmental Health & Safety team considers all aspects of what our employees may encounter and works to minimize risk. Key to these efforts are data and preventive actions. We measure Lost Time Incident Rate, a reliable indication of Total Recordable Injuries Rate severity, and use a risk reduction process that thoroughly analyzes injuries and near misses.

**OUR IMPACT**

As a leading beverage company, we have the opportunity and responsibility to make a positive impact for people, communities, and planet. *KDP Impact* is our multi-year environmental, social, and governance agenda comprised of strategic initiatives that aim to make a positive impact with every drink. Rooted in action, realized through partnerships, and measured in results, we focus our commitments in the seven key impact areas where we can create meaningful change. These seven key impact areas are as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Climate and nature action

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Water use and stewardship

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Packaging and circular economy

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Human rights, responsible sourcing, and supply chain livelihoods

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Consumer health and well-being

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Employee health, safety, and well-being; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Corporate governance and ethics.

We are committed to transparency and disclosure of our strategies, programs, progress, and governance. Our report on our impact, which is issued annually, is available on our website at www.keurigdrpepper.com.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

**GOVERNMENTAL REGULATIONS ON OUR BUSINESS**

In the normal course of our business, we are subject to a variety of federal, state, and local laws and regulations in the countries in which we do business. Regulations in the U.S., as well as jurisdictions including Canada, Mexico, and the European Union, apply to many aspects of our business, including our products and their ingredients, manufacturing, safety, labeling, transportation, packaging, advertising, and sale. For example, our products and their manufacturing, labeling, marketing, and sale in the U.S. are subject to various aspects of the Federal Food, Drug, and Cosmetic Act, the Federal Trade Commission Act, the Robinson-Patman Act, the Clayton Act, the Sherman Act, the Lanham Act, state consumer protection laws, and state warning and labeling laws, such as the state of California's Safe Drinking Water and Toxic Enforcement Act of 1986.

Various countries, states, provinces, and other authorities have enacted eco-taxes, extended producer responsibility laws, water-use restrictions, deposit or reuse/refill mandates, fees on certain products or packaging, restrictions or bans on the use of certain types of packaging, including single-use plastics, and regulations on PFAS, and other chemicals of concern. Regulators have also expressed concerns about the processing and use of particular ingredients or additives in beverage products. Various jurisdictions have adopted, and others may seek to adopt, bans or restrictions on the use of certain ingredients or substances in products or packaging, as well as significant additional product labeling or warning requirements or limitations on the marketing or sale of our products because of what they contain or allegations that they cause adverse health effects. Certain countries, as well as cities and municipalities within the U.S., have passed various taxes on the distribution of sugar-sweetened and diet beverages. We expect that legislation or regulations like those described above will continue to be proposed in the future at local, state and federal levels, both in the U.S. and elsewhere.

**OTHER INFORMATION**

We are required to file annual, quarterly, and current reports, proxy statements and other information with the SEC. The SEC maintains a website that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC at http://www.sec.gov.

Our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to the Exchange Act, are also available free of charge on our website at http://www.keurigdrpepper.com as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. Information on any of our websites is not incorporated by reference in this document or any of our other filings with the SEC.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

**ITEM 1A. RISK FACTORS**

In addition to the other information set forth in this Annual Report, the following factors should be considered, which could materially affect our business, financial condition, and results of operations. The risks described below are not the only risks we face. Risks and uncertainties not currently known to us or that we currently deem to be immaterial also may have a material adverse affect on our business, financial condition, or results of operations.

**RISK FACTORS SUMMARY**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Disruption of our manufacturing and distribution operations or supply chain, including increased input costs, may adversely affect our financial condition or results of operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We operate in highly competitive categories, and any inability to compete effectively could adversely impact our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may not effectively respond to changing consumer preferences and shopping behavior, which could impact our financial results.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Concerns about the safety, quality, or health effects of our products could negatively affect our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Damage to our reputation or brand image can adversely affect our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• If we do not successfully manage our acquisitions of and investments in new businesses or brands, our operating results may adversely be affected.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Failure to realize benefits or successfully manage the potential negative consequences of our productivity initiatives can adversely affect our financial performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our facilities and operations may require substantial investment and upgrading, and such investments may not achieve the intended financial benefits.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We depend on key information systems, and our use of information technology exposes us to business disruptions that could adversely affect us.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our intellectual property rights could be infringed or we could infringe the intellectual property rights of others, and adverse events regarding licensed intellectual property could harm our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Failure to attract, retain, develop, and motivate a highly skilled and diverse workforce, or failure to effectively manage changes in our workforce, could significantly impact our operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may not be able to renew collective bargaining agreements on satisfactory terms, or we could experience union activity, including new unionization, labor disputes, or work stoppages.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Increases in our cost of employee benefits in the future could reduce our profitability.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We negotiate with our suppliers to optimize our terms and conditions, including payment terms, and reductions in our payment terms with our suppliers could adversely affect our liquidity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• An impairment of the value of our goodwill and other indefinite lived intangible assets could have a material adverse effect on our financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We depend on third-party bottling and distribution companies for a significant portion of our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Changes in the retail landscape or in sales to any key customer can adversely affect our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Failure to maintain strategic relationships with brand owners and private label brands could adversely impact our future growth and business, potentially resulting in the termination of those agreements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Equity method investments are managed independently of us and may have different interests than we do. Their decisions could impact our financial performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The use of information technology by our third-party commercial partners and service providers exposes us to business disruptions or other negative impacts that could adversely affect us.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We rely on the performance of a limited number of suppliers and manufacturers for our brewers, and a limited number of order fulfillment companies for our brewers, beverage concentrates, and syrups.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our financial results may be negatively impacted by unfavorable economic and geopolitical conditions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• U.S. and international laws and regulations could adversely affect our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Litigation or legal proceedings could expose us to significant liabilities and damage our reputation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Increased concerns related to the use or disposal of plastics or other packaging materials can adversely affect our business and financial performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Significant additional labeling or warning requirements or limitations on the marketing or sale of our products may inhibit sales of affected products.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our use of information technology and third-party service providers exposes us to cybersecurity breaches and other business disruptions that could adversely affect us.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Failure to comply with personal data protection and privacy laws can adversely affect our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Climate change or related legislation could adversely affect our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Water scarcity and quality could adversely affect our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fluctuations in our effective tax rate may result in volatility in our financial results.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may not complete the proposed JDE Peet's Acquisition within the time frame we anticipate, or at all, which could adversely affect our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The market price of our common stock may decline as a result the JDE Peet's Acquisition.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We will incur significant direct and indirect costs as a result of the JDE Peet's Acquisition.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The JDE Peet's Acquisition will expose us to inherent risks in JDE Peet's' business and those geographies where JDE Peet's currently operates, which could adversely affect our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• If our due diligence investigation of JDE Peet's was inadequate or if unexpected risks related to JDE Peet's and its business materialize, it could have a material adverse effect on our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may not successfully integrate JDE Peet's into our business, or such integration may be more difficult, time-consuming, or costly than expected, which could adversely affect our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We will be subject to business uncertainties related to the JDE Peet's Acquisition.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We will incur and assume significant debt as a result of the JDE Peet's Acquisition, which could adversely affect our financial performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In connection with the JDE Peet's Acquisition, we expect to consummate the JV Investment, which could restrict our operational and corporate flexibility, impact our cash resources, and/or depress the market price of our common stock.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The issuance of Convertible Preferred Stock in connection with the JDE Peet's Acquisition may adversely affect the rights and market price of our common stock as well as our capital resources.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may issue additional equity securities in the future to raise proceeds to fund the JDE Peet's Acquisition, which may result in further dilution to our existing shareholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Separation may not be completed on the terms or timeline currently contemplated, if at all, and will involve significant time, expenses, and resources, which could adversely affect our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may be unable to achieve some or all of the anticipated strategic and financial benefits from the Separation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Following the Separation, we may not maintain a satisfactory credit rating, which could adversely affect the financial performance of our businesses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Following the Separation, the price of our common stock may decline and may experience greater volatility.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

**RISKS RELATED TO OUR OPERATIONS**

***Disruption of our manufacturing and distribution operations or supply chain, including increased input costs, may adversely affect our financial condition or results of operations.***

We have experienced, and could continue to experience, disruptions in our supply chain and our manufacturing and distribution operations, which could have a material adverse effect on our business. Some raw materials and supplies used in the production of our products, including packaging materials, are available from a limited number of suppliers or from a sole supplier, or are in short supply when seasonal demand is at its peak. Certain raw materials and supplies used in the production of our products are sourced from countries experiencing civil unrest, political instability, or unfavorable economic conditions. Adverse weather conditions may affect the supply of agricultural commodities from which key ingredients for our products are derived. We may not be able to maintain favorable arrangements and relationships with suppliers, and our contingency plans may not be effective to mitigate disruptions that may arise from shortages or discontinuation of any raw materials and other supplies that we use in the manufacture and distribution of our products. In order to ensure a continuous supply of high-quality raw materials, some of our inventory purchase obligations include long-term purchase commitments for certain strategic raw materials; the timing of these may not always coincide with the period in which we need the supplies to fulfill customer demand. Any sustained or significant disruption to the manufacturing or sourcing of raw materials could increase our costs and interrupt product supply, which could adversely impact our business. Additionally, if demand increases beyond our production capabilities, we may need to expand our capacity. Alternative facilities with sufficient capacity or capabilities may not be available, may cost substantially more than existing facilities, or may take a significant time to start production, each of which could negatively affect our business and financial performance.

The raw materials and other supplies, including agricultural commodities (such as coffee, apples, and corn), fuel and packaging materials, transportation, and other supply chain inputs that we use for the manufacturing, production, and distribution of our products are subject to price volatility and fluctuations in availability caused by many factors, including: changes in supply and demand; supplier capacity constraints; inflation; weather conditions (including the effects of climate change); natural disasters; disease or pests; agricultural uncertainty; cost increases in farm inputs; health epidemics, pandemics, or other contagious outbreaks; labor shortages, strikes, or work stoppages; changes in or the enactment of new laws and regulations; governmental actions or controls (including import/export restrictions, such as new, increased, or retaliatory tariffs, sanctions, quotas, or trade barriers); port congestion or delays; transport capacity constraints; cybersecurity incidents or other disruptions; political uncertainties; acts of terrorism; governmental instability; speculation in global trading of commodities, such as coffee; or fluctuations in foreign currency exchange rates. Many of these factors could also cause a significant disruption at our manufacturing and distribution facilities or the facilities of our bottlers, contract manufacturers, or distributors, which could have a material adverse effect on our business. We have been affected by a number of these factors, led by inflationary pressures on input and other costs, which may continue.

Many of our raw materials and supplies are purchased in the open market, and the prices we pay for such items are subject to fluctuation. Under many of our supply arrangements, the price we pay for raw materials fluctuates along with certain changes in underlying commodities costs. This could lead to higher and more variable inventory levels or higher raw material costs for us. In our coffee business, the quality of the coffee we seek tends to trade on a negotiated basis at a premium above the "C" price of coffee. This premium depends upon the supply and demand at the time of purchase and can vary significantly. Volatility in coffee prices can impact our ability to enter into fixed-price purchase commitments. We frequently enter into "price-to-be-fixed" supply contracts with defined quality, quantity, delivery, and other negotiated terms, but the date, and therefore price, at which the base coffee commodity price component will be fixed has not yet been established.

When input prices increase unexpectedly or significantly, we may be unwilling or unable to increase our product prices or unable to effectively hedge against price increases to offset these increased costs without suffering reduced volume, revenue, margins, and operating results. To the extent that price increases are not sufficient to offset higher costs adequately or in a timely manner, or if they result in significant decreases in sales volume, our financial condition or results of operations may be adversely affected. In addition, price decreases in commodities that we have effectively hedged could also increase our cost of goods sold for mark-to-market changes in the derivative instruments.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

***We operate in highly competitive categories, and any inability to compete effectively could adversely impact our business.***

The beverage industry is highly competitive and continues to evolve in response to changing consumer preferences. We compete with multinational corporations that can rapidly respond to competitive pressures and changes in consumer preferences by introducing new products, changing their route-to-market, reducing prices, or increasing promotional activities. We also compete with various smaller or regional companies and private label manufacturers, which may be more innovative, better able to bring new products to market, and better able to quickly serve niche markets. Additionally, we compete for contract manufacturing with other bottlers and manufacturers.

A significant portion of our business is attributable to sales of K-Cup pods for use with Keurig brewing systems. Continued acceptance of Keurig brewers to further increase household penetration is a significant factor in our growth plans. Any substantial or sustained decline in the sale of Keurig brewers could materially and adversely affect our business. Keurig brewers compete against all sellers and types of coffeemakers, as well as cafes and coffee shops. Our competitive position may be weakened if we do not succeed in differentiating Keurig brewers from our competitors' products.

Our sales of beverages, Keurig brewers, K-Cup pods, and other products may be negatively affected by numerous factors including our inability to maintain or increase prices, our inability to effectively promote our products, new entrants into the market, the decision of wholesalers, retailers, or consumers to purchase competitors' products instead of ours, increased marketing costs, and higher in-store placement and slotting fees driven by our competitors' willingness to spend aggressively. In addition, the continued growth of e-commerce may create additional consumer price deflation by, among other things, facilitating comparison shopping, and could potentially threaten the value of some of our legacy route-to-market strategies and thus negatively affect revenues. If we are unable to effectively compete, our business and our financial results would be negatively affected.

***We may not effectively respond to changing consumer preferences and shopping behavior, which could impact our financial results.***

Consumers' preferences continually evolve due to a variety of factors, including changing demographics of the population, social trends, changes in consumer lifestyles and consumption patterns, including from the use of weight loss drugs, concerns or perceptions regarding the health effects or environmental impact of our products or packaging, concerns regarding the location of origin or source of ingredients and products, changes in consumers' spending habits, negative publicity, economic downturn, or other factors. If we do not effectively anticipate and respond to changing trends and consumer beverage preferences, including through innovation and renovation, our sales and growth could suffer. Addressing changes in consumer preferences may require successful development, introduction, and marketing of new products and line extensions. There are inherent risks associated with new product or packaging innovation, including uncertainties about trade and consumer acceptance or potential impacts on our existing product offerings. Successful innovation may depend on our ability to obtain, protect, and maintain necessary intellectual property rights and to avoid infringing upon the intellectual property rights of others. Failure to innovate successfully could compromise our competitive position and impact our product sales, financial condition, and operating results.

Consumers are increasingly focused on sustainability, with particular attention to the recyclability or reuse of product packaging, reducing consumption of single-use plastics and non-recyclable materials, and the environmental impact of manufacturing operations. If we do not meet consumer demands by continuing to provide sustainable packaging options and focusing on sustainability throughout our manufacturing operations, our sales could suffer.

Consumer shopping behavior is also rapidly evolving. Changes in mobility, travel, and leisure activity patterns, the acceleration of e-commerce, inflation and economic uncertainty, and pandemics, epidemics, or other disease outbreaks, among others, have impacted and could continue to impact consumer shopping behavior and demand for our products. If we are unable to meet the consumer where and when they desire their products or if we are unable to respond to changes in distribution channels, our financial results could be adversely impacted.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

***Concerns about the safety, quality, or health effects of our products could negatively affect our business.***

The success of our business depends in part on our ability to maintain consumer confidence in the safety and quality of all of our products, including beverage products, their ingredients, their packaging, and our brewers. A failure or perceived failure to meet our quality, health, or safety standards, particularly as we expand our product offerings through innovation, partnerships, or acquisitions into new beverage categories, including product contamination or tampering, undeclared allergens, or allegations of mislabeling, whether actual or perceived, has occurred, and may in the future occur, in our operations or those of our bottlers, manufacturers, distributors, or suppliers. This could result in time-consuming and expensive production interruptions, recalls, market withdrawals, product liability claims, and negative publicity. It could also result in the destruction of product inventory, lost sales due to the unavailability of product for a period of time, fines from applicable regulatory agencies, and higher-than-anticipated rates of warranty returns and other returns of goods. Moreover, negative publicity may result from false, unfounded, or nominal liability claims or limited recalls.

In addition, adverse public opinion, third-party studies, or other allegations, whether or not valid, regarding the perceived or potential negative health effects of processing or ingredients in our beverage products, such as concerns about the caloric intake associated with soft drinks or the use of synthetic colors, nutritive and non-nutritive sweeteners or other additives in our beverages, or chemicals of concern or other substances in our ingredients or materials, may contribute to actual or threatened legal action against us, negative consumer perception of our products, new or increased taxes on our products, or additional government regulation, including new or increased restrictions on the inclusion of our products in benefit programs, such as the U.S. supplemental nutrition assistance program known as SNAP, any of which could result in decreased demand for our products or reformulations of existing products to remove such ingredients or substances, which may be costly and reduce their appeal. Such risks may be increased if government officials make public statements about alleged risks purportedly associated with processing, particular ingredients used in our products, or unintentional contaminants that may be present in the water supply.

Any or all of these events may lead to a loss of consumer confidence and trust, could damage the reputation of our brands, and may cause consumers to choose other products, which could negatively affect our business and financial performance.

***Damage to our reputation or brand image can adversely affect our business.***

Our ability to maintain our reputation and the brand image of our products is important to our success. Our corporate image and reputation has in the past been, and could in the future be, adversely impacted by a variety of factors, including: any failure by us or our business partners to achieve goals or maintain high standards relating to ethical and business practices, including with respect to human rights, child labor laws, workplace conditions, employee health and safety, the nutrition profile of our products, packaging, water use, and impact on the environment; any failure to address health or other concerns about our products, products we distribute, or particular ingredients in our products, including concerns regarding whether certain of our products contribute to obesity or an increase in public health costs; our research and development efforts; any product quality or safety issues, including the recall of any of our products; any failure to comply with laws and regulations; and consumer perception of our advertising campaigns, sponsorship arrangements, marketing programs, use of social media, and our response to political and social issues or catastrophic events or any failure to effectively respond to negative or inaccurate comments about us on social media or otherwise regarding any of the foregoing. Damage to our reputation or brand image could decrease demand for our products, thereby adversely affecting our business.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

***If we do not successfully manage our acquisitions of and investments in new businesses or brands, our operating results may adversely be affected.***

From time to time, we acquire or invest in businesses or brands, form joint ventures, and enter into licensing and distribution agreements. If we are unable to complete such transactions or successfully integrate and develop acquired businesses, we could fail to achieve the expected increases in revenues and operating results or the anticipated synergies and cost savings. Additional acquisition risks which could adversely affect our financial results include the diversion of management attention from our existing business, potential loss of key employees, suppliers, or customers from the acquired business, assumption of unforeseen risks and liabilities, and greater than anticipated operating costs of the acquired business, among others. Our quality management protocols, which are designed to ensure product quality and safety, may not be sufficiently robust to fully manage the expanded range of product offerings introduced through new investments or licensing or distribution agreements, which may increase our costs or subject us to negative publicity. In addition, we may also experience delays in extending our respective internal control over financial reporting to new acquisitions or investments, which may increase the risk of misstatements in our financial records and in our consolidated financial statements.

In the past we have been, and in the future we may be, unable to realize the expected benefits of acquisitions, investments, or licensing or distribution agreements; it may also take longer than expected to realize the expected benefits. Our ability to manage and improve the performance of acquired businesses or brands and our other investments and ventures will impact our financial performance. If we are unable to achieve the strategic and financial objectives for such transactions, our consolidated results could be negatively affected.

Refer to the *Risks Related to the JDE Peet's Acquisition* section for risks specific to the JDE Peet's Acquisition.

***Failure to realize benefits or successfully manage the potential negative consequences of our productivity initiatives can adversely affect our financial performance.***

We pursue strategic initiatives that are transformative in nature and are expected to generate significant cost savings or productivity over time. These strategic initiatives have included investments in new technologies and optimization of certain processes and of our manufacturing footprint. Some of our productivity initiatives may result in unintended consequences, such as business disruptions, distraction of management and employees, reduced morale and productivity, inability to obtain expected savings to reinvest into the business, inability to attract or retain employees, negative publicity, and disruption of the internal control structures of the affected business operations. If we are unable to successfully implement our productivity initiatives as planned, or do not achieve expected savings as a result of these initiatives, we may not realize all or any of the anticipated benefits, resulting in adverse effects on our financial performance.

***Our facilities and operations may require substantial investment and upgrading, and such investments may not achieve the intended financial benefits.***

We continue to incur significant costs to maintain or upgrade various technologies, facilities, and equipment or restructure our operations, including closing existing facilities or opening new ones. We invest in new and emerging technologies, including the use of automation, connected data, robotics, and artificial intelligence throughout our operations, including in our manufacturing and distribution facilities and our sales organization.

If the cost of our investments is higher than anticipated, the investments and upgrades are not sufficient to meet our near-term future business needs, our business does not develop as anticipated to appropriately utilize new or upgraded facilities, or third parties fail to complete the construction or renovation of facilities or production equipment in a timely manner or in accordance with our specifications, we may be delayed in realizing the intended benefits or our costs and financial performance could be negatively affected.

We have ongoing programs to invest and upgrade our manufacturing, distribution, and other facilities. These investments require us to rely on third parties for the construction and renovation of our facilities and manufacturing of our production equipment. We have experienced delays related to the production equipment contained within our manufacturing facilities, including delays in receiving the equipment or in operating the equipment according to specifications outlined by the manufacturer, which have led to increased costs, and we may continue to experience such delays and cost increases.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

***We depend on key information systems, and our use of information technology exposes us to business disruptions that could adversely affect us.***

Our information systems contain proprietary and other confidential information related to our business. These systems and services are vulnerable to interruptions or other failures resulting from, among other things, natural disasters, terrorist attacks, software, equipment, or telecommunications failures, processing errors, computer viruses, other security issues or supplier defaults. Security, backup, and disaster recovery measures may not be adequate or implemented properly to avoid such disruptions or failures. Any disruption or failure of these systems or services could cause substantial errors, processing inefficiencies, security breaches, inability to use the systems or process transactions, loss of customers, or other business disruptions, all of which could negatively affect our business and financial performance. Our users' data and customer information may be improperly accessed, used, or disclosed if we fail to adopt or adhere to adequate information security practices, or in the event of a breach of our networks, which could subject us to legal action, reputational harm, or otherwise negatively impact our business and financial performance.

***Our intellectual property rights could be infringed or we could infringe the intellectual property rights of others, and adverse events regarding licensed intellectual property could harm our business.***

We possess intellectual property that is important to our business. This intellectual property includes ingredient formulas, trademarks, copyrights, patents, business processes, and other trade secrets. We cannot be certain that the legal steps taken to protect our rights will be sufficient or that others will not infringe or misappropriate our rights. If we fail to adequately protect our intellectual property rights, or if changes in laws diminish or remove the current legal protections available to them, the competitiveness of our products may be eroded and our business could suffer. We and third parties, including competitors, could come into conflict over intellectual property rights, resulting in disruptive and expensive litigation. If we are unable to protect our intellectual property rights, our brands, products, and business could be harmed.

We also license various intellectual property rights from third parties and license certain intellectual property rights to third parties. In some countries, third parties own certain intellectual property that we own in other countries. For example, the Dr Pepper trademark and formula is owned by Coca-Cola in some countries outside North America. Adverse events affecting those third parties or their products could also negatively impact our brands.

***Failure to attract, retain, develop, and motivate a highly skilled and diverse workforce, or failure to effectively manage changes in our workforce, could significantly impact our operations.***

The labor market has experienced and may continue to experience labor shortages, inflation in labor costs, and increased employee turnover, which has impacted and may continue to impact our ability to attract and retain a highly skilled and diverse workforce. Competition in the labor market for qualified employees has increased alongside current and prospective employees' changing expectations for compensation, benefits, and flexible work models. Unplanned turnover or failure to develop and implement succession plans for senior management and other key personnel could deplete our institutional knowledge base and erode our competitiveness. Failure to attract, retain, develop, and motivate a highly skilled and diverse workforce, including employees with specialized capabilities, can damage our business results and our reputation.

***We may not be able to renew collective bargaining agreements on satisfactory terms, or we could experience union activity, including new unionization, labor disputes, or work stoppages.***

Many of our employees that are involved in the manufacturing or distribution of our products are covered by collective bargaining agreements. Additional employees have sought and may continue to seek to be covered by collective bargaining agreements, which may be facilitated by changing labor laws and regulations. These agreements typically expire every three to four years at various dates. We may not be able to renew our existing collective bargaining agreements on satisfactory terms or at all. This could result in labor disputes, strikes, or work stoppages, which could impair our ability to manufacture and distribute our products and result in a substantial loss of sales. The terms of existing, renewed, or expanded agreements could also significantly increase our costs or negatively affect our ability to increase operational efficiency.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

***Increases in our cost of employee benefits in the future could reduce our profitability.***

Our profitability is substantially affected by costs for employee health care, pension and other retirement programs, and other benefits. In recent years, these costs have increased significantly due to factors such as increases in health care costs, declines in investment returns on pension assets, and changes in discount rates used to calculate pension and related liabilities. These factors will continue to put pressure on our business and financial performance. There can be no assurance that we will succeed in limiting future cost increases, and continued upward cost pressure could have a material adverse effect on our business and financial performance.

**RISKS RELATED TO OUR FINANCIAL PERFORMANCE**

***We negotiate with our suppliers to optimize our terms and conditions, including payment terms, and reductions in our payment terms with our suppliers could adversely affect our liquidity.***

We negotiate with our suppliers to optimize our terms and conditions, which includes the consideration of payment terms. Excluding our suppliers who require cash at date of purchase or sale, our current payment terms with our suppliers generally range from 10 to 360 days. The length of our payment terms has been reduced in recent periods and may continue to be reduced, including as a result of a supplier being replaced, renegotiation of a supplier's contract during the procurement process, through efforts to increase the overall pool of potential suppliers for selection, or in order to receive favorable pricing or other terms during commercial negotiations. Reductions in our payment terms have negatively affected, and could continue to negatively affect, our liquidity and our ability to maximize our working capital. Reduced payment terms have contributed to, and could continue to contribute to, our need to utilize various financing arrangements for short-term liquidity.

***An impairment of the value of our goodwill and other indefinite lived intangible assets could have a material adverse effect on our financial statements.***

As of December 31, 2025, we had $55 billion of total assets, of which approximately $20 billion were goodwill and approximately $24 billion were intangible assets. Intangible assets include both definite and indefinite lived intangible assets in connection with brands, trade names, acquired technology, customer relationships, contractual arrangements, and distribution rights. We conduct impairment tests on goodwill and all indefinite lived intangible assets annually, as of October 1, or more frequently if circumstances indicate that all or a portion of the carrying amount of an asset may not be recoverable. In addition, definite lived intangible assets, property, plant, and equipment, and equity method investments are evaluated for impairment or accelerated depreciation as circumstances indicate.

The impairment tests require us to make an estimate of the fair value of our reporting units and other intangible assets. We have in the past recorded impairments, including during the year ended December 31, 2025, and could do so again as a result of changes in assumptions, estimates or circumstances, some of which are beyond our control. Factors which could result in an impairment include changes in our financial and operating outlook and changes in our discount rates, which could change due to factors such as movement in risk free interest rates, changes in general market interest rates and market beta volatility, and changes to management's view of forecasted risk, among others. Since a number of factors may influence determinations of fair value of intangible assets, we are unable to predict whether impairments of goodwill or other indefinite lived intangibles will occur in the future. Any such impairment would result in us recognizing a non-cash charge in our Consolidated Statements of Income, which could adversely affect our results of operations and our effective tax rate.

**RISKS RELATING TO OUR RELATIONSHIPS WITH THIRD PARTIES**

***We depend on third-party bottling and distribution companies for a significant portion of our business.***

We license rights to third parties to bottle and distribute our products. A portion of our income from operations is generated from sales of beverage concentrates to third-party bottling companies that we do not own. Some of these bottlers are also our direct competitors, or also bottle and distribute products for our competitors. In addition, some of the finished products we manufacture are distributed by third parties. As independent companies, these bottlers and distributors may have the right to determine whether, and to what extent, they produce and distribute our products, our competitors' products and their own products. They may devote more resources to other products, prioritize their own products, or take other actions detrimental to our brands.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

In most cases, they are able to terminate their bottling and distribution arrangements with us without cause. In some cases, the license agreements include buy-out rights that allow us to exit for a fee, and we may have additional limited termination rights. The termination of any material license arrangement could adversely affect our business and financial performance, and any disputes could be costly and divert management attention. We may need to increase support for our brands in certain territories to maintain our route-to-market and may not be able to pass price increases through to third-party bottlers and distributors. Deteriorating economic conditions could negatively impact the financial viability of third-party bottlers.

***Changes in the retail landscape or in sales to any key customer can adversely affect our business.***

The retail industry is experiencing continued consolidation of ownership and purchasing power, resulting in large retailers or buying groups with increased purchasing power, which impacts our ability to compete. Retailers may seek lower prices from us, may demand increased marketing or promotional expenditures in support of their businesses, and may be more likely to use their distribution networks to introduce and develop private-label brands, any of which could negatively affect our profitability. In addition, our industry is being affected by rapid growth in discount retailers and in e-commerce retailers, including traditional retailers who are expanding their e-commerce capabilities, and our business will be adversely affected if we are unable to maintain and develop successful relationships with such retailers. Further, we must maintain mutually beneficial relationships with our key customers to compete effectively. Any inability to resolve a significant dispute with any of our key customers, a change in the business condition (financial or otherwise) of any of our key customers, even if unrelated to us, a significant reduction in sales to any key customer, or the loss of any of our key customers may adversely affect our business.

***Failure to maintain strategic relationships with brand owners and private label brands could adversely impact our future growth and business, potentially resulting in the termination of those agreements.***

We regularly enter into strategic relationships for the manufacturing, distribution, and sale of K-Cup pods with partner customers, as well as with retailers for their private label brands. As independent companies, our strategic partners make their own business decisions which may not align with our interests. If we are unable to provide an appropriate mix of incentives to our strategic partners through a combination of premium performance and service, pricing, and marketing and advertising support, or if these strategic partners are not satisfied with our technological or other development efforts, they may take actions that adversely impact us, including entering into agreements with competing contract manufacturers or vertically integrating to manufacture their own Keurig-compatible pods. Increasing competition among Keurig-compatible pod manufacturers and moving to vertical integration may result in price compression, which could have an adverse effect on our gross margins. The loss of strategic partners could also adversely impact our future profitability and growth, awareness of Keurig brewers, our ability to attract additional brands or private label parties to do business with us or our ability to attract new consumers to buy Keurig brewers.

We also regularly enter into strategic relationships for the manufacturing and/or distribution of beverage products from partner brand owners, including in emerging or fast-growing segments in which we may not currently have a brand presence. If our partner brands terminate their agreements with us, it could negatively affect our revenues and results of operations.

***Equity method investments are managed independently of us and may have different interests than we do. Their decisions could impact our financial performance.***

We regularly review our product portfolio and evaluate strategic transactions, such as equity method investments, generally to gain entry into categories where we do not participate or to expand our presence in areas where our participation is currently limited. The success of these transactions is dependent upon, among other things, our ability to realize the full extent of the expected returns and benefits as a result of the transaction, within the anticipated time frame, or at all. As these equity method investments are managed independently, we may be impacted by their business decisions or other actions, as they may have different interests than we do. We recognize a portion of our investees' financial results within our net income based upon our ownership interest, unless the investment agreement indicates an alternative allocation of earnings or losses.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

We also assess our equity method investments as and when required by U.S. GAAP to determine whether they are impaired and, if they are, we record appropriate impairment charges. Our equity method investees also perform similar recoverability and impairment tests, and we record our share of impairment charges recorded by them, if any, adjusted, as appropriate, for the impact of items such as basis differences, deferred taxes, and deferred gains. It is possible that we may be required to record significant impairment charges or our proportionate share of significant impairment charges recorded by equity method investees in the future and, if we do so, our net income could be materially adversely affected.

***The use of information technology by our third-party commercial partners and service providers exposes us to business disruptions or other negative impacts that could adversely affect us.***

We rely on third-party service providers, including cloud data service and other information technology service providers, suppliers, distributors, contractors, and other business partners, for certain areas of our business, including certain finance, accounting, and IT functions, workforce management, and payroll processing. Some of our commercial partners may also receive or store information provided by us or our users through their websites, including information entrusted to them by customers. Our users' data and customer information may be improperly accessed, used, or disclosed if these third-party commercial partners fail to adopt or adhere to adequate information security practices or fail to comply with their respective online policies, or in the event of a breach of our or their networks. If any of these third-party service providers or vendors do not perform effectively, or if we fail to adequately monitor their performance (including compliance with service level agreements or regulatory or legal requirements), we may experience business disruption, systems performance degradation, processing inefficiencies or other systems disruptions, the loss of or damage to intellectual property or sensitive data through security breaches, or otherwise incorrect or adverse effects on financial reporting, litigation, claims, legal or regulatory proceedings, inquiries or investigations, fines or penalties, remediation costs, damage to our reputation, a negative impact on employee morale, or the loss of current or potential customers, all of which can adversely affect our business.

These third parties are subject to similar risks as we are relating to cybersecurity, privacy violations, business interruption, and systems and employee failures, and are subject to legal, regulatory, and market risks of their own. We do not have control over their business operations or governance and compliance systems, practices and procedures, which increases our financial, legal, reputational, and operational risk. We have in the past, and may in the future, experience indirect impacts of events that take place at our third-party service providers and other business partners. If we are unable to effectively manage our third-party relationships, or for any reason our third-party service providers or business partners fail to satisfactorily fulfill their commitments and responsibilities, our financial results could suffer.

***We rely on the performance of a limited number of suppliers and manufacturers for our brewers, and a limited number of order fulfillment companies for our brewers, beverage concentrates, and syrups.***

A small number of companies, located primarily in Asia, co-manufacture the vast majority of our brewers. Our manufacturers may not be able to scale their manufacturing operations to match increasing consumer demand for our brewers at competitive costs. If our manufacturers were to cease or interrupt production or otherwise fail to supply brewers to us as agreed, we would be unable to obtain brewers for an indeterminate period of time, which could adversely affect our product sales and operating results.

The majority of the distribution of our brewers, beverage concentrates, and syrups is handled by third-party order fulfillment companies in the U.S. Our third-party manufacturers and order fulfillment companies are subject to disruption, including as a result of health epidemics, natural disasters, information technology failures, commercial or international trade disputes, governmental regulatory and enforcement actions, labor stoppages or strikes, financial issues, or otherwise. These issues could delay importation and increase the cost of products, delay the fulfillment of the brewers, beverage concentrates, and syrups to our customers, or require us to locate alternative manufacturers or order fulfillment companies to avoid disruption, which could adversely affect our product sales and operating results.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

**GENERAL RISK FACTORS**

***Our financial results may be negatively impacted by unfavorable economic and geopolitical conditions.***

Changes in economic and financial conditions in the U.S., Canada, Mexico, or other geographies where we do business may negatively impact consumer confidence and consumer spending, which could result in a reduction in our sales volume and/or switching to lower price offerings. Similarly, disruptions in financial and credit markets worldwide may impact our ability to manage normal commercial relationships with customers, suppliers, and creditors. These disruptions could have a negative impact on the ability of our customers to pay their obligations on time, the ability of our vendors to supply materials in a timely manner, or the risk of counterparty default, each of which could reduce our cash flow.

We cannot predict how current or future economic conditions will affect our business partners, including financial institutions with whom we do business, and any negative impact on any of the foregoing may also have an adverse impact on our business. Disruptions in financial and credit markets could also have a negative effect on our ability to raise capital, including through the issuance of unsecured commercial paper or senior notes. In addition, declines in the securities and credit markets could affect our pension and PRMB assets and obligations, which in turn could increase our funding requirements.

Unstable geopolitical conditions or events in certain markets, including civil unrest, acts of war, terrorism, or governmental changes, or changes in international relations could undermine global consumer confidence and reduce consumers' purchasing power, thereby reducing demand for our products. Restrictions on business activities, which have been or may be imposed or expanded as a result of political and economic instability, deterioration of economic relations between countries, such as changes in or terminations of existing trade agreements, or the imposition of tariffs (including recent U.S. tariffs imposed or threatened to be imposed on Canada, Mexico, China, Brazil, and other countries, and any retaliatory actions taken by such countries), or otherwise, has and could continue to impact our profitability or otherwise have an adverse effect on our business.

We do not currently have operations in Russia, Ukraine, or the Middle East, but due to the impact of the ongoing conflicts in those regions on the global economy, we have experienced and may continue to experience supply chain constraints; inflation in input costs, logistics, manufacturing, and labor costs; volatility in fuel and commodity prices and fluctuations in foreign exchange rates and interest rates, any of which could adversely impact our results of operations.

***U.S. and international laws and regulations could adversely affect our business.***

We are subject to a variety of federal, state, and local laws and regulations in the U.S., Canada, Mexico, and other countries in which we conduct business. These laws and regulations apply to many aspects of our business, including the manufacture, safety, sourcing, labeling, storing, transportation, marketing, advertising, distribution, pricing, and sale of our products. Other laws and regulations that may impact our business relate to competition and antitrust, the environment, relations with distributors and retailers, employment, privacy, health, and trade practices. Our expanding international business will also expose us to economic factors, regulatory requirements, increasing competition, and other risks associated with doing business in foreign countries, including import or export restrictions and tariffs. Our international business is also subject to U.S. laws, regulations, and policies, including anti-corruption and export laws and regulations.

Any significant change in laws or regulations or their interpretation, in any of these jurisdictions, or the introduction of higher standards or more stringent laws or regulations, could result in increased compliance costs or capital expenditures or significant challenges to our ability to continue to produce and sell products that generate a significant portion of our sales and profits. Certain jurisdictions in which our products are sold have either imposed, or are considering imposing, new or increased taxes on the manufacture, distribution, or sale of certain of our products, particularly our beverages, as a result of ingredients (including sweeteners or alcohol) or packaging and packaging materials, which could increase the cost of certain of our products, reduce overall consumption of our products or lead to negative publicity, resulting in an adverse effect on our business and financial performance. Increasing governmental and societal attention to environmental, social, and governance matters has resulted and could continue to result in new laws or regulatory requirements, including new or expanded disclosure requirements that are expected to continue to expand the nature, scope, and complexity of matters on which we are required to report. In addition, the entry into new markets or categories has resulted in and could continue to result in our business being subject to additional regulations resulting in higher compliance costs. Violations of laws or regulations could damage our reputation and/or result in criminal, civil, or administrative actions with substantial financial penalties and operational limitations.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

***Litigation or legal proceedings could expose us to significant liabilities and damage our reputation.***

We have been, and in the future may be, a party to various litigation, claims, legal (including regulatory) proceedings, inquiries, and investigations that may include employment, tort, contract, real estate, antitrust, environmental, recycling/sustainability, intellectual property, commercial, securities, false advertising, packaging, product labeling, consumer protection, discriminatory pricing, privacy, tax, insurance, and other claims. We have been, and in the future may be, a defendant in class action litigation, including litigation regarding employment practices, product labeling, including under California's "Proposition 65," public statements and disclosures under securities laws, antitrust, advertising, consumer protection, and wage and hour laws. Plaintiffs in class action litigation may seek to recover amounts that are large and may be indeterminable for some period of time. We evaluate litigation claims and legal proceedings to assess the likelihood of unfavorable outcomes and estimate, if possible, the amount of potential losses, and we establish an accrual as appropriate based upon assessments and estimates in accordance with our accounting policies. We base our assessments, estimates and disclosures on the information available to us at the time and rely on legal and management judgment. Actual outcomes or losses may differ materially from assessments and estimates. Costs to defend litigation claims and legal proceedings and the cost and any required actions arising out of actual settlements, judgments or resolutions of these claims and legal proceedings may negatively affect our business and financial performance. Any adverse publicity resulting from allegations made in litigation claims or legal proceedings may also adversely affect our reputation, which in turn could adversely affect our results of operations.

***Increased concerns related to the use or disposal of plastics or other packaging materials can adversely affect our business and financial performance.***

We rely on diverse packaging solutions to safely deliver products to our customers and consumers. Concern has grown with respect to the use or disposal of plastics and their potential impact on health and the environment, which may contribute to actual or threatened legal action against us, negative consumer perception of our products, additional government regulation, or new or increased taxes on our products. Various jurisdictions in which our products are sold have imposed or are considering imposing laws, regulations, or policies intended to encourage the use of sustainable packaging, waste reduction, or increased recycling rates, or to restrict the sale of products utilizing certain packaging. These laws, regulations, and policies vary in form and scope between jurisdictions and include extended producer responsibility policies, plastic or packaging taxes, restrictions on certain products and materials, requirements for bottle caps to be tethered to bottles, restrictions or bans on the use of certain types of packaging, including single-use plastics and packaging containing PFAS, or other chemicals of concern, restrictions on labeling related to recyclability, and requirements to charge deposit fees. These laws and regulations have in the past and could continue to increase the cost of our products, impact demand for our products, result in negative publicity and require us and our business partners to increase capital expenditures to invest in reducing the amount of virgin plastic or other materials used in our packaging, to develop alternative packaging or product formats or to revise product labeling, all of which can adversely affect our business and financial performance. Changes in legislation could restrict the sale of our products that use such packaging materials, which could reduce our sales and profits.

***Significant additional labeling or warning requirements or limitations on the marketing or sale of our products may inhibit sales of affected products.***

Various jurisdictions have adopted and may seek to adopt bans or restrictions on the use of certain ingredients or substances in products, as well as significant additional product labeling or warning requirements or limitations on the marketing or sale of our products because of what they contain or allegations that they cause adverse health effects. For example, under one such law in California, known as Proposition 65, if the state has determined that a substance causes cancer or harms human reproduction or development, a warning must be provided for any product sold in the state that exposes consumers to that substance, unless the exposure falls under an established safe harbor level or another exemption is applicable. If we were required to add Proposition 65 warnings on the labels of one or more of our products produced for sale in California, the resulting consumer reaction to the warnings and potential adverse publicity could negatively affect our sales both in California and in other markets. Regulators have also expressed concerns about the processing and use of particular ingredients or additives in beverage products. The imposition or proposed imposition of bans or restrictions on the use of certain ingredients or substances in products, or of additional limitations on the marketing or sale of our products, has in the past and could continue to reduce overall consumption of our products, lead to negative publicity or leave consumers with the perception that our products do not meet their health and wellness needs, resulting in an adverse effect on our business and financial performance.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

***Our use of information technology and third-party service providers exposes us to cybersecurity breaches and other business disruptions that could adversely affect us.***

We, and our third-party service providers, use information technology to support our global business processes and activities, including supporting critical business operations; communicating with our suppliers, customers, and employees; maintaining financial information and effective accounting processes and financial and disclosure controls; engaging in mergers and acquisitions and other corporate transactions; conducting research and development activities; meeting regulatory, legal, and tax requirements; and executing various digital marketing and consumer promotion activities. Global shared service centers managed by third parties provide an increasing amount of services to conduct our business, including a number of accounting, internal control, information technology, human resources, and computing functions. Continuity of business applications and services has been, and may in the future be, disrupted by events such as infection by viruses or malware. In addition, our continuity of business applications and operations has been, and may in the future be, disrupted by other issues, including cybersecurity attacks (which may include social engineering, business email compromise, cyber extortion, denial of service, attempts to exploit vulnerabilities, hacking, website defacement, theft of passwords and other credentials, or unauthorized use of computing resources for digital currency mining); issues with or errors in systems' maintenance or security; migration of applications to the cloud; power outages; hardware or software failures; telecommunication failures; natural disasters; terrorist attacks; unintentional or malicious actions of employees or contractors; and fires and other catastrophic occurrences and other cyber incidents.

Like most major corporations, we are regularly subject to cyberattacks and other cyber incidents, including the types of attacks and incidents described above. If we do not allocate and effectively manage the resources necessary to continue building and maintaining our information technology infrastructure, or if we fail to identify in a timely manner or appropriately respond to cyberattacks or other cyber incidents, including with respect to third-party service providers, our business has been and can continue to be adversely affected, which has resulted in and can continue to result in some or all of the following: business disruption, systems performance degradation, processing inefficiencies or other systems disruptions, the loss of or damage to intellectual property or sensitive data (including confidential information that we process and maintain about our employees or consumers through our e-commerce platform) through security breaches or otherwise, incorrect or adverse effects on financial reporting, litigation, claims, legal or regulatory proceedings, inquiries or investigations, fines or penalties, remediation costs, damage to our reputation or a negative impact on employee morale or the loss of current or potential customers, all of which can adversely affect our business. In addition, these risks also exist in acquired businesses, joint ventures, or companies we invest in or partner with that use separate information systems or that have not yet been fully integrated into our information systems.

Similar risks exist with respect to our third-party service providers, including cloud data service and other information technology service providers, suppliers, distributors, contractors, and other business partners, that we rely upon for certain areas of our business, including payroll processing, health and benefit plan administration, and certain finance and accounting functions. When risks such as these materialize, the need for us to coordinate with various third-party service providers, including with respect to timely notification and access to personnel and information concerning an incident, and for third-party service providers to coordinate amongst themselves might make it more challenging to resolve the related issues. As a result, we are subject to the risk that the activities associated with our third-party service providers can adversely affect our business even if the attack or breach does not directly impact our systems or information.

Although the cybersecurity incidents that we have experienced to date, as well as those reported to us by our third-party service providers, have not had a material effect on our business, financial condition, or results of operations, such incidents could have a material adverse effect on us in the future. Security measures, including network security, backup and disaster recovery, upgrading systems and networks, enhanced training, and other security measures to protect our systems and data, cannot guarantee that we will be successful in preventing or responding to all cyber incidents, systems disruptions, system compromises, or misuses of data. In addition, due to the constantly evolving nature of security threats, we cannot predict the form and impact of any future incident, and the cost and operational expense of implementing, maintaining, and enhancing protective measures to guard against increasingly complex and sophisticated cyber threats could increase significantly. Although we maintain insurance coverage that may, subject to policy terms and conditions, cover certain aspects of a breach or disruption, such insurance coverage may be insufficient to cover all losses.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

***Failure to comply with personal data protection and privacy laws can adversely affect our business.***

We are subject to a variety of continuously evolving and developing laws and regulations in numerous jurisdictions regarding privacy, data protection, and data security, including those related to the collection, storage, handling, use, disclosure, transfer, and security of personal data. Privacy and data protection laws may be interpreted and applied differently from one jurisdiction to another and may create inconsistent or conflicting requirements. In addition, new legislation in this area may be enacted in other jurisdictions at any time. Our efforts to comply with privacy and data protection laws may impose significant costs and challenges that are likely to increase over time, and we could experience substantial penalties, litigation, claims, legal or regulatory proceedings, inquiries or investigations, damage to our reputation, and fines or penalties related to violation of existing or future data privacy laws and regulations.

Further, as a retailer accepting debit and credit cards for payment, as well as other digital payment tools, we are subject to industry data protection standards and protocols such as the Payment Card Industry Data Security Standard. In certain circumstances, our contracts with payment card processors and payment card networks (such as Visa, Mastercard, American Express, and Discover) generally require us to adhere to payment card network rules which could make us liable to payment card issuers and others if information in connection with payment cards and payment card transactions that we process is compromised, which liabilities could be substantial.

***Climate change or related legislation could adversely affect our business.***

Climate change may increase the frequency or severity of natural disasters and other extreme weather conditions, which could pose physical risks to our facilities, impair our production capabilities, disrupt our supply chain, or impact demand for our products. Climate change is already affecting the agricultural sector, and disruptions to crop growing conditions are expected to increase with extreme weather events, increasing temperatures, and changing water availability. Disruptions to crop growing conditions can cause changes in geographical ranges of crops, as well as weeds, diseases, and pests that affect those crops. These impacts have in the past and may in the future limit availability or increase the price volatility of key agricultural commodities, such as coffee, corn, citrus, cocoa, and apples, which are important sources of ingredients for our products.

Concern over climate change, including global warming, has led to legislative and regulatory initiatives limiting greenhouse gas emissions and increasing disclosure obligations. Increased compliance costs due to legal or regulatory requirements, along with initiatives to meet our sustainability goals, may cause higher costs associated with, or disruptions in, the manufacturing and distribution of our beverage products. As a result, the effects of climate change and legal or regulatory initiatives to address climate change could have an adverse impact on our business and results of operations. In addition, any failure to achieve or properly report on our goals with respect to reducing our impact on the environment or perception of a failure to act responsibly with respect to the environment or to effectively respond to regulatory requirements concerning climate change can lead to adverse publicity, which could result in reduced demand for our products, damage to our reputation or increase the risk of litigation. Any of the foregoing can adversely affect our business.

***Water scarcity and quality could adversely affect our business.***

Water is the primary ingredient in many of our products and is used across our operations. The competition for water among domestic, agricultural, and manufacturing users is increasing in the countries where we operate. Even where water is widely available, water purification and waste treatment infrastructure limitations and regulations could increase costs or constrain our operations. As water becomes scarcer, the quality of the water deteriorates, including due to the effects of climate change, or requirements on water purification or filtration increase, we may experience increased production costs; manufacturing constraints; supply chain disruption; higher compliance costs; increased capital expenditures; the interruption or cessation of operations at, or relocation of, our facilities or the facilities of our business partners; challenges to efficiency gains due to higher water usage in compliance with more stringent water quality standards; failure to achieve our water efficiency and conservation goals; perception of our failure to act responsibly with respect to water use or to effectively respond to legal or regulatory requirements concerning water scarcity and quality; or damage to our reputation, any of which can adversely affect our business.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

***Fluctuations in our effective tax rate may result in volatility in our financial results.***

We are subject to income taxes and non-income-based taxes in many U.S. and certain foreign jurisdictions. Tax legislation may be enacted, domestically or abroad, that impacts our effective tax rate. Changes in tax laws, regulations, related interpretations, and tax accounting standards in the U.S. and various foreign jurisdictions in which we operate may impact our effective tax rate and adversely affect our financial results. In addition, our effective tax rate in any given financial statement period may be significantly impacted by changes in the mix and level of earnings or by changes to existing accounting rules, tax regulations, or interpretations of existing law. Significant judgment is required in determining our annual income tax expense and in evaluating our tax positions. Although we believe our tax estimates, including intercompany transfer pricing policies, are reasonable, the final determination of tax audits and any related disputes could be materially different from our historical income tax provisions, estimates, and accruals. The results of audits or related disputes could have a material adverse effect on our financial statements for the period or periods for which the applicable final determinations are made and for periods for which the statute of limitations is open.

**RISKS RELATED TO THE JDE PEET'S ACQUISITION**

***We may not complete the proposed JDE Peet's Acquisition within the time frame we anticipate, or at all, which could adversely affect our business.***

On August 24, 2025, we entered into the JDE Peet's Acquisition Agreement, and on January 16, 2026, pursuant to the terms of the JDE Peet's Acquisition Agreement, we commenced a tender offer to acquire all of the issued ordinary shares of JDE Peet's. The JDE Peet's Acquisition is expected to close in the first half of 2026 and will depend on a number of conditions being satisfied, including receiving the minimum number of tenders and other closing conditions. Our ability to complete the proposed JDE Peet's Acquisition in the anticipated timeline, or at all, could be impacted by any or all of the following events, which may have an adverse impact on our business:

The requisite number of JDE Peet's shareholders may not tender their shares.

The JDE Peet's Acquisition Agreement provides that the completion of the proposed JDE Peet's Acquisition will be subject to the satisfaction or waiver of certain conditions, including the minimum tender of at least 95% of the shares of JDE Peet's, which will be reduced if the shareholders of JDE Peet's adopt resolutions for the implementation of certain post-closing measures and such resolutions are in full force and effect on the tender offer closing date. Pursuant to the JDE Peet's Acquisition Agreement, the board of directors of JDE Peet's has recommended our offer to purchase JDE Peet's for acceptance by shareholders. Concurrently with the entry into the JDE Peet's Acquisition Agreement, we obtained irrevocable undertakings from Acorn Holdings B.V. and certain directors of JDE Peet's, who collectively hold in the aggregate, as of the date of such undertakings, approximately 69% of the shares of JDE Peet's. Pursuant to the terms of the irrevocable undertakings, Acorn and JDE Peet's directors have committed to tender their shares of JDE Peet's in the offer and to vote in favor of the resolutions proposed at the JDE Peet's Extraordinary General Meeting. Accordingly, additional shareholders of JDE Peet's will need to tender their shares in the offer for the offer to reach the minimum acceptance threshold and we cannot guarantee we will be successful in obtaining 100% of shares of JDE Peet's. If we are unable to obtain the requisite acceptance threshold of shares of JDE Peet's, additional measures may be performed to enable us to acquire the remaining shares, which may delay or impact our ability to complete the JDE Peet's Acquisition.

There could be legal proceedings in connection with the JDE Peet's Acquisition, the outcomes of which are uncertain, could result in substantial costs, and which could delay or prevent the completion of the JDE Peet's Acquisition.

In connection with the JDE Peet's Acquisition, plaintiffs may file lawsuits against us, JDE Peet's, and/or the directors and officers of either company. Securities class action lawsuits and derivative lawsuits are often brought against public companies that have entered into merger agreements. Even if such a lawsuit is unsuccessful, defending against these claims can result in substantial costs. An adverse judgment could also result in monetary damages. Both defense costs and adverse judgments could have a negative impact on our liquidity and financial condition. Such legal proceedings could also prevent or delay the completion of the JDE Peet's Acquisition and result in additional costs to us.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

***The market price of our common stock may decline as a result the JDE Peet's Acquisition.***

The market price of our common stock may decline as a result of the JDE Peet's Acquisition if, among other things, we are unable to achieve the expected benefits and synergies of the JDE Peet's Acquisition, if the JDE Peet's Acquisition is not completed within the anticipated timeframe, or if the transaction costs related to the JDE Peet's Acquisition are greater than expected.

The market price of our common stock also may decline if we do not achieve the expected benefits and synergies of the JDE Peet's Acquisition as rapidly or to the extent anticipated by financial or industry analysts, or if the effect of the JDE Peet's Acquisition on our financial position, results of operations, or cash flows is not consistent with the expectations of financial or industry analysts. The market price declined following the announcement of the JDE Peet's Acquisition and the Separation.

***We will incur significant direct and indirect costs as a result of the JDE Peet's Acquisition.***

We have incurred and expect to incur a number of costs associated with the JDE Peet's Acquisition, including legal, accounting, consulting, and other advisory fees, financing costs, and other transaction-related costs. The JDE Peet's Acquisition will require significant management and employee resources, which could impact our ability to grow our business and pursue additional strategic opportunities. Certain costs related to the JDE Peet's Acquisition will be incurred regardless of whether the acquisition is completed, which may provide no benefit if such acquisition fails to be completed. While we have assumed that a certain level of transaction expenses will be incurred, factors beyond our control could affect the total amount or the timing of these expenses. Many of the expenses that will be incurred, by their nature, are difficult to estimate accurately. These costs could restrict our resources and adversely affect our financial condition and results of operations leading up to, and following, the JDE Peet's Acquisition.

***The JDE Peet's Acquisition will expose us to inherent risks in JDE Peet's' business and those geographies where JDE Peet's currently operates, which could adversely affect our business.***

If consummated successfully, the JDE Peet's Acquisition would represent a significant transformation of our coffee business and will expand our operations to those geographies where JDE Peet's currently operates, including Russia, which represented 6% of consolidated revenue and 1% of total assets for JDE Peet's in both 2024 and 2023, as reported in their 2024 annual report. Upon completion of the JDE Peet's Acquisition, we would be subject to a variety of risks associated with JDE Peet's' business, in addition to those we already face in our current business. These risks include changes in consumer preferences, volatility in the prices of raw materials, consumer perceptions of the brands, competition in the retail market place, additional legal and regulatory regimes, and other risks. In addition, we will be exposed to risks inherent in operating in a significant number of geographies in which we have not operated or have been less present in the past, including countries that are experiencing significant unstable geopolitical conditions. These risks include, among others:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the difficulty of managing and staffing foreign offices;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the increased travel, infrastructure, legal, and compliance costs associated with new international locations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• tariffs, sanctions, such as those imposed in response to the Russia and Ukraine conflict, trade barriers, trade disputes, and other regulatory or contractual limitations on our ability to operate in new foreign markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• exposure to foreign currency exchange risk;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• adaptation to different business cultures, languages, and market structures; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• military conflicts, such as the Russia and Ukraine conflict, and other geopolitical issues.

As we expand our business, our success will depend, in large part, on our ability to anticipate and effectively manage these risks and other risks associated with growing international operations. We cannot predict how such conditions may affect our business, or those with whom we do business, and any ongoing or new conflicts could adversely impact our business.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

***If our due diligence investigation of JDE Peet's was inadequate or if unexpected risks related to JDE Peet's and its business materialize, it could have a material adverse effect on our business.***

We conducted a due diligence review related to our planned acquisition of JDE Peet's. However, we cannot be sure that our diligence surfaced all material issues that may be present inside JDE Peet's or its business, or that it would be possible to uncover all material issues through a customary amount of due diligence, or that factors outside of JDE Peet's and its business and outside of its control will not arise later. If any such material issues arise, they may materially and adversely impact our ongoing business and our shareholders' investment.

***We may not successfully integrate JDE Peet's into our business, or such integration may be more difficult, time-consuming, or costly than expected, which could adversely affect our business.***

The combination of two businesses is a complex, costly, and time-consuming process. As a result, we will be required to devote significant management attention and resources to combining JDE Peet's' operations, processes, policies, and systems with our business. The failure to meet the challenges involved in combining the businesses and to realize the anticipated benefits of the JDE Peet's Acquisition could cause an interruption of, or a loss of momentum in, our activities and could adversely affect the results of our operations. The overall combination of JDE Peet's' and our businesses may also result in material unanticipated expenses, liabilities, competitive responses, losses of customer and other business relationships, and other unexpected issues. The difficulties of combining the operations of the businesses include, among others:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the diversion of management attention to integration matters;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• difficulties in integrating operations and systems;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• challenges in conforming standards, controls, procedures, accounting and other policies, business cultures, and compensation structures between the two companies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• difficulties in assimilating employees and in attracting and retaining key personnel;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• challenges in keeping existing customers and obtaining new customers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• difficulties in managing the expanded operations of a large company which operates in additional geographic markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• integrating the companies' financial reporting and internal control systems, including compliance by the combined company with Section 404 of the Sarbanes-Oxley Act of 2002, as amended, and the rules promulgated by the SEC; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• potential unknown liabilities, adverse consequences, and unforeseen increased expenses associated with the integration.

Many of these factors may be outside of the control of KDP and JDE Peet's, and any one of them could result in increased costs, decreased expected revenues, and diversion of management time and energy, which could materially impact our business, financial condition, and results of operations. In addition, even if JDE Peet's' business operations are successfully integrated with ours, the full benefits of the JDE Peet's Acquisition may not be realized, including expected cost synergies and sales or growth opportunities. Moreover, many of the integration expenses that we expect to incur are, by their nature, difficult to estimate accurately. These expenses could, particularly in the near term, exceed the savings that we expect to achieve. As a result, it cannot be assured that the integration of JDE Peet's will result in the realization of the full anticipated benefits anticipated from the JDE Peet's Acquisition within the anticipated time frames, or at all.

Further, the success of the JDE Peet's Acquisition will depend in part on the retention of key employees. We may not be able to retain senior executives or key personnel. Furthermore, uncertainty about the effect of the JDE Peet's Acquisition on JDE Peet's employees may impair its ability to retain and motivate key personnel until and after the completion of the JDE Peet's Acquisition. If such key employees are not retained, we may not realize the anticipated benefits of the JDE Peet's Acquisition.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

***We will be subject to business uncertainties related to the JDE Peet's Acquisition.***

Uncertainty about the effects of the JDE Peet's Acquisition may have an adverse effect on us, both prior and subsequent to completion of the acquisition. These uncertainties could disrupt our business or the business of JDE Peet's, and cause our collective customers, suppliers, vendors, partners, among others, to defer entering into contracts with the two companies, seek to change or cancel existing business relationships, or make other decisions concerning us and JDE Peet's that may be unfavorable to us. These uncertainties about the various effects of the JDE Peet's Acquisition on our business have caused, and may continue to cause, declines and greater volatility in the price of our common stock. We cannot guarantee that our stock price will fully recover from such declines after the JDE Peet's Acquisition is completed.

Retention and motivation of certain employees, both at KDP and JDE Peet's, may be challenging during the pendency of the JDE Peet's Acquisition due to uncertainty about their future roles and difficulty of integration. If key employees depart because of issues related to the uncertainty and difficulty of integration or a desire not to remain with us, our business following the JDE Peet's Acquisition could be negatively impacted.

Additionally, as discussed below, we expect to incur significant debt related to fund this transaction, and the resulting leverage level of our business may lead to a decline in our common stock price. We may also pursue other funding alternatives that may create dilution in our stock price, including the issuance of shares of our common stock, sale of certain assets, and reductions in the net income available to our shareholders, among others.

***We will incur and assume significant debt as a result of the JDE Peet's Acquisition, which could adversely affect our financial performance.***

We currently maintain investment grade credit ratings with Moody's and S&P for both our long-term debt and commercial paper. However, we will take on a significant amount of debt in order to complete the JDE Peet's Acquisition, as well as assume the existing debt of JDE Peet's, which could impact our credit ratings. We cannot provide assurances that our current credit ratings will remain in effect or that the ratings will not be lowered by Moody's and S&P. Increased indebtedness and any actual or anticipated downgrade of our credit ratings may have adverse effects on our borrowing costs, access to capital markets, liquidity, flexibility in responding to changing market conditions in the event of a general downturn in economic conditions or our business, and, as a result, our financial performance.

Additionally, the agreements that will govern any debt incurred or assumed in connection with the JDE Peet's Acquisition may contain various covenants that may, subject to certain significant exceptions, restrict our ability to, among other things, respond to market conditions, take advantage of business opportunities, incur debt, have liens on our property, and/or sell or convey certain of our assets. Our ability to comply with these provisions may be affected by events beyond our control. Failure to comply with these covenants could result in an event of default, which, if not cured or waived, could accelerate our repayment obligations and could result in a default and acceleration under other agreements containing cross-default provisions. Under these circumstances, we might not have sufficient funds or other resources to satisfy all of our obligations, which may adversely impact our business.

In an effort to limit our potential leverage in connection with the completion of the JDE Peet's Acquisition, we may elect to pursue alternative financing arrangements, which may include, but are not limited to, the issuance of junior hybrid securities, equity-linked securities, or other financing options. While these instruments may improve our leverage level and help preserve our credit ratings, each of these alternatives may involve other downsides. If these alternative financing strategies do not achieve their intended results, or if the market reacts negatively to their specific terms, this may have an adverse effect on our business or stock price.

***In connection with the JDE Peet's Acquisition, we expect to consummate the JV Investment, which could restrict our operational and corporate flexibility, impact our cash resources, and/or depress the market price of our common stock.***

In connection with the previously announced JV Commitment Letter, we entered into the JV Transaction Agreement, under which we will contribute the Coffee Production Assets, as well as certain of our related coffee assets (including sales and distribution) in Canada to the Pod Manufacturing JV, and the JV Investors will contribute, through the JV Investor Partner, $4 billion in cash in exchange for a 49% interest in the Pod Manufacturing JV. The remaining 51% ownership interest will remain under our ownership.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

The JV Transaction Agreement provides that, at the closing of the JV Investment, we and the JV Investor Partner will enter into the Pod Manufacturing JV Agreement, which sets forth each partner's rights and responsibilities with respect to the Pod Manufacturing JV. A portion of all distributions by the Pod Manufacturing JV will be paid to the JV Investors, thereby reducing distributions to us. The JV Investor Partner will also have certain governance and consent rights that will restrict our operational and corporate flexibility with respect to the Pod Manufacturing JV. In addition, we may be required to contribute additional resources, including cash, to the Pod Manufacturing JV, which would reduce our cash available for other purposes. In the event of a change of control, the Pod Manufacturing JV would be required to redeem the interests of the JV Investors, which would reduce the cash available for distributions to us. Under certain circumstances, the interests of the JV Investors may be converted into shares of our common stock (or following the Separation, the common stock of the separated global coffee business), which could have a dilutive impact on holders of our existing common stock. Any sales of such common stock, or the perception that such shares may be sold, could depress the market price of our common stock. Furthermore, if we materially breach our obligations to the Pod Manufacturing JV, we may be required to pay monetary damages, or the JV Investors may be entitled to replace us as the operator of the Pod Manufacturing JV.

***The issuance of Convertible Preferred Stock in connection with the JDE Peet's Acquisition may adversely affect the rights and market price of our common stock as well as our capital resources.***

Under the Preferred Investment Agreement, we agreed to issue and sell shares of Convertible Preferred Stock to the Preferred Investors, subject to customary closing conditions. When issued, the Convertible Preferred Stock will rank senior to our common stock, meaning that, in the event of our liquidation, dissolution, or winding up, holders of the Convertible Preferred Stock would be paid in full prior to any proceeds being paid to holders of our common stock.

Preferred Investors will be entitled to dividends at a rate of 4.75% per annum, subject to increase in certain cases. They will also be entitled to participate in dividends paid to holders of our common stock on an as-converted basis, provided that any such dividends received on an as-converted basis will reduce, on a dollar-for-dollar basis, the dividends holders are entitled to receive on the Convertible Preferred Stock. Such dividends will reduce our cash available for other purposes, including working capital, strategic activities, and returning cash to holders of our common stock.

Preferred Investors will be entitled to vote, on an as-converted basis, together with holders of our common stock on all matters submitted to a vote of the holders of our common stock, effectively reducing the relative voting power of the holders of our common stock.

In addition, the conversion of the Convertible Preferred Stock to common stock would dilute the ownership interest of existing holders of our common stock, and any sales in the public market of the common stock issuable upon conversion of the Convertible Preferred Stock could adversely affect prevailing market prices of our common stock. We will grant certain Preferred Investors customary registration rights in respect of their Convertible Preferred Stock, and any shares of common stock issued upon conversion of the Convertible Preferred Stock. These registration rights would facilitate the resale of such securities into the public market, and any such resale would increase the number of shares available for public trading. Sales by the Preferred Investors of a substantial number of shares of our common stock in the public market, or the perception that such sales might occur, could have a material adverse effect on the price of our common stock.

In the event of a fundamental change, as defined in the document governing the Convertible Preferred Stock, we will be required to offer to repurchase the Convertible Preferred Stock, which would reduce the amount of cash available to us for other purposes.

Certain Preferred Investors will also have certain preemptive rights, which may impact our ability to raise capital in the future.

Our obligations to the Preferred Investors could limit our ability to obtain additional financing or increase our borrowing costs, which could have an adverse effect on our financial condition. The rights of the Preferred Investors could also result in divergent interests between the Preferred Investors and holders of our common stock.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

The Preferred Investment Agreement provides that, prior to the closing of the JDE Peet's Acquisition, we (i) will use reasonable best efforts to operate our business in the ordinary course in all material respects (without restricting our activities with respect to the JDE Peet's Acquisition, the Preferred Investment, the JV Investment, the Separation, and the related transactions), and (ii) unless the KKR Investor and the Apollo Investor otherwise consent in writing (such consent not to be unreasonably withheld, conditioned, or delayed), not take any other action that, if taken following the issuance of the Preferred Investment, would require the prior written consent of the holders of the Convertible Preferred Stock or result in an adjustment to the conversion price unless such adjustment is effected in connection with the issuance of the Convertible Preferred Stock.

In addition, the Preferred Investment Agreement provides that, without the prior written consent of the KKR Investor or the Apollo Investor (so long as the KKR Investor or the Apollo Investor owns at least 50% of its initial Preferred Investment), we (i) will not amend the JDE Peet's Acquisition Agreement in a manner that would be materially adverse to the KKR Investor or the Apollo Investor, and (ii) will not permit the Separation to be consummated if (A) our pro forma total net leverage, as defined in the Preferred Investment Agreement, immediately following the Separation is greater than 4.00 to 1.00, if a Qualified IPO shall have been consummated on or prior to the Separation, or 4.25 to 1.00, if a Qualified IPO shall not have been consummated on or prior to the Separation, or (B) the corporate rating of either of the separated businesses, on a pro forma basis at the time of the Separation, would be less than investment grade from either Moody's or S&P. For so long as the Convertible Preferred Stock is outstanding, in the event of a ratings downgrade by either Moody's or S&P, we will be subject to additional negative covenants that would restrict our operational flexibility.

***We may issue additional equity securities in the future to raise proceeds to fund the JDE Peet's Acquisition, which may result in further dilution to our existing shareholders.***

If we raise additional capital in order to fund the JDE Peet's Acquisition, or to reduce our leverage after the JDE Peet's Acquisition, through the issuance of additional equity securities, our existing shareholders may experience further dilution. The terms of the securities we issue in the future may be more favorable to our new investors and introduce additional complexity to our capital structure.

**RISKS RELATED TO THE SEPARATION**

***The Separation may not be completed on the terms or timeline currently contemplated, if at all, and will involve significant time, expenses, and resources, which could adversely affect our business.***

On August 25, 2025, we announced our intention to separate our beverage and coffee portfolios into two independent, publicly traded companies via a tax-free spin-off of our coffee business. The anticipated Separation is expected to occur subsequent to the completion of the JDE Peet's Acquisition. We cannot assure that the Separation will be completed on the anticipated timeline, if at all, or that the terms of the Separation will not change. The transaction will follow the satisfaction of customary conditions, including reviews and final approval by our Board, relevant tax opinions with respect to the tax-free nature of the transaction, effectiveness of appropriate filings with the SEC, and acceptance of the spin-off company for listing by a national securities exchange approved by our Board, the completion of audited financials of the new independent company, among others. The failure to satisfy any of the required conditions could delay the completion of the Separation for a significant period of time or prevent it from occurring at all.

Unanticipated developments, including changes in the competitive conditions of our markets, possible delays in obtaining various tax opinions or rulings or failure of the spin-off transaction to qualify for non-recognition treatment for U.S. federal income tax purposes, the filing and effectiveness of appropriate filings with the SEC and the listing on a stock exchange, negotiating challenges, the uncertainty of the financial markets, changes in the law, and challenges in executing the Separation, could delay or prevent the completion of the Separation, or cause the Separation to occur on terms or conditions that are different or less favorable than initially expected. Any changes to the Separation or delay in completing the Separation could cause us not to realize some or all of the expected benefits, or realize them on a different timeline than initially expected. Further, our Board could decide, either because of a failure of conditions or because of market or other factors, to abandon the Separation. No assurance can be given as to whether and when the Separation will occur.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

Whether or not we complete the Separation, our ongoing business may be adversely affected, and we may be subject to certain risks and consequences as a result of pursuing the separation of our two businesses, including the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We anticipate that the process of completing the Separation will be time-consuming and involve significant additional costs and expenses, which may not yield a discernible benefit if the Separation is not completed. Additionally, if the Separation is not completed, we will still be required to pay certain costs and expenses incurred in connection therewith, such as professional fees.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Executing the Separation will require significant time and attention from our senior management and employees, which may impact management's attention to operating and growing our business and could adversely affect our business. Our employees may also be distracted due to uncertainty about their future roles with the separate companies pending completion of the Separation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may also experience increased difficulties in attracting, retaining, and motivating employees leading up to, and following, completion of the Separation, which could harm our businesses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Some of our customers or suppliers may delay or defer decisions or may end their relationships with us.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We may experience negative reactions from the financial markets if we fail to complete the Separation or fail to complete it on a timely basis.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We could incur substantial additional costs and experience temporary business interruptions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Transfer or assignment to us of some contracts and other assets will require the consent of a third party. If such consent is not given, we may not be entitled to the benefit of such contracts, investments, and other assets in the future.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The announcement and pendency of the Separation may cause some investors to sell shares of our common stock, which could create greater volatility or decline in the price of our shares.

Any of the above factors could cause the Separation, or the failure to execute the Separation, to have an adverse effect on our business and financial performance.

***We may be unable to achieve some or all of the anticipated strategic and financial benefits from the Separation.***

We may not realize the anticipated strategic, financial, operational, or other benefits from the Separation. We also cannot predict with certainty when the expected benefits will occur or the extent to which they will be achieved. If the Separation is completed, our operational and financial profile will change and we will face new risks. As two independent, publicly traded companies, our beverage and coffee businesses will each be smaller, less-diversified companies and may be more vulnerable to changing market conditions. There is no assurance that each separate company will be successful. The announcement and/or completion of the Separation may cause uncertainty for or disruptions with our customers, partners, suppliers, and employees, which may negatively impact these relationships or our operations. In addition, we will incur costs in connection with, or as a result of, the spin-offs, including costs of operating as independent, publicly-traded companies that the two businesses will no longer be able to share. Those costs may exceed our estimates or could negate some of the benefits we expect to realize. Significant unexpected costs or failure to realize the intended benefits of the Separation could result in a material adverse effect on the business, financial condition, results of operations, and trading price of us or the separated businesses.

***Following the Separation, we may not maintain a satisfactory credit rating, which could adversely affect the financial performance of our businesses.***

It is management's intent to structure each stand-alone business in a way to achieve investment grade credit ratings upon completion of the Separation. If we are not able to achieve or maintain satisfactory credit ratings post-separation, whether as a result of our actions or factors which are beyond our control, the independent businesses may face increased borrowing costs and limited access to raise funds in capital markets. A failure to achieve or maintain investment grade ratings could also impact business relationships with vendors, suppliers, regulators, and other business partners. There is no guarantee that we will be able to achieve or maintain our targeted credit ratings, and failure to do so may adversely affect the liquidity and financial performance of the businesses following the proposed Separation.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

***Following the Separation, the price of our common stock may decline and may experience greater volatility.***

Upon completion of the Separation, the price of our common stock may decline compared to its level immediately prior to, as it will no longer include the value of the separated business. In addition, the price of our common stock may experience greater volatility until the market has fully analyzed our value without the separated business. We can not guarantee that the combined value of the shares of the two resulting companies will be equal to or greater than what the value of our common stock would have been had the proposed Separation not occurred.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

**ITEM 1B. UNRESOLVED STAFF COMMENTS**

None.

**ITEM 1C. CYBERSECURITY**

We, and our third-party service providers, use information technology to support our global business processes and activities, which exposes us to cybersecurity risks. Our overall risk management system includes ongoing cybersecurity risk assessment and reporting, incident management, and a diligence and risk management process for third-party service providers. Employees with network access participate in ongoing phishing, social engineering, and cybersecurity awareness training efforts, and we also conduct periodic tabletop exercises led by external consultants.

Our cybersecurity risk assessment and reporting process leverages the National Institute of Standards and Technology's Cybersecurity Framework and is managed by our CISO, whose team comprises both internal personnel and third-party cybersecurity consultants. The CISO provides periodic reports to management, including our CEO, as well as other executive leadership members, and to the Audit and Finance Committee of our Board, which has oversight for cybersecurity risk management. These reports include updates on critical cybersecurity risks and the threat landscape; updates on the status of ongoing cybersecurity improvement initiatives, the internal control environment, and ongoing internal audit activities; and, if relevant, the status of actions taken with respect to certain cybersecurity incidents identified during the period.

We have an overall incident management plan, which is intended to provide guidance and protocols to facilitate timely notification and communication to key internal and external stakeholders, as appropriate, during an incident. A subset of this incident management plan is our Security Incident Response Plan, or SIRP, which is based on leading cybersecurity incident response practices. Incidents may be escalated to the CISO, our Chief Information Officer, our Chief Legal Officer, or other members of management or the Board, depending on the severity of the incident, and are handled according to the SIRP protocols, which includes incident detection and analysis; containment, eradication and recovery; and post-incident monitoring. We have developed a framework for assessing the materiality of any such incidents, including a committee responsible for determining whether the incident is material for disclosure. The committee includes our CISO, our Chief Information Officer, our Chief Legal Officer, our Senior Vice President and Controller (Principal Accounting Officer), our head of Internal Audit, and other members of management with relevant subject matter expertise. We also maintain cybersecurity insurance coverage that is intended to cover potential costs related to cybersecurity incidents and information systems failures, subject to customary limitations, exclusions, and deductibles.

Our CISO has more than 27 years of experience in cybersecurity and information technology, including, prior to joining KDP in 2019, more than 11 years as a principal in Ernst & Young's cybersecurity practice. Our CISO reports directly to our Chief Information Officer, who also has over 38 years of experience in information technology and cybersecurity.

To date, we have not identified any risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, which have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations, or financial condition. For additional description of cybersecurity risks and potential related impacts on us, refer to the risk factors captioned *"Our use of information technology and third-party service providers exposes us to cybersecurity breaches and other business disruptions that could adversely affect us"* and *"The use of information technology by our third-party commercial partners and service providers exposes us to business disruptions or other negative impacts that could adversely affect us"* in Item 1A, Risk Factors, in this Annual Report on Form 10-K.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u> 

**ITEM 2. PROPERTIES**

We have two global corporate headquarters, located in Frisco, Texas and Burlington, Massachusetts, both of which are leased.

The following table summarizes our principal manufacturing plants and principal warehouse and distribution facilities by geography and reportable segment as of December 31, 2025:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **U.S. Refreshment Beverages** | **U.S. Refreshment Beverages** | **U.S. Coffee** | **U.S. Coffee** | **International** | **International** | **Total** | **Total** |
| | Owned | Leased | Owned | Leased | Owned | Leased | Owned | Leased |
| **United States** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Production facilities | **7** | **12** | **—** | **5** | **—** | **—** | **7** | **17** |
| &nbsp;&nbsp;Warehouse and distribution facilities | **26** | **66** | **—** | **7** | **—** | **—** | **26** | **73** |
| **Foreign** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Production facilities | **1** | **—** | **—** | **—** | **3** | **1** | **4** | **1** |
| &nbsp;&nbsp;Warehouse and distribution facilities | **—** | **—** | **—** | **—** | **5** | **65** | **5** | **65** |
| Total | **34** | **78** | **—** | **12** | **8** | **66** | **42** | **156** |

---

We believe our facilities are well-maintained and adequate, that they are being appropriately utilized, and that they have sufficient capacity for their present intended purposes. The extent of utilization of such facilities varies based on seasonal demand for our products and the status of our investments to maintain or upgrade various technologies or equipment within such facilities. We ceased operations at our Windsor, Virginia manufacturing facility during the year ended December 31, 2025.

We periodically review our space requirements, and we look to consolidate and dispose or sublet facilities we no longer need as appropriate.

**ITEM 3. LEGAL PROCEEDINGS**

We are occasionally subject to litigation or other legal proceedings relating to our business. Refer to Note 18 of the Notes to our Consolidated Financial Statements related to commitments and contingencies, which is incorporated herein by reference.

**ITEM 4. MINE SAFETY DISCLOSURES**

Not applicable.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**PART II**

**ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES**

Our common stock is listed on Nasdaq's Global Select Market under the ticker symbol "KDP". As of December 31, 2025, there were 7,159 stockholders of record of our common stock. Our Board has declared a regular quarterly cash dividend and expects to continue to pay such dividends on a quarterly basis.

**COMPARISON OF TOTAL STOCKHOLDER RETURN**

The following performance graph compares the cumulative total returns of KDP for a five-year period with the cumulative total returns of the S&P 500 Index and the S&P Food and Beverage Select Industry Index. The graph assumes that $100 was invested on December 31, 2020, with dividends reinvested quarterly. Performance shown in the graph is not necessarily indicative of future performance.

![835](kdp-20251231_g2.jpg)

**ISSUER REPURCHASES OF EQUITY SECURITIES**

On October 1, 2021, our Board authorized a share repurchase program of up to $4 billion of our outstanding common stock, enabling us to return value to shareholders. The $4 billion authorization was effective for four years, from January 1, 2022 through December 31, 2025. We did not repurchase any shares during the fourth quarter of 2025.

**ITEM 6. [RESERVED]**

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS** 

This section of this Annual Report on Form 10-K generally discusses the years ended December 31, 2025 and 2024 and year-over-year comparisons between the years ended December 31, 2025 and 2024. Discussions of the periods prior to the year ended December 31, 2024 that are not included in this Annual Report on Form 10-K are found in "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2024 and the discussion therein for the year ended December 31, 2024 compared to the year ended December 31, 2023 is incorporated by reference into this Annual Report.

This Annual Report on Form 10-K contains the names of some of our owned or licensed trademarks, trade names and service marks, which we refer to as our brands. All of the product names included in this Annual Report on Form 10-K are either our registered trademarks or those of our licensors.

**OVERVIEW**

KDP is a leading beverage company in North America that manufactures, markets, distributes, and sells hot and cold beverages and single serve brewing systems. We have a broad portfolio of iconic beverage brands, including Dr Pepper, Canada Dry, Mott's, A&W, Peñafiel, GHOST, 7UP, Snapple, Green Mountain Coffee Roasters, Clamato, The Original Donut Shop, and Core Hydration, as well as the Keurig brewing system. Our beverage brands are some of the most recognized beverage brands in North America, with significant consumer awareness levels and long histories that evoke strong emotional connections with consumers. We offer more than 125 owned, licensed, and partner brands, supported by powerful distribution capabilities.

**SEGMENTS**

Our operating and reportable segments are as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The U.S. Refreshment Beverages segment reflects sales in the U.S. from the manufacture and distribution of branded concentrates, syrups, finished beverages, and other consumables, including the sales of our own brands and third-party brands, to third-party bottlers, distributors, and retailers.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The U.S. Coffee segment reflects sales in the U.S. from the manufacture and distribution of finished goods relating to our K-Cup pods, single serve brewers, and other coffee products to partners, retailers, and directly to consumers through our Keurig.com website.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The International segment reflects sales in international markets, including the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Sales in Canada, Mexico, the Caribbean, and other international markets from the manufacture and distribution of branded concentrates, syrup, and finished beverages, including sales of our own brands and third-party brands, to third-party bottlers, distributors, and retailers.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Sales in Canada from the manufacture and distribution of finished goods relating to our single serve brewers, K-Cup pods, and other coffee products.

**VOLUME**

In evaluating our performance, we use different volume measures for LRB and for K-Cup pods and appliances.

For LRB, we measure our sales volume in 288 fluid ounce equivalent cases.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• For beverage concentrates, we measure our sales volume as concentrate case sales for concentrates sold by us to our bottlers and distributors. A concentrate case is the amount of concentrate needed to make one case of 288 fluid ounces of finished beverage, the equivalent of 24 twelve-ounce servings. It does not include any other component of the finished beverage other than concentrate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• For packaged beverages, we measure volume as case sales to customers. A case sale represents a unit of measurement equal to 288 fluid ounces of packaged beverage sold by us. Case sales include both our owned brands and certain brands licensed to and/or distributed by us.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

For our K-Cup pods and appliances, we measure our sales volume as the number of appliances and the number of individual K-Cup pods sold to our customers.

**EXECUTIVE SUMMARY** 

***Financial Overview***

**As Reported, in millions (except Diluted EPS)**

![74](kdp-20251231_g3.jpg)![75](kdp-20251231_g4.jpg)

![77](kdp-20251231_g5.jpg)![78](kdp-20251231_g6.jpg)

***Uncertainties and Trends Affecting Our Business***

Refer to Item 1A, *Risk Factors*, as well as the *Uncertainties and Trends Affecting Liquidity and Capital Resources* section below, for more information about risks and uncertainties facing us.

Refer to Note 7 of the Notes to our Consolidated Financial Statements and Item 7A, *Quantitative and Qualitative Disclosures About Market Risk* for management's discussion of how we manage our exposure to foreign exchange risk, interest rate risk, and commodity risk.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**RESULTS OF OPERATIONS**

*References in the financial tables to percentage changes that are not meaningful are denoted by "NM".*

***For the Year Ended December 31, 2025 Compared to the Year Ended December 31, 2024:***

Consolidated Operations

The following table sets forth our consolidated results of operations for the years ended December 31, 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **Dollar** | **Percentage** |
| ***(in millions, except per share amounts)*** | **2025** | **2024** | **Change** | **Change** |
| **Net sales** | $**16603** | $15351 | $1252 | 8.2% |
| Cost of sales | **7604** | 6822 | 782 | 11.5% |
| &nbsp;&nbsp;**Gross profit** | **8999** | 8529 | 470 | 5.5% |
| Selling, general, and administrative expenses | **5351** | 5013 | 338 | 6.7% |
| Impairment of goodwill | **—** | 306 | (306) | NM |
| Impairment of intangible assets | **78** | 412 | (334) | NM |
| Other operating (income) expense, net | **(5)** | 207 | (212) | NM |
| &nbsp;&nbsp;**Income from operations** | **3575** | 2591 | 984 | 38.0% |
| Interest expense, net | **754** | 735 | 19 | 2.6% |
| Other expense (income), net | **134** | (58) | 192 | NM |
| &nbsp;&nbsp;&nbsp;**Income before provision for income taxes** | **2687** | 1914 | 773 | 40.4% |
| Provision for income taxes | **608** | 473 | 135 | 28.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net income** | $**2079** | $1441 | $638 | 44.3% |
| **Earnings per common share:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $**1.53** | $1.06 | $0.47 | 44.3% |
| &nbsp;&nbsp;&nbsp;Diluted | **1.53** | 1.05 | 0.48 | 45.7% |
| Gross margin | **54.2%** | 55.6% |  | (140) bps |
| Operating margin | **21.5%** | 16.9% |  | 460 bps |
| Effective tax rate | **22.6%** | 24.7% |  | (210) bps |

---

Sales Volumes

---

| | |
|:---|:---|
| | **Percentage Change** |
| LRB | **1.0%** |
| K-Cup pods | **(3.9)%** |
| Appliances | **(18.0)%** |

---

Net Sales Drivers

---

| | |
|:---|:---|
| | **Percentage Change** |
| Volume / mix<sup>(1)</sup> | **4.8%** |
| Net price realization | **3.8%** |
| FX | **(0.4)%** |
| Total | **8.2%** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The acquisition of GHOST contributed 3.8 percentage points to our consolidated volume / mix growth for the year ended December 31, 2025.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

Gross profit increased $470 million, or 5.5%, to $8,999 million for the year ended December 31, 2025 compared to $8,529 million in the prior year. This performance primarily reflected the gross profit impact of net sales growth (9 percentage points), partially offset by the net unfavorable impact from changes in ingredients, materials, and productivity, inclusive of tariffs (4 percentage points).

SG&A expenses increased $338 million, or 6.7%, to $5,351 million for the year ended December 31, 2025 compared to $5,013 million in the prior year, primarily driven by increased transportation and warehousing expenses (4 percentage points), costs associated with the JDE Peet's Acquisition and Separation (2 percentage points), and higher labor costs (2 percentage points).

Impairment of goodwill in the prior year reflected a non-cash impairment charge of $306 million within the U.S. Warehouse Direct reporting unit in the U.S. Refreshment Beverages segment. Refer to Note 6 of the Notes to our Consolidated Financial Statements for further information.

Impairment of intangible assets decreased $334 million to $78 million, driven by the favorable comparison of non-cash impairment charges for intangible brand assets compared to the prior year. Refer to Note 6 of the Notes to our Consolidated Financial Statements for further information.

Other operating (income) expense, net reflected a favorable change of $212 million for the year ended December 31, 2025, primarily driven by the favorable comparison of the $225 million termination fee associated with ABI incurred in the prior year. Refer to Note 4 of the Notes to our Consolidated Financial Statements for further information.

Income from operations increased $984 million, or 38.0%, to $3,575 million for the year ended December 31, 2025 compared to $2,591 million in the prior year, driven by the favorable comparison of our non-cash impairment charges for goodwill and intangible assets compared to the prior year, increased gross profit, and the favorable comparison to the termination fee associated with ABI incurred in the prior year. These benefits were partially offset by increased SG&A expenses.

Interest expense, net increased $19 million, or 2.6%, to $754 million for the year ended December 31, 2025 compared to $735 million for the prior year, primarily driven by increased debt and higher financing costs (12 percentage points), which were mostly offset by a favorable year-over-year change in unrealized mark-to-market activity (10 percentage points).

Other expense (income), net reflected an unfavorable change of $192 million for the year ended December 31, 2025, primarily driven by an increase of $214 million in our mandatory redemption liability for GHOST.

The effective tax rate decreased 210 bps to 22.6% for the year ended December 31, 2025, compared to 24.7% in the prior year, primarily driven by the favorable comparison of the tax impact of our non-cash goodwill impairment charge in the prior year (230 bps).

Net income increased $638 million, or 44.3%, to $2,079 million for the year ended December 31, 2025, primarily driven by increased income from operations, partially offset by the increase in our mandatory redemption liability for GHOST.

Diluted EPS increased 45.7% to $1.53 per diluted share as compared to $1.05 in the prior year.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

Results of Operations by Segment

The following tables provide certain results of operations for our reportable segments for the years ended December 31, 2025 and 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **Percentage Change** |
| ***(in millions)*** | **2025** | **2024** | **Percentage Change** |
| **Net sales** |  |  |  |
| &nbsp;&nbsp;&nbsp;U.S. Refreshment Beverages | $**10439** | $9331 | 11.9% |
| &nbsp;&nbsp;&nbsp;U.S. Coffee | **3990** | 3967 | 0.6% |
| &nbsp;&nbsp;&nbsp;International | **2174** | 2053 | 5.9% |
| **Total net sales** | $**16603** | $15351 | 8.2% |
| **Income from operations** |  |  |  |
| &nbsp;&nbsp;&nbsp;U.S. Refreshment Beverages | $**2939** | $1878 | 56.5% |
| &nbsp;&nbsp;&nbsp;U.S. Coffee | **962** | 1079 | (10.8)% |
| &nbsp;&nbsp;&nbsp;International | **546** | 545 | 0.2% |
| &nbsp;&nbsp;&nbsp;Unallocated corporate costs | **(872)** | (911) | (4.3)% |
| **Total income from operations** | $**3575** | $2591 | 38.0% |
| **Operating margin** |  |  |  |
| U.S. Refreshment Beverages | **28.2%** | 20.1% | 810 bps |
| U.S. Coffee | **24.1%** | 27.2% | (310) bps |
| International | **25.1%** | 26.5% | (140) bps |

---

Sales Volumes

---

| | | | |
|:---|:---|:---|:---|
| | **LRB** | **K-Cup Pods** | **Appliances** |
| U.S. Refreshment Beverages | **0.7%** | **— %** | **— %** |
| U.S. Coffee | **NM** | **(4.8)%** | **(19.9)%** |
| International | **2.3%** | **2.0%** | **(1.7)%** |

---

Net Sales Drivers

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Volume / Mix**<sup>(1)</sup> | **Net Price Realization** | **FX** | **Total** |
| U.S. Refreshment Beverages | **9.0%** | **2.9%** | **— %** | **11.9%** |
| U.S. Coffee | **(4.2)%** | **4.8%** | **— %** | **0.6%** |
| International | **3.1%** | **6.2%** | **(3.4)%** | **5.9%** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The acquisition of GHOST contributed 6.2 percentage points to our volume / mix growth in U.S. Refreshment Beverages for the year ended December 31, 2025.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

*U.S. Refreshment Beverages*

Sales volume increased 0.7% for the year ended December 31, 2025, led by growth in our energy portfolio, including the acquisition of GHOST, and in carbonated soft drinks. These benefits were partially offset by softness in our still beverages portfolio.

Net sales increased 11.9% to $10,439 million for the year ended December 31, 2025, led by volume / mix growth, including a benefit from the acquisition of GHOST, as well as higher net price realization.

Income from operations increased 56.5% to $2,939 million for the year ended December 31, 2025. This performance was led by the favorable comparison of our non-cash impairment charges for goodwill and intangible assets compared to the prior year (34 percentage points), the gross profit impact of net sales growth (32 percentage points), and the favorable comparison of the termination fee associated with ABI incurred in the prior year (12 percentage points). These benefits were partially offset by increased transportation and warehousing expenses (8 percentage points) and higher labor costs (5 percentage points).

*U.S. Coffee*

Appliance volume decreased 19.9%, reflecting price elasticity impacts, category softness, and continued retailer inventory management. K-Cup pod volume decreased 4.8%, reflecting price elasticity impacts.

Net sales increased 0.6% to $3,990 million for the year ended December 31, 2025, driven by higher net price realization, partially offset by unfavorable volume / mix.

Income from operations decreased 10.8% to $962 million for the year ended December 31, 2025, driven by a net unfavorable change in ingredients, materials, and productivity, inclusive of tariffs (22 percentage points), partially offset by the benefit of net sales growth (11 percentage points).

*International*

LRB sales volume increased 2.3%. Appliance volumes decreased 1.7%, and K-Cup pod volumes increased 2.0%.

Net sales increased 5.9% to $2,174 million in the year ended December 31, 2025, reflecting higher net price realization and volume / mix growth, partially offset by unfavorable FX translation.

Income from operations increased 0.2% to $546 million for the year ended December 31, 2025, reflecting the benefit from the gross profit impact of net sales growth (17 percentage points), which was mostly offset by a net unfavorable impact from changes in ingredients, materials, and productivity (10 percentage points) and increased transportation and warehousing expenses (7 percentage points).

**LIQUIDITY AND CAPITAL RESOURCES**

***Overview***

We believe our financial condition and liquidity remain strong. We manage all aspects of our business, including monitoring the financial health of our customers, suppliers, and other third-party relationships, implementing gross margin enhancement strategies through our productivity initiatives, and developing new opportunities for growth such as innovation and agreements with partners to distribute brands that are accretive to our portfolio.

Cash generated by our foreign operations is generally repatriated to the U.S. periodically. We do not expect restrictions or taxes on repatriation of cash held outside the U.S. to have a material effect on our overall business, liquidity, financial condition, or results of operations for the foreseeable future.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

The following summarizes our cash activity for the years ended December 31, 2025, 2024, and 2023:

![945](kdp-20251231_g7.jpg)

***Principal Sources of Capital Resources***

Our principal sources of liquidity are our cash and cash equivalents, cash generated from our operations, and borrowing capacity currently available under our 2025 Revolving Credit Agreement. Additionally, we have an uncommitted commercial paper program where we can issue unsecured commercial paper notes on a private placement basis. Based on our current and anticipated level of operations, we believe that our operating cash flows will be sufficient to meet our anticipated obligations related to our normal course of business (excluding the impacts of the JDE Peet's Acquisition described below) for the next twelve months and thereafter for the foreseeable future. To the extent that our operating cash flows are not sufficient to meet our liquidity needs, we may utilize cash on hand or amounts available under our financing arrangements. From time to time, we may seek additional deleveraging, refinancing, or liquidity enhancing transactions, including entering into transactions to repurchase or redeem outstanding indebtedness or otherwise seek transactions to reduce interest expense, extend debt maturities, and improve our capital and liquidity structure.

Sources of Liquidity - Operations

Net cash provided by operating activities decreased $228 million for the year ended December 31, 2025, as compared to the year ended December 31, 2024. The decrease was driven by the unfavorable comparison in working capital, partially offset by a higher net income adjusted for non-cash items in the current period.

Sources of Liquidity - Financing

![37](kdp-20251231_g8.jpg)

Refer to Note 5 of the Notes to our Consolidated Financial Statements for management's discussion of our financing arrangements.

As of December 31, 2025, we were in compliance with all debt covenants, and we have no reason to believe that we will be unable to satisfy these covenants.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

We also have an active shelf registration statement, filed with the SEC on August 15, 2025, which allows us to issue an indeterminate number or amount of common stock, preferred stock, debt securities, and warrants from time to time in one or more offerings at the direction of our Board.

Credit Ratings

Our credit ratings are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Rating Agency** | **Long-Term Debt Rating** | **Commercial Paper Rating** | **Outlook** | **Date of Last Change** |
| Moody's | Baa1 | P-2 | Ratings Under Review | August 25, 2025 |
| S&P | BBB | A-2 | Watch Negative | August 25, 2025 |

---

As a result of our announcement of the JDE Peet's Acquisition and the corresponding financing arrangements anticipated for the transaction, Moody's and S&P have revised their outlook on our credit ratings. On August 25, 2025, Moody's placed KDP ratings under review for downgrade, and S&P has placed KDP on CreditWatch Negative.

These debt and commercial paper ratings impact the interest we pay on our financing arrangements. A downgrade of one or both of our debt and commercial paper ratings could increase our interest expense and decrease the cash available to fund anticipated obligations.

***Principal Uses of Capital Resources***

Our capital allocation priorities are investing to grow our business both organically and inorganically, strengthening our balance sheet, and returning cash to shareholders through regular quarterly dividends. We dynamically adjust our cash deployment plans based on the specific opportunities available in a given period, but over time we allocate capital to balance each of these priorities.

Regular Quarterly Dividends

We have declared total dividends of $0.92 per share and $0.89 per share for the years ended December 31, 2025 and 2024, respectively.

Acquisitions of Businesses and Purchases of Intangible Assets

From time to time, we acquire brand ownership companies to expand our portfolio. We also invest in the expansion of our DSD network through transactions with strategic independent bottlers or third-party brand ownership companies to enhance competitive distribution scale. These transactions could be accounted for either as an acquisition of a business or, if the majority of the transaction price represents the acquisition of a single intangible asset, as an asset acquisition. In the second quarter of 2025, we completed the Dyla acquisition. Refer to Note 4 of the Notes to our Consolidated Financial Statements for additional information. Purchases of intangible assets were $17 million and $59 million for the years ended December 31, 2025 and 2024, respectively.

Capital Expenditures

Purchases of property, plant, and equipment were $486 million and $563 million for the years ended December 31, 2025 and 2024, respectively.

Capital expenditures, which includes both purchases of property, plant, and equipment and amounts included in accounts payable and accrued expenses, primarily related to investments in manufacturing capabilities, both in the U.S. and internationally, for the years ended December 31, 2025 and 2024. Capital expenditures included in accounts payable and accrued expenses were $204 million and $220 million for the years ended December 31, 2025 and 2024, respectively, which primarily related to these investments.

Repurchases of Common Stock

Our Board authorized a four-year share repurchase program of up to $4 billion of our outstanding common stock, which ended on December 31, 2025. Repurchases and retirements of common stock, including payments on our share excise tax obligation, were $9 million and $1,110 million during the years ended December 31, 2025 and 2024, respectively.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

Equity Method Investments

From time to time, we invest in beverage startup companies or in brand ownership companies to grow our presence in certain product categories, or enter into various licensing and distribution agreements to expand our product portfolio. Our investments generally involve acquiring a minority interest in equity securities of a company, in certain cases with a protected path to ownership at our future option.

***JDE Peet's Acquisition***

We entered into various transactions in order to finance the JDE Peet's Acquisition, including the Bridge Credit Agreement and Delayed Draw Term Loan Agreement. Refer to Note 5 of the Notes to our Consolidated Financial Statements for additional information on these borrowing arrangements. We additionally entered into the JV Transaction Agreement, under which the JV Investors will make a minority investment into the Pod Manufacturing JV for an aggregate purchase price of $4 billion. We also entered into the Preferred Investment Agreement, under which we will issue and sell 4.5 million shares of Convertible Preferred Stock for an aggregate purchase price of $4.5 billion. These transactions are expected to be completed substantially concurrently with the closing of the JDE Peet's Acquisition. Refer to Note 3 and Note 22 of the Notes to our Consolidated Financial Statements for additional information. We may issue additional debt securities and pursue other financing options, as warranted.

***Residual Value Guarantees***

We have a number of leasing arrangements and one licensing arrangement with VIEs for which we are not the primary beneficiary. Each one of these arrangements contain an RVG. As of December 31, 2025, we have not recorded any liabilities as it is not probable that we will have to make any payments required under the RVGs. Refer to Note 19 of the Notes to our Consolidated Financial Statements for further information.

***Uncertainties and Trends Affecting Liquidity and Capital Resources***

Disruptions in financial and credit markets, including those caused by inflation, global economic uncertainty or economic downturns, fluctuations in interest rates, or the imposition of new tariffs or changes to existing tariffs, trade wars, barriers or restrictions, or threats of such actions, and related uncertainty, may impact our ability to manage normal commercial relationships with our customers, suppliers, and creditors, and may also impact our ability to access liquidity through financial markets in a timely and cost-effective manner. These disruptions could have a negative impact on the ability of our customers to timely pay their obligations to us, thus reducing our cash flow, or the ability of our vendors to timely supply materials.

Customer and consumer demand for our products may also be impacted by the risk factors discussed under "Risk Factors" in Part 1, Item 1A in this Annual Report on Form 10-K, as well as subsequent filings with the SEC, that could have a material effect on production, delivery, and consumption of our products, which could result in a reduction in our sales volume.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

We believe that the following events, trends, and uncertainties may also impact liquidity:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to either repay existing debt maturities through cash flow from operations or refinance through future issuances of senior unsecured notes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to access and/or renew our committed financing arrangements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our ability to issue unsecured uncommitted commercial paper notes on a private placement basis;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Financing and other funding arrangements entered into in connection to the JDE Peet's Acquisition;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Future mergers, acquisitions, or debt or equity investments, which may include brand ownership companies, regional bottling companies, distributors, and/or distribution rights to further extend our geographic coverage;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Seasonality and other variability in our operating cash flows, which could impact short-term liquidity;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our continued payment of regular quarterly dividends;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Future repurchases of our common stock or special dividends to drive total shareholder return;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our continued capital expenditures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fluctuations in our tax obligations; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A potential significant downgrade in our credit ratings, which could limit i) our ability to issue debt at terms that are favorable to us, or ii) a financial institution's willingness to participate in our accounts payable program and reduce the attractiveness of the accounts payable program to participating suppliers who may sell payment obligations from us to financial institutions, which could impact our accounts payable program.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**CRITICAL ACCOUNTING ESTIMATES**

The process of preparing our consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and judgments that affect the reported amounts of assets, liabilities, revenue, and expenses. Critical accounting estimates are both fundamental to the portrayal of a company's financial condition and results and require difficult, subjective, or complex estimates and assessments. These estimates and judgments are based on historical experience, future expectations, and other factors and assumptions we believe to be reasonable under the circumstances. The most significant estimates and judgments are reviewed on an ongoing basis and revised when necessary. We have not made any material changes in the accounting methodology we use to assess or measure our critical accounting estimates. We have identified the items described below as our critical accounting estimates. We do not believe there is a reasonable likelihood that there will be a material change in the future estimates or assumptions we use in our critical accounting estimates. However, if actual results are not consistent with our estimates or assumptions, we may be exposed to gains or losses that could be material to our consolidated financial statements. See Note 2 of the Notes to our Consolidated Financial Statements for a discussion of these and other accounting policies.

***Impairment Assessment of Goodwill and Other Indefinite Lived Intangible Assets***

We conduct tests for impairment of our goodwill and our other indefinite lived intangible assets annually as of October 1, or more frequently if events or circumstances indicate the carrying amount may not be recoverable. We use present value and other valuation techniques to make this assessment. If the carrying amount of goodwill or an intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. For purposes of impairment testing, we assign goodwill to the reporting unit that benefits from the synergies arising from each business combination, and we also assign indefinite lived intangible assets to our reporting units.

Our reportable segments as of October 1, 2025 were:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***• U.S. Refreshment Beverages*** (reporting units: U.S. Beverage Concentrates, U.S. Warehouse Direct, Direct Store Delivery, and GHOST)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***• U.S. Coffee*** (reporting unit: U.S. Coffee)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***• International*** (reporting units: Canada Beverage Concentrates, Canada Warehouse Direct, Canada Coffee, and Latin America Beverages)

For both goodwill and other indefinite lived intangible assets, we have the option to first assess qualitative factors to determine whether the fair value of either the reporting unit or indefinite lived intangible asset is "more likely than not" less than its carrying value, also known as a Step 0 analysis.

If a quantitative analysis is required:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The impairment test for indefinite lived intangible assets encompasses calculating a fair value of an indefinite lived intangible asset and comparing the fair value to its carrying value. If the carrying value exceeds the estimated fair value, impairment is recorded.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The impairment tests for goodwill include comparing fair value of the respective reporting unit with its carrying value, including goodwill and considering any indefinite lived intangible asset impairment charges.

As of October 1, 2025, we performed a quantitative analysis for goodwill and certain of our indefinite lived brand assets, whereby we used an income approach, or in some cases a combination of income and market based approaches, to determine the fair value of our assets, as well as an overall consideration of market capitalization and enterprise value. These types of analyses contain uncertainties because they require management to make assumptions and to apply judgment to estimate industry and economic factors and the profitability of future business strategies. These assumptions could be negatively impacted by various risks discussed in Item 1A, *Risk Factors*, in this Annual Report on Form 10-K.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

Critical assumptions and estimates for quantitative analyses include revenue growth and profit performance over the next five year period, based on our strategic plan, as well as an appropriate discount rate and long-term growth rate, as applicable. Our strategic plan is updated as part of our annual planning process and is reviewed and approved by management, and includes assumptions related to macroeconomic conditions, competitive activities, productivity initiatives, and available market data. Discount rates are based on a weighted average cost of equity and cost of debt, adjusted with various risk premiums. Long-term growth rates are based on the long-term inflation forecast, industry and category growth trends, and the long-term economic growth potential.

The following table provides the range of rates used in the analysis as of October 1, 2025:

---

| | | |
|:---|:---|:---|
| **Rate** | **Minimum** | **Maximum** |
| Discount rates | **9.5%** | **12.0%** |
| Long-term growth rates | **0.0%** | **3.5%** |

---

The following table shows the non-cash impairment charges that were recorded for goodwill and for indefinite lived brand assets for the years presented:

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| ***(in millions)*** | **2025** | **2024** | **2023** |
| Goodwill<sup>(1)</sup> | $**—** | $306 | $— |
| Indefinite lived brand assets<sup>(2)</sup> | **78** | 412 |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Goodwill attributed to the U.S. WD reporting units was impaired during the year ended December 31, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Indefinite lived brand assets were impaired during the years ended December 31, 2025 and 2024 to bring the respective carrying values equal to their fair values.

Sensitivity Analysis - Discount Rate

For goodwill, holding all other assumptions in the analysis constant, including the revenue and profit performance assumption, the effect of a 0.50% increase in the discount rate used to determine the fair value of the reporting units as of October 1, 2025, would not result in any impairment charges on any of our reporting units.

For the indefinite lived priority brand assets quantitatively assessed, holding all other assumptions in the analysis constant, including the revenue and profit performance assumption, the effect of a 0.50% increase in the discount rate used to determine the fair value of those assets as of October 1, 2025, would impact the amount of headroom over the carrying value of those assets as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in millions)*** | **Selected Discount Rate** | **Selected Discount Rate** | **Discount Rate Increase of 0.50%** | **Discount Rate Increase of 0.50%** |
| **Headroom Percentage** | **Carrying Value** | **Fair Value** | **Carrying Value** | **Fair Value** |
| 0%<sup>(1)</sup> | $**1110** | $**1110** | $**2560** | $**2430** |
| Less than 25% | **2847** | **3110** | **1397** | **1540** |
| 25 - 50% | **314** | **440** | **3798** | **5360** |
| In excess of 50% | **15639** | **29280** | **12155** | **22570** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Carrying value at the selected discount rate reflects the results of the annual impairment analysis recognized during the year ended December 31, 2025.

Sensitivity Analysis - Long-Term Growth Rate

For goodwill, holding all other assumptions in the analysis constant, including the discrete period revenue and profit performance assumptions as well as the discount rates, the effect of a 0.50% decrease in the long-term growth rate used to determine the fair value of the reporting units as of October 1, 2025, would not result in any impairment charges on any of our reporting units.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

For the indefinite lived priority brand assets quantitatively assessed, holding all other assumptions in the analysis constant, including the discrete period revenue and profit performance assumptions as well as the discount rates, the effect of a 0.50% decrease in the long-term revenue growth rate used to determine the fair value of those assets as of October 1, 2025, would impact the amount of headroom over the carrying value of those assets as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in millions)*** | **Selected Long-Term Growth Rate** | **Selected Long-Term Growth Rate** | **Long-Term Growth Rate<br> Decrease of 0.50%** | **Long-Term Growth Rate<br> Decrease of 0.50%** |
| **Headroom Percentage** | **Carrying Value** | **Fair Value** | **Carrying Value** | **Fair Value** |
| 0%<sup>(1)</sup> | $**1110** | $**1110** | $**2560** | $**2480** |
| Less than 25% | **2847** | **3110** | **1397** | **1550** |
| 25 - 50% | **314** | **440** | **3798** | **5460** |
| In excess of 50% | **15639** | **29280** | **12155** | **22930** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Carrying value at the selected long-term growth rate reflects the results of the annual impairment analysis recognized during the year ended December 31, 2025.

Refer to Note 6 of the Notes to our Consolidated Financial Statements for additional information about our impairment assessments.

***Revenue Recognition***

We recognize revenue when performance obligations under the terms of a contract with the customer are satisfied. Accruals for customer incentives, sales returns, and marketing programs are established for the expected payout based on contractual terms, volume-based metrics, and/or historical trends.

Our customer incentives, sales returns, and marketing accrual methodology contains uncertainties because it requires management to make assumptions and to apply judgment regarding our contractual terms in order to estimate our customer participation and volume performance levels which impact the revenue recognition. Our estimates are based primarily on a combination of known or historical transaction experiences. Differences between estimated revenue and actual revenue are normally insignificant and are recognized into earnings in the period differences are determined.

Additionally, judgment is required to ensure the classification of the spend is correctly recorded as either a reduction from gross sales or advertising and marketing expense, which is a component of our SG&A expenses.

A 10% change in the accrual for our customer incentives, sales returns, and marketing programs would have affected our income from operations by $53 million for the year ended December 31, 2025.

***Income Taxes***

We establish income tax liabilities to remove some or all of the income tax benefit of any of our income tax positions based upon one of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the tax position is not "more likely than not" to be sustained,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the tax position is "more likely than not" to be sustained, but for a lesser amount, or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the tax position is "more likely than not" to be sustained, but not in the financial period in which the tax position was originally taken.

Our liability for uncertain tax positions contains uncertainties because management is required to make assumptions and to apply judgment to estimate the exposures associated with our various tax positions.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

Our income tax returns, like those of most companies, are periodically audited by domestic and foreign tax authorities. These audits include questions regarding our tax positions, including the timing and amount of deductions and the allocation of income among various tax jurisdictions. As these audits progress, events may occur that cause us to change our liability for uncertain tax positions. To the extent we prevail in matters for which a liability for uncertain tax positions has been established, or are required to pay amounts in excess of our established liability, our effective tax rate in a given financial statement period could be materially affected. An unfavorable tax settlement generally would require use of our cash and may result in an increase in our effective tax rate in the period of resolution. A favorable tax settlement may be recognized as a reduction in our effective tax rate in the period of resolution.

***Business Combinations***

We record acquisitions using the purchase method of accounting. All of the assets acquired and liabilities assumed are recorded at fair value as of the acquisition date. The excess of the purchase price over the estimated fair values of the net tangible and intangible assets acquired is recorded as goodwill.

The application of the purchase method of accounting for business combinations requires management to make significant estimates and assumptions in the determination of the fair value of assets acquired and liabilities assumed, in order to properly allocate purchase price consideration between assets that are depreciated and amortized from goodwill. The fair value assigned to tangible and intangible assets acquired and liabilities assumed are based on management's estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. Significant assumptions and estimates include the cash flows that an asset is expected to generate in the future, the appropriate weighted-average cost of capital, and the cost savings expected to be derived from acquiring an asset, if applicable.

Further, certain of our acquisitions may include other forms of consideration, including mandatorily redeemable liabilities and other earn-out arrangements. As of the acquisition date, we record such consideration, as applicable, at the estimated fair value of the expected future payments associated with the obligation. Any changes to the recorded fair value of the consideration are recognized in earnings in the period in which they occur.

If the actual results differ from the estimates and judgments used in these estimates, the amounts recorded in the financial statements may be exposed to potential impairment of the intangible assets and goodwill, as discussed in *Impairment Assessment of Goodwill and Other Indefinite Lived Intangible Assets* above.

***Impairment Assessment of Equity Method Investments Without Readily Determinable Fair Values***

Equity method investments are reviewed quarterly to determine whether a significant event or change in circumstances has occurred that may have an adverse effect on the fair value of each investment. When such events or changes occur, we evaluate the fair value compared to our carrying value of the investment. For investments in non-publicly traded companies, management's assessment of fair value is based on various valuation methodologies, including the option pricing model when the investment is in a preferred class of security, discounted cash flows, market multiples, and the impact of our contractual terms with the investee, as appropriate. We consider the assumptions that we believe a market participant would use in evaluating estimated future cash flows when employing the discounted cash flow methodologies. The ability to accurately predict future cash flows, especially in emerging and developing markets, may impact the determination of fair value. In the event the fair value of an investment declines below our carrying value, management is required to determine if the decline in fair value is other than temporary. If management determines the decline is other than temporary, an impairment charge is recorded.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

***Investments in Variable Interest Entities***

We hold equity investments in entities that are considered VIEs, including Nutrabolt and Chobani. We would be required to consolidate a VIE for which we are determined to be the primary beneficiary. To determine if we are the primary beneficiary of a VIE, we assess specific criteria and use judgment when determining if we have the power to direct the significant activities of the VIE and the obligation to absorb losses or receive benefits from the VIE that may be significant to the VIE. Factors considered include risk and reward sharing, voting rights, involvement in day-to-day capital and operating decisions, representation on a VIE's governance structure, existence of unilateral kick-out rights exclusive of protective rights or voting rights, and level of economic disproportionality between us and the VIE's other partner(s).

We have determined that we are not the primary beneficiary of any VIEs. Refer to Note 19 of the Notes to our Consolidated Financial Statements for additional information on our investments in VIEs.

**EFFECT OF RECENT ACCOUNTING PRONOUNCEMENTS**

Refer to Note 2 of the Notes to our Consolidated Financial Statements for a discussion of recently issued accounting standards and recently adopted provisions of U.S. GAAP.

**SUPPLEMENTAL GUARANTOR FINANCIAL INFORMATION**

The Notes are fully and unconditionally guaranteed by certain of our direct and indirect subsidiaries (the "Guarantors"), as defined in the indentures governing the Notes. The Guarantors are 100% owned either directly or indirectly by us and jointly and severally guarantee, subject to the release provisions described below, our obligations under the Notes. None of our subsidiaries organized outside of the U.S., any of the subsidiaries held by Maple Parent Holdings Corp. prior to the DPS Merger, or any of the subsidiaries acquired after the DPS Merger (collectively, the "Non-Guarantors") guarantee the Notes. The subsidiary guarantees with respect to the Notes are subject to release upon the occurrence of certain events, including the sale of all or substantially all of a subsidiary's assets, the release of the subsidiary's guarantee of our other indebtedness, our exercise of the legal defeasance option with respect to the Notes, and the discharge of our obligations under the applicable indenture.

The following schedules present the summarized financial information for Keurig Dr Pepper Inc. (the "Parent") and the Guarantors on a combined basis after intercompany eliminations; the Parent and the Guarantors' amounts due from and amounts due to Non-Guarantors are disclosed separately. The consolidating schedules are provided in accordance with the reporting requirements of Rule 13-01 under SEC Regulation S-X for the issuer and guarantor subsidiaries.

The summarized financial information for the Parent and Guarantors were as follows:

---

| | |
|:---|:---|
| ***(in millions)*** | **For the Year Ended December 31, 2025** |
| Net sales | $**10515** |
| Gross profit | **5339** |
| Income from operations | **1523** |
| Net income | **2094** |

---

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| ***(in millions)*** | **2025** | **2024** |
| Current assets | $**2964** | $2373 |
| Non-current assets | **51756** | 49827 |
| Total assets<sup>(1)</sup> | $**54720** | $52200 |
| Current liabilities | $**6926** | $6101 |
| Non-current liabilities | **21390** | 20984 |
| Total liabilities<sup>(2)</sup> | $**28316** | $27085 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Includes $8 million and $115 million of intercompany receivables due to the Parent and Guarantors from the Non-Guarantors as of December 31, 2025 and December 31, 2024, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Includes $2,610 million and $1,997 million of intercompany payables due to the Non-Guarantors from the Parent and Guarantors as of December 31, 2025 and December 31, 2024, respectively.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

We are exposed to market risks arising from changes in market rates and prices, including movements in foreign currency exchange rates, interest rates, and commodity prices. We regularly enter into derivatives or other financial instruments to hedge or mitigate commercial risks. We do not enter into derivative instruments for speculative purposes. Refer to Note 7 of the Notes to our Consolidated Financial Statements for further information about our derivative instruments.

**FOREIGN EXCHANGE RISK**

The majority of our net sales, expenses, and capital purchases are transacted in U.S. dollars. However, we have exposure with respect to foreign exchange rate fluctuations. Our primary exposure to foreign exchange rates is the Canadian dollar, the Mexican peso, and the Euro against the U.S. dollar, including significant anticipated Euro-denominated cash outflows resulting from the intended JDE Peet's Acquisition. Exchange rate gains or losses related to foreign currency transactions are recognized as transaction gains or losses in earnings as incurred.

We use derivative instruments such as foreign exchange forward contracts to manage a portion of our exposure to changes in foreign exchange rates. As of December 31, 2025, we had derivative contracts outstanding with notional values of $13,033 million, including approximately $11,810 million of forward contracts associated with the planned JDE Peet's Acquisition. These contracts mature at various dates through June 2027. The fair value of foreign currency derivatives that qualify for hedge accounting resulted in a net unrealized loss of $13 million as of December 31, 2025, and the impact of a 10% weakening in the U.S. dollar is estimated to decrease the fair value by approximately $68 million. The fair value of foreign currency derivatives that do not qualify for hedge accounting resulted in a net unrealized loss of $40 million as of December 31, 2025, and the impact of a 10% weakening in the U.S. dollar is estimated to increase the fair value by approximately $1,248 million. Any increase or decrease in the value of the foreign currency derivatives would have an approximately offsetting change in the underlying hedged risk.

**INTEREST RATE RISK**

We centrally manage our debt portfolio through the use of interest rate contracts and monitor our mix of fixed-rate and variable-rate debt. As of December 31, 2025, the face value of our fixed-rate debt, excluding lease obligations, was $13,214 million, and our variable-rate debt was $3,060 million, inclusive of commercial paper. From time to time, we also enter into interest rate contracts that effectively result in variable-rate interest payments or receipts. These derivative instruments are generally based on SOFR and a credit spread. As of December 31, 2025, we had derivative contracts outstanding with aggregate notional value of $3.8 billion, $1.5 billion of which relate to planned future issuances of long-term debt, and maturing at various dates through November 2046.

We estimate that the potential impact to our interest rate expense associated with variable rate interest payments resulting from a hypothetical interest rate change of 1%, based on amounts outstanding as of December 31, 2025, would be an increase or decrease of approximately $69 million.

**COMMODITY RISK**

We are subject to market risks with respect to commodities because our ability to recover increased costs through higher pricing may be limited by the competitive environment in which we operate. Our principal commodities risks relate to our purchases of coffee beans, PET, Polypropylene, aluminum, diesel fuel, corn (for high fructose corn syrup), apple juice concentrate, sucrose, and natural gas (for use in processing and packaging).

We utilize commodities derivative instruments and supplier pricing agreements to hedge the risk of movements in commodity prices for limited time periods for certain commodities. As of December 31, 2025, we had derivative contracts outstanding with a notional value of $595 million maturing at various dates through January 2028. The fair market value of these contracts as of December 31, 2025 was a net asset of $18 million. As of December 31, 2025, a 10% change (up or down) in commodity prices is estimated to increase or decrease the fair value of these derivative instruments by approximately $60 million. Any change in the value of the commodities derivatives instruments would have an approximately offsetting change in the underlying hedged risk.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA**

---

| | |
|:---|:---|
| | **<u>Page Number</u>** |
| <u>[Consolidated Statements of Income](#ic5c36f045fc7456185fd61e2116f03f7_172)</u> | <u>[51](#ic5c36f045fc7456185fd61e2116f03f7_172)</u> |
| <u>[Consolidated Statements of Comprehensive Income](#ic5c36f045fc7456185fd61e2116f03f7_175)</u> | <u>[52](#ic5c36f045fc7456185fd61e2116f03f7_175)</u> |
| <u>[Consolidated Balance Sheets](#ic5c36f045fc7456185fd61e2116f03f7_178)</u> | <u>[53](#ic5c36f045fc7456185fd61e2116f03f7_178)</u> |
| <u>[Consolidated Statements of Cash Flows](#ic5c36f045fc7456185fd61e2116f03f7_181)</u> | <u>[54](#ic5c36f045fc7456185fd61e2116f03f7_181)</u> |
| <u>[Consolidated Statements of Changes in Stockholders' Equity](#ic5c36f045fc7456185fd61e2116f03f7_184)</u> | <u>[56](#ic5c36f045fc7456185fd61e2116f03f7_184)</u> |
| <u>[Notes to Consolidated Financial Statements](#ic5c36f045fc7456185fd61e2116f03f7_187)</u> | <u>[57](#ic5c36f045fc7456185fd61e2116f03f7_187)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[1. Business and Basis of Presentation](#ic5c36f045fc7456185fd61e2116f03f7_190)</u> | <u>[57](#ic5c36f045fc7456185fd61e2116f03f7_190)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[2. Significant Accounting Policies](#ic5c36f045fc7456185fd61e2116f03f7_196)</u> | <u>[58](#ic5c36f045fc7456185fd61e2116f03f7_196)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[3. JDE Peet's Acquisition and Related Transactions](#ic5c36f045fc7456185fd61e2116f03f7_2453)</u> | <u>[70](#ic5c36f045fc7456185fd61e2116f03f7_2453)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[4. Other Acquisitions](#ic5c36f045fc7456185fd61e2116f03f7_202)</u> | <u>[71](#ic5c36f045fc7456185fd61e2116f03f7_202)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[5. Long-Term Obligations and Borrowing Arrangements](#ic5c36f045fc7456185fd61e2116f03f7_199)</u> | <u>[73](#ic5c36f045fc7456185fd61e2116f03f7_199)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[6. Goodwill and Intangible Assets](#ic5c36f045fc7456185fd61e2116f03f7_217)</u> | <u>[77](#ic5c36f045fc7456185fd61e2116f03f7_217)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[7. Derivatives](#ic5c36f045fc7456185fd61e2116f03f7_223)</u> | <u>[80](#ic5c36f045fc7456185fd61e2116f03f7_223)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[8. Leases](#ic5c36f045fc7456185fd61e2116f03f7_226)</u> | <u>[83](#ic5c36f045fc7456185fd61e2116f03f7_226)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[9. Segments](#ic5c36f045fc7456185fd61e2116f03f7_229)</u> | <u>[85](#ic5c36f045fc7456185fd61e2116f03f7_229)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[10. Net Sales](#ic5c36f045fc7456185fd61e2116f03f7_232)</u> | <u>[88](#ic5c36f045fc7456185fd61e2116f03f7_232)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[11. Earnings per Share](#ic5c36f045fc7456185fd61e2116f03f7_235)</u> | <u>[88](#ic5c36f045fc7456185fd61e2116f03f7_235)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[1](#ic5c36f045fc7456185fd61e2116f03f7_238)[2](#ic5c36f045fc7456185fd61e2116f03f7_238)[. Employee Benefit Plans](#ic5c36f045fc7456185fd61e2116f03f7_238)</u> | <u>[89](#ic5c36f045fc7456185fd61e2116f03f7_238)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[1](#ic5c36f045fc7456185fd61e2116f03f7_241)[3](#ic5c36f045fc7456185fd61e2116f03f7_241)[. Stock-Based Compensation](#ic5c36f045fc7456185fd61e2116f03f7_241)</u> | <u>[93](#ic5c36f045fc7456185fd61e2116f03f7_241)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[1](#ic5c36f045fc7456185fd61e2116f03f7_244)[4](#ic5c36f045fc7456185fd61e2116f03f7_244)[.](#ic5c36f045fc7456185fd61e2116f03f7_244)[Equity Method](#ic5c36f045fc7456185fd61e2116f03f7_244)[Investments](#ic5c36f045fc7456185fd61e2116f03f7_244)</u> | <u>[95](#ic5c36f045fc7456185fd61e2116f03f7_244)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[1](#ic5c36f045fc7456185fd61e2116f03f7_247)[5](#ic5c36f045fc7456185fd61e2116f03f7_247)[. Income Taxes](#ic5c36f045fc7456185fd61e2116f03f7_247)</u> | <u>[95](#ic5c36f045fc7456185fd61e2116f03f7_247)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[16. Accumulated Other Comprehensive Income (Loss)](#ic5c36f045fc7456185fd61e2116f03f7_250)</u> | <u>[99](#ic5c36f045fc7456185fd61e2116f03f7_250)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[1](#ic5c36f045fc7456185fd61e2116f03f7_253)[7](#ic5c36f045fc7456185fd61e2116f03f7_253)[. Property, Plant, and Equipment](#ic5c36f045fc7456185fd61e2116f03f7_253)</u> | <u>[100](#ic5c36f045fc7456185fd61e2116f03f7_253)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[1](#ic5c36f045fc7456185fd61e2116f03f7_259)[8](#ic5c36f045fc7456185fd61e2116f03f7_259)[. Commitments and Contingencies](#ic5c36f045fc7456185fd61e2116f03f7_259)</u> | <u>[101](#ic5c36f045fc7456185fd61e2116f03f7_259)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[19.](#ic5c36f045fc7456185fd61e2116f03f7_265)[Transactions with Variable Interest Entities](#ic5c36f045fc7456185fd61e2116f03f7_265)</u> | <u>[102](#ic5c36f045fc7456185fd61e2116f03f7_265)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[2](#ic5c36f045fc7456185fd61e2116f03f7_268)[0](#ic5c36f045fc7456185fd61e2116f03f7_268)[. Restructuring](#ic5c36f045fc7456185fd61e2116f03f7_268)</u> | <u>[104](#ic5c36f045fc7456185fd61e2116f03f7_268)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[2](#ic5c36f045fc7456185fd61e2116f03f7_271)[1](#ic5c36f045fc7456185fd61e2116f03f7_271)[. Related Parties](#ic5c36f045fc7456185fd61e2116f03f7_271)</u> | <u>[105](#ic5c36f045fc7456185fd61e2116f03f7_271)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;<u>[2](#ic5c36f045fc7456185fd61e2116f03f7_277)[2](#ic5c36f045fc7456185fd61e2116f03f7_277)[. Subsequent Events](#ic5c36f045fc7456185fd61e2116f03f7_277)</u> | <u>[106](#ic5c36f045fc7456185fd61e2116f03f7_277)</u> |
| <u>[Reports of Independent Registered Accounting Firm](#ic5c36f045fc7456185fd61e2116f03f7_280)</u> (PCAOB ID No. 34) | <u>[107](#ic5c36f045fc7456185fd61e2116f03f7_280)</u> |

---

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**CONSOLIDATED STATEMENTS OF INCOME**

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| ***(in millions, except per share data)*** | **2025** | **2024** | **2023** |
| **Net sales** | $**16603** | $15351 | $14814 |
| Cost of sales | **7604** | 6822 | 6734 |
| &nbsp;&nbsp;&nbsp;**Gross profit** | **8999** | 8529 | 8080 |
| Selling, general, and administrative expenses | **5351** | 5013 | 4912 |
| Impairment of goodwill | **—** | 306 |  |
| Impairment of intangible assets | **78** | 412 | 2 |
| Other operating (income) expense, net | **(5)** | 207 | (26) |
| &nbsp;&nbsp;&nbsp;**Income from operations** | **3575** | 2591 | 3192 |
| Interest expense, net | **754** | 735 | 496 |
| Other expense (income), net | **134** | (58) | (61) |
| &nbsp;&nbsp;&nbsp;**Income before provision for income taxes** | **2687** | 1914 | 2757 |
| Provision for income taxes | **608** | 473 | 576 |
| &nbsp;&nbsp;**Net income** | $**2079** | $1441 | $2181 |
| **Earnings per common share:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $**1.53** | $1.06 | $1.56 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | **1.53** | 1.05 | 1.55 |
| **Weighted average common shares outstanding:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | **1358.1** | 1362.2 | 1399.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | **1362.8** | 1368.3 | 1408.4 |

---

The accompanying notes are an integral part of these consolidated financial statements.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| ***(in millions)*** | **2025** | **2024** | **2023** |
| **Net income** | $**2079** | $1441 | $2181 |
| Other comprehensive income |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustments | **401** | (612) | 288 |
| &nbsp;&nbsp;Net change in pension and post-retirement liability, net of tax of $0, $0, and $2, respectively | **(2)** |  | (4) |
| &nbsp;&nbsp;Net change in cash flow hedges, net of tax of $13, $(24), and $29, respectively | **(21)** | 21 | (98) |
| &nbsp;&nbsp;&nbsp;Total other comprehensive income (loss) | **378** | (591) | 186 |
| **Comprehensive income** | **2457** | 850 | 2367 |

---

The accompanying notes are an integral part of these consolidated financial statements.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**CONSOLIDATED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| ***(in millions, except share and per share data)*** | **2025** | **2024** |
| **Assets** | **Assets** | **Assets** |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $**1026** | $510 |
| &nbsp;&nbsp;&nbsp;Restricted cash and restricted cash equivalents | **18** | 80 |
| &nbsp;&nbsp;&nbsp;Trade accounts receivable, net | **1671** | 1502 |
| &nbsp;&nbsp;&nbsp;Inventories | **1733** | 1299 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | **818** | 606 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total current assets** | **5266** | 3997 |
| Property, plant, and equipment, net | **3230** | 2964 |
| Equity method investments | **1660** | 1543 |
| Goodwill | **20247** | 20053 |
| Intangible assets, net | **23725** | 23634 |
| Deferred tax assets | **36** | 39 |
| Other non-current assets | **1295** | 1200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total assets** | $**55459** | $53430 |
| **Liabilities and Stockholders' Equity** | **Liabilities and Stockholders' Equity** | **Liabilities and Stockholders' Equity** |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $**2996** | $2985 |
| &nbsp;&nbsp;&nbsp;Accrued expenses | **1379** | 1584 |
| &nbsp;&nbsp;&nbsp;Structured payables | **25** | 41 |
| &nbsp;&nbsp;&nbsp;Short-term borrowings and current portion of long-term obligations | **3105** | 2642 |
| &nbsp;&nbsp;Other current liabilities | **785** | 835 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total current liabilities** | **8290** | 8087 |
| Long-term obligations | **13036** | 12912 |
| Deferred tax liabilities | **5526** | 5435 |
| Other non-current liabilities | **3091** | 2753 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total liabilities** | **29943** | 29187 |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;Preferred stock, $0.01 par value, 15,000,000 shares authorized, no shares issued as of December 31, 2025 and 2024 | **—** |  |
| &nbsp;&nbsp;Common stock, $0.01 par value, 2,000,000,000 shares authorized, 1,358,663,795 and 1,356,664,609 shares issued and outstanding as of December 31, 2025 and 2024, respectively | **14** | 14 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | **19778** | 19712 |
| &nbsp;&nbsp;&nbsp;Retained earnings | **5622** | 4793 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive income (loss) | **102** | (276) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total stockholders' equity** | **25516** | 24243 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total liabilities and stockholders' equity** | $**55459** | $53430 |

---

The accompanying notes are an integral part of these consolidated financial statements.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| ***(in millions)*** | **2025** | **2024** | **2023** |
| **Operating activities:** |  |  |  |
| **Net income** | $**2079** | $1441 | $2181 |
| Adjustments to reconcile net income to net cash provided by operating activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation expense | **455** | 422 | 402 |
| &nbsp;&nbsp;&nbsp;Amortization of intangibles | **138** | 133 | 137 |
| &nbsp;&nbsp;&nbsp;Other amortization expense | **160** | 178 | 181 |
| &nbsp;&nbsp;&nbsp;Provision for sales returns | **60** | 70 | 61 |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | **45** | (254) | (4) |
| &nbsp;&nbsp;&nbsp;Employee stock-based compensation expense | **97** | 98 | 116 |
| &nbsp;&nbsp;&nbsp;(Gain) loss on disposal of property, plant, and equipment | **(2)** | 16 | (1) |
| &nbsp;&nbsp;&nbsp;Unrealized (gain) loss on foreign currency | **(6)** | 33 | (13) |
| &nbsp;&nbsp;&nbsp;Unrealized (gain) loss on derivatives | **(1)** | 91 | 31 |
| &nbsp;&nbsp;&nbsp;Settlements of interest rate contracts | **—** |  | 54 |
| &nbsp;&nbsp;&nbsp;Earnings of equity method investments | **(81)** | (42) | (33) |
| &nbsp;&nbsp;&nbsp;Earned equity from distribution arrangements | **(54)** | (94) | (44) |
| &nbsp;&nbsp;&nbsp;Impairment of goodwill | **—** | 306 |  |
| &nbsp;&nbsp;&nbsp;Impairment of intangible assets | **78** | 412 | 2 |
| &nbsp;&nbsp;&nbsp;Other, net | **26** |  | 6 |
| &nbsp;&nbsp;&nbsp;Changes in assets and liabilities, excluding the effects of business acquisitions: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade accounts receivable | **(202)** | (209) | 70 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | **(405)** | (92) | 182 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes receivable and payable, net | **(141)** | 133 | (199) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current and non-current assets | **(216)** | (227) | (192) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | **(212)** | (196) | (1618) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current and non-current liabilities | **173** |  | 10 |
| &nbsp;&nbsp;Net change in operating assets and liabilities | **(1003)** | (591) | (1747) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | **1991** | 2219 | 1329 |
| **Investing activities:** |  |  |  |
| Acquisitions of businesses, net of cash acquired | **(149)** | (1000) |  |
| Purchases of property, plant, and equipment | **(486)** | (563) | (425) |
| Proceeds from sales of property, plant, and equipment | **14** | 4 | 9 |
| Purchases of intangibles | **(17)** | (59) | (56) |
| Investments in equity method investments | **(1)** | (7) | (316) |
| Other, net | **66** | 11 | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | $**(573)** | $(1614) | $(784) |

---

The accompanying notes are an integral part of these consolidated financial statements.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

(CONTINUED)

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| ***(in millions)*** | **2025** | **2024** | **2023** |
| **Financing activities:** |  |  |  |
| Proceeds from issuance of Notes | $**2000** | $3000 | $— |
| Repayments of Notes | **(1029)** | (1150) | (500) |
| Net issuance (repayment) of commercial paper | **594** | (480) | 1697 |
| Proceeds from term loan | **—** | 990 |  |
| Repayment of term loan | **(990)** |  |  |
| Proceeds from structured payables | **31** | 49 | 130 |
| Repayments of structured payables | **(47)** | (129) | (148) |
| Cash dividends paid | **(1250)** | (1194) | (1142) |
| Repurchases of common stock, inclusive of excise tax obligation | **(9)** | (1110) | (706) |
| Tax withholdings related to net share settlements | **(31)** | (61) | (62) |
| Payments on finance leases | **(129)** | (115) | (95) |
| Deferred financing charges paid | **(134)** | (16) |  |
| Other, net | **(5)** | (7) | (6) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash used in financing activities | **(999)** | (223) | (832) |
| **Cash, cash equivalents, restricted cash, and restricted cash equivalents:** |  |  |  |
| Net change from operating, investing, and financing activities | **419** | 382 | (287) |
| Effect of exchange rate changes | **17** | (41) | 19 |
| Beginning balance | **608** | 267 | 535 |
| Ending balance | $**1044** | $608 | $267 |
| **Supplemental cash flow disclosures of non-cash investing and financing activities:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Capital expenditures included in accounts payable and accrued expenses | $**204** | $220 | $276 |
| &nbsp;&nbsp;&nbsp;Acquisitions of businesses | **—** | 98 |  |
| &nbsp;&nbsp;&nbsp;Dividends declared but not yet paid | **312** | 312 | 299 |
| &nbsp;&nbsp;&nbsp;Mandatory redemption liability at acquisition | **—** | 689 |  |
| **Supplemental cash flow disclosures:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Cash paid for interest | **594** | 494 | 443 |

---

The accompanying notes are an integral part of these consolidated financial statements.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock Issued** | **Common Stock Issued** | **Additional <br>Paid-In Capital** | **Retained Earnings** | **Accumulated Other Comprehensive Income (Loss)** | **Total <br>Stockholders' Equity** | **Non-Controlling Interest** | **Total Equity** |
| ***(in millions, except per share data)*** | **Shares** | **Amount** | **Additional <br>Paid-In Capital** | **Retained Earnings** | **Accumulated Other Comprehensive Income (Loss)** | **Total <br>Stockholders' Equity** | **Non-Controlling Interest** | **Total Equity** |
| Balance as of December 31, 2022 | 1408.4 | $14 | $21444 | $3539 | $129 | $25126 | $(1) | $25125 |
| Net income |  |  |  | 2181 |  | 2181 |  | 2181 |
| Other comprehensive income |  |  |  |  | 186 | 186 |  | 186 |
| Dividends declared, $0.83 per share |  |  |  | (1160) |  | (1160) |  | (1160) |
| Repurchases of common stock, inclusive of excise tax obligation | (21.7) |  | (711) |  |  | (711) |  | (711) |
| Shares issued under employee stock-based compensation plans and other | 3.7 |  |  |  |  |  |  |  |
| Tax withholdings related to net share settlements |  |  | (62) |  |  | (62) |  | (62) |
| Stock-based compensation and stock options exercised |  |  | 117 |  |  | 117 |  | 117 |
| Non-controlling interest surrender of shares |  |  |  | (1) |  | (1) | 1 |  |
| Balance as of December 31, 2023 | 1390.4 | 14 | 20788 | 4559 | 315 | 25676 |  | 25676 |
| Net income |  |  |  | 1441 |  | 1441 |  | 1441 |
| Other comprehensive loss |  |  |  |  | (591) | (591) |  | (591) |
| Dividends declared, $0.89 per share |  |  |  | (1207) |  | (1207) |  | (1207) |
| Repurchases of common stock, inclusive of excise tax obligation | (38.0) |  | (1114) |  |  | (1114) |  | (1114) |
| Shares issued under employee stock-based compensation plans and other | 4.3 |  |  |  |  |  |  |  |
| Tax withholdings related to net share settlements |  |  | (61) |  |  | (61) |  | (61) |
| Stock-based compensation and stock options exercised |  |  | 99 |  |  | 99 |  | 99 |
| Balance as of December 31, 2024 | 1356.7 | 14 | 19712 | 4793 | (276) | 24243 |  | 24243 |
| Net income | **—** | **—** | **—** | **2079** | **—** | **2079** | **—** | **2079** |
| Other comprehensive income | **—** | **—** | **—** | **—** | **378** | **378** | **—** | **378** |
| Dividends declared, $0.92 per share | **—** | **—** | **—** | **(1250)** | **—** | **(1250)** | **—** | **(1250)** |
| Shares issued under employee stock-based compensation plans and other | **2.0** | **—** | **—** | **—** | **—** | **—** | **—** | **—** |
| Tax withholdings related to net share settlements | **—** | **—** | **(31)** | **—** | **—** | **(31)** | **—** | **(31)** |
| Stock-based compensation | **—** | **—** | **97** | **—** | **—** | **97** | **—** | **97** |
| **Balance as of December 31, 2025** | **1358.7** | $**14** | $**19778** | $**5622** | $**102** | $**25516** | $**—** | $**25516** |

---

The accompanying notes are an integral part of these consolidated financial statements.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**1. Business and Basis of Presentation**

**ORGANIZATION AND NATURE OF OPERATIONS**

Keurig Dr Pepper Inc. is a leading coffee and beverage company in North America that manufactures, markets, distributes, and sells hot and cold beverages and single serve brewing systems.

References in this Annual Report on Form 10-K to "KDP", "we", "us", and "our" refer to Keurig Dr Pepper Inc. and all wholly-owned subsidiaries included in the consolidated financial statements. Definitions of terms used in this Annual Report on Form 10-K are included within the Master Glossary.

This Annual Report on Form 10-K refers to some of our owned or licensed trademarks, trade names, and service marks, which are referred to as our brands. All of the product names included herein are either KDP registered trademarks or those of our licensors.

**BASIS OF PRESENTATION**

The accompanying consolidated financial statements have been prepared in accordance with U.S. GAAP.

**FISCAL YEAR END**

Our fiscal year end is December 31, and our interim fiscal quarters are March 31, June 30, and September 30. One of our significant subsidiaries, Maple Parent Holdings Corp., has a fiscal year end of the last Saturday in December, and its interim fiscal quarters end every thirteenth Saturday. The fiscal year for Maple Parent Holdings Corp. includes 52 weeks for the years ended December 31, 2025, 2024, and 2023. We do not adjust for the difference in fiscal year, as the difference is within the range permitted by the Exchange Act.

**PRINCIPLES OF CONSOLIDATION**

We consolidate all wholly owned subsidiaries.

We consolidate investments in companies in which we hold the majority interest. In these cases, the third-party equity interest is referred to as non-controlling interest. Generally, non-controlling interests are presented as a separate component within equity in the Consolidated Balance Sheets, and net earnings attributable to the non-controlling interests are presented separately in the Consolidated Statements of Income. However, if the investment agreement contains a mandatorily redeemable financial instrument for the non-controlling interests, such mandatorily redeemable interests are recorded as a liability, rather than equity, in the Consolidated Balance Sheets, and no earnings are attributable to the non-controlling interests.

We would be required to consolidate VIEs for which we have been determined to be the primary beneficiary. To determine if we are the primary beneficiary, we assess specific criteria and use judgment when determining if we have the power to direct the significant activities of the VIE and the obligation to absorb losses or receive benefits from the VIE that may be significant to the VIE. Factors considered include risk and reward sharing, voting rights, involvement in day-to-day capital and operating decisions, representation on a VIE's governance structure, existence of unilateral kick-out rights exclusive of protective rights or voting rights, and level of economic disproportionality between us and the VIE's other partner(s). We have determined that we are not the primary beneficiary of any VIEs. However, future events may require us to consolidate VIEs if we become the primary beneficiary.

We use the equity method to account for investments in companies if the investment provides us with the ability to exercise significant influence over operating and financial policies of the investee. Consolidated net income includes our proportionate share of the net income or loss of these companies. Judgment regarding the level of influence over each equity method investment includes considering key factors such as ownership interest, representation on the Board or similar governing body, participation in policy-making decisions, and material intercompany transactions.

We eliminate from our financial results all intercompany transactions between entities included in the consolidated financial statements.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

**RECLASSIFICATIONS**

We reclassified certain current and prior period amounts within the Consolidated Statements of Income and Consolidated Statements of Cash Flows in order to conform to current year presentation. These reclassifications had no impact on our net income or total cash, cash equivalents, restricted cash, and restricted cash equivalents, respectively.

**2. Significant Accounting Policies** 

**USE OF ESTIMATES**

The process of preparing our consolidated financial statements in conformity with U.S. GAAP requires the use of estimates and judgments that affect reported amounts. These estimates and judgments are based on historical experience, future expectations, and other factors and assumptions we believe to be reasonable under the circumstances. These estimates and judgments are reviewed on an ongoing basis and are revised when necessary. Changes in estimates are recorded in the period of change. Actual amounts may differ from these estimates.

**SIGNIFICANT ACCOUNTING POLICIES**

***Fair Value***

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Based upon the transparency of inputs to the valuation of an asset or liability, a three-level hierarchy has been established for fair value measurements. The three-level hierarchy for disclosure of fair value measurements is as follows:

*Level 1* - Quoted market prices in active markets for identical assets or liabilities.

*Level 2* - Observable inputs such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.

*Level 3* - Valuations with one or more unobservable significant inputs that reflect the reporting entity's own assumptions.

The fair value of Notes and marketable securities as of December 31, 2025 and 2024 are based on quoted market prices for publicly traded securities.

We estimate fair values of financial instruments measured at fair value in the consolidated financial statements on a recurring basis to ensure they are calculated based on market rates to settle the instruments. These values represent the estimated amounts we would pay or receive to terminate agreements, taking into consideration current market rates and creditworthiness.

The mandatory redemption liability for GHOST is a liability measured on a recurring basis that is considered Level 3 within the fair value hierarchy. Refer to the *Mandatory Redemption Liability* section below for further information.

Transfers between levels are recognized at the end of each reporting period. There were no transfers of financial instruments between the levels of fair value hierarchy during the years ended December 31, 2025, 2024, and 2023.

***Acquisitions***

We evaluate the facts and circumstances of each acquisition to determine whether the transaction should be accounted for as an asset acquisition or a business combination.

Asset Acquisitions

When substantially all of the fair value of the assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets, the transaction is accounted for as an asset acquisition. Direct transaction costs associated with asset acquisitions are capitalized.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

Business Combinations

We include the results of operations of the acquired business in the consolidated financial statements prospectively from the acquisition date. We allocate the purchase consideration to the assets acquired and liabilities assumed in the acquired entity generally based on their fair values at the acquisition date. The excess of the fair value of purchase consideration over the fair value of these assets acquired and liabilities assumed in the acquired entity is recorded as goodwill. During the measurement period, we will continue to obtain information to assist in determining the fair value of net assets acquired, which may differ from these preliminary estimates. Measurement period adjustments, if applicable, will be applied in the reporting period in which the adjustment amounts are determined. Certain of our acquisitions may include other forms of consideration, including mandatorily redeemable liabilities and other earn-out arrangements. As of the acquisition date, we record such consideration, as applicable, at the estimated fair value of the expected future payments associated with the obligation. Any changes to the recorded fair value of the consideration are recognized in earnings in the period in which they occur.

Transaction expenses are recognized separately from the business combination and are expensed as incurred. These charges primarily include direct third-party professional fees for advisory and consulting services and other incremental costs related to the acquisition.

***Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents***

Cash and cash equivalents include cash and investments in short-term, highly liquid securities, with original maturities of three months or less.

We are exposed to potential risks associated with its cash and cash equivalents. We place our cash and cash equivalents with high credit quality financial institutions. Deposits with these financial institutions may exceed the amount of insurance provided; however, these deposits typically are redeemable upon demand and, therefore, we believe the financial risks associated with these financial instruments are minimal.

The carrying value of cash, cash equivalents, restricted cash, and restricted cash equivalents is valued as of the balance sheet date equating fair value and is classified as Level 1. The following table provides a reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents reported with the Consolidated Balance Sheets to the total of the same amounts shown in the Consolidated Statements of Cash Flows:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| ***(in millions)*** | **2025** | **2024** |
| Cash and cash equivalents | $**1026** | $510 |
| Restricted cash and restricted cash equivalents<sup>(1)</sup> | **18** | 80 |
| Non-current restricted cash and restricted cash equivalents<sup>(2)</sup> | **—** | 18 |
| &nbsp;&nbsp;&nbsp;Total cash, cash equivalents, restricted cash, and restricted cash equivalents | $**1044** | $608 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Restricted cash and restricted cash equivalents consists primarily of amounts held in escrow in connection with the acquisition of GHOST as of December 31, 2025 and 2024, as well as Kalil Acquisition as of December 31, 2024, with a corresponding holdback liability recorded in Other current liabilities. Refer to Note 4 for additional information.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Non-current restricted cash and restricted cash equivalents, reported within Other non-current assets in the Consolidated Balance Sheets, consists of amounts held in escrow in connection with the acquisition of GHOST as of December 31, 2024, with a corresponding holdback liability recorded in Other non-current liabilities. Refer to Note 4 for additional information.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

***Trade Accounts Receivable and Allowance for Expected Credit Losses***

Trade accounts receivable are recorded at the invoiced amount and do not bear interest.

We are exposed to potential credit risks associated with our accounts receivable, as we generally do not require collateral on our accounts receivable. We determine the required allowance for expected credit losses using information such as customer credit history and financial condition, industry and market segment information, credit reports, and economic trends and conditions. Allowances can be affected by changes in the industry, customer credit issues, or customer bankruptcies, or expectations of any such events in a future period when reasonable and supportable. Historical information is utilized beyond reasonable and supportable forecast periods. Amounts are charged against the allowance when it is determined that expected credit losses may occur. Activity in the allowance for expected credit loss accounts was not significant for the years ended December 31, 2025, 2024, and 2023.

Concentration of credit risk with respect to accounts receivable is limited due to the large number of customers in various channels comprising our customer base. Walmart is a major customer as described in Note 9. As of December 31, 2025 and 2024, Walmart accounted for approximately $186 million and $205 million of trade receivables, respectively, which exceeded 10% of our total trade accounts receivable.

***Inventories***

Inventories consist of raw materials, WIP, and finished goods. Raw materials include various commodity costs for our ingredients and materials sourced from various providers. The costs of finished goods inventories manufactured by us include raw materials, direct labor, and indirect production and overhead costs. Finished goods also include the purchases of brewing systems and certain beverages from third-party manufacturers. Inventories are stated at the lower of cost or net realizable value. Cost is measured using standard cost, which approximates first-in, first-out. We make adjustments for excess and obsolete inventories based on an assessment of slow-moving and obsolete inventories, determined by historical usage and demand.

The following table summarizes our inventories:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| ***(in millions)*** | **2025** | **2024** |
| Raw materials | $**706** | $520 |
| WIP | **8** | 9 |
| Finished goods | **1019** | 770 |
| &nbsp;&nbsp;&nbsp;Total | $**1733** | $1299 |

---

***Property, Plant, and Equipment, Net***

Property, plant, and equipment is stated at cost plus capitalized interest on borrowings during the actual construction period of major capital projects, net of accumulated depreciation. Significant improvements which substantially extend the useful lives of assets are capitalized, and expenditures for repairs and maintenance which do not improve or extend the life of the assets are expensed as incurred. We capitalize certain computer software and software development costs incurred in connection with developing or obtaining computer software for internal use, which are included in property, plant, and equipment. When property, plant, and equipment is sold, the costs and the related accumulated depreciation are removed from the accounts, and any net gain or loss is recorded in Other operating (income) expense, net in the Consolidated Statements of Income.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

For financial reporting purposes, depreciation is computed on the straight-line method over the estimated useful asset lives as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Type of Asset** | **Useful Life** | **Useful Life** | **Useful Life** |
| Buildings and improvements | 3 | to | 40 years |
| Machinery and equipment | 2 | to | 20 years |
| Cold drink equipment | 2 | to | 7 years |
| Computer software | 2 | to | 8 years |

---

Leasehold improvements, which are primarily considered building improvements, are depreciated over the shorter of the estimated useful life of the assets or the lease term. Estimated useful lives are periodically reviewed and, when warranted, are updated.

We periodically review long-lived assets for impairment whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. In order to assess recoverability, we compare the estimated undiscounted future pre-tax cash flows from the use of the group of assets, as defined, to the carrying amount of such assets. Measurement of an impairment loss is based on the excess of the carrying amount of the group of assets over the long-lived asset's fair value, and any impairment loss is recorded in Other operating (income) expense, net, in the Consolidated Statements of Income. For the years ended December 31, 2025, 2024, and 2023, no impairment loss was recorded related to these assets.

***Leases***

We lease certain facilities and machinery and equipment, including fleet. These leases expire at various dates through 2044. Some lease agreements contain standard renewal provisions that allow us to renew the lease at rates equivalent to fair market value at the end of the lease term. Our lease agreements do not contain any material restrictive covenants. Certain leases with VIEs, which include manufacturing and distribution properties and our Frisco headquarters, contain an RVG at the end of the term. Refer to Note 19 for additional information about RVGs.

Operating leases are included within Other non-current assets, Other current liabilities, and Other non-current liabilities within the Consolidated Balance Sheets. Finance leases are included within Property, plant, and equipment, net, Other current liabilities, and Other non-current liabilities. Leases with an initial term of 12 months or less are not recognized in the Consolidated Balance Sheets.

Right of use assets and lease liabilities are recognized in the Consolidated Balance Sheets at the present value of future minimum lease payments over the lease term on the commencement date. When the rate implicit in the lease is not provided to us, we use our incremental borrowing rate based on information available at the commencement date to determine the present value of future minimum lease payments. Our incremental borrowing rate is determined using a portfolio of secured borrowing rates commensurate with the term of the lease and is reassessed on a quarterly basis.

We have lease agreements with lease and non-lease components, which are generally accounted for as a single lease component.

Sale-and-leaseback transactions occur when we sell assets to a third-party and subsequently lease them back. The resulting leases that qualify for sale-and-leaseback accounting are evaluated and accounted for as operating leases. A transaction that does not qualify for sale-and-leaseback accounting as a result of finance lease classification or the failure to meet certain revenue recognition criteria is accounted for as a financing transaction. For a financing transaction, we retain the assets sold within Property, plant, and equipment, net and record a financing obligation equal to the amount of cash proceeds received. Rental payments under such transactions are recognized as a reduction of the financing obligation and as interest expense using an effective interest method.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

***Investments***

Deferred Compensation Plan

We have a U.S. non-qualified defined contribution plan. Contributions under the non-qualified defined contribution plan are maintained in a rabbi trust and are not readily available to us. The rabbi trust consists of readily marketable equity securities, which are included in Other non-current assets in the Consolidated Balance Sheets. Gains or losses from such investments are charged to Other expense (income), net in the Consolidated Statements of Income.

The corresponding deferred compensation liability is included in Other non-current liabilities in the Consolidated Balance Sheets, with changes in this obligation recognized as adjustments to compensation expense and recorded in SG&A expenses.

Investments in Other Equity Securities

We consolidate investments in companies in which we hold the majority interest. In these cases, the third-party equity interest is referred to as non-controlling interest. Generally, non-controlling interests are presented as a separate component within equity in the Consolidated Balance Sheets, and net earnings attributable to the non-controlling interests are presented separately in the Consolidated Statements of Income. However, if the investment agreement contains a mandatorily redeemable financial instrument for the non-controlling interests, such mandatorily redeemable interests are recorded as a liability, rather than equity, in the Consolidated Balance Sheets, and no earnings are attributable to the non-controlling interests.

Effective December 31, 2024, we hold a majority interest in GHOST. This investment contains a mandatorily redeemable financial instrument for the non-controlling interests. Refer to Note 4 for further information about the GHOST Transactions.

We also hold investments in certain entities which are accounted for as equity method investments, equity securities with readily determinable fair value, or equity securities without readily determinable value.

The companies over which we exert significant influence, but do not control the financial and operating decisions, are accounted for as equity method investments. Equity method investments are reported at cost, which includes third-party transaction costs, and are adjusted each period for dividends paid, if any, as well as our share of the investee's net income or loss, unless the investment agreement indicates an alternative allocation of earnings or losses. Our share of the net income or loss resulting from these investments is recorded in Other expense (income), net in the Consolidated Statements of Income. To the extent we earn additional equity in these investments from achieving certain contractual milestones in our distribution activities, the earned equity is recorded as a reduction in Cost of sales and included in the Earned equity from distribution arrangements line in the Consolidated Statements of Cash Flows. Any gains and losses resulting from the sale of these investments are recorded in Gain on sale of equity method investment. The carrying value of our equity method investments is reported in Equity method investments in the Consolidated Balance Sheets. Distributions received from equity method investments are classified using the cumulative earnings approach in the Consolidated Statements of Cash Flows.

Our equity method investments in certain privately held entities do not have readily determinable fair values and are periodically evaluated for impairment. An impairment loss would be recorded whenever a decline in value of an investment below its carrying amount is determined to be other than temporary.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

Investments with readily determinable fair values for which we do not have the ability to exercise significant influence are measured at fair value. Fair values of these equity securities are determined using quoted market prices from daily exchange traded markets, based on the closing price as of the balance sheet date, and are classified as Level 1 and reported in Other non-current assets in the Consolidated Balance Sheets. Unrealized mark-to-market gains and losses are recorded to Other expense (income), net. The following table presents the amount of unrealized mark-to-market losses (gains), net, on our Vita Coco investment recognized in the Consolidated Statements of Income related to these securities during the periods presented:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***(in millions)*** | **2025** | **2024** | **2023** |
| Unrealized mark-to-market losses (gains)<sup>(1)</sup> | $**32** | $(17) | $(16) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)We sold our investment in Vita Coco and recorded a realized gain of $34 million in the first quarter of 2025.

***Goodwill and Intangible Assets***

Intangible assets are classified into two categories:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• intangible assets with definite lives subject to amortization, and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• intangible assets with indefinite lives not subject to amortization.

The majority of the intangible asset balance is made up of brands which we have determined to have indefinite useful lives. In arriving at the conclusion that a brand has an indefinite useful life, we review factors such as size, diversification, and market share of each brand. We expect to acquire, hold, and support brands for an indefinite period through consumer marketing and promotional support. We also consider factors such as our ability to continue to protect the legal rights that arise from these intangible assets indefinitely or the absence of any regulatory, economic, or competitive factors that could truncate the life of these intangible assets. If the criteria are not met, the brand is considered to have a finite useful life.

Identifiable intangible assets deemed to have determinable finite useful lives are amortized on a straight-line basis over the period of which the expected economic benefit is derived. Amortization expense is recorded in SG&A expenses in the Consolidated Statements of Income. The estimated useful lives of intangible assets with definite lives are as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Type of Asset** | **Useful Life** | **Useful Life** | **Useful Life** |
| Acquired technology |  |  | 20 years |
| Brands | 5 | to | 10 years |
| Contractual arrangements | 10 | to | 20 years |
| Customer relationships | 10 | to | 40 years |
| Distribution rights | 4 | to | 10 years |
| Trade names |  |  | 10 years |
| Other | 3 | to | 10 years |

---

For intangible assets with definite lives, tests for impairment are performed if conditions exist that indicate the carrying value may not be recoverable.

For goodwill and indefinite lived intangible assets, we perform quarterly analyses to evaluate whether any triggering events have occurred which may indicate that the carrying amount of an asset may not be recoverable. We also conduct tests for impairment annually on the first day of the fourth quarter, or more frequently if events or circumstances indicate the carrying amount may not be recoverable.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

For both goodwill and other indefinite lived intangible assets, we have the option to first assess qualitative factors to determine whether the fair value of either the reporting unit or indefinite lived intangible asset is "more likely than not" less than its carrying value, also known as a Step 0 analysis. When performing a quantitative, or Step 1, analysis, we use the income approach, or in some cases a combination of income and market based approaches, to determine the fair value of our assets, as well as an overall consideration of market capitalization and enterprise value.

The tests for impairment include significant judgment in estimating the fair value of reporting units and intangible assets. Management's estimates of fair value, which fall under Level 3 and are non-recurring, are based on historical and forecasted revenues and profit performance and discount rates. Fair value is based on what the reporting units and intangible assets would be worth to a third-party market participant. Discount rates are based on a weighted average cost of equity and cost of debt, adjusted with various risk premiums.

Goodwill is assigned to reporting units for purposes of impairment testing. A reporting unit is the same as an operating segment or one level below an operating segment. As of October 1, 2025, our reporting units were as follows:

---

| | |
|:---|:---|
| **Reportable Segments** | **Reporting Units** |
| **U.S. Refreshment Beverages** | U.S. Beverage Concentrates |
| | U.S. WD |
| | DSD |
| | GHOST |
| **U.S. Coffee** | U.S. Coffee |
| **International** | Canada Beverage Concentrates |
| | Canada WD |
| | Canada Coffee |
| | Latin America Beverages |

---

If the carrying value of the reporting unit or intangible asset exceeds its fair value, an impairment charge will be recorded in current earnings for the difference up to the carrying value of the goodwill or intangible asset recorded. Refer to Note 6 for additional information.

***Capitalized Customer Incentive Programs***

We provide support to certain customers to cover various programs and initiatives to increase net sales, including contributions to customers or vendors for cold drink equipment used to market and sell our products. These programs and initiatives generally directly benefit us over a period of time. Accordingly, costs of these programs and initiatives are recorded in Prepaid expenses and other current assets and Other non-current assets in the Consolidated Balance Sheets. The costs for these programs are amortized over the period to be directly benefited based upon a methodology consistent with our contractual rights under these arrangements.

***Accounts Payable***

We have agreements with third-party administrators which allow participating suppliers to track our payment obligations, and, if voluntarily elected by the supplier, to sell our payment obligations to financial institutions. Suppliers can sell one or more of our payment obligations at their sole discretion, and our rights and obligations to our suppliers, including amounts due and scheduled payment terms, are not impacted. We have no economic interest in a supplier's decision to enter into these agreements and no direct financial relationship with the financial institutions.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

The table below summarizes activity in our outstanding obligations under supplier financing arrangements, which are confirmed as valid and included in accounts payable:

---

| | | |
|:---|:---|:---|
| | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***(in millions)*** | **2025** | **2024** |
| Balance, beginning of the period | $**1740** | $2389 |
| &nbsp;&nbsp;Additions | **3424** | 2999 |
| &nbsp;&nbsp;Settlements | **(3791)** | (3639) |
| &nbsp;&nbsp;Effect of exchange rate changes | **5** | (9) |
| Balance, end of the period | $**1378** | $1740 |

---

***Structured Payables***

In the event that we determine that a commercial arrangement described above is more representative of a financing transaction, the payment obligation would be reclassified to structured payables.

Additionally, we have entered into an agreement with a supply chain payment processing intermediary, for the intermediary to act as a virtual credit card sponsor. The card sponsor bills us the original payment amount, effectively financing the transaction. The agreement permits us to utilize the third party to make a broad range of payments.

Structured payables have equal priority with accounts payable and are treated as non-recourse obligations. We record interest for the period the structured payables obligation is outstanding and reflect the proceeds and payments related to these transactions as a financing activity in the Consolidated Statements of Cash Flows.

***Mandatory Redemption Liability***

Certain of our acquisitions may include other forms of consideration, including mandatorily redeemable liabilities and other earn-out arrangements. As of the acquisition date, we record such consideration, as applicable, at the estimated fair value of the expected future payments associated with the obligation. Any changes to the recorded fair value of the consideration are recognized in earnings in the period in which they occur.

Subsequent to the date of acquisition, if future payments are expected to differ from our estimate as of the date of acquisition, any related fair value adjustments are recognized in the period that such expectation is considered probable. Changes in the fair value of payments are recorded within Other expense (income), net in the Consolidated Statements of Income.

For the year ended December 31, 2025, the fair value of our mandatory redemption liability for GHOST was estimated using the Monte Carlo simulation method, which incorporates significant inputs not observable in the market (Level 3 inputs) including forecasted EBITDA expectations, adjusting for market risks and volatility, calculating redemption prices, discounting to present terms with the cost of debt, and averaging results across scenarios to determine fair value, incorporating the market price of risk and volatility estimates from similar companies. As of December 31, 2025 and 2024, the fair value of our mandatory redemption liability associated with GHOST was $880 million and $689 million, respectively, and is included within Other non-current liabilities within the Consolidated Balance Sheets.

***Pension and Post-retirement Medical Benefits***

We have U.S. and foreign pension and PRMB plans which provide benefits to a defined group of employees who satisfy age and length of service requirements at our discretion. As of December 31, 2025, we have several stand-alone non-contributory defined benefit plans and PRMB plans. Depending on the plan, pension and PRMB benefits are based on a combination of factors, which may include salary, age, and years of service.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

Employee pension and PRMB plan obligations and the associated expense included in the consolidated financial statements are determined from actuarial analyses based on plan assumptions, employee demographic data, years of service, compensation, benefits and claims paid, and employer contributions. Non-cash settlement charges occur when the total amount of lump sum payments made to participants of various U.S. defined pension plans exceed the estimated annual interest and service costs.

The components of net periodic benefit cost other than the service cost component are included in Other expense (income), net, in the Consolidated Statements of Income. The service cost component is included in either Cost of sales or SG&A expenses, depending on the classification of the employee's other compensation costs.

The objective with respect to the funding of our pension plans is to provide adequate assets for the payment of future benefits. Pursuant to this objective, we will fund the pension plans as required by governmental regulations and may consider discretionary contributions as conditions warrant.

We participate in several multi-employer pension plans and makes contributions to those plans, which are recorded in either Cost of sales or SG&A expenses, depending on the classification of the employee's other compensation costs.

***Risk Management Programs***

We retain selected levels of property, casualty, workers' compensation, health, cyber, and other business risks. Many of these risks are covered under conventional insurance and reinsurance programs with deductibles or self-insured retentions. Accrued liabilities related to the retained casualty and health risks are calculated based on loss experience and development factors, which contemplate a number of variables including claim history and expected trends, and are recorded in Other current liabilities and Other non-current liabilities in the Consolidated Balance Sheets.

***Income Taxes***

Income taxes are accounted for using the asset and liability approach, which involves determining the temporary differences between assets and liabilities recognized for financial reporting and the corresponding amounts recognized for tax purposes and computing the tax-related carryforwards at the enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be reversed. The resulting amounts are deferred tax assets or liabilities. The total of taxes currently payable per the tax return, the deferred tax expense or benefit, and the impact of uncertain tax positions represents the income tax expense or benefit for the year for financial reporting purposes.

We periodically assess the likelihood of realizing our deferred tax assets based on the amount that we believe is more likely than not to be realized. We base our judgment of the recoverability of deferred tax assets primarily on historical earnings, our estimate of current and expected future earnings, and prudent and feasible tax planning strategies.

We establish income tax liabilities to remove some or all of the income tax benefit of any of our income tax positions at the time we determine that the positions become uncertain based upon one of the following: (1) the tax position is not "more likely than not" to be sustained, (2) the tax position is "more likely than not" to be sustained, but for a lesser amount, or (3) the tax position is "more likely than not" to be sustained, but not in the financial period in which the tax position was originally taken. The evaluation of whether or not a tax position is uncertain is based on the following: (1) we presume the tax position will be examined by the relevant taxing authority such as the IRS that has full knowledge of all relevant information, (2) the technical merits of a tax position are derived from authorities such as legislation and statutes, legislative intent, regulations, rulings, and case law, and their applicability to the facts and circumstances of the tax position, and (3) each tax position is evaluated without considerations of the possibility of offset or aggregation with other tax positions taken. We adjust these income tax liabilities when our judgment changes as a result of new information. Any change will impact income tax expense in the period in which such determination is made.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

***Derivative Instruments***

We are exposed to market risks arising from adverse changes in interest rates, FX rates, and commodity prices. We manage these risks through a variety of strategies, including the use of interest rate contracts, FX forward contracts, commodity forward, future, swap, and option contracts, and supplier pricing agreements.

We do not hold or issue derivative financial instruments for trading or speculative purposes. All derivative instruments are recorded on a gross basis, including those subject to master netting arrangements.

We formally designate and account for certain interest rate contracts and FX forward contracts that meet established accounting criteria under U.S. GAAP as cash flow hedges. For such contracts, the effective portion of the gain or loss on the derivative instruments is recorded, net of applicable taxes, in AOCI. When net income is affected by the variability of the underlying transaction, the applicable offsetting amount of the gain or loss from the derivative instrument deferred in AOCI is reclassified to net income. Cash flows from derivative instruments designated in a qualifying hedging relationship are classified in the same category as the cash flows from the underlying hedged items. If a cash flow hedge were to cease to qualify for hedge accounting, or were terminated, the derivatives would continue to be carried on the balance sheet at fair value until settled, and hedge accounting would be discontinued prospectively. If the underlying hedged transaction ceases to exist, any associated amounts reported in AOCI would be reclassified to earnings at that time.

For derivatives that are not designated or for which the designated hedging relationship is discontinued, the gain or loss on the instrument is recognized in earnings in the period of change.

We have exposure to credit losses from derivative instruments in an asset position in the event of nonperformance by the counterparties to the agreements. Historically, we have not experienced material credit losses as a result of counterparty nonperformance. We select and periodically review our counterparties based on credit ratings, limit our exposure to a single counterparty under defined guidelines, and monitor the market position of the derivative instruments upon execution of a hedging transaction and at least on a quarterly basis.

***Loss Contingencies***

Legal Matters

From time to time, we are involved in various claims, proceedings, and litigation, including those described in Note 18. We accrue for specific legal proceedings when we determine that the likelihood of an unfavorable outcome is probable and the amount of loss can be reasonably estimated. Management has also identified certain other legal matters where it believes an unfavorable outcome is reasonably possible and/or for which no estimate of possible losses can be made, and where applicable, provides disclosure of such legal matters in Note 18.

Product Warranties

We provide for the estimated cost of product warranties associated with our brewers in cost of sales, at the time product revenue is recognized. Warranty costs are estimated primarily using historical warranty information in conjunction with current engineering assessments applied to the expected repair or replacement costs. The estimate for warranties requires assumptions relating to expected warranty claims which are based on historical claims and known current year factors.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

***Supplemental Balance Sheet Information***

The following table provides supplemental financial information from the Consolidated Balance Sheets:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| ***(in millions)*** | **2025** | **2024** |
| Prepaid expenses | $**334** | $173 |
| Other current assets | **484** | 433 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total prepaid expenses and other current assets | $**818** | $606 |
| Accrued customer trade | $**444** | $439 |
| Accrued termination fees<sup>(1)</sup> | **—** | 225 |
| Other accrued expenses | **935** | 920 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total accrued expenses | $**1379** | $1584 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)We paid the termination fee related to the GHOST Transactions in full in the first quarter of 2025. Refer to Note 4 for additional information.

***Revenue Recognition***

We recognize revenue when performance obligations under the terms of a contract with the customer are satisfied. Branded product sales, which include LRBs, K-Cup pods, appliances, and other, occur once control is transferred upon delivery to the customer. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods. The amount of consideration we receive and revenue we recognize varies with changes in customer incentives offered to our customers and their customers. These incentives and discounts, which are recorded as a reduction of revenue, include cash discounts, price allowances, volume-based rebates, product placement fees, and other financial support for items such as trade promotions, displays, new products, consumer incentives, and advertising assistance. Accruals are established for the expected payout based on contractual terms, volume-based metrics, and/or historical trends, and require management judgment with respect to estimating customer participation and performance levels. Sales taxes and other similar taxes are excluded from revenue. Costs associated with shipping and handling activities, such as merchandising, are included in SG&A expenses as revenue is recognized.

***Cost of Sales***

Cost of goods sold includes all costs to acquire and manufacture our products including raw materials, direct and indirect labor, manufacturing overhead, including depreciation expense, and all other costs incurred to bring the product to salable condition. All other costs incurred after this condition is met are considered selling costs and included in SG&A expenses.

***Selling, General, and Administrative Expenses***

Transportation and Warehousing Costs

We incurred $2,087 million, $1,910 million, and $1,783 million of transportation and warehousing costs during the years ended December 31, 2025, 2024, and 2023, respectively. These amounts, which primarily relate to shipping and handling costs, are recorded in SG&A expenses in the Consolidated Statements of Income.

Advertising and Marketing Expense

Advertising and marketing production costs related to television, print, radio, and other marketing investments are expensed as of the first date the advertisement takes place. All other advertising and marketing costs are expensed as incurred. Advertising and marketing expenses were approximately $629 million, $657 million, and $640 million for the years ended December 31, 2025, 2024, and 2023, respectively. Advertising and marketing expenses are recorded in SG&A expenses in the Consolidated Statements of Income. Prepaid advertising and marketing costs are recorded as Other current and Other non-current assets in the Consolidated Balance Sheets.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

Research and Development Costs

Research and development costs are expensed when incurred and amounted to $70 million, $70 million, and $66 million for the years ended December 31, 2025, 2024, and 2023, respectively. These expenses are recorded primarily in SG&A expenses in the Consolidated Statements of Income.

Stock-Based Compensation Expense

Stock-based compensation expense is recognized within SG&A expenses in the Consolidated Statements of Income related to the fair value of employee stock-based awards, ratably over the vesting period, and only for awards expected to vest. Estimated forfeiture rates are based on historical data and are periodically reassessed.

Compensation cost is based on the grant-date fair value. The fair value of RSUs and PSUs is determined based on the number of units granted and the grant date price of common stock.

Restructuring and Integration Costs

We implement restructuring programs from time to time and incur costs that are designed to improve operating effectiveness and lower costs. When these programs are implemented, we incur expenses, such as employee separations, lease terminations, and other direct exit costs, that qualify as exit and disposal costs under U.S. GAAP. Severance costs are recorded once they are both probable and estimable. Restructuring liabilities that qualify as exit and disposal costs under U.S. GAAP are included in accounts payable and accrued expenses in the consolidated financial statements.

We also incur expenses that are an integral component of, and directly attributable to, the restructuring activities, which do not qualify as exit and disposal costs, such as accelerated depreciation, asset impairments, IT implementation costs, and other incremental costs. We have recorded these costs within SG&A expenses in the Consolidated Statements of Income, and these costs are held within unallocated corporate costs.

***Foreign Currency Translation and Transactions***

We translate assets and liabilities of our foreign subsidiaries from their respective functional currencies to U.S. dollars at the appropriate spot rates as of the balance sheet date. The functional currency of our operations outside the U.S. is generally the local currency of the country where the operations are located, or U.S. dollars. The results of operations are translated into U.S. dollars at a monthly average rate, calculated using daily exchange rates.

Differences arising from the translation of opening balance sheets of these entities to the rate at the end of the financial year are recognized in AOCI. The differences arising from the translation of foreign results at the average rate are also recognized in AOCI. Such translation differences are recognized as income or expense in the period in which we dispose of the operations.

Transactions in foreign currencies are recorded at the approximate rate of exchange at the transaction date. Assets and liabilities resulting from these transactions are translated at the rate of exchange in effect at the balance sheet date. Such differences are recorded in Cost of sales or Other expense (income), net in the Consolidated Statements of Income, depending on the nature of the underlying transaction.

***Earnings per Share***

Basic EPS is computed by dividing Net income by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the assumed conversion of all dilutive securities determined through the treasury stock method.

***Repurchases of Common Stock***

Shares repurchased under authorized share repurchase programs are retired, and the excess purchase price over the par value is recorded to additional paid-in capital.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

The 1% excise tax associated with shares repurchased is recorded to additional paid-in capital. Cash paid related to the excise tax on net share repurchases is included in the Repurchases of common stock, inclusive of excise tax obligation line in the Consolidated Statements of Cash Flows.

**RECENTLY ISSUED ACCOUNTING STANDARDS**

In February 2024, the FASB issued ASU 2024-03, *Income Statement Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40)*. The objective of ASU 2024-03 is to require entities to provide enhanced disclosures of income statement expenses through disaggregation of specific expense captions. ASU 2024-03 is effective for public companies starting in annual periods beginning after December 15, 2026 and in interim periods beginning after December 15, 2027. We are currently evaluating ASU 2024-03 and the impact of the disclosures to our consolidated financial statements.

**RECENTLY ADOPTED PROVISIONS OF U.S. GAAP**

As of January 1, 2025 we prospectively adopted ASU 2023-09, *Income Taxes (Topic 740): Improvements to Income Tax Disclosures*. The objective of ASU 2023-09 is to enhance disclosures related to income taxes, including specific thresholds for inclusion within the tabular disclosure of income tax rate reconciliation and specified information about income taxes paid. ASU 2023-09 is effective for public companies starting in annual periods beginning after December 15, 2024. Refer to Note 15 for additional information on our income tax related disclosures.

**3. JDE Peet's Acquisition and Related Transactions**

**JDE PEET'S ACQUISITION**

On August 24, 2025, we entered into the JDE Peet's Acquisition Agreement, and on January 16, 2026, pursuant to JDE Peet's Acquisition Agreement, KDP commenced a tender offer to acquire all of the issued ordinary shares, excluding ordinary shares in treasury, of JDE Peet's for a cash offer price of €31.85 per share, without interest. JDE Peet's is a global pure-play coffee company with a portfolio of leading brands including Jacobs, L'OR, and Peet's. The JDE Peet's Acquisition is expected to occur early in the second quarter of 2026 and is subject to the satisfaction or waiver of closing conditions, including the acceptance of the offer by the shareholders of JDE Peet's.

We additionally entered into a series of transactions in order to fund a portion of the consideration of the JDE Peet's Acquisition, as described below. The JV Investment and Preferred Investment are subject to customary closing conditions, including the substantially concurrent closing of the JDE Peet's Acquisition.

**BORROWING ARRANGEMENTS**

In connection with the JDE Peet's Acquisition, we entered into the Bridge Credit Agreement and the Delayed Draw Term Loan Agreement. Refer to Note 5 for additional information on these borrowing arrangements.

**JV INVESTMENT**

On October 26, 2025, we entered into the JV Commitment Letter, under which we will contribute the Coffee Production Assets, as well as certain of our related coffee assets (including sales and distribution) in Canada to the Pod Manufacturing JV, and the JV Investors will contribute, through the JV Investor Partner, $4 billion in cash in exchange for a 49% interest in the Pod Manufacturing JV. The remaining 51% ownership interest will remain under our ownership. Further, the JV Commitment Letter names each of Apollo Global Securities, LLC and KKR Capital Markets, LLC as a joint lead arranger with respect to certain of the transactions. On February 23, 2026, the JV Transaction Agreement was executed. Refer to Note 22 for additional information on the significant terms of the JV Transaction Agreement.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

**PREFERRED INVESTMENT**

On October 27, 2025, we entered into the Preferred Investment Agreement with the KKR Investor and the Apollo Investor. Under the Preferred Investment Agreement, we agreed to issue and sell to the Preferred Investors, and the Preferred Investors agreed to purchase from us, 3 million shares of our Convertible Preferred Stock, with a par value of $0.01 per share, for a purchase price of $1,000 per share and an aggregate purchase price of $3 billion. The transaction is exempt from the registration requirements of the Securities Act of 1933, as amended. On February 23, 2026, we amended the Preferred Investment Agreement, under which the Preferred Investors agreed to purchase an additional 1.5 million shares of our Convertible Preferred Stock. Refer to Note 22 for additional information.

The Convertible Preferred Stock will rank senior to our common stock with respect to dividend and distribution on liquidation rights. The Convertible Preferred Stock will have a liquidation preference of $1,000 per share. The holders of the Convertible Preferred Stock will be entitled to dividends at a rate of 4.75% per annum, subject to increase in certain cases, and to participate in dividends paid to holders of our common stock on an as-converted basis, provided that any such dividends received on an as-converted basis will reduce, on a dollar-for-dollar basis, the dividends holders are entitled to receive on the Convertible Preferred Stock. Dividends on the Convertible Preferred Stock will be paid in cash. We may choose to defer payment of all or part of any dividends due on the Convertible Preferred Stock; however, we will accrue additional dividends until paid in cash and we will not be able to declare or pay any dividends on or make repurchases of our common stock, subject to certain conditions.

The Convertible Preferred Stock will be convertible into shares of our common stock, at our election or, in certain specified circumstances, the election of the Preferred Investors, at an initial conversion price of $37.25 (which will be subject to anti-dilution adjustments, as well as an adjustment in the event that we complete the Separation). Holders may convert up to, in the aggregate, 50% of the Convertible Preferred Stock allocated among such holders and their permitted transferees pro rata at any time, and may convert the remainder following the earliest of the closing of the Separation, the 18-month anniversary of the issuance of the Convertible Preferred Stock, upon foreclosure by a lender under a bona fide loan or other financing arrangement or the 12-month anniversary of any initial public offering of the remaining beverage business if the Separation has not yet occurred. We may require, at any time after the 3-year anniversary of the issuance of the Convertible Preferred Stock to be converted if the closing price per share of our common stock exceeds 150% of the conversion price then in effect for at least twenty trading days in any period of thirty consecutive trading days. After the seventh anniversary of the issue date, we will have the option to redeem the Convertible Preferred Stock at the then-applicable redemption price. In the case of a fundamental change, we will be required to offer to repurchase the Convertible Preferred Stock at a specified price. Preferred Investors will vote with holders of our common stock on an as-converted basis, following the satisfaction of certain conditions.

The Preferred Investment is subject to customary closing conditions, including, among others: (i) the continued accuracy of the representations and warranties contained in the Preferred Investment Agreement; (ii) the performance in all material respects by each party of its respective covenants and agreements under the Preferred Investment Agreement; (iii) the expiration of applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976; and (iv) the substantially concurrent closing of the JDE Peet's Acquisition.

**4. Other Acquisitions**

**DYLA ACQUISITION**

On June 2, 2025, we completed the acquisition of Dyla for aggregate consideration of $98 million. Dyla is a leading player in powdered drink mixes and liquid water enhancers. Prior to the acquisition, we held direct and indirect ownership interests in Dyla and accounted for the investment as an equity method investment. We paid $72 million in cash, net of our previous ownership interest, in order to complete the acquisition.

Our allocation of consideration exchanged to the net tangible and intangible assets acquired and liabilities assumed was based on estimated fair values as of June 2, 2025, and the consideration was primarily allocated to intangible assets and goodwill. In the third quarter of 2025, we finalized our allocation of consideration exchanged in the Dyla acquisition, with no significant measurement period adjustments recorded.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

**GHOST TRANSACTIONS**

On December 31, 2024, we acquired a 60% ownership interest in GHOST for aggregate consideration of $999 million. GHOST is a lifestyle sports nutrition business with a portfolio anchored by GHOST Energy, a leading RTD energy brand. As part of the GHOST Transactions, we also entered into an agreement which requires us to purchase the remaining equity interests in GHOST in 2028.

Additionally, we executed an agreement with GHOST and ABI which terminated the distribution rights for certain GHOST products by ABI, effective March 3, 2025, for a termination payment to ABI of $225 million, after which, we assumed the distribution of such products. The termination payment was accrued as of December 31, 2024 and paid in the first quarter of 2025, with the corresponding expense included within Other operating (income) expense, net in the Consolidated Statements of Income.

Under the acquisition method of accounting, total consideration was as follows:

---

| | |
|:---|:---|
| ***(in millions)*** | **Total Consideration** |
| Initial payment to acquire 60% of GHOST | $**999** |
| Fair value of mandatory redemption liability for the remainder of the business on December 31, 2024<sup>(1)</sup> | **689** |
| &nbsp;&nbsp;Total consideration | $**1688** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Refer to Note 2 for additional information on the estimation of fair value of our mandatory redemption liability.

The initial payment of $999 million was funded primarily by proceeds drawn from the Term Loan Agreement. Refer to Note 5 for additional information.

The following is a summary of the allocation of consideration based on estimated fair values of assets acquired and liabilities assumed in the GHOST Transactions as of December 31, 2024:

---

| | |
|:---|:---|
| ***(in millions)*** | **Fair Value** |
| &nbsp;&nbsp;Brand | $**1146** |
| &nbsp;&nbsp;Assets acquired, net of liabilities assumed | **82** |
| &nbsp;&nbsp;Customer relationships | **23** |
| &nbsp;&nbsp;Goodwill<sup>(1)</sup> | **437** |
| Total consideration | **1688** |
| Less: Holdback placed in escrow<sup>(2)</sup> | **(90)** |
| Acquisition of business | $**1598** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The goodwill created in the GHOST Transactions is expected to be deductible for tax purposes and is included in our U.S. Refreshment Beverages segment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Amount includes both the current and non-current portion of the holdback liability as of December 31, 2024. Refer to Note 2 for additional information.

In the first quarter of 2025, we finalized our allocation of consideration, with no significant measurement period adjustments recorded.

**KALIL ACQUISITION**

On August 9, 2024, we acquired all of Kalil's production, sales, and distribution assets for total consideration of $103 million. Kalil is an independent bottler with bottling and distribution rights in Arizona to key KDP brands, including Canada Dry, 7UP, A&W, Snapple, and Core Hydration. Upon completion of the Kalil Acquisition, approximately $8 million of cash was held back and placed in escrow, which was released in the fourth quarter of 2025.

In 2025, we finalized our allocation of consideration to the net tangible and intangible assets acquired and liabilities assumed in the Kalil Acquisition, which was primarily allocated to property, plant, and equipment and other intangible assets, based on estimated fair values as of August 9, 2024. No significant measurement period adjustments recorded.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

**5. Long-term Obligations and Borrowing Arrangements** 

The following table summarizes our long-term obligations:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| ***(in millions)*** | **2025** | **2024** |
| Notes | $**13931** | $12948 |
| Term loan | **—** | 990 |
| Less: current portion of long-term obligations | **(895)** | (1026) |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term obligations | $**13036** | $12912 |

---

The following table summarizes our short-term borrowings and current portion of long-term obligations:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| ***(in millions)*** | **2025** | **2024** |
| Commercial paper notes | $**2210** | $1616 |
| Current portion of long-term obligations: |  |  |
| &nbsp;&nbsp;Notes | **895** | 1026 |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term borrowings and current portion of long-term obligations | $**3105** | $2642 |

---

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

**SENIOR UNSECURED NOTES**

Our Notes consisted of the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in millions)*** | | | **December 31,** | **December 31,** |
| **Issuance** |<br>**Maturity Date** |<br>**Rate** | **2025** | **2024** |
| 2025 Merger Notes | May 25, 2025 | 4.417% | $**—** | $529 |
| 2025 Notes | November 15, 2025 | 3.400% | **—** | 500 |
| 2026 Notes | September 15, 2026 | 2.550% | **400** | 400 |
| 2026-B Notes | November 15, 2026 | Floating<sup>(2)</sup> | **500** |  |
| 2027-B Notes | March 15, 2027 | Floating<sup>(2)</sup> | **350** | 350 |
| 2027-C Notes | March 15, 2027 | 5.100% | **750** | 750 |
| 2027 Notes | June 15, 2027 | 3.430% | **500** | 500 |
| 2028 Notes | May 15, 2028 | 4.350% | **500** |  |
| 2028 Merger Notes | May 25, 2028 | 4.597% | **1112** | 1112 |
| 2029-B Notes | March 15, 2029 | 5.050% | **750** | 750 |
| 2029 Notes | April 15, 2029 | 3.950% | **1000** | 1000 |
| 2030 Notes | May 1, 2030 | 3.200% | **750** | 750 |
| 2030-B Notes | May 15, 2030 | 4.600% | **500** |  |
| 2031 Notes | March 15, 2031 | 2.250% | **500** | 500 |
| 2031-B Notes | March 15, 2031 | 5.200% | **500** | 500 |
| 2032 Notes | April 15, 2032 | 4.050% | **850** | 850 |
| 2034 Notes | March 15, 2034 | 5.300% | **650** | 650 |
| 2035 Notes | May 15, 2035 | 5.150% | **500** |  |
| 2038 Merger Notes | May 25, 2038 | 4.985% | **211** | 211 |
| 2045 Notes | November 15, 2045 | 4.500% | **550** | 550 |
| 2046 Notes | December 15, 2046 | 4.420% | **400** | 400 |
| 2048 Merger Notes | May 25, 2048 | 5.085% | **391** | 391 |
| 2050 Notes | May 1, 2050 | 3.800% | **750** | 750 |
| 2051 Notes | March 15, 2051 | 3.350% | **500** | 500 |
| 2052 Notes | April 15, 2052 | 4.500% | **1150** | 1150 |
| Principal amount |  |  | **14064** | 13093 |
| &nbsp;&nbsp;&nbsp;Adjustment from principal amount to carrying amount<sup>(1)</sup> | &nbsp;&nbsp;&nbsp;Adjustment from principal amount to carrying amount<sup>(1)</sup> | &nbsp;&nbsp;&nbsp;Adjustment from principal amount to carrying amount<sup>(1)</sup> | **(133)** | (145) |
| Carrying amount |  |  | $**13931** | $12948 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The carrying amount includes unamortized discounts, debt issuance costs, and fair value adjustments related to the DPS Merger.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Our floating rate notes bear interest at a rate equal to Compounded SOFR (as defined in the respective supplemental indenture) plus a spread of 0.58% and 0.88% for the 2026-B Notes and the 2027-B Notes, respectively

On May 5, 2025, we completed the issuance of the 2026-B Notes, 2028 Notes, 2030-B Notes, and 2035 Notes, with an aggregate principal amount of $2 billion. The discount associated with these notes was approximately $4 million, and we incurred $10 million in debt issuance costs. The proceeds from the issuance were used for the repayment of outstanding commercial paper borrowings.

The 2025 Merger Notes and 2025 Notes were both repaid at maturity using proceeds from commercial paper.

Notes, among other things, contain customary default provisions and limit our ability to incur indebtedness secured by principal properties, to enter into certain sale and leaseback transactions, and to enter into certain mergers or transfers of substantially all of our assets. The Notes are fully and unconditionally guaranteed by certain of our direct and indirect subsidiaries. As of December 31, 2025, we were in compliance with all financial covenant requirements of the Notes.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

**VARIABLE-RATE BORROWING ARRANGEMENTS**

***Delayed Draw Term Loan Agreement***

In connection with the JDE Peet's Acquisition, we entered into the Delayed Draw Term Loan Agreement on December 18, 2025, among KDP, as borrower, the lenders party thereto, and Morgan Stanley Senior Funding, Inc. as administrative agent. We incurred approximately $15 million in deferred financing fees related to the issuance, which were capitalized and are being amortized to Interest expense, net through February 2027.

The Delayed Draw Term Loan Agreement provides for a 364-day senior unsecured term loan facility in an aggregate amount not to exceed €10.35 billion, the proceeds of which may be used to fund the JDE Peet's Acquisition, as well as related fees and expenses.

Borrowings under the Delayed Draw Term Loan Agreement will bear interest at a rate per annum equal to EURIBOR plus a margin of 0.750% to 1.750% depending on the rating of certain of our index debt. The undrawn commitments under the facility are subject to a commitment fee which commenced on December 23, 2025 at a per annum rate of 0.060% to 0.200% depending on the rating of certain of our index debt. The Delayed Draw Term Loan Agreement contains customary representations and warranties for investment grade financings. The Delayed Draw Term Loan Agreement also contains (i) certain affirmative covenants, including those that impose reporting and/or operating obligations on us and our subsidiaries, (ii) certain negative covenants that generally limit, subject to exceptions, us and our subsidiaries from taking certain actions, including incurring liens and consummating certain fundamental changes, (iii) financial covenants in the form of a minimum interest coverage ratio of 3.25 to 1.00 that will apply after the initial funding date and a maximum total net leverage ratio of 6.25 to 1.00 that will apply after the initial funding date only upon a downgrade in the ratings of certain of our index debt, and (iv) events of default customary for financings of this type.

As of December 31, 2025, the full amount of the Delayed Draw Term Loan Agreement remains available and undrawn.

***Bridge Credit Agreement***

In connection and concurrently with the entry into the JDE Peet's Acquisition Agreement, we entered into the Bridge Credit Agreement, a 364-day senior unsecured bridge loan facility in an aggregate amount not to exceed €16.2 billion, on August 24, 2025, among KDP, as borrower, with the lenders party thereto, and Morgan Stanley Senior Funding, Inc. as administrative agent. We incurred approximately $91 million in deferred financing fees related to the issuance, which were capitalized and are being amortized to Interest expense, net through February 2027. We paid additional fees of $15 million on December 23, 2025, as the facility remained undrawn.

Borrowings under the Bridge Credit Agreement will bear interest at a rate per annum equal to EURIBOR plus a margin of 0.750% to 2.500% depending on the rating of certain of our index debt and the period for which the bridge loan remains outstanding after the initial funding date. The undrawn commitments under the facility are subject to a commitment fee, which commenced on December 23, 2025, at a per annum rate of 0.060% to 0.200% depending on the rating of certain of our index debt. The Bridge Credit Agreement contains customary representations and warranties for investment grade financings. The Bridge Credit Agreement also contains (i) certain affirmative covenants, including those that impose reporting and/or operating obligations on us and our subsidiaries, (ii) certain negative covenants that generally limit, subject to exceptions, us and our subsidiaries from taking certain actions, including incurring liens and consummating certain fundamental changes, (iii) financial covenants in the form of a minimum interest coverage ratio of 3.25 to 1.00 that will apply after the initial funding date and a maximum total net leverage ratio of 6.25 to 1.00 that will apply after the initial funding date only upon a downgrade in the ratings of certain of our index debt, and (iv) events of default customary for financings of this type.

On December 18, 2025, the Bridge Credit Agreement facility was reduced to €5.85 billion as a result of the execution of the Delayed Draw Term Loan Agreement, as discussed above. As of December 31, 2025, the remaining amount of the Bridge Credit Agreement remains available and undrawn.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

***Term Loan Agreement***

On October 25, 2024, we entered into the Term Loan Agreement among KDP, as borrower, the lenders party thereto and Bank of America, N.A., as administrative agent. On December 31, 2024, we drew $990 million on the first tranche of the Term Loan Agreement and used the proceeds to fund the GHOST Transactions.

On January 31, 2025, we repaid the amount outstanding under the Term Loan Agreement using proceeds from commercial paper. On May 7, 2025, we terminated the Term Loan Agreement. We had no outstanding loan balances as of the termination date.

***Revolving Credit Agreement***

On March 31, 2025, we entered into the 2025 Revolving Credit Agreement among KDP, as borrower, the lenders from time to time party thereto and JPMorgan Chase, Bank, N.A., as administrative agent. We incurred approximately $4 million in deferred financing fees related to the issuance. On September 30, 2025, the 2025 Revolving Credit Agreement was amended to increase the capacity to $4.3 billion.

The following table summarizes information about the 2025 Revolving Credit Agreement:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in millions)*** | | **December 31, 2025** | **December 31, 2025** | **December 31, 2024** |
| **Issuance** |<br>**Maturity Date** | **Capacity** | **Carrying Value** | **Carrying Value** |
| 2025 Revolving Credit Agreement<sup>(1)</sup> | March 31, 2030 | $**4300** | $**—** | $— |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The 2025 Revolving Credit Agreement has $200 million of letters of credit limit, with none utilized as of December 31, 2025.

Borrowings under the 2025 Revolving Credit Agreement will bear interest at a rate per annum equal to, at our option, the term SOFR rate plus a margin of 0.750% to 1.250% or the alternative base rate plus a margin of zero to 0.250%, in each case, depending on the rating of certain of our index debt. The 2025 Revolving Credit Agreement contains customary representations and warranties for investment grade financings. The 2025 Revolving Credit Agreement also contains (i) certain customary affirmative covenants, including those that impose certain reporting and/or performance obligations on us and our subsidiaries, (ii) certain customary negative covenants that generally limit, subject to various exceptions, us and our subsidiaries from taking certain actions, including, without limitation, incurring liens and consummating certain fundamental changes, (iii) a financial covenant in the form of a minimum interest coverage ratio of 3.25 to 1.00, and (iv) customary events of default (including a change of control) for financings of this type.

As of December 31, 2025, we were in compliance with our minimum interest coverage ratio with respect to the 2025 Revolving Credit Agreement.

***Commercial Paper Program***

We have a commercial paper program, under which we may issue unsecured commercial paper notes on a private placement basis. The maximum aggregate amount available under the facility is $4 billion. The maturities of the commercial paper notes vary, but commercial paper notes are classified as short-term, as maturities do not exceed one year. We issue commercial paper notes as needed for general corporate purposes. Outstanding commercial paper notes rank equally with all of the commercial paper notes' existing and future unsecured borrowings.

The following table provides information about our weighted average borrowings under our commercial paper program:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***(in millions, except %)*** | **2025** | **2024** | **2023** |
| Weighted average commercial paper borrowings | $**2285** | $2270 | $1267 |
| Weighted average borrowing rates | **4.54%** | 5.42% | 5.41% |

---

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

***Letters of Credit Facility***

In addition to the portion of the 2025 Revolving Credit Agreement reserved for issuance of letters of credit, we have an incremental letter of credit facility. Under this facility, $150 million is available for the issuance of letters of credit, $63 million of which was utilized as of December 31, 2025 and $87 million of which remains available for use.

**FAIR VALUE DISCLOSURES**

The fair value of our commercial paper approximates the carrying value and is considered Level 2 within the fair value hierarchy.

The fair values of our Notes are based on current market rates available to us and are considered Level 2 within the fair value hierarchy. The difference between the fair value and the carrying value represents the theoretical net premium or discount that would be paid or received to retire all the Notes and related unamortized costs to be incurred at such date. The fair value of our Notes was $13,196 million and $12,036 million as of December 31, 2025 and 2024, respectively.

**6. Goodwill and Intangible Assets** 

**GOODWILL**

Changes in the carrying amount of goodwill by reportable segment are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in millions)*** | **U.S. Refreshment Beverages** | **U.S. Coffee** | **International** | **Total** |
| Balance as of December 31, 2023 | $8714 | $8622 | $2866 | $20202 |
| &nbsp;&nbsp;Foreign currency translation |  |  | (290) | (290) |
| &nbsp;&nbsp;Acquisitions<sup>(1)</sup> | 447 |  |  | 447 |
| &nbsp;&nbsp;Impairment<sup>(2)</sup> | (306) |  |  | (306) |
| Balance as of December 31, 2024<sup>(3)</sup> | 8855 | 8622 | 2576 | 20053 |
| &nbsp;&nbsp;Foreign currency translation | **—** | **—** | **179** | **179** |
| &nbsp;&nbsp;Acquisitions<sup>(1)</sup> | **15** | **—** | **—** | **15** |
| Balance as of December 31, 2025<sup>(3)</sup> | $**8870** | $**8622** | $**2755** | $**20247** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Refer to Note 4 for additional information on acquisitions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Impairment activity during the year ended December 31, 2024 represents impairment of our U.S. WD reporting unit. Refer to *Impairment Analysis - 2024 Impairment Analysis* below for further information.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)As of December 31, 2025 and 2024, goodwill for the U.S. Refreshment Beverages segment is inclusive of accumulated impairment losses of $306 million. There were no accumulated impairment losses for goodwill as of December 31, 2023.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

**INTANGIBLE ASSETS OTHER THAN GOODWILL**

The net carrying amounts of intangible assets other than goodwill are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| ***(in millions)*** | **Gross Amount** | **Accumulated Amortization** | **Net Amount** | **Gross Amount** | **Accumulated Amortization** | **Net Amount** |
| **Intangible assets with definite lives:** | | | | | | |
| &nbsp;&nbsp;Acquired technology | $**1146** | $**(694)** | $**452** | $1146 | $(621) | $525 |
| &nbsp;&nbsp;Customer relationships | **683** | **(301)** | **382** | 666 | (270) | 396 |
| &nbsp;&nbsp;Contractual arrangements | **146** | **(30)** | **116** | 144 | (21) | 123 |
| &nbsp;&nbsp;Trade names | **126** | **(126)** | **—** | 126 | (124) | 2 |
| &nbsp;&nbsp;Brands | **76** | **(40)** | **36** | 51 | (32) | 19 |
| &nbsp;&nbsp;Distribution rights | **162** | **(35)** | **127** | 66 | (23) | 43 |
| &nbsp;&nbsp;Other | **25** | **(3)** | **22** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total intangible assets with definite lives | $**2364** | $**(1229)** | $**1135** | $2199 | $(1091) | $1108 |
| **Intangible assets with indefinite lives:** |  |  |  |  |  |  |
| &nbsp;&nbsp;Brands<sup>(1)</sup> |  |  | $**19993** |  |  | $19848 |
| &nbsp;&nbsp;Trade names |  |  | **2478** |  |  | 2478 |
| &nbsp;&nbsp;Distribution rights |  |  | **119** |  |  | 200 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total intangible assets with indefinite lives |  |  | **22590** |  |  | 22526 |
| Total intangible assets, net |  |  | $**23725** |  |  | $23634 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The change in brands with indefinite lives was driven by favorable foreign currency translation impacts of $223 million, which was partially offset by non-cash impairment charges of $78 million during the year ended December 31, 2025. Refer to *2025 Impairment Analysis* below for further information.

Amortization expense for intangible assets with definite lives was as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| ***(in millions)*** | **2025** | **2024** | **2023** |
| Amortization expense | $**138** | $133 | $137 |

---

Amortization expense of these intangible assets is expected to be as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **For the Years Ending December 31,** | **For the Years Ending December 31,** | **For the Years Ending December 31,** | **For the Years Ending December 31,** | **For the Years Ending December 31,** |
| ***(in millions)*** | **2026** | **2027** | **2028** | **2029** | **2030** |
| Expected amortization expense | $**134** | $**117** | $**109** | $**106** | $**100** |

---

**GOODWILL AND INTANGIBLE ASSETS IMPAIRMENT**

***2025 Impairment Analysis***

For the year ended December 31, 2025, we performed a Step 0 analysis for certain indefinite lived intangible assets, including trade names and certain distribution rights, and did not identify any indicators of impairment. For goodwill, indefinite lived brands, and reacquired distribution rights, we performed a Step 1 analysis. As a result, non-cash impairment charges of $78 million were recorded specific to certain brands in the U.S. Refreshment Beverages segment. The primary factor that led to the brand impairment determination as of October 1, 2025 was an increase in our discount rate.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

***2024 Impairment Analysis***

For the year ended December 31, 2024, we performed a Step 0 analysis for certain indefinite lived intangible assets, including trade names and distribution rights, and did not identify any indicators of impairment. For goodwill and indefinite lived brands, we performed a Step 1 analysis. As a result, non-cash impairment charges of $412 million were recorded specific to certain brands in the U.S. Refreshment Beverages segment, and a non-cash impairment charge of $306 million was recorded to goodwill related to the U.S. Warehouse Direct reporting unit in the U.S. Refreshment Beverages segment. The primary factors that led to the brand impairment determination as of October 1, 2024, primarily led by Snapple, were a downward outlook for operating cash flows in our strategic plan, which led to a reduction in the long-term growth rate. The primary factors that led to the goodwill impairment determination as of October 1, 2024, driven by our U.S. Warehouse Direct reporting unit, were headwinds experienced by certain brands in our still portfolio, including a downward outlook for operating cash flows in our strategic plan, which led to a reduction in the long-term growth rate.

***2023 Impairment Analysis***

For the year ended December 31, 2023, we performed a Step 1 analysis on all goodwill and indefinite lived intangible assets. No impairments were recorded as a result of these analyses.

***Additional Impairment Considerations***

The following table provides the range of rates considered to be significant inputs that were used in the annual impairment analyses as of October 1, 2025, 2024, and 2023:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2024** | **2024** | **2023** | **2023** |
|<br>**Rate** | **Minimum** | **Maximum** | **Minimum** | **Maximum** | **Minimum** | **Maximum** |
| Discount rates | **9.5%** | **12.0%** | 7.0% | 9.5% | 8.0% | 13.5% |
| Long-term growth rates | **— %** | **3.5%** | —% | 3.5% | —% | 4.0% |
| Royalty rates<sup>(1)</sup> | **1.0%** | **1.0%** | 1.0% | 1.0% | 1.0% | 10.0% |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Royalty rates were used in a Step 1 quantitative analysis of certain non-priority brands for the years ended December 31, 2025, 2024, and 2023, and trade names for the year ended December 31, 2023.

The results of the impairment analyses of our indefinite lived priority brands as of October 1, 2025, 2024, and 2023 were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2024** | **2024** | **2023** | **2023** |
|<br>**Headroom Percentage** | **Carrying Value** | **Fair Value** | **Carrying Value** | **Fair Value** | **Carrying Value** | **Fair Value** |
| **<u>Brands</u>** |  |  |  |  |  |  |
| 0%<sup>(1)</sup> | $**1110** | $**1110** | $280 | $280 | $— | $— |
| Less than 25% | **2847** | **3110** | 2580 | 2900 | 2274 | 2493 |
| 26 - 50% | **314** | **440** | 1488 | 2160 | 2339 | 3018 |
| In excess of 50% | **15639** | **29280** | 14481 | 34490 | 14767 | 29002 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Carrying value reflects the results of the annual impairment analysis recognized during the years ended December 31, 2025 and 2024.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

**7. Derivatives**

**INTEREST RATES**

***Economic Hedges***

We are exposed to interest rate risk related to our borrowing arrangements and obligations. We enter into interest rate contracts to provide predictability in our overall cost structure and to manage the balance of fixed-rate and variable-rate debt. We primarily enter into receive-fixed, pay-variable and receive-variable, pay-fixed swaps, and swaption contracts. A natural hedging relationship exists in which changes in the fair value of the instruments act as an economic offset to changes in the fair value of the underlying items. Changes in the fair value of these instruments are recorded in earnings throughout the term of the derivative instrument and are generally reported in Interest expense, net in the Consolidated Statements of Income. As of December 31, 2025, economic interest rate derivative instruments have maturities ranging from March 2027 to November 2046.

***Cash Flow Hedges***

From time to time, we designate certain interest rate contracts as cash flow hedges in order to manage the exposures resulting from changes in interest rates as described above. In October 2025, in order to hedge the variability in cash flows from interest rate changes associated with our planned future issuances of long-term debt, we entered into forward starting swaps with terms ranging from 5 to 30 years and designated them as cash flow hedges.

**FOREIGN EXCHANGE**

We are exposed to FX risk in our foreign subsidiaries and with certain counterparties in foreign jurisdictions, which may transact in currencies that are different from the functional currencies of our legal entities. Additionally, the balance sheets of these subsidiaries are subject to exposure from movements in exchange rates.

***Economic Hedges***

We hold FX forward contracts to economically manage the balance sheet exposures resulting from changes in the FX rates described above. The intent of these FX contracts is to minimize the impact of FX risk associated with balance sheet positions not in local currency. In these cases, a hedging relationship exists in which changes in the fair value of the instruments act as an economic offset to changes in the fair value of the underlying items.

Additionally, we have significant anticipated Euro-denominated cash outflows resulting from the intended JDE Peet's Acquisition, as described in Note 3. To reduce our exposure to exchange rate fluctuations associated with the planned acquisition consideration and related financing, we entered into FX forward contracts during the third quarter of 2025.

Changes in the fair value of these instruments are recorded in earnings throughout the term of the derivative instrument and are reported in the same caption of the Consolidated Statements of Income as the associated risk. As of December 31, 2025, these FX contracts have maturities ranging from January 2026 to October 2026.

***Cash Flow Hedges***

We designate certain FX forward contracts as cash flow hedges in order to manage the exposures resulting from changes in the FX rates described above. These designated FX forward contracts relate to forecasted inventory purchases in U.S. dollars of our foreign subsidiaries. The intent of these FX contracts is to provide predictability in our overall cost structure. As of December 31, 2025, these FX contracts have maturities ranging from January 2026 to June 2027.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

**COMMODITIES**

***Economic Hedges***

We centrally manage the exposure to volatility in the prices of certain commodities used in our production process and transportation through various derivative contracts. We generally hold some combination of future, swap, and option contracts that economically hedge certain risks. In these cases, a hedging relationship exists in which changes in the fair value of the instruments act as an economic offset to changes in the fair value of the underlying items or as an offset to certain costs of production. Changes in the fair value of these instruments are recorded in earnings throughout the term of the derivative instrument and are reported in the same line item of the Consolidated Statements of Income as the hedged transaction. Unrealized gains and losses are recognized as a component of unallocated corporate costs until our reportable segments are affected by the completion of the underlying transaction, at which time the gain or loss is reflected as a component of the respective segment's income from operations. As of December 31, 2025, these commodity contracts have maturities ranging from January 2026 to January 2028.

**NOTIONAL AMOUNTS OF DERIVATIVE INSTRUMENTS**

The following table presents the notional amounts of our outstanding derivative instruments by type:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| ***(in millions)*** | **2025** | **2024** |
| Interest rate contracts |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Forward starting swaps, not designated as hedging instruments | $**2300** | $1700 |
| &nbsp;&nbsp;&nbsp;&nbsp;Forward starting swaps, designated as cash flow hedges | **1500** |  |
| FX contracts |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Forward contracts, not designated as hedging instruments<sup>(1)</sup> | **12436** | 490 |
| &nbsp;&nbsp;&nbsp;&nbsp;Forward contracts, designated as cash flow hedges | **597** | 486 |
| Commodity contracts, not designated as hedging instruments<sup>(2)</sup> | **595** | 515 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Includes €10 billion of FX forward contracts entered into during the third quarter of 2025 in connection with the planned JDE Peet's Acquisition.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Notional value for commodity contracts is calculated as the expected volume times strike price per unit on a gross basis.

**FAIR VALUE OF DERIVATIVE INSTRUMENTS**

The fair values of commodity contracts, interest rate contracts, and FX forward contracts are determined based on inputs that are readily available in public markets or can be derived from information available in publicly quoted markets. The fair values of commodity contracts are valued using the market approach based on observable market transactions, primarily underlying commodities futures or physical index prices, at the reporting date. Interest rate contracts are valued using models based primarily on readily observable market parameters, such as SOFR forward rates, for all substantial terms of our contracts and credit risk of the counterparties. FX forward contracts are valued using quoted FX forward rates at the reporting date. Therefore, we have categorized these contracts as Level 2.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

***Not Designated as Hedging Instruments***

The following table summarizes the location of the fair value of our derivative instruments which are not designated as hedging instruments within the Consolidated Balance Sheets. All such instruments are considered Level 2 within the fair value hierarchy.

---

| | | | |
|:---|:---|:---|:---|
| | | **December 31,** | **December 31,** |
| ***(in millions)*** | **Balance Sheet Location** | **2025** | **2024** |
| **Assets:** |  |  |  |
| &nbsp;&nbsp;&nbsp;FX forward contracts | Prepaid expenses and other current assets | $**5** | $7 |
| &nbsp;&nbsp;&nbsp;Commodity contracts | Prepaid expenses and other current assets | **47** | 32 |
| &nbsp;&nbsp;&nbsp;FX forward contracts | Other non-current assets | **—** | 4 |
| &nbsp;&nbsp;&nbsp;Commodity contracts | Other non-current assets | **3** | 2 |
| **Liabilities:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest rate contracts | Other current liabilities | $**16** | $22 |
| &nbsp;&nbsp;&nbsp;FX forward contracts | Other current liabilities | **38** | 4 |
| &nbsp;&nbsp;&nbsp;Commodity contracts | Other current liabilities | **9** | 82 |
| &nbsp;&nbsp;&nbsp;Interest rate contracts | Other non-current liabilities | **381** | 345 |
| &nbsp;&nbsp;&nbsp;Commodity contracts | Other non-current liabilities | **23** | 3 |

---

***Designated as Hedging Instruments***

The following table summarizes the location of the fair value of our derivative instruments which are designated as hedging instruments within the Consolidated Balance Sheets. All such instruments are considered Level 2 within the fair value hierarchy.

---

| | | | |
|:---|:---|:---|:---|
| | | **December 31,** | **December 31,** |
| ***(in millions)*** | **Balance Sheet Location** | **2025** | **2024** |
| **Assets:** |  |  |  |
| &nbsp;&nbsp;&nbsp;FX contracts | Prepaid expenses and other current assets | $**2** | $41 |
| &nbsp;&nbsp;&nbsp;FX contracts | Other non-current assets | **1** |  |
| &nbsp;&nbsp;&nbsp;Interest rate contracts | Other non-current assets | **37** |  |
| **Liabilities:** |  |  |  |
| &nbsp;&nbsp;&nbsp;FX contracts | Other current liabilities | $**16** | $— |
| &nbsp;&nbsp;&nbsp;Interest rate contracts | Other current liabilities | **2** |  |

---

**IMPACT OF DERIVATIVE INSTRUMENTS NOT DESIGNATED AS HEDGING INSTRUMENTS**

The following table presents the amount of losses (gains) recognized in the Consolidated Statements of Income related to derivative instruments not designated as hedging instruments under U.S. GAAP during the periods presented. Amounts include both realized and unrealized gains and losses.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***(in millions)*** | **Income Statement Location** | **2025** | **2024** | **2023** |
| Interest rate contracts | Interest expense, net | $**2** | $63 | $(26) |
| FX forward contracts | Cost of sales | **(4)** | (6) | (2) |
| FX forward contracts | Other expense (income), net | **36** | (10) | 5 |
| Commodity contracts | Cost of sales | **(117)** | 28 | 22 |
| Commodity contracts | SG&A expenses | **1** | 10 | 17 |

---

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

**IMPACT OF CASH FLOW HEDGES**

The following table presents the amount of net gains reclassified from AOCI into the Consolidated Statements of Income related to derivative instruments designated as cash flow hedging instruments during the periods presented:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***(in millions)*** | **Income Statement Location** | **2025** | **2024** | **2023** |
| Interest rate contracts<sup>(1)</sup> | Interest expense, net | $**(13)** | $(12) | $(74) |
| FX contracts | Cost of sales | **(17)** | (3) |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Amounts recognized during the year ended December 31, 2023 include the realized gains associated with the termination of forward starting swaps designated as cash flow hedges of approximately $66 million.

We expect to reclassify approximately $14 million of pre-tax net gains and $10 million of pre-tax net losses from AOCI into net income during the next twelve months related to interest rate contracts and FX contracts, respectively.

**8. Leases** 

The following table presents the components of lease cost:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***(in millions)*** | **2025** | **2024** | **2023** |
| Operating lease cost | $**182** | $170 | $159 |
| Finance lease cost |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of right-of-use assets | **113** | 95 | 81 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest on lease liabilities | **38** | 33 | 25 |
| Variable lease cost<sup>(1)</sup> | **36** | 37 | 39 |
| Short-term lease cost | **—** | 2 | 1 |
| Sublease income | **—** | (1) |  |
| Total lease cost | $**369** | $336 | $305 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Variable lease cost primarily consists of common area maintenance costs, property taxes, and adjustments for inflation.

The following tables present supplemental information about our leases:

---

| | | | |
|:---|:---|:---|:---|
| | | **December 31,** | **December 31,** |
| ***(in millions)*** | **Balance Sheet Location** | **2025** | **2024** |
| **Assets:** |  |  |  |
| Operating lease right-of-use assets | Other non-current assets | $**845** | $880 |
| Finance lease right-of-use assets<sup>(1)</sup> | Property, plant, and equipment, net | **919** | 784 |
| **Liabilities:** |  |  |  |
| Operating lease liability | Other current liabilities | $**127** | $128 |
| Finance lease liability | Other current liabilities | **179** | 125 |
| Operating lease liability | Other non-current liabilities | **764** | 790 |
| Finance lease liability | Other non-current liabilities | **745** | 677 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Amounts are presented net of accumulated amortization of $426 million and $334 million as of December 31, 2025 and 2024, respectively.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

---

| | | | |
|:---|:---|:---|:---|
| | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***(in millions)*** | **2025** | **2024** | **2023** |
| **Cash paid for amounts included in the measurement of lease liabilities:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating cash flows from operating leases | $**175** | $161 | $149 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating cash flows from finance leases | **38** | 32 | 25 |
| &nbsp;&nbsp;&nbsp;&nbsp;Financing cash flows from finance leases | **129** | 115 | 95 |
| **Right-of-use assets obtained in exchange for lease obligations:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating leases<sup>(1)</sup> | $**126** | $118 | $112 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance leases<sup>(2)</sup> | **278** | 196 | 109 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Includes impacts from lease modifications of $16 million during the year ended December 31, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Includes impacts from lease modifications of $45 million during the year ended December 31, 2025.

The following table presents information about our weighted average discount rate and remaining lease term:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| | **2025** | **2024** |
| **Weighted average discount rate** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating leases | **5.3%** | 5.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance leases | **4.8%** | 4.5% |
| **Weighted average remaining lease term** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating leases | **8 years** | 9 years |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance leases | **9 years** | 9 years |

---

**SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS**

Future minimum lease payments for non-cancellable leases that have commenced and are reflected in the Consolidated Balance Sheets as of December 31, 2025 were as follows:

---

| | | |
|:---|:---|:---|
| ***(in millions)*** | **Operating Leases** | **Finance Leases** |
| 2026 | $**156** | $**221** |
| 2027 | **155** | **135** |
| 2028 | **123** | **124** |
| 2029 | **116** | **118** |
| 2030 | **108** | **115** |
| Thereafter | **446** | **420** |
| &nbsp;&nbsp;&nbsp;&nbsp;Total future minimum lease payments | **1104** | **1133** |
| Less: imputed interest | **(213)** | **(209)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Present value of minimum lease payments | $**891** | $**924** |

---

**SIGNIFICANT LEASES THAT HAVE NOT YET COMMENCED**

As of December 31, 2025, we have entered into leases that have not yet commenced with estimated aggregated future lease payments of approximately $157 million. These leases will commence in 2026 and 2027, with initial lease terms ranging from 5 years to 10 years.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

**ASSET SALE-LEASEBACK TRANSACTION**

In 2023, we entered into an asset sale-leaseback transaction with the Veyron SPEs. A gain on the sale-leaseback of $6 million was recorded in Other operating (income) expense, net during the year ended December 31, 2023, and the leaseback is accounted for as an operating lease.

The initial term of the leaseback is 15 years, with two 10-year renewal options. The renewal options are not reasonably assured as (i) our position that the dynamic environment in which we operate precludes our ability to be reasonably certain of exercising the renewal options in the distant future and (ii) the options are contingent on us remaining investment grade and no change-in-control as of the end of the lease term. The leaseback has an RVG. Refer to Note 19 for additional information about RVGs associated with the asset sale-leaseback transaction.

**9. Segments**

Our three operating and reportable segments consist of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The U.S. Refreshment Beverages segment reflects sales in the U.S. from the manufacture and distribution of branded concentrates, syrups, finished beverages, and other consumables, including the sales of our own brands and third-party brands, to third-party bottlers, distributors, and retailers.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The U.S. Coffee segment reflects sales in the U.S. from the manufacture and distribution of finished goods relating to our K-Cup pods, single serve brewers and accessories, and other coffee products to partners, retailers, and directly to consumers through the Keurig.com website.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The International segment reflects sales in international markets, including the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Sales in Canada, Mexico, the Caribbean, and other international markets from the manufacture and distribution of branded concentrates, syrups, and finished beverages, including sales of our own brands and third-party brands, to third-party bottlers, distributors, and retailers.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Sales in Canada from the manufacture and distribution of finished goods relating to our single serve brewers, K-Cup pods, and other coffee products.

Segment results are based on management reports provided to the CODM, which is Tim Cofer, our CEO. Net sales and income from operations are the significant financial measures used to assess the operating performance of our operating segments. The CODM periodically monitors our actual results and remaining forecast versus our annual budget for these financial measures, and this information is used to assess performance of the reportable segments, determine the payout of short-term incentive plan compensation, and to establish management's base salaries.

Intersegment sales are recorded at cost and are eliminated in the Consolidated Statements of Income. We have not provided disclosures of intersegment sales or total assets for each reportable segment, as our CODM does not review and is not provided with this information. "Other segment expense (income)" includes Other operating (income) expense, net, as well as other financial statement captions for infrequent charges, such as impairment of goodwill or intangible assets, used to arrive at "Income from operations - reportable segments". "Unallocated corporate costs" are excluded from our measurement of segment performance and include unrealized commodity derivative gains and losses and certain general corporate expenses.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

Information about our operations and significant expenses by reportable segment is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in millions)*** | **U.S. Refreshment Beverages** | **U.S. Coffee** | **International** | **Total** |
| **For the year ended December 31, 2025** | | | | |
| Net sales | $**10439** | $**3990** | $**2174** | $**16603** |
| Cost of sales | **4217** | **2364** | **1083** |  |
| SG&A expenses | **3206** | **659** | **548** |  |
| Other segment expense (income)<sup>(1)</sup> | **77** | **5** | **(3)** |  |
| &nbsp;&nbsp;Income from operations - reportable segments | $**2939** | $**962** | $**546** | $**4447** |
| Unallocated corporate costs |  |  |  | **(872)** |
| &nbsp;&nbsp;Income from operations |  |  |  | **3575** |
| Interest expense, net |  |  |  | **754** |
| Other expense, net |  |  |  | **134** |
| &nbsp;&nbsp;&nbsp;Income before provision for income taxes |  |  |  | $**2687** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)During the year ended December 31, 2025, Other segment items within the U.S. Refreshment Beverages segment primarily consisted of non-cash impairment charges of $78 million recorded specific to certain indefinite lived brand assets. Refer to Note 6 for additional information about these non-cash impairment charges.

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in millions)*** | **U.S. Refreshment Beverages** | **U.S. Coffee** | **International** | **Total** |
| **For the year ended December 31, 2024** | | | | |
| Net sales | $9331 | $3967 | $2053 | $15351 |
| Cost of sales | 3608 | 2210 | 996 |  |
| SG&A expenses | 2904 | 684 | 521 |  |
| Other segment expense (income)<sup>(1)</sup> | 941 | (6) | (9) |  |
| &nbsp;&nbsp;Income from operations - reportable segments | $1878 | $1079 | $545 | $3502 |
| Unallocated corporate costs |  |  |  | (911) |
| &nbsp;&nbsp;Income from operations |  |  |  | 2591 |
| Interest expense, net |  |  |  | 735 |
| Other income, net |  |  |  | (58) |
| &nbsp;&nbsp;&nbsp;Income before provision for income taxes |  |  |  | $1914 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)During the year ended December 31, 2024, Other segment items within the U.S. Refreshment Beverages segment primarily consisted of non-cash impairment charges of $412 million recorded specific to certain indefinite lived brand assets and $306 million recorded to the WD reporting unit goodwill. Refer to Note 6 for additional information about these non-cash impairment charges. Other segment items within the U.S. Refreshment Beverages segment also included the $225 million termination payment to ABI for distribution rights related to the GHOST Transactions. Refer to Note 4 for additional information.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in millions)*** | **U.S. Refreshment Beverages** | **U.S. Coffee** | **International** | **Total** |
| **For the year ended December 31, 2023** | | | | |
| Net sales | $8821 | $4071 | $1922 | $14814 |
| Cost of sales | 3536 | 2228 | 979 |  |
| SG&A expenses | 2810 | 691 | 476 |  |
| Other segment income | (8) | (6) | (8) |  |
| &nbsp;&nbsp;Income from operations - reportable segments | $2483 | $1158 | $475 | $4116 |
| Unallocated corporate costs |  |  |  | (924) |
| &nbsp;&nbsp;Income from operations |  |  |  | 3192 |
| Interest expense, net |  |  |  | 496 |
| Other income, net |  |  |  | (61) |
| &nbsp;&nbsp;&nbsp;Income before provision for income taxes |  |  |  | $2757 |

---

**GEOGRAPHIC DATA**

The following tables present information about our operations by geographic region:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***(in millions)*** | **2025** | **2024** | **2023** |
| **Net sales** |  |  |  |
| &nbsp;&nbsp;&nbsp;U.S. | $**14502** | $13368 | $12961 |
| &nbsp;&nbsp;&nbsp;Foreign | **2101** | 1983 | 1853 |
| Net sales | $**16603** | $15351 | $14814 |

---

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| ***(in millions)*** | **2025** | **2024** |
| **Property, plant, and equipment, net** |  |  |
| &nbsp;&nbsp;&nbsp;U.S. | $**2657** | $2450 |
| &nbsp;&nbsp;&nbsp;Foreign | **573** | 514 |
| Total property, plant, and equipment, net | $**3230** | $2964 |

---

**MAJOR CUSTOMER**

Walmart is considered a major customer, accounting for more than 10% of our total net sales, and is represented in all three of our reportable segments. The following table provides our net sales to Walmart:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***(in millions)*** | **2025** | **2024** | **2023** |
| **Net sales** |  |  |  |
| &nbsp;&nbsp;&nbsp;Walmart | $**2654** | $2514 | $2476 |

---

Additionally, customers in our U.S. Refreshment Beverages and International segments buy concentrate from us, which is used in finished goods sold by our third-party bottlers to Walmart. These indirect sales further increase the concentration of risk associated with our consolidated net sales as it relates to Walmart.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

**10. Net Sales**

The following table disaggregates our net sales by portfolio:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in millions)*** | **U.S. Refreshment Beverages** | **U.S. Coffee** | **International** | **Total** |
| **For the year ended December 31, 2025** | | | | |
| &nbsp;&nbsp;LRB | $**10144** | $**69** | $**1389** | $**11602** |
| &nbsp;&nbsp;K-Cup pods | **—** | **3213** | **564** | **3777** |
| &nbsp;&nbsp;&nbsp;Appliances | **—** | **582** | **64** | **646** |
| &nbsp;&nbsp;&nbsp;Other | **295** | **126** | **157** | **578** |
| Net sales | $**10439** | $**3990** | $**2174** | $**16603** |
| **For the year ended December 31, 2024** | **For the year ended December 31, 2024** |  |  |  |
| &nbsp;&nbsp;LRB | $9196 | $38 | $1332 | $10566 |
| &nbsp;&nbsp;K-Cup pods |  | 3112 | 502 | 3614 |
| &nbsp;&nbsp;&nbsp;Appliances |  | 694 | 78 | 772 |
| &nbsp;&nbsp;&nbsp;Other | 135 | 123 | 141 | 399 |
| Net sales | $9331 | $3967 | $2053 | $15351 |
| **For the year ended December 31, 2023** |  |  |  |  |
| &nbsp;&nbsp;LRB | $8675 | $— | $1230 | $9905 |
| &nbsp;&nbsp;K-Cup pods |  | 3207 | 477 | 3684 |
| &nbsp;&nbsp;&nbsp;Appliances |  | 725 | 74 | 799 |
| &nbsp;&nbsp;&nbsp;Other | 146 | 139 | 141 | 426 |
| Net sales | $8821 | $4071 | $1922 | $14814 |

---

LRB represents net sales of owned and partner brands within our portfolio and includes branded concentrates, syrup, and finished beverages, including contract manufacturing of KDP branded products for our bottlers and distributors. K-Cup pods represents net sales from owned brands, partner brands, and private label owners. Net sales for partner brands and private label owners are contractual and long-term in nature.

**11. Earnings Per Share**

The following table presents our basic and diluted EPS and shares outstanding:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***(in millions, except per share data)*** | **2025** | **2024** | **2023** |
| Net income | $**2079** | $1441 | $2181 |
| Weighted average common shares outstanding | **1358.1** | 1362.2 | 1399.3 |
| Dilutive effect of stock-based awards | **4.7** | 6.1 | 9.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted average common shares outstanding and common stock equivalents | **1362.8** | 1368.3 | 1408.4 |
| Basic EPS | $**1.53** | $1.06 | $1.56 |
| Diluted EPS | **1.53** | 1.05 | 1.55 |
| Anti-dilutive shares excluded from the diluted weighted average shares outstanding calculation | **1.3** | 0.8 | 1.0 |

---

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

**12. Employee Benefit Plans** 

**DEFINED BENEFIT PENSION PLANS**

***Overview***

We have several non-contributory defined benefit plans, each having a measurement date of December 31. To participate in the defined benefit plans, eligible employees must have been employed for at least one year. Employee benefit plan obligations and expenses included in the consolidated financial statements are determined using actuarial analyses based on plan assumptions including employee demographic data such as years of service and compensation, benefits and claims paid, and employer contributions, among others. We also participate in various multi-employer defined benefit plans.

One of our U.S. defined benefit pension plans, which is a cash balance plan, was suspended and the accrued benefit was frozen effective December 31, 2008. Participants in this plan no longer earn additional benefits for future services or salary increases. The cash balance plans maintain individual record-keeping accounts for each participant, which are annually credited with interest credits equal to the 12-month average of one-year U.S. Treasury Bill rates, plus 1%, with a required minimum rate of 5%. Additionally, accrued benefits for non-union employees in another of our U.S. defined benefit pension plans were frozen effective November 1, 2025. No additional benefits related to future services or salary increases were accrued for these certain non-union participants after October 31, 2025. This freeze resulted in no curtailment gain or loss.

***Financial Statement Impact***

The following table sets forth amounts recognized in our financial statements and the pension plans' funded status:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| ***(in millions)*** | **2025** | **2024** |
| **Projected benefit obligations** |  |  |
| Beginning balance | $**159** | $169 |
| &nbsp;&nbsp;&nbsp;Service cost | **3** | 3 |
| &nbsp;&nbsp;&nbsp;Interest cost | **9** | 9 |
| &nbsp;&nbsp;&nbsp;Actuarial losses (gains), net | **6** | (5) |
| &nbsp;&nbsp;&nbsp;Benefits paid | **(5)** | (5) |
| &nbsp;&nbsp;&nbsp;Impact of changes in FX rates | **3** | (4) |
| &nbsp;&nbsp;&nbsp;Plan amendments | **1** |  |
| &nbsp;&nbsp;&nbsp;Settlements | **(9)** | (8) |
| Ending balance | $**167** | $159 |
| **Fair value of plan assets** |  |  |
| Beginning balance | $**127** | $134 |
| &nbsp;&nbsp;&nbsp;Actual return on plan assets | **11** |  |
| &nbsp;&nbsp;Employer contributions | **7** | 6 |
| &nbsp;&nbsp;&nbsp;Benefits paid | **(5)** | (5) |
| &nbsp;&nbsp;&nbsp;Settlements | **(9)** | (8) |
| Ending balance | $**131** | $127 |
| **Net liability recognized** | $**(36)** | $(32) |
| &nbsp;&nbsp;&nbsp;&nbsp;Current liability | $**(2)** | $(1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-current liability | **(34)** | (31) |

---

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

The accumulated benefit obligations for all defined benefit pension plans were $161 million and $156 million as of December 31, 2025 and 2024, respectively. The following table summarizes key pension plan information regarding plans whose accumulated benefit obligations exceed the fair value of their respective plan assets:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| ***(in millions)*** | **2025** | **2024** |
| Aggregate projected benefit obligation | $**167** | $159 |
| Aggregate accumulated benefit obligation | **161** | 156 |
| Aggregate fair value of plan assets | **131** | 127 |

---

The following table summarizes the components of our net periodic benefit cost:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***(in millions)*** | **2025** | **2024** | **2023** |
| Service cost | $**3** | $3 | $3 |
| Interest cost | **9** | 9 | 9 |
| Expected return on assets | **(6)** | (6) | (8) |
| Settlements | **1** | 1 | 1 |
| &nbsp;&nbsp;&nbsp;Total net periodic benefit costs | $**7** | $7 | $5 |

---

We use the corridor approach for amortization of actuarial gains or losses. The corridor is calculated as 10% of the greater of the plans' projected benefit obligation or assets. The amortization period for plans with active participants is the average future service of covered active employees, and the amortization period for plans with no active participants is the average future lifetime of plan participants. The estimated service costs or net actuarial losses for the defined benefit pension plans amortized from AOCI into periodic benefit cost in 2026 are expected to be insignificant.

The following table summarizes amounts included in AOCI for our defined benefit plans:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| ***(in millions)*** | **2025** | **2024** |
| Net actuarial loss | $**13** | $12 |
| Prior service cost | **3** | 2 |
| &nbsp;&nbsp;&nbsp;Total | $**16** | $14 |

---

***Contributions and Expected Benefit Payments***

The following table summarizes the contributions made to our defined benefit plans for the years ended December 31, 2025, 2024, and 2023, as well as our projected contributions for the year ended December 31, 2026:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Projected** | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***(in millions)*** | **2026** | **2025** | **2024** | **2023** |
| Non-discretionary contributions | $**8** | $**7** | $6 | $12 |

---

The following table summarizes the estimated future benefit payments for our defined benefit plans:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| ***(in millions)*** | **2026** | **2027** | **2028** | **2029** | **2030** | **2031-2035** |
| Estimated future benefit payments | $**15** | $**13** | $**13** | $**14** | $**14** | $**75** |

---

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

***Actuarial Assumptions***

Our pension expense was calculated based upon a number of actuarial assumptions including discount rates, retirement age, mortality rates, and expected long-term rate of return on plan assets for pension benefits.

The following information is provided for our U.S. defined benefit pension plans, as our foreign defined benefit pension plans are not material to our consolidated financial statements.

The discount rate that was utilized for determining our projected benefit obligations as of December 31, 2025 and 2024, as well as projected 2026 net periodic benefit cost, for U.S. plans was selected based upon an interest rate yield curve. The yield curve is constructed based on the yields of a large number of U.S. AA rated bonds as of December 31, 2025. The population of bonds utilized to calculate the discount rate includes those having an average yield between the 10th and 90th percentiles. Projected cash flows from the U.S. plans are then matched to spot rates along that yield curve in order to determine their present value and a single equivalent discount rate is calculated that produces the same present value as the spot rates.

Expected mortality is a key assumption in the measurement for pension benefit obligations. For our U.S. plans, we used the Pri-2012 mortality tables and the Mortality Improvement Scale MP-2021, published by the Society of Actuaries' Retirement Plans Experience Committee, for the years ended December 31, 2025 and 2024.

The following table summarizes the weighted-average actuarial assumption used to determine benefit obligations at the plan measurement dates for U.S. plans:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| | **2025** | **2024** |
| Discount rate | **5.35%** | 5.60% |

---

The following table summarizes the weighted-average actuarial assumptions used to determine the net periodic benefit costs for U.S. plans:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| | **2025** | **2024** | **2023** |
| Discount rate | **5.35%** | 5.60% | 5.10% |
| Expected long-term rate of return | **5.00%** | 4.95% | 4.75% |

---

For the years ended December 31, 2025, 2024, and 2023, the expected long-term rate of return on U.S. pension fund assets held by our pension trusts was determined based on several factors, including the impact of active portfolio management and projected long-term returns of broad equity and bond indices. The plans' historical returns were also considered.

***Investment Policy and Strategy***

We have established formal investment policies for the assets associated with our U.S. defined benefit pension plans. Our investment policy and strategy are mandated by our Investment Committee. The overriding investment objective is to provide for the availability of funds for pension obligations as they become due, to maintain an overall level of financial asset adequacy, and to maximize long-term investment return consistent with a reasonable level of risk. We actively manage the investments in our portfolio, with periodic review of investment performance both by investment manager and asset class, as well as review of overall market conditions and consideration of our long-term investment objectives. The investments under our sponsored pension plan assets are currently well diversified. The plans' asset allocation policy is reviewed at least annually. Factors considered when determining the appropriate asset allocation include changes in plan liabilities, an evaluation of market conditions, tolerance for risk and cash requirements for benefit payments.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

As of December 31, 2025 and 2024, we were in compliance with the investment policy for our U.S. defined benefit pension, which allows for a varying asset allocation dependent on each plan's funded status, as follows:

---

| | |
|:---|:---|
| | **Target Allocation** |
| Return-seeking<sup>(1)</sup> | **40-60%** |
| Liability-hedging<sup>(2)</sup> | **40-60%** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Return-seeking assets generally consist of common collective trust funds comprised of equity securities, liquid alternatives, and fixed income securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Liability-hedging assets consist of common collective trust funds comprised of a mix of fixed income securities and hedging instruments aimed to achieve a target interest rate.

**FAIR VALUE OF THE PENSION ASSETS**

Assets contributed by us to our pension plans become the property of the individual plans. Even though we no longer have control over these assets, we are indirectly impacted by subsequent fair value adjustments to these assets. The actual return on these assets impacts our future net periodic benefit cost, as well as amounts recognized in the Consolidated Balance Sheets. As such, we use a variety of valuation techniques depending on the type of instrument in order to measure the fair value of assets held by our pension plans.

The following table presents the total fair value of major categories of the pension plan assets for the years ended December 31, 2025 and 2024:

---

| | | | |
|:---|:---|:---|:---|
| | | **December 31,** | **December 31,** |
| ***(in millions)*** | **Fair Value Hierarchy Level** | **2025** | **2024** |
| Cash and cash equivalents | Level 1 | $**3** | $23 |
| Investments measured at NAV<sup>(1)</sup> | N/A | **128** | 104 |
| &nbsp;&nbsp;Total fair value of plan assets |  | $**131** | $127 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Primarily consists of common collective trust funds, which are valued using NAV as a practical expedient.

**PRMB PLANS**

We have several non-contributory defined benefit PRMB plans, each having a measurement date of December 31. The majority of these PRMB plans have been frozen. To participate in the defined benefit plans, eligible employees must have been employed by KDP for at least one year. The PRMB plans are limited to qualified expenses and are subject to deductibles, co-payment provisions, and other provisions. Our PRMB plans are not significant to the consolidated financial statements as of December 31, 2025 and 2024.

**MULTI-EMPLOYER PLANS**

We participate in several multi-employer plans, which are trustee-managed multi-employer defined benefit pension plans for union-represented employees under certain collective bargaining agreements. The risks of participating in these multi-employer plans are different from single-employer plans, as assets contributed to the multi-employer plan by one employer may be used to provide benefits to employees of other participating employers. Additionally, if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers.

Contributions paid into the multi-employer plans are expensed as incurred. Multi-employer plan expenses were $8 million, $11 million, and $6 million for each of the years ended December 31, 2025, 2024, and 2023, respectively.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

***Individually Significant Multi-Employer Plan***

We participate in one multi-employer plan, Central States, which is considered to be individually significant. The following table presents information about Central States as of December 31, 2025:

---

| | |
|:---|:---|
| Plan's employer identification number | 36-6044243 |
| Plan number | 001 |
| Expiration dates of collective bargaining agreements<sup>(1)</sup> | May 6, 2026 through March 1, 2028 |
| Financial Improvement Plan/Rehabilitation Plan status pending/implemented | Implemented |
| Pension Protection Act zone status | Critical |
| Surcharge imposed | Yes |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Central States includes six collective bargaining agreements as of December 31, 2025. The largest agreement, which is set to expire February 28, 2027, covers approximately 59% of the employees included in Central States. One of the collective bargaining agreements is set to expire during 2026, covering approximately 10% of the employees included in Central States.

The most recent Pension Protection Act zone status available as of December 31, 2025 is for the plan's year-end as of December 31, 2024. Central States has not utilized any extended amortization provisions that affect the calculation of the zone status.

Our contributions to Central States did not exceed 5% of the total contributions made to Central States for the years ended December 31, 2025, 2024, and 2023.

Future estimated contributions to Central States based on the number of covered employees and the terms of the collective bargaining agreements are as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| ***(in millions)*** | **2026** | **2027** | **2028** | **2029** | **2030** |
| Future estimated contributions to Central States | $**2** | $**2** | $**2** | $**2** | $**2** |

---

**DEFINED CONTRIBUTION PLANS**

We sponsor various qualified defined contribution plans that cover U.S. and foreign based employees who meet certain eligibility requirements. The U.S. plans permit both pre-tax and after-tax contributions, which are subject to limitations imposed by IRS regulations. We make matching contributions and discretionary profit sharing contributions to these plans. We incurred contribution expense of $69 million, $67 million, and $64 million to the defined contribution plans for the years ended December 31, 2025, 2024, and 2023, respectively.

We also sponsor a non-qualified defined contribution plan for certain employees which is maintained in a rabbi trust and is not readily available to us. The fair value of the securities within this plan was $33 million as of both December 31, 2025 and 2024. There were $4 million, $4 million, and $6 million in gains associated with these trading securities during the years ended December 31, 2025, 2024, and 2023, respectively.

**13. Stock-Based Compensation**

The components of stock-based compensation expense are presented below:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***(in millions)*** | **2025** | **2024** | **2023** |
| Total stock-based compensation expense | $**97** | $98 | $116 |
| Income tax benefit | **(18)** | (16) | (19) |
| &nbsp;&nbsp;&nbsp;Stock-based compensation expense, net of tax | $**79** | $82 | $97 |

---

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

**DESCRIPTION OF STOCK-BASED COMPENSATION PLAN**

The 2019 Incentive Plan, under which employees and non-employee directors can be granted stock options, stock appreciation rights, stock awards, RSUs, and PSUs, was adopted in 2019 and expires in 2029. This incentive plan provides for the issuance of up to an aggregate of 27,425,720 shares of our common stock in stock-based compensation awards.

RSUs generally vest on the following schedule:

---

| | |
|:---|:---|
| **Period Granted** | **Vesting Terms** |
| RSUs granted in 2020 through 2024 | 5-year term with graded vesting as follows: <br>0% in year 1, 0% in year 2, 60% in year 3, 20% in year 4, 20% in year 5 |
| RSUs granted in 2025 | 4-year term with ratable vesting |

---

However, from time to time, we grant RSUs outside of the normal grant cycle which have different terms and vesting conditions. For all RSU grants, we recognize the expense ratably over the vesting period.

**RESTRICTED SHARE UNITS**

The table below summarizes RSU activity:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **RSUs** | **Weighted Average Grant Date Fair Value** | **Weighted Average Remaining Contractual Term (Years)** | **Aggregate Intrinsic Value (in millions)** |
| Balance as of December 31, 2024 | 12488799 | $29.70 | 2.0 | $401 |
| &nbsp;&nbsp;&nbsp;Granted | **5040348** | **29.93** |  |  |
| &nbsp;&nbsp;&nbsp;Vested and released | **(2930040)** | **30.40** |  | **96** |
| &nbsp;&nbsp;&nbsp;Forfeited | **(1478270)** | **29.84** |  |  |
| Balance as of December 31, 2025 | **13120837** | **29.62** | **1.8** | **368** |

---

The weighted average grant date fair value for RSUs granted for the years ended December 31, 2025, 2024, and 2023 was $29.93, $26.66, and $30.60, respectively. The aggregate fair value of the RSUs vested and released for the years ended December 31, 2025, 2024, and 2023 was $89 million, $165 million, and $134 million, respectively.

As of December 31, 2025, there was $187 million of unrecognized compensation cost related to unvested RSUs that is expected to be recognized over a weighted average period of 2.8 years.

**PERFORMANCE SHARE UNITS**

In March 2025, the Remuneration & Nomination Committee of the Board approved PSU grants. Each PSU represents the right to receive one share of our common stock. The PSUs vest 3 years from the grant date, to the extent that the performance metrics are achieved during a predetermined performance period. The performance metrics include net sales growth and adjusted diluted EPS growth, as defined in the respective grant agreement, and are measured on a constant currency basis. The payout percentage for all PSUs granted ranges from 0% to 200%. Beginning in 2025, the fair value of PSUs is determined based on the number of units granted and the grant date price of common stock.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

The table below summarizes PSU activity:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **PSUs** | **Weighted Average Grant Date Fair Value** | **Weighted Average Remaining Contractual Term (Years)** | **Aggregate Intrinsic Value (in millions)** |
| Balance as of December 31, 2024 |  | $— | 0.0 | $— |
| &nbsp;&nbsp;&nbsp;Granted | **464354** | **30.61** |  |  |
| &nbsp;&nbsp;&nbsp;Vested and released | **—** | **—** |  | **—** |
| &nbsp;&nbsp;&nbsp;Forfeited or expired | **(17536)** | **30.71** |  |  |
| Balance as of December 31, 2025 | **446818** | **30.60** | **2.2** | **13** |

---

As of December 31, 2025, there was $10 million of unrecognized compensation cost related to unvested PSUs that is expected to be recognized over a weighted average period of 2.2 years.

**14. Equity Method Investments**

The following table summarizes our equity method investments:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| ***(in millions)*** | **2025** | **2024** |
| Nutrabolt<sup>(1)</sup> | $**1168** | $1097 |
| Chobani<sup>(2)</sup> | **359** | 313 |
| Tractor<sup>(3)</sup> | **52** | 56 |
| Athletic Brewing<sup>(4)</sup> | **53** | 47 |
| Other | **28** | 30 |
| &nbsp;&nbsp;&nbsp;Total equity method investments | $**1660** | $1543 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)We hold a 35.8% interest on an as-converted basis in Nutrabolt, consisting of 30.4% in Class A preferred shares acquired through our initial investment, which are treated as in-substance common stock, and 5.4% in Class B common shares earned through the achievement of certain milestones included in the distribution agreement with Nutrabolt.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)We hold a 5.9% interest in Chobani, reflecting additional equity interests issued through the achievement of certain milestones included in the distribution agreement with Chobani.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)We hold a 21.9% interest in Tractor.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)We hold a 11.7% interest in Athletic Brewing, reflecting additional equity interests received in the first quarter of 2025 in accordance with our investment agreement. This earned equity is recorded in Other expense (income), net in the Consolidated Statements of Income.

***Nutrabolt Investment***

Our interest in preferred units earns the greater of (i) a 5% annual coupon on the preferred equity units plus any accretion for amounts not yet paid or (ii) our share of Nutrabolt's earnings as if our preferred equity was converted into common units. We recorded preferred dividends of $49 million, $46 million, and $44 million during the years ended December 31, 2025, 2024, and 2023, respectively, which increased the investment balance for Nutrabolt.

**15. Income Taxes**

Income before provision for income taxes was as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***(in millions)*** | **2025** | **2024** | **2023** |
| U.S. | $**1289** | $696 | $1665 |
| Foreign | **1398** | 1218 | 1092 |
| &nbsp;&nbsp;&nbsp;Total | $**2687** | $1914 | $2757 |

---

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

The provision for income taxes has the following components:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***(in millions)*** | **2025** | **2024** | **2023** |
| **Current:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Federal | $**255** | $377 | $270 |
| &nbsp;&nbsp;&nbsp;State | **68** | 108 | 117 |
| &nbsp;&nbsp;&nbsp;Foreign | **240** | 242 | 193 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current provision | $**563** | $727 | $580 |
| **Deferred:** |  |  |  |
| &nbsp;&nbsp;&nbsp;Federal | $**10** | $(199) | $31 |
| &nbsp;&nbsp;&nbsp;State | **13** | (55) | 2 |
| &nbsp;&nbsp;&nbsp;Foreign | **22** |  | (37) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total deferred provision | **45** | (254) | (4) |
| Total provision for income taxes | $**608** | $473 | $576 |

---

The following tables reconcile the provision for income taxes computed at the U.S. federal statutory tax rate to the provision for income taxes reported in the Consolidated Statements of Income:

---

| | | |
|:---|:---|:---|
| | **For the Year Ended December 31, 2025** | **For the Year Ended December 31, 2025** |
| ***($ in millions)*** | **Amount** | **Percentage** |
| Statutory federal income tax rate | $**564** | **21.0%** |
| State income taxes, net<sup>(1)</sup> | **59** | **2.2** |
| Impact of foreign operations |  |  |
| &nbsp;&nbsp;Ireland |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Statutory tax rate difference between Ireland and U.S. | **(71)** | **(2.6)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | **20** | **0.7** |
| &nbsp;&nbsp;Other foreign jurisdictions | **21** | **0.8** |
| Effect of cross-border tax laws | **9** | **0.3** |
| Tax credits | **(28)** | **(1.0)** |
| Nontaxable or nondeductible items | **12** | **0.4** |
| Changes in unrecognized tax benefits | **22** | **0.8** |
| &nbsp;&nbsp;Total provision for income taxes | $**608** | **22.6%** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)California, Tennessee, New Jersey, Florida, Illinois, and Texas comprise more than 50% of State income taxes, net.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

---

| | | |
|:---|:---|:---|
| | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| | **2024** | **2023** |
| Statutory federal income tax rate | 21.0% | 21.0% |
| State income taxes, net | 2.1 | 3.2 |
| Impact of foreign operations | (1.4) | (1.7) |
| Tax credits | (6.2) | (3.7) |
| Valuation allowance for deferred tax assets | 0.6 |  |
| U.S. taxation of foreign earnings | 5.1 | 3.0 |
| Goodwill impairment | 2.7 |  |
| Deferred rate change | (0.4) | (0.3) |
| Uncertain tax positions |  | 0.1 |
| U.S. federal provision to return | 0.2 |  |
| Excess tax deductions on stock-based compensation | (0.2) | (0.3) |
| Other | 1.2 | (0.4) |
| &nbsp;&nbsp;Effective tax rate | 24.7% | 20.9% |

---

Deferred tax assets and liabilities were comprised of the following:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| ***(in millions)*** | **2025** | **2024** |
| **Deferred tax assets:** |  |  |
| &nbsp;&nbsp;&nbsp;Operating lease liability | $**236** | $229 |
| &nbsp;&nbsp;&nbsp;Net operating losses carryforwards | **24** | 30 |
| &nbsp;&nbsp;&nbsp;Tax credit carryforwards | **5** | 10 |
| &nbsp;&nbsp;&nbsp;Accrued expenses | **152** | 154 |
| &nbsp;&nbsp;&nbsp;Research and development capitalization | **45** | 94 |
| &nbsp;&nbsp;&nbsp;Accrued termination fees | **52** | 56 |
| &nbsp;&nbsp;&nbsp;Other | **84** | 107 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total deferred tax assets | **598** | 680 |
| &nbsp;&nbsp;&nbsp;&nbsp;Valuation allowances | **(24)** | (25) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total deferred tax assets, net of valuation allowances | $**574** | $655 |
| **Deferred tax liabilities:** |  |  |
| &nbsp;&nbsp;&nbsp;Brands, trade names and other intangible assets | $**(5540)** | $(5486) |
| &nbsp;&nbsp;&nbsp;Property, plant, and equipment | **(230)** | (299) |
| &nbsp;&nbsp;&nbsp;Right of use assets | **(234)** | (224) |
| &nbsp;&nbsp;&nbsp;Other | **(60)** | (42) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total deferred tax liabilities | **(6064)** | (6051) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net deferred tax liabilities | $**(5490)** | $(5396) |

---

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

**CASH PAID FOR INCOME TAXES**

For the year ended December 31, 2025, our cash paid for income taxes, net of refunds received, consisted of the following:

---

| | |
|:---|:---|
| ***(in millions)*** | **For the Year Ended December 31, 2025** |
| U.S. |  |
| &nbsp;&nbsp;Federal | $**103** |
| &nbsp;&nbsp;State | **95** |
| Foreign |  |
| &nbsp;&nbsp;Mexico | **103** |
| &nbsp;&nbsp;Ireland | **102** |
| &nbsp;&nbsp;Canada | **31** |
| &nbsp;&nbsp;Other foreign jurisdictions | **26** |
| Total cash paid for income taxes, net of refunds received | $**460** |

---

We paid $331 million and $507 million in cash for income taxes, net of refunds received, during the years ended December 31, 2024 and 2023, respectively.

**CARRYFORWARDS**

As of December 31, 2025 and 2024, we had $24 million and $30 million, respectively, in tax-effected net operating loss carryforwards. Of the $24 million of net operating loss carryforwards as of December 31, 2025, $21 million will not expire, $1 million related to state income tax will begin to expire in 2027, and the remaining $2 million related to foreign income tax will begin to expire in the year 2035.

As of December 31, 2025 and 2024, we had $5 million and $10 million of credit carryforwards, respectively. As of December 31, 2025, the $5 million of state tax credit carryforwards will begin to expire in the year 2027.

**VALUATION ALLOWANCES**

For the year ended December 31, 2025, the changes in our valuation allowances were insignificant.

**UNDISTRIBUTED FOREIGN EARNINGS**

An actual repatriation from our foreign subsidiaries could still be subject to additional foreign withholding taxes. We have analyzed our global working capital and cash requirements and continue to be indefinitely reinvested in our undistributed earnings, except for amounts in excess of our working capital and cash requirements. We have recorded any potential withholding tax liabilities, if necessary, attributable to repatriation.

**OTHER TAX MATTERS**

We file income tax returns for U.S. federal purposes and in various state jurisdictions. We also file income tax returns in various foreign jurisdictions, principally Canada, Ireland, Mexico, and Singapore. The U.S. and most state income tax returns for years prior to 2020 are closed to examination by applicable tax authorities. Canadian and Mexican income tax returns are generally open for audit for tax years 2020 and forward, and Ireland income tax returns are open for audit for tax years 2021 and forward.

Certain taxpayers may elect to transfer an eligible credit to an unrelated transferee taxpayer where the transferee taxpayer is then able to use the transferred tax credit against its own taxable income. During the years ended December 31, 2025, 2024, and 2023, we executed agreements with eligible taxpayers to purchase federal tax credits of $266 million, $260 million, and $270 million, respectively, which will be used against our federal tax liability. The discounts negotiated for the transfer of eligible federal tax credits of $23 million, $20 million, and $16 million were recorded as an income tax benefit in the Consolidated Statements of Income for the years ended December 31, 2025, 2024, and 2023, respectively.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

On July 4, 2025, the OBBB was signed into law in the U.S., which includes a broad range of tax reform provisions. The OBBB resulted in no significant impacts to our consolidated financial statements.

**UNRECOGNIZED TAX BENEFITS**

The following is a reconciliation of the changes in the gross balance of unrecognized tax benefits:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***(in millions)*** | **2025** | **2024** | **2023** |
| Balance, beginning of the period | $**12** | $13 | $15 |
| &nbsp;&nbsp;Increases related to tax positions taken during the current year | **3** | 2 | 3 |
| &nbsp;&nbsp;Increases (decreases) related to tax positions taken during the prior year | **17** | (1) | (2) |
| &nbsp;&nbsp;Decreases related to lapse of applicable statute of limitations | **—** | (2) | (3) |
| Balance, end of the period | $**32** | $12 | $13 |

---

The total amount of unrecognized tax benefits that would reduce the effective tax rate if recognized is $28 million after considering the federal impact of state income taxes.

We accrue interest and penalties on our uncertain tax positions as a component of our provision for income taxes. We recognized $5 million, $1 million, and $1 million of expense related to interest and penalties for uncertain tax positions for each of the years ended December 31, 2025, 2024, and 2023, respectively. We had a total of $9 million and $3 million accrued for interest and penalties for our uncertain tax positions reported as part of other non-current liabilities as of both December 31, 2025 and 2024.

**16. Accumulated Other Comprehensive Income (Loss)**

The following table provides a summary of changes in AOCI, net of taxes:

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***(in millions)*** | **Foreign Currency Translation** | **Pension and PRMB Liabilities** | **Cash Flow Hedges** | **Total** |
| Balance as of December 31, 2022 | $(86) | $(10) | $225 | $129 |
| &nbsp;&nbsp;Other comprehensive income (loss) | 288 | (5) | (41) | 242 |
| &nbsp;&nbsp;Amounts reclassified from AOCI |  | 1 | (57) | (56) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other comprehensive income (loss) | 288 | (4) | (98) | 186 |
| Balance as of December 31, 2023 | 202 | (14) | 127 | 315 |
| &nbsp;&nbsp;Other comprehensive (loss) income | (612) | (1) | 33 | (580) |
| &nbsp;&nbsp;Amounts reclassified from AOCI |  | 1 | (12) | (11) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other comprehensive (loss) income | (612) |  | 21 | (591) |
| Balance as of December 31, 2024 | (410) | (14) | 148 | (276) |
| &nbsp;&nbsp;Other comprehensive income (loss) | **401** | **(3)** | **2** | **400** |
| &nbsp;&nbsp;Amounts reclassified from AOCI | **—** | **1** | **(23)** | **(22)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Total other comprehensive income (loss) | **401** | **(2)** | **(21)** | **378** |
| Balance as of December 31, 2025 | $**(9)** | $**(16)** | $**127** | $**102** |

---

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

The following table presents the amount of losses (gains), net, reclassified from AOCI into the Consolidated Statements of Income:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***(in millions)*** | **Income Statement Caption** | **2025** | **2024** | **2023** |
| **Pension and PRMB liabilities** | SG&A expenses | $**1** | $2 | $1 |
| Income tax benefit |  | **—** | (1) |  |
| &nbsp;&nbsp;Total, net of tax |  | $**1** | $1 | $1 |
| **Cash flow hedges:** |  |  |  |  |
| Interest rate contracts<sup>(1)</sup> | Interest expense, net | $**(13)** | $(12) | $(74) |
| FX contracts | Cost of sales | **(17)** | (3) |  |
| &nbsp;&nbsp;Total |  | **(30)** | (15) | (74) |
| Income tax expense |  | **7** | 3 | 17 |
| &nbsp;&nbsp;Total, net of tax |  | $**(23)** | $(12) | $(57) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Amounts reclassified from AOCI into interest expense during the year ended December 31, 2023 include the realized gains associated with the termination of forward starting swaps designated as cash flow hedges of approximately $66 million.

**17. Property, Plant, and Equipment**

Property, plant, and equipment, net consisted of the following:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| ***(in millions)*** | **2025** | **2024** |
| Land | $**57** | $58 |
| Buildings and improvements | **912** | 825 |
| Machinery and equipment | **3862** | 3290 |
| Cold drink equipment | **170** | 142 |
| Software | **543** | 517 |
| Construction-in-progress | **289** | 384 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property, plant, and equipment, gross | **5833** | 5216 |
| Less: accumulated depreciation | **(2603)** | (2252) |
| &nbsp;&nbsp;&nbsp;&nbsp;Property, plant, and equipment, net | $**3230** | $2964 |

---

The following table summarizes the location of depreciation expense within the Consolidated Statements of Income:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***(in millions)*** | **2025** | **2024** | **2023** |
| Cost of sales | $**246** | $234 | $231 |
| SG&A expenses | **209** | 188 | 171 |
| &nbsp;&nbsp;&nbsp;Total depreciation expense | $**455** | $422 | $402 |

---

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

**18. Commitments and Contingencies** 

We are occasionally subject to litigation or other legal proceedings. We accrue for specific legal proceedings when we determine that the likelihood of an unfavorable outcome is probable and the amount of loss can be reasonably estimated, and such accruals were $3 million and $2 million as of December 31, 2025 and 2024, respectively. We have also identified certain other legal matters where we believe an unfavorable outcome is reasonably possible and/or for which no estimate of possible losses can be made. We do not believe that the outcome of these, or any other, pending legal matters, individually or collectively, will have a material adverse effect on our results of operations, financial condition, or liquidity.

**ANTITRUST LITIGATION**

In February 2014, TreeHouse Foods, Inc. and certain affiliated entities filed suit against our wholly-owned subsidiary, Keurig (formerly known as Green Mountain Coffee Roasters, Inc.), in the U.S. District Court for the Southern District of New York ("SDNY") (TreeHouse Foods, Inc. et al. v. Green Mountain Coffee Roasters, Inc. et al.). The TreeHouse complaint asserted claims under the federal antitrust laws and various state laws, contending that Keurig had monopolized alleged markets for single serve coffee brewers and single serve coffee pods. The TreeHouse complaint sought treble monetary damages, declaratory relief, injunctive relief and attorneys' fees. In the months that followed, a number of additional actions, including claims from another coffee manufacturer (JBR, Inc.), as well as putative class actions on behalf of direct and indirect purchasers of Keurig's products, were filed in various federal district courts, asserting claims and seeking relief substantially similar to the claims asserted and relief sought in the TreeHouse complaint. Additional similar actions were filed by individual direct purchasers (including McLane Company, Inc., BJ's Wholesale Club, Inc., Winn-Dixie Stores Inc. and Bi-Lo Holding LLC) in 2019 and in 2021. All of these actions were transferred to the SDNY for coordinated pre-trial proceedings (In re: Keurig Green Mountain Single-Serve Coffee Antitrust Litigation) (the "Multidistrict Antitrust Litigation").

In July 2020, Keurig reached an agreement with one of the plaintiff groups in the Multidistrict Antitrust Litigation, the putative indirect purchaser class, to settle the claims asserted for $31 million. The settlement class consisted of individuals and entities in the United States that purchased, from persons other than Keurig and not for purposes of resale, Keurig manufactured or licensed single serve beverage portion packs during the applicable class period (beginning in September 2010 for most states). The settlement was approved and paid, and the indirect purchasers' claims have been dismissed.

In October 2025, the SDNY court denied the direct purchasers plaintiffs' motion for class certification. While the court's order does not preclude individual purchasers from pursuing their own direct claims, the court found that the plaintiffs did not meet the federal requirements to pursue their case on a classwide basis. The direct purchaser plaintiffs have filed a petition with the United States Court of Appeals for the Second Circuit, seeking to appeal the SDNY court's decision.

Discovery in all remaining matters pending in the Multidistrict Antitrust Litigation is concluded, with the plaintiffs (which no longer include the purported direct purchaser class) collectively claiming approximately $1.5 billion of monetary damages. Keurig strongly disputes the merits of the claims and the calculation of damages. Keurig has fully briefed summary judgment motions that, if successful, would end the cases entirely.

Keurig intends to continue vigorously defending the remaining lawsuits. At this time, we are unable to predict the outcome of these lawsuits, the potential loss or range of loss, if any, associated with the resolution of these lawsuits or any potential effect they may have on us or our operations. Accordingly, we have not accrued for a loss contingency. Additionally, as the timelines in these cases may be beyond our control, we can provide no assurance as to whether or when there will be material developments in these matters.

**ENVIRONMENTAL, HEALTH, AND SAFETY MATTERS**

We operate many manufacturing, bottling, and distribution facilities. In these and other aspects of our business, we are subject to a variety of federal, state, and local environmental, health, and safety laws and regulations. We maintain environmental, health, and safety policies and a quality environmental, health, and safety program designed to ensure compliance with applicable laws and regulations. However, the nature of our business exposes us to the risk of claims with respect to environmental, health, and safety matters, and there can be no assurance that material costs or liabilities will not be incurred in connection with such claims.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

The federal Comprehensive Environmental Response, Compensation and Liability Act of 1980, also known as the Superfund law, as well as similar state laws, generally impose joint and several liability for cleanup and enforcement costs on current and former owners and operators of a site without regard to fault or the legality of the original conduct. We were notified by the Environmental Protection Agency that we are a potentially responsible party for study and cleanup costs at Superfund sites in New Jersey and in Michigan. Investigation and remediation costs are yet to be determined, therefore no reasonable estimate exists on which to base a loss accrual.

**PRODUCT WARRANTIES**

We offer a one year warranty on all Keurig brewing systems. We provide for the estimated cost of product warranties, primarily using historical information and current repair or replacement costs, at the time product revenue is recognized. Product warranties are included in accrued expenses in the accompanying Consolidated Balance Sheets.

---

| | |
|:---|:---|
| ***(in millions)*** | **Accrued Product Warranties** |
| Balance as of December 31, 2023 | $11 |
| &nbsp;&nbsp;Accruals for warranties issued | 14 |
| &nbsp;&nbsp;Settlements | (15) |
| Balance as of December 31, 2024 | 10 |
| &nbsp;&nbsp;Accruals for warranties issued | **8** |
| &nbsp;&nbsp;Settlements | **(12)** |
| Balance as of December 31, 2025 | $**6** |

---

**19. Transactions with Variable Interest Entities**

**EQUITY METHOD INVESTMENTS WHICH QUALIFY AS VIES**

Certain of our equity investments are in entities which qualify as VIEs. We have determined that we are not the primary beneficiary of these VIEs and therefore are not required to consolidate them, as the primary shareholder of each respective VIE has control over the board and decision-making for the activities that most significantly impact the VIE's economic performance, including sales, marketing, and operations. As of December 31, 2025 and 2024, our investments in Nutrabolt and Chobani represent investments in entities which qualify as VIEs but for which we are not the primary beneficiary. We have no obligation to provide additional funding to these VIEs, and thus our maximum exposure and risk of loss related to these VIEs is limited to the carrying value of our investment. Refer to Note 14 for the carrying value of these investments.

**OTHER TRANSACTIONS WITH VIES**

We have a number of leasing arrangements and one licensing arrangement with special purpose entities for which we are not the primary beneficiary, as we have limited power based on the contractual agreements to direct the activities that most significantly impact the VIEs' performance.

***Leasing Arrangements***

As of December 31, 2025, we have entered into sixteen lease transactions with VIEs. Each lease has an RVG based on a percentage of the VIEs' purchase price; however, we concluded it was not probable that we will owe an amount at the end of each individual lease term, as the fair values of the properties are not expected to fall below the RVGs at the end of each individual lease term. As such, we recorded each lease obligation excluding the associated RVG. The aggregate maximum undiscounted RVG associated with the leasing arrangements was $653 million and $652 million as of December 31, 2025 and 2024, respectively. This aggregate maximum value assumes that the fair value of each property at the end of either the original lease term or renewal term is equal to zero, which we have concluded is not probable.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

The following table provides the carrying amounts of the right-to-use assets and lease obligations recorded in the Consolidated Balance Sheets associated with these leasing arrangements related to the VIEs as of December 31, 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| ***(in millions)*** | **2025** | **2024** |
| Non-current assets | $**361** | $386 |
| Current liabilities | **26** | 24 |
| Non-current liabilities | **351** | 376 |

---

The leasing agreements included as of December 31, 2025 and 2024 include nine manufacturing sites, five distribution centers, one multipurpose property, and our Frisco, Texas headquarters.

***Licensing Arrangement***

ABC, a wholly-owned subsidiary of ours, has provided a guarantee in connection with its distribution agreement with the Veyron SPEs to be paid only in the event the Veyron SPEs sell specific distribution rights and the value of those distribution rights does not exceed $142 million, which is the maximum undiscounted amount that we could pay under the RVG. All obligations with respect to the guarantee will cease upon termination of the distribution agreement, which would occur upon notice by ABC not to renew the distribution agreement, us no longer being investment grade at the end of the term, or the sale of the distribution rights by the Veyron SPEs. As of December 31, 2025, we have not recorded a liability as it is not probable that we will have to make any payments required under the RVG, as the fair value of the distribution rights is not expected to fall below $142 million over the term of the agreement.

As of December 31, 2025, we had $77 million in fixed service fee commitments related to the 15-year distribution agreement, which was effective on December 28, 2020, with the Veyron SPEs. These commitments were used to assist the Veyron SPEs in obtaining financing. Such fixed service fee payments began on January 1, 2021.

Fixed service fees over the next five years are expected to be as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **For the Years Ending December 31,** | **For the Years Ending December 31,** | **For the Years Ending December 31,** | **For the Years Ending December 31,** | **For the Years Ending December 31,** |
| ***(in millions)*** | **2026** | **2027** | **2028** | **2029** | **2030** |
| Fixed service fees | $**7** | $**8** | $**8** | $**8** | $**7** |

---

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

**20. Restructuring**

**RESTRUCTURING PROGRAMS**

***Network Optimization***

In March 2024, we announced a restructuring program designed to more effectively and efficiently meet the needs of consumers and customers. Our restructuring program includes the closure of certain facilities and other costs intended to optimize our manufacturing and distribution footprint throughout our operations.

The restructuring program is expected to incur pre-tax restructuring charges in an estimated range of $170 million to $190 million through 2026, primarily comprised of asset related costs.

***2023 CEO Succession and Associated Realignment***

In 2023, we began to implement succession planning for our CEO, including a realignment of our executive and operating leadership team, in order to reinforce enterprise capabilities to support growth and to control costs. The program is expected to incur charges of approximately $80 million, primarily driven by severance costs, which were substantially completed as of December 31, 2024, and the sign-on bonus for our CEO.

**RESTRUCTURING CHARGES**

Restructuring and integration expenses for the defined programs during the periods presented were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| ***(in millions)*** | **2025** | **2024** | **2023** |
| 2024 Network Optimization | $**62** | $51 | $— |
| 2023 CEO Succession and Associated Realignment | **1** | 40 | 35 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total restructuring charges | $**63** | $91 | $35 |

---

**RESTRUCTURING LIABILITIES**

Restructuring liabilities that qualify as exit and disposal costs under U.S. GAAP are included in accounts payable and accrued expenses in the consolidated financial statements. Restructuring liabilities, primarily consisting of workforce reduction costs, were as follows:

---

| | |
|:---|:---|
| ***(in millions)*** | **Restructuring Liabilities** |
| Balance as of December 31, 2023 | $27 |
| &nbsp;&nbsp;Charges to expense | 34 |
| &nbsp;&nbsp;Cash payments | (17) |
| Balance as of December 31, 2024 | 44 |
| &nbsp;&nbsp;Charges to expense | **(6)** |
| &nbsp;&nbsp;Cash payments | **(30)** |
| Balance as of December 31, 2025 | $**8** |

---

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

**21. Related Parties** 

**IDENTIFICATION OF RELATED PARTIES**

***JAB***

Prior to February 28, 2025, JAB held a significant but non-controlling interest in KDP and representation on our Board. JAB and its affiliates also hold investments in a number of other companies that have commercial relationships with us. These commercial relationships may take the form of our purchase of raw materials, our license of the companies' trademarks for use in the manufacturing of K-Cup pods, our sale of products for resale to retail customers, or our manufacture or distribution of products to, or on behalf of, these companies. Prior to February 28, 2025, JAB and its affiliates were included in our disclosures of related party transactions.

On February 28, 2025, JAB BevCo B.V., a subsidiary of JAB, sold 87 million shares of our common stock through an underwritten secondary offering. Following this sale, JAB beneficially owned less than 10% of our outstanding common stock and the members of the Board affiliated with JAB resigned. Effective February 28, 2025, these disclosures are no longer applicable to JAB and its affiliates, and they are no longer included in our tabular disclosures below.

***Other Related Parties***

We hold investments in certain brand ownership companies, and in certain instances, we also have rights in specified territories to bottle and/or distribute the brands owned by such companies. We purchase inventory from these brand ownership companies and sell finished product to third-party customers, primarily in the U.S. Refer to Note 14 for additional information about our equity method investments.

**OPERATING TRANSACTIONS WITH RELATED PARTIES**

Trade accounts receivable, net from related parties were $31 million and $30 million as of December 31, 2025 and 2024, respectively, primarily related to product sales and royalty revenues. Accounts payable to related parties were $47 million and $35 million as of December 31, 2025 and 2024, respectively, primarily related to purchases of finished goods inventory for distribution.

Revenues from and expenses associated with these related parties were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **For the Year Ended December 31,** | **For the Year Ended December 31,** | **For the Year Ended December 31,** |
| ***(in millions)*** | **2025** | **2024** | **2023** |
| Revenues from related parties | $**24** | $163 | $143 |
| Expenses associated with related parties<sup>(1)</sup> | **163** | 128 | 132 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Expenses associated with related parties includes a reduction of $53 million, $93 million, and $42 million related to earned equity for the achievement of certain milestones included in our distribution agreement with related parties, which were recognized as a reduction of Cost of sales in the Consolidated Statements of Income for the years ended December 31, 2025, 2024, and 2023, respectively.

**OTHER TRANSACTIONS WITH RELATED PARTIES**

We made payments to Nutrabolt totaling $2 million, $8 million, and $52 million to acquire certain distribution rights during the years ended December 31, 2025, 2024, and 2023, respectively.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**KEURIG DR PEPPER INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

(CONTINUED)

**22. Subsequent Events**

**JV INVESTMENT**

In connection with the previously announced JV Commitment Letter, as described in Note 3, on February 23, 2026, we entered into the JV Transaction Agreement with the Pod Manufacturing JV, certain of our subsidiaries, and the JV Investor Partner.

Following completion of the transactions contemplated by the JV Transaction Agreement, the Pod Manufacturing JV will own or otherwise have access to our manufacturing assets and facilities used in the manufacturing of K-Cup pods and other unbrewed single-serve beverages in the United States and Canada. Following the closing of the JV Investment, the Pod Manufacturing JV intends to use the net proceeds from this transaction to fund a portion of the JDE Peet's Acquisition.

The JV Transaction Agreement provides that, at the closing of the JV Investment, we and the JV Investor Partner will enter into the Pod Manufacturing JV Agreement, which sets forth each partner's rights and responsibilities with respect to the Pod Manufacturing JV, including with respect to the limited partner committee (a majority of the members of which will be appointed by us), certain unanimous approval rights in favor of the JV Investor Partner, mechanisms for capital contributions to be made to the Pod Manufacturing JV, limitations on transfers by the partners, a call right exercisable by us beginning on the eighth anniversary of the closing of the JV Investment and ending on the fifteenth anniversary of the closing (or earlier upon the occurrence of certain triggering events), a conversion right exercisable by the JV Investor Partner after the fifteenth anniversary of the closing but before the thirtieth anniversary of the closing whereby the JV Investor Partner may elect to convert its interest in the Pod Manufacturing JV into shares of our common stock or its successor, based on the JV Investor Partner's remaining economic interest (subject to the call right), and tag-along rights for the JV Investor Partner if we desire to transfer our units. The Pod Manufacturing JV Agreement also sets forth distribution mechanics, pursuant to which the Pod Manufacturing JV shall make quarterly distributions of available cash (subject to certain limitations, including for operating costs and reserves) to its partners generally in proportion to their ownership interests.

The closing of the JV Transaction Agreement is subject to limited customary conditions. The parties expect to close the transactions substantially concurrently with the completion of the JDE Peet's Acquisition. The JV Transaction Agreement provides certain termination rights for both us and the JV Investor Partner, including if the JV Investment does not occur on or before March 3, 2027, if there is a material breach of the JV Transaction Agreement by the other party that is not cured within the applicable cure period, or if a law or order prevents the consummation of the transactions.

**PREFERRED INVESTMENT**

On February 23, 2026, we amended the Preferred Investment Agreement, under which the Preferred Investors agreed to purchase an additional 1.5 million shares of Convertible Preferred Stock, resulting in a total purchase of 4.5 million shares. Refer to Note 3 for additional information on the Preferred Investment Agreement.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

To the stockholders and the Board of Directors of Keurig Dr Pepper Inc.

**OPINION ON THE FINANCIAL STATEMENTS**

We have audited the accompanying consolidated balance sheets of Keurig Dr Pepper Inc. and subsidiaries (the "Company") as of December 31, 2025 and 2024, the related consolidated statements of income, comprehensive income, changes in stockholders' equity, and cash flows, for each of the three years in the period ended December 31, 2025, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2025, in conformity with accounting principles generally accepted in the United States of America.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2025, based on criteria established in *Internal Control - Integrated Framework (2013)* issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 24, 2026, expressed an unqualified opinion on the Company's internal control over financial reporting.

**BASIS FOR OPINION**

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

**CRITICAL AUDIT MATTER**

The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

***Indefinite-Lived Intangible Assets and Goodwill Valuation - Certain of the Brand Assets and Reporting Units - Refer to Notes 2 and 6 to the financial statements***

Critical Audit Matter Description

As discussed in Notes 2 and 6, the Company has indefinite-lived brand intangible assets ("brand assets") and goodwill. The Company's evaluation of brand assets and goodwill for impairment is performed annually as of October 1, or more frequently if events or circumstances indicate the carrying amount may not be recoverable and involves the comparison of the fair value of each brand asset or reporting unit to its carrying value. The Company used the income approach and a combination of income and market based approaches to estimate the fair value of brand assets and reporting units, respectively. These methods required management to make significant estimates and assumptions, specifically related to discount rates and forecasted cash flows. Assumptions may be sensitive to future market or industry conditions, as well as company-specific conditions, and changes in these assumptions could have a significant impact on the calculation of fair value. Given the significant judgments made by management to estimate certain of the fair values, a high degree of auditor judgment and an increased extent of effort were required to perform audit procedures that evaluated the reasonableness of management's estimates and assumptions.

How the Critical Audit Matter Was Addressed in the Audit

Our audit procedures consisted of risk assessment and testing management's impairment analyses including the underlying business and valuation assumptions for certain of the fair values. Those procedures included, but were not limited to, the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We tested the effectiveness of controls over the Company's brand assets and goodwill impairment review process.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We evaluated the reasonableness of management's ability to forecast revenue growth and margins by considering:

–Historical revenue and margins.

–Analysis of current and future business strategies for the projected periods.

–Information in industry reports.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• With the assistance of our fair value specialists, we evaluated the reasonableness of the valuation methodologies and assumptions, including discount rates.

/s/ Deloitte & Touche LLP

Dallas, TX

February 24, 2026

We have served as the Company's auditor since 2016.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

To the stockholders and the Board of Directors of Keurig Dr Pepper Inc.

**OPINION ON INTERNAL CONTROL OVER FINANCIAL REPORTING**

We have audited the internal control over financial reporting of Keurig Dr Pepper Inc. and subsidiaries (the "Company") as of December 31, 2025, based on criteria established in *Internal Control - Integrated Framework (2013)* issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2025, based on criteria established in *Internal Control - Integrated Framework (2013)* issued by COSO.

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2025, of the Company and our report dated February 24, 2026, expressed an unqualified opinion on those financial statements.

**BASIS FOR OPINION**

The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control over Financial Reporting, appearing under Item 9A. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

**DEFINITION AND LIMITATIONS OF INTERNAL CONTROL OVER FINANCIAL REPORTING**

A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ Deloitte & Touche LLP

Dallas, Texas

February 24, 2026

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE**

Not applicable.

**ITEM 9A. CONTROLS AND PROCEDURES**

**EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES**

As required by Rules 13a-15(b) and 15d-15(b) under the Exchange Act, management, with the participation of our CEO and CFO, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2025, and has concluded that our disclosure controls and procedures were effective to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is (i) recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms and (ii) accumulated and communicated to management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

**REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING**

Our management is responsible for establishing and maintaining adequate internal control over financial reporting for KDP, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control system is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the financial statements for external purposes in accordance with U.S. GAAP.

Our management, with the participation of the CEO and CFO, assessed the effectiveness of internal control over financial reporting. Based on the criteria for effective internal control over financial reporting established in *Internal Control - Integrated Framework (2013)* issued by the Committee of Sponsoring Organizations of the Treadway Commission, management concluded that the internal control over financial reporting was effective as of December 31, 2025.

All internal control systems, no matter how well designed, have inherent limitations and may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

**ATTESTATION REPORT OF THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

The effectiveness of our internal control over financial reporting as of December 31, 2025 has been audited by Deloitte & Touche LLP, our independent registered public accounting firm, as stated in their attestation report, which is included in Item 8, "Financial Statements and Supplementary Data," of this Annual Report on Form 10-K.

***Changes in Internal Control Over Financial Reporting***

As of December 31, 2025, management has concluded that there have been no changes in our internal control over financial reporting that occurred during our fourth quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**ITEM 9B. OTHER INFORMATION**

**USE OF RULE 10B5-1 TRADING ARRANGEMENTS**

On December 10, 2025, Robert Gamgort, Chairman of the Board, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act ("Rule 10b5-1(c)") for the sale of up to 1,400,000 shares of KDP's common stock until January 1, 2027.

During the fourth quarter of 2025, no other directors or executive officers of KDP adopted, modified, or terminated any contract, instruction, or written plan for the purchase or sale of KDP securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any "non-Rule 10b5-1 trading arrangement," as defined in Item 408 of Regulation S-K.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**DEPARTURE OF CHAIRMAN OF THE BOARD OF DIRECTORS**

On February 23, 2026, the Board accepted the resignation of Robert Gamgort as Chairman of the Board and a director of the Company, and the Board appointed Pamela Patsley, a current member of the Board, to serve as Chair of the Board, in each case, effective as of March 31, 2026. Mr. Gamgort's resignation was not related to any disagreement with the Company on any matter relating to its operations, policies or practices. Accordingly, the Board will reduce its size to ten members upon Mr. Gamgort's resignation.

Ms. Patsley has served as a member of the Board since July 2018 and served as Lead Independent Director of the Board since December 2024. Ms. Patsley served as the Executive Chairman of MoneyGram International, Inc. from 2016 to 2018 and its Executive Chairman and Chief Executive Officer from 2009 to 2015. Prior to joining the Board, Ms. Patsley served on the board of directors of Dr Pepper Snapple Group, Inc.

**ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS**

Not applicable.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**PART III**

**ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE**

Information required to be set forth hereunder has been omitted and will be incorporated by reference, when filed, from our Proxy Statement.

**ITEM 11. EXECUTIVE COMPENSATION**

Information required to be set forth hereunder has been omitted and will be incorporated by reference, when filed, from our Proxy Statement.

**ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS**

Information required to be set forth hereunder has been omitted and will be incorporated by reference, when filed, from our Proxy Statement.

**ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE**

Information required to be set forth hereunder has been omitted and will be incorporated by reference, when filed, from our Proxy Statement.

**ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES**

Information required to be set forth hereunder has been omitted and will be incorporated by reference, when filed, from our Proxy Statement.

**PART IV**

**ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES**

**FINANCIAL STATEMENTS**

The following financial statements are included in Part II, Item 8, "Financial Statements and Supplementary Data," in this Annual Report on Form 10-K:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Consolidated Statements of Income for the years ended December 31, 2025, 2024, and 2023.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Consolidated Statements of Comprehensive Income for the years ended December 31, 2025, 2024, and 2023.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Consolidated Balance Sheets as of December 31, 2025 and 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Consolidated Statements of Cash Flows for the years ended December 31, 2025, 2024, and 2023.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Consolidated Statements of Changes in Stockholders' Equity for the years ended December 31, 2025, 2024, and 2023.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Notes to Consolidated Financial Statements for the years ended December 31, 2025, 2024, and 2023 and as of December 31, 2025 and 2024.

**SCHEDULES**

Schedules are omitted because they are not required or applicable, or the required information is included in the Consolidated Financial Statements or related notes.

**EXHIBITS**

See Exhibit Index.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**EXHIBIT INDEX**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | |
|<br>**No.** |<br>**Exhibit Description** | **Form** | **Date of Filing** | **Exhibit Number** |<br>**Footnote** |
| <u>[2.1](https://www.sec.gov/Archives/edgar/data/1418135/000095014225002257/eh250670939_ex0201.htm)</u> | Merger Protocol, dated as of August 24, 2025, among Keurig Dr Pepper Inc. and JDE Peet's N.V. | 8-K | 8/25/2025 | 2.1 | ‡ |
| <u>[2.2](https://www.sec.gov/Archives/edgar/data/1418135/000095014225002257/eh250670939_ex0202.htm)</u> | Form of Irrevocable Undertaking, dated as of August 24, 2025 | 8-K | 8/25/2025 | 2.2 |  |
| <u>[3.1](https://www.sec.gov/Archives/edgar/data/1418135/000095012308005530/y57446exv3w1.htm)</u> | Amended and Restated Certificate of Incorporation of Dr Pepper Snapple Group, Inc. | 8-K | 5/12/2008 | 3.1 |  |
| <u>[3.2](https://www.sec.gov/Archives/edgar/data/1418135/000141813512000028/dps-ex32_2012630.htm)</u> | Certificate of Amendment to Amended and Restated Certificate of Incorporation of Dr Pepper Snapple Group, Inc. effective as of May 17, 2012 | 10-Q | 7/26/2012 | 3.2 |  |
| <u>[3.3](https://www.sec.gov/Archives/edgar/data/1418135/000129993316002518/exhibit1.htm)</u> | Certificate of Second Amendment to Amended and Restated Certificate of Incorporation of Dr Pepper Snapple Group, Inc. effective as of May 19, 2016 | 8-K | 5/20/2016 | 3.1 |  |
| <u>[3.4](https://www.sec.gov/Archives/edgar/data/1418135/000110465918044357/a18-16509_3ex3d1.htm)</u> | Certificate of Third Amendment to the Amended and Restated Certificate of Incorporation of Dr Pepper Snapple Group, Inc. effective as of July 9, 2018 | 8-K | 7/9/2018 | 3.1 |  |
| <u>[3.5](https://www.sec.gov/Archives/edgar/data/1418135/000141813525000013/kdp-ex35_20241231keurigdrp.htm)</u> | Amended and Restated By-Laws of Keurig Dr Pepper Inc. effective as of February 20, 2025 | 10-K | 2/25/2025 | 3.5 |  |
| <u>[4.1](https://www.sec.gov/Archives/edgar/data/1418135/000095012309072823/d70522exv4w1.htm)</u> | Indenture, dated as of December 15, 2009, between Dr Pepper Snapple Group, Inc. and Wells Fargo Bank, N.A., as trustee | 8-K | 12/23/2009 | 4.1 |  |
| <u>[4.2](https://www.sec.gov/Archives/edgar/data/1418135/000141813515000043/ex41fifthindenture.htm)</u> | Fifth Supplemental Indenture, dated as of November 9, 2015, among Dr Pepper Snapple Group, Inc., the guarantors party thereto and Wells Fargo Bank, N.A., as trustee | 8-K | 11/10/2015 | 4.1 |  |
| <u>[4.3](https://www.sec.gov/Archives/edgar/data/1418135/000141813515000043/ex43formof2045notes.htm)</u> | 4.50% Senior Note due 2045 (in global form), dated November 9, 2015, in the principal amount of $250,000,000 | 8-K | 11/10/2015 | 4.3 |  |
| <u>[4.4](https://www.sec.gov/Archives/edgar/data/1418135/000141813516000079/ex41sixthindenture.htm)</u> | Sixth Supplemental Indenture, dated as of September 16, 2016, among Dr Pepper Snapple Group, Inc., the guarantors party thereto and Wells Fargo Bank, N.A., as trustee | 8-K | 9/16/2016 | 4.1 |  |
| <u>[4.5](https://www.sec.gov/Archives/edgar/data/1418135/000141813516000079/ex42formof2026notes.htm)</u> | 2.55% Senior Note due 2026 (in global form), dated September 16, 2016, in the principal amount of $400,000,000 | 8-K | 9/16/2016 | 4.2 |  |
| <u>[4.6](https://www.sec.gov/Archives/edgar/data/1418135/000141813516000103/ex41seventhindenture.htm)</u> | Seventh Supplemental Indenture, dated as of December 14, 2016, among Dr Pepper Snapple Group, Inc., the guarantors party thereto and Wells Fargo Bank, N.A., as trustee | 8-K | 12/14/2016 | 4.1 |  |
| <u>[4.7](https://www.sec.gov/Archives/edgar/data/1418135/000141813516000103/ex44formof2027notes.htm)</u> | 3.43% Senior Note due 2027 (in global form), dated December 14, 2016, in the principal amount of $400,000,000 | 8-K | 12/14/2016 | 4.4 |  |
| <u>[4.8](https://www.sec.gov/Archives/edgar/data/1418135/000141813516000103/ex45formof2046notes.htm)</u> | 4.42% Senior Note due 2046 (in global form), dated December 14, 2016, in the principal amount of $400,000,000 | 8-K | 12/14/2016 | 4.5 |  |
| <u>[4.9](https://www.sec.gov/Archives/edgar/data/1418135/000110465917006174/a17-3651_1ex4d2.htm)</u> | Eighth Supplemental Indenture, dated as of January 31, 2017, among Bai Brands LLC, a New Jersey limited liability company, 184 Innovations Inc., a Delaware corporation (each as a new subsidiary guarantor under the Indenture dated April 30, 2008 (as referenced in Item 4.1 in this Exhibit Index), Dr Pepper Snapple Group, Inc., each other then-existing Guarantor under the Indenture) and Wells Fargo, National Bank, N.A., as trustee | 8-K | 2/2/2017 | 4.2 |  |
| <u>[4.10](https://www.sec.gov/Archives/edgar/data/1418135/000141813517000031/a41ninthsupplementalindent.htm)</u> | Ninth Supplemental Indenture, dated as of June 15, 2017, among Dr Pepper Snapple Group, Inc., the guarantors party thereto, and Wells Fargo Bank, N.A., as trustee | 8-K | 6/15/2017 | 4.1 |  |

---

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | |
|<br>**No.** |<br>**Exhibit Description** | **Form** | **Date of Filing** | **Exhibit Number** |<br>**Footnote** |
| <u>[4.11](https://www.sec.gov/Archives/edgar/data/1418135/000110465918044358/a18-16509_2ex4d1.htm)</u> | Base Indenture, dated as of May 25, 2018 between Maple Escrow Subsidiary and Wells Fargo Bank, N.A. as trustee | 8-K | 7/9/2018 | 4.1 |  |
| <u>[4.12](https://www.sec.gov/Archives/edgar/data/1418135/000110465918044358/a18-16509_2ex4d4.htm)</u> | Third Supplemental Indenture (including the form of note), dated as of May 25, 2018, among Maple Escrow Subsidiary, Inc. and Maple Parent Holdings Corp. as parent guarantor, and Wells Fargo Bank, N.A., as trustee relating to the 2025 Notes | 8-K | 7/9/2018 | 4.4 |  |
| <u>[4.13](https://www.sec.gov/Archives/edgar/data/1418135/000110465918044358/a18-16509_2ex4d5.htm)</u> | Fourth Supplemental Indenture (including the form of note), dated as of May 25, 2018, among Maple Escrow Subsidiary, Inc. and Maple Parent Holdings Corp. as parent guarantor, and Wells Fargo Bank, N.A., as trustee relating to the 2028 Notes | 8-K | 7/9/2018 | 4.5 |  |
| <u>[4.14](https://www.sec.gov/Archives/edgar/data/1418135/000110465918044358/a18-16509_2ex4d6.htm)</u> | Fifth Supplemental Indenture (including the form of note), dated as of May 25, 2018, among Maple Escrow Subsidiary, Inc. and Maple Parent Holdings Corp. as parent guarantor, and Wells Fargo Bank, N.A., as trustee relating to the 2038 Notes | 8-K | 7/9/2018 | 4.6 |  |
| <u>[4.15](https://www.sec.gov/Archives/edgar/data/1418135/000110465918044358/a18-16509_2ex4d7.htm)</u> | Sixth Supplemental Indenture (including the form of note), dated as of May 25, 2018, among Maple Escrow Subsidiary, Inc. and Maple Parent Holdings Corp. as parent guarantor, and Wells Fargo Bank, N.A., as trustee relating to the 2048 Notes | 8-K | 7/9/2018 | 4.7 |  |
| <u>[4.16](https://www.sec.gov/Archives/edgar/data/1418135/000110465918044358/a18-16509_2ex4d8.htm)</u> | Seventh Supplemental Indenture, dated as of July 9, 2018, among Keurig Dr Pepper Inc., the subsidiary guarantors thereto, and Wells Fargo Bank, N.A., as trustee | 8-K | 7/9/2018 | 4.8 |  |
| <u>[4.1](https://www.sec.gov/Archives/edgar/data/1418135/000110465920045968/tm2015044d3_ex4-1.htm)[7](https://www.sec.gov/Archives/edgar/data/1418135/000110465920045968/tm2015044d3_ex4-1.htm)</u> | Tenth Supplemental Indenture (including 3.20% Senior Notes Due 2030 and 3.80% Senior Notes Due 2050 (in global form)), dated as of April 13, 2020, among Keurig Dr Pepper Inc., the subsidiary guarantors thereto, and Wells Fargo Bank, N.A., as trustee | 8-K | 4/13/2020 | 4.1 |  |
| <u>[4.1](https://www.sec.gov/Archives/edgar/data/0001418135/000119312521081448/d153075dex41.htm)[8](https://www.sec.gov/Archives/edgar/data/0001418135/000119312521081448/d153075dex41.htm)</u> | Eleventh Supplemental Indenture (including 0.750% Senior Notes Due 2024, 2.250% Senior Notes Due 2031, and 3.350% Senior Notes Due 2051 (in global form)), dated as of March 15, 2021, among Keurig Dr Pepper Inc., the subsidiary guarantors thereto, and Wells Fargo Bank, N.A. as trustee | 8-K | 3/15/2021 | 4.1 |  |
| <u>[4.](https://www.sec.gov/Archives/edgar/data/1418135/000119312522115217/d294206dex41.htm)[19](https://www.sec.gov/Archives/edgar/data/1418135/000119312522115217/d294206dex41.htm)</u> | Twelfth Supplemental Indenture, dated as of April 22, 2022, among Keurig Dr Pepper Inc., the guarantors party thereto and Computershare Trust Company, N.A., as trustee | 8-K | 4/22/2022 | 4.1 |  |
| <u>[4.2](https://www.sec.gov/Archives/edgar/data/1418135/000119312524062259/d767072dex41.htm)[0](https://www.sec.gov/Archives/edgar/data/1418135/000119312524062259/d767072dex41.htm)</u> | Base Indenture, dated as of March 7, 2024, among Keurig Dr Pepper Inc., the guarantors party thereto and U.S. Bank Trust Company, National Association, as trustee | 8-K | 3/7/2024 | 4.1 |  |
| <u>[4.](https://www.sec.gov/Archives/edgar/data/1418135/000119312524062259/d767072dex42.htm)[21](https://www.sec.gov/Archives/edgar/data/1418135/000119312524062259/d767072dex42.htm)</u> | First Supplemental Indenture (including Floating Rate Senior Notes Due 2027, 5.100% Senior Notes Due 2027, 5.050% Senior Notes Due 2029, 5.200% Senior Notes Due 2031, and 5.300% Senior Notes Due 2034 (in global form)), dated as of March 7, 2024, among Keurig Dr Pepper Inc., the subsidiary guarantors thereto and U.S. Bank Trust Company, National Association, as trustee | 8-K | 3/7/2024 | 4.2 |  |
| <u>[4.2](https://www.sec.gov/Archives/edgar/data/1418135/000141813525000013/kdp-ex35_20241231keurigdrp.htm)[2](https://www.sec.gov/Archives/edgar/data/1418135/000141813525000013/kdp-ex35_20241231keurigdrp.htm)</u> | Term Loan Credit Agreement, dated as of October 25, 2024, among Keurig Dr Pepper Inc., the lenders party thereto and Bank of America, N.A., as administrative agent | 10-K | 2/25/2025 | 4.35 |  |

---

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | |
|<br>**No.** |<br>**Exhibit Description** | **Form** | **Date of Filing** | **Exhibit Number** |<br>**Footnote** |
| <u>[4.2](https://www.sec.gov/Archives/edgar/data/1418135/000119312525112841/d941579dex41.htm)[3](https://www.sec.gov/Archives/edgar/data/1418135/000119312525112841/d941579dex41.htm)</u> | Second Supplemental Indenture, dated as of May 5, 2025, among Keurig Dr Pepper Inc., the guarantors party thereto and U.S. Bank Trust Company, National Association, as trustee | 8-K | 5/5/2025 | 4.1 |  |
| <u>[4.2](https://www.sec.gov/Archives/edgar/data/1418135/000119312525112841/d941579dex41.htm)[4](https://www.sec.gov/Archives/edgar/data/1418135/000119312525112841/d941579dex41.htm)</u> | Form of Floating Rate Senior Note due 2026 | 8-K | 5/5/2025 | 4.2 |  |
| <u>[4.2](https://www.sec.gov/Archives/edgar/data/1418135/000119312525112841/d941579dex41.htm)[5](https://www.sec.gov/Archives/edgar/data/1418135/000119312525112841/d941579dex41.htm)</u> | Form of 4.350% Senior Note due 2028 | 8-K | 5/5/2025 | 4.3 |  |
| <u>[4.2](https://www.sec.gov/Archives/edgar/data/1418135/000119312525112841/d941579dex41.htm)[6](https://www.sec.gov/Archives/edgar/data/1418135/000119312525112841/d941579dex41.htm)</u> | Form of 4.600% Senior Note due 2030 | 8-K | 5/5/2025 | 4.4 |  |
| <u>[4.2](https://www.sec.gov/Archives/edgar/data/1418135/000119312525112841/d941579dex41.htm)[7](https://www.sec.gov/Archives/edgar/data/1418135/000119312525112841/d941579dex41.htm)</u> | Form of 5.150% Senior Note due 2035 | 8-K | 5/5/2025 | 4.5 |  |
| <u>[4.2](kdp-ex428xeighthsupplement.htm)[8](kdp-ex428xeighthsupplement.htm)</u> | Eighth Supplemental Indenture, dated as of August 15, 2025, among Keurig Dr Pepper Inc., the guarantors party thereto, and U.S. Bank Trust Company, National Association, as trustee |  |  |  | \* |
| <u>[4.](kdp-ex429xthirteenthsupple.htm)[29](kdp-ex429xthirteenthsupple.htm)</u> | Thirteenth Supplemental Indenture, dated as of August 15, 2025, among Keurig Dr Pepper Inc., the guarantors party thereto, and U.S. Bank Trust Company, National Association, as trustee |  |  |  | \* |
| <u>[4.](kdp-ex430xdescriptionofsec.htm)[30](kdp-ex430xdescriptionofsec.htm)</u> | Description of registered securities |  |  |  | \* |
| <u>[10.1](https://www.sec.gov/Archives/edgar/data/1418135/000141813519000044/exhibit101keurigdrpepperin.htm)</u> | Keurig Dr Pepper Inc. Omnibus Stock Incentive Plan of 2019 | 8-K | 6/11/2019 | 10.1 | ++ |
| <u>[10.2](https://www.sec.gov/Archives/edgar/data/1418135/000141813522000005/kdp-ex1011_20211231.htm)</u> | Keurig Dr Pepper Short-Term Incentive Plan and Sales Incentive Plan | 10-K | 2/24/2022 | 10.11 | ++ |
| <u>[10.3](https://www.sec.gov/Archives/edgar/data/1418135/000119312522095668/d335432dex101.htm)</u> | Letter Agreement by and between KDP and Robert J. Gamgort dated April 5, 2022 | 8-K | 4/5/2022 | 10.1 | ++ |
| <u>[10.4](https://www.sec.gov/Archives/edgar/data/1418135/000141813522000017/kdp-ex104_2022630.htm)</u> | Keurig Dr Pepper Inc. Executive Severance Plan, effective as of July 29, 2022 | 10-Q | 7/28/2022 | 10.4 | ++ |
| <u>[10.5](https://www.sec.gov/Archives/edgar/data/1418135/000141813523000003/kdp-ex1018letteragreements.htm)</u> | Letter Agreement by and between KDP and Sudhanshu Priyadarshi dated October 21, 2022 | 10-K | 2/23/2023 | 10.18 | ++ |
| <u>[10.6](https://www.sec.gov/Archives/edgar/data/1418135/000141813523000003/kdp-ex1020kdpshorttermince.htm)</u> | Keurig Dr Pepper Short-Term Incentive Plan | 10-K | 2/23/2023 | 10.20 | ++ |
| <u>[10.7](https://www.sec.gov/Archives/edgar/data/1418135/000141813523000018/kdp-ex101letteragreementti.htm)</u> | Letter Agreement by and between KDP and Timothy Cofer dated September 18, 2023 | 10-Q | 10/26/2023 | 10.1 | ++ |
| <u>[10.8](kdp-ex108xletteragreementb.htm)</u> | Letter Agreement by and between KDP and Anthony DiSilvestro dated November 21, 2025 |  |  |  | \*<br>++ |
| <u>[10.9](kdp-ex109xletteragreementb.htm)</u> | Letter Agreement by and between KDP and Sudhanshu Priyadarshi dated November 21, 2025 |  |  |  | \*<br>++ |
| <u>[10.10](https://www.sec.gov/Archives/edgar/data/1418135/000141813525000013/kdp-ex1019ghostlifestylell.htm)</u> | Amended and Restated Contribution and Merger Agreement, dated December 31, 2024, by and among Ghost Lifestyle LLC, The American Bottling Company, Phantom Merger Sub I LLC and certain other parties thereto | 10-K | 2/25/2025 | 10.19 | ‡ |
| <u>[10.11](https://www.sec.gov/Archives/edgar/data/1418135/000141813525000013/kdp-ex1020ghostlifestylell.htm)</u> | Ghost Lifestyle LLC Second Amended and Restated Limited Liability Company Agreement, dated December 31, 2024 | 10-K | 2/25/2025 | 10.20 | ‡ |
| <u>[10.12](https://www.sec.gov/Archives/edgar/data/1418135/000141813525000051/kdp-creditagreement2025.htm)</u> | Credit Agreement, dated as of March 31, 2025,<br>among Keurig Dr Pepper Inc., JPMorgan Chase<br>Bank, N.A. as administrative agent, and the<br>lenders and issuing banks party thereto | 8-K | 3/31/2025 | 10.1 | ‡ |
| <u>[10.13](https://www.sec.gov/Archives/edgar/data/1418135/000095014225002257/eh250670939_ex1001.htm)</u> | Bridge Credit Agreement, dated as of August 24, 2025, among Keurig Dr Pepper Inc., the lenders party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent | 8-K | 8/25/2025 | 10.1 | ‡ |
| <u>[10.14](https://www.sec.gov/Archives/edgar/data/1418135/000141813525000125/kdp-ex102_2025930.htm)</u> | Revolving Credit Agreement Amendment, dated as of September 30, 2025, among Keurig Dr Pepper Inc., the lenders party thereto and JPMorgan Chase, Bank, N.A., as administrative agent | 10-Q | 10/27/2025 | 10.2 |  |

---

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | |
|<br>**No.** |<br>**Exhibit Description** | **Form** | **Date of Filing** | **Exhibit Number** |<br>**Footnote** |
| <u>[10.15](https://www.sec.gov/Archives/edgar/data/1418135/000119312525257489/d36737dex101.htm)</u> | Preferred Investment Agreement, dated as of<br>October 27, 2025, by and between Keurig Dr<br>Pepper Inc., the KKR Investor and the Apollo<br>Investor | 8-K | 10/30/2025 | 10.1 |  |
| <u>[10.16](https://www.sec.gov/Archives/edgar/data/1418135/000119312526064353/d897620dex103.htm)</u> | Amendment to Preferred Investment Agreement, dated as of February 23, 2026, by and among Keurig Dr Pepper Inc., the KKR Investor and the Apollo Investor | 8-K | 2/23/2026 | 10.3 |  |
| <u>[10.17](https://www.sec.gov/Archives/edgar/data/1418135/000119312525257489/d36737dex102.htm)</u> | JV Commitment Letter, dated October 26, 2025,<br>between Keurig Dr Pepper Inc. and each of the JV<br>Investors | 8-K | 10/30/2025 | 10.2 |  |
| <u>[10.18](https://www.sec.gov/Archives/edgar/data/1418135/000119312526064353/d897620dex101.htm)</u> | Transaction Agreement, dated as of February 23, 2026, by and among Keurig Dr Pepper Inc., the Pod Manufacturing JV, Keurig Green Mountain, Inc., KGM Manufacturing LLC, Keurig Production Holding, LLC and the JV Investor Partner | 8-K | 2/23/2026 | 10.1 |  |
| <u>[10.19](https://www.sec.gov/Archives/edgar/data/1418135/000119312526064353/d897620dex102.htm)</u> | Form of Amended and Restated Limited Partnership Agreement of the Pod Manufacturing JV, by and among the Pod Manufacturing JV, Keurig JV GP, LLC, Keurig Production Subco, LLC, Keurig Lux Holdco, S.a.r.l. and the JV Investor Partner | 8-K | 2/23/2026 | 10.2 |  |
| <u>[10.](https://www.sec.gov/Archives/edgar/data/1418135/000095014225003251/eh250718644_ex1001.htm)[20](https://www.sec.gov/Archives/edgar/data/1418135/000095014225003251/eh250718644_ex1001.htm)</u> | Delayed Draw Term Loan Agreement dated as December 18, 2025, among Keurig Dr Pepper Inc., the lenders party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent | 8-K | 12/19/2025 | 10.1 |  |
| <u>[10.](https://www.sec.gov/Archives/edgar/data/1418135/000095014225003251/eh250718644_ex1002.htm)[21](https://www.sec.gov/Archives/edgar/data/1418135/000095014225003251/eh250718644_ex1002.htm)</u> | Amendment No.1 to Bridge Credit Agreement, dated as of December 18, 2025, among Keurig Dr Pepper Inc., the lenders party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent | 8-K | 12/19/2025 | 10.2 |  |
| <u>[10.](kdp-ex1022restrictedstocku.htm)[22](kdp-ex1022restrictedstocku.htm)</u> | Restricted Stock Unit Award Terms and Conditions under the Keurig Dr Pepper Omnibus Stock Incentive Plan of 2019 |  |  |  | \*<br>++ |
| <u>[10.2](kdp-ex1023matchingrestrict.htm)[3](kdp-ex1023matchingrestrict.htm)</u> | Matching Restricted Stock Unit Award Terms and Conditions under the Keurig Dr Pepper Omnibus Stock Incentive Plan of 2019 |  |  |  | \*<br>++ |
| <u>[10.2](kdp-ex1024performancestock.htm)[4](kdp-ex1024performancestock.htm)</u> | Performance Stock Unit Award Terms and Conditions under the Keurig Dr Pepper Omnibus Stock Incentive Plan of 2019 |  |  |  | \*<br>++ |
| <u>[10.2](kdp-ex1025boardltiawardter.htm)[5](kdp-ex1025boardltiawardter.htm)</u> | Directors' Restricted Stock Unit Award Terms and Conditions under the Keurig Dr Pepper Omnibus Incentive Plan of 2019 |  |  |  | \*<br>++ |
| <u>[19.1](https://www.sec.gov/Archives/edgar/data/1418135/000141813525000013/kdp-ex191insidertradingpol.htm)</u> | Insider Trading Policy | 10-K | 2/25/2025 | 19.1 |  |
| <u>[21.1](kdp-ex211_20251231subsidia.htm)</u> | List of Subsidiaries of Keurig Dr Pepper Inc. |  |  |  | \* |
| <u>[22.1](kdp-ex221_20251231guaranto.htm)</u> | List of Guarantor Subsidiaries |  |  |  | \* |
| <u>[23.1](kdp-ex231_20251231consento.htm)</u> | Consent of Deloitte & Touche LLP |  |  |  | \* |
| <u>[31.1](kdp-ex311_20251231.htm)</u> | Certification of Chief Executive Officer of Keurig Dr Pepper Inc. pursuant to Rule 13a-14(a) or 15d-14(a) promulgated under the Exchange Act. |  |  |  | \* |
| <u>[31.2](kdp-ex312_20251231.htm)</u> | Certification of Chief Financial Officer of Keurig Dr Pepper Inc. pursuant to Rule 13a-14(a) or 15d-14(a) promulgated under the Exchange Act. |  |  |  | \* |
| <u>[32.1](kdp-ex321_20251231.htm)</u> | Certification of Chief Executive Officer of Keurig Dr Pepper Inc. pursuant to Rule 13a-14(b) or 15d-14(b) promulgated under the Exchange Act, and Section 1350 of Chapter 63 of Title 18 of the United States Code. |  |  |  | \*\* |

---

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | |
|<br>**No.** |<br>**Exhibit Description** | **Form** | **Date of Filing** | **Exhibit Number** |<br>**Footnote** |
| <u>[32.2](kdp-ex322_20251231.htm)</u> | Certification of Chief Financial Officer of Keurig Dr Pepper Inc. pursuant to Rule 13a-14(b) or 15d-14(b) promulgated under the Exchange Act, and Section 1350 of Chapter 63 of Title 18 of the United States Code. |  |  |  | \*\* |
| <u>[97.1](https://www.sec.gov/Archives/edgar/data/1418135/000141813524000007/kdp_ex971x20231231.htm)</u> | Keurig Dr Pepper Inc. Clawback Policy, As Adopted on September 18, 2023 | 10-K | 2/22/2024 | 97.1 | ++ |
| 101 | The following financial information from Keurig Dr Pepper Inc.'s Annual Report on Form 10-K for the year ended December 31, 2025, formatted in XBRL (eXtensible Business Reporting Language): (i) Consolidated Statements of Income, (ii) Consolidated Statements of Comprehensive Income, (iii) Consolidated Balance Sheets, (iv) Consolidated Statements of Cash Flows, (v) Consolidated Statement of Changes in Stockholders' Equity, and (vi) the Notes to the Audited Consolidated Financial Statements. |  |  |  | \* |
| 104 | The cover page from this Annual Report on Form 10-K, formatted as Inline XBRL. |  |  |  | \* |

---

\* Filed herewith.

\*\* Furnished herewith.

++ Indicates a management contract or compensatory plan or arrangement.

‡ Certain portions of this exhibit have been omitted from this filing pursuant to Item 601 of Regulation S-K.

**ITEM 16. FORM 10-K SUMMARY**

Not applicable.

------

<u>[**Table of Contents**](#ic5c36f045fc7456185fd61e2116f03f7_7)</u>

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
| **Keurig Dr Pepper Inc.** | **Keurig Dr Pepper Inc.** |
| By: | /s/ Anthony DiSilvestro |
| Name: | Anthony DiSilvestro |
| Title: | Chief Financial Officer |
|  | (Principal Financial Officer) |
| Date: | February 24, 2026 |

---

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on February 24, 2026.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| By: | /s/ Timothy Cofer | /s/ Timothy Cofer | By: | /s/ Anthony DiSilvestro | /s/ Anthony DiSilvestro |
|  | Name: | Timothy Cofer |  | Name: | Anthony DiSilvestro |
|  | Title: | Chief Executive Officer |  | Title: | Chief Financial Officer |
|  |  | (Principal Executive Officer) |  |  | (Principal Financial Officer) |
| By: | /s/ Angela A. Stephens | /s/ Angela A. Stephens | By: | /s/ Robert J. Gamgort | /s/ Robert J. Gamgort |
|  | Name: | Angela A. Stephens |  | Name: | Robert J. Gamgort |
|  | Title: | Senior Vice President and Controller<br>(Principal Accounting Officer) |  | Title: | Chairman of the Board of Directors |
|  |  | Senior Vice President and Controller<br>(Principal Accounting Officer) |  |  | Chairman of the Board of Directors |
| By: | /s/ Oray Boston | /s/ Oray Boston | By: | /s/ Juliette Hickman | /s/ Juliette Hickman |
|  | Name: | Oray Boston |  | Name: | Juliette Hickman |
|  | Title: | Director |  | Title: | Director |
| By: | /s/ Pamela Patsley | /s/ Pamela Patsley | By: | /s/ Debra Sandler | /s/ Debra Sandler |
|  | Name: | Pamela Patsley |  | Name: | Debra Sandler |
|  | Title: | Director |  | Title: | Director |
| By: | /s/ Robert Singer | /s/ Robert Singer | By: | /s/ Michael Van de Ven | /s/ Michael Van de Ven |
|  | Name: | Robert Singer |  | Name: | Michael Van de Ven |
|  | Title: | Director |  | Title: | Director |
| By: | /s/ Lawson Whiting | /s/ Lawson Whiting |  |  |  |
|  | Name: | Lawson Whiting |  |  |  |
|  | Title: | Director |  |  |  |

---

## Exhibit 4.28

**EXHIBIT 4.28**

This EIGHTH SUPPLEMENTAL INDENTURE (this "<u>Eighth Supplemental Indenture</u>"), dated as of August 15, 2025, among KEURIG DR PEPPER INC., a Delaware corporation (the "<u>Company</u>"), the Guarantors listed in <u>Schedule I</u> (the "<u>Guarantors</u>"), COMPUTERSHARE TRUST COMPANY, N.A., successor in interest to WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking corporation (the "<u>Retiring Trustee</u>"), and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, a national banking corporation (the "<u>Successor Trustee</u>").

**RECITALS**

WHEREAS, the Company, as successor to Maple Escrow Subsidiary, Inc., and the Retiring Trustee have heretofore executed and delivered an indenture, dated as of May 25, 2018 (the "<u>Base Indenture</u>"), providing for the issuance by the Company from time to time of its debt securities to be issued in one or more series;

WHEREAS, Section 9.1 of the Base Indenture provides, among other things, that the Company, any Guarantors and the Retiring Trustee may, without the consent of Holders, enter into indentures supplemental to the Base Indenture to evidence and provide for the acceptance under the Base Indenture of a successor trustee;

WHEREAS, Section 7.8 of the Base Indenture provides, among other things, that the Retiring Trustee may resign at any time by so notifying the Company;

WHEREAS, the Company desires to appoint U.S. Bank Trust Company, National Association to serve as the Successor Trustee under the Base Indenture and with respect to the debt securities of any series issued and authenticated under the terms of the supplemental indentures to the Base Indenture listed on <u>Schedule II</u> hereto (the "<u>Debt Securities</u>");

WHEREAS, the Successor Trustee is willing to and by its execution of this Eighth Supplemental Indenture does hereby accept the appointment as trustee for all Debt Securities;

&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Section 9.1(5) of the Base Indenture permits the Company, the Guarantors, and the Trustee, without notice to or consent of any Holder, to amend or supplement the Indenture to make any change that does not adversely affect the legal rights of any Holders under the Indenture; and

&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, each of the Company, the Guarantors, the Retiring Trustee and the Successor Trustee have agreed to amend Section 7.7 of the Base Indenture as provided for herein and the Company and the Guarantors have determined that such amendment does not adversely affect the legal rights of any Holder under the Indenture.

NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration, the sufficiency and adequacy of which are hereby acknowledged, the parties hereto hereby agree as follows:

------

**ARTICLE I<br>DEFINITIONS AND INCORPORATION BY REFERENCE**

Section 1.01<u>Definitions</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All capitalized terms used herein and not otherwise defined below shall have the meanings ascribed thereto in the Base Indenture.

**ARTICLE II<br>APPLICATION OF SUPPLEMENTAL INDENTURE** 

Section 2.01<u>Resignation of the Retiring Trustee</u>. Pursuant to Section 7.8 of the Base Indenture, the Retiring Trustee hereby acknowledges its replacement as Trustee, Registrar and Paying Agent under the Base Indenture and under each indenture supplemental thereto (collectively, the "<u>Indenture</u>") with respect to all Debt Securities. The Retiring Trustee hereby assigns, transfers, delivers and confirms to the Successor Trustee all right, title, and interest of the Retiring Trustee in and to the trust under the Indenture with respect to all Debt Securities, all funds and other assets held in trust under the Indenture and all rights, powers, privileges, responsibilities, trusts, obligations, immunities, indemnities and duties of the Retiring Trustee, the Registrar and the Paying Agent under the Indenture. Notwithstanding the resignation of the Retiring Trustee as Trustee, Paying Agent, and Registrar under the Indenture, the Company shall remain obligated under the Indenture to compensate, reimburse and indemnify the Retiring Trustee in connection with its prior service as Trustee, Paying Agent, and Registrar as provided in the Indenture. The Company acknowledges its obligations set forth under the Indenture, including without limitation, to pay all amounts owing and payable to the Retiring Trustee pursuant to Section 7.7 of the Base Indenture (the "<u>Resigning Trustee Amounts</u>"). The Successor Trustee hereby agrees that any exercise of the charging lien of the Successor Trustee, including in connection with any bankruptcy proceeding and/or from any proceeds of collateral, shall include the payment of any and all outstanding Resigning Trustee Amounts.

Section 2.02<u>Appointment of the Successor Trustee</u>. Effective as of the date first written above (the "<u>Effective Date</u>"), the Company hereby appoints the Successor Trustee as Trustee under the Indenture with respect to all Debt Securities. The Successor Trustee is hereby vested with all rights, powers, privileges, responsibilities, trusts, obligations, immunities, protections, indemnities and duties of the Trustee, Registrar and Paying Agent under the Indenture with respect to each series of Debt Securities.

Section 2.03<u>Acceptance by the Successor Trustee</u>. The Successor Trustee hereby: (a) accepts its appointment as Trustee, Registrar and Paying Agent under the Indenture with respect to all Debt Securities; (b) agrees to perform and shall be bound by every provision of the Indenture applicable to the "Trustee" thereunder, as fully and effectually as if originally named therein as Trustee; and (c) represents and warrants that it is qualified and eligible under the provisions of Article VII of the Base Indenture and applicable law to act as Trustee with respect to the Securities.

------

Section 2.04&nbsp;&nbsp;&nbsp;&nbsp;<u>Amendment.</u> The Company, the Guarantors, the Retiring Trustee and the Successor Trustee hereby agree to amend the first paragraph of Section 7.7 of the Base Indenture as follows:

"The Company and any Guarantor, jointly and severally, shall pay to the Trustee from time to time compensation for its acceptance of this Indenture and services hereunder as the Company and the Trustee shall from time to time agree in writing. The Trustee's compensation shall not be limited by any law on compensation of a trustee of an express trust. The Company shall reimburse the Trustee promptly upon request for all reasonable out-of-pocket expenses incurred or made by it, including costs of collection, costs of preparing and reviewing reports, certificates and other documents, costs of preparation and mailing of notices to Holders, in addition to the compensation for its services. Such expenses shall include the reasonable compensation and expenses, disbursements and advances of the Trustee's agents, counsel, accountants and experts. The Company and any Guarantor, jointly and severally, shall indemnify the Trustee against any and all losses, liabilities, damages, claims, penalties, fines or expenses (including reasonable attorneys' fees and expenses) (for purposes of this Section 7.7, "losses") incurred by it in connection with the administration of this trust and the performance of its duties hereunder, including the costs and expenses of enforcing this Indenture (including this Section 7.7) and of defending itself against any claims (whether asserted by any Holder, the Company or otherwise), except to the extent such losses may be attributable to its gross negligence or willful misconduct (as determined by a court of competent jurisdiction in a final and non-appealable decision). The Trustee shall notify the Company promptly of any claim for which it may seek indemnity. Failure by the Trustee to so notify the Company shall not relieve the Company of its obligations hereunder. The Company shall defend the claim with counsel reasonably satisfactory to the Trustee and the Trustee shall provide reasonable cooperation at the Company's and/or the Guarantors' expense in the defense. The Trustee may have separate counsel and the Company shall pay the fees and expenses of such counsel provided that the Company and the Guarantors shall not be required to pay such fees and expenses if it assumes the Trustee's defense, and, in the reasonable judgment of outside counsel to the Trustee, there is no conflict of interest between the Company and the Trustee in connection with such defense. Any settlement which affects the Trustee may not be entered into without the written consent of the Trustee, which consent shall not be unreasonably delayed, conditioned or withheld, unless the Trustee is given a full and unconditional release from liability with respect to the claims covered thereby and such settlement does not include a statement or admission of fault, culpability or failure to act by or on behalf of the Trustee. The Company and the Guarantors shall not be under any obligation to pay for any written settlement without its consent, which consent shall not be unreasonably delayed, conditioned or withheld. The Company and the Guarantors need not reimburse any expense incurred by the Trustee through the Trustee's own willful misconduct or gross negligence."

------

Section 2.05<u>Representations and Warranties of the Retiring Trustee to the Company and the Successor Trustee</u>. The Retiring Trustee represents and warrants to the Company and the Successor Trustee that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)The Retiring Trustee understands that all of the rights, powers, privileges, responsibilities, trusts, obligations, immunities, protections, indemnities and duties of the Trustee outlined in the Indenture are hereby assigned, delivered and conveyed to the Successor Trustee (except as stated in Section 2.01 hereof);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)The Retiring Trustee has full power and authority to execute and deliver this Eighth Supplemental Indenture and to perform its obligations hereunder; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)The Eighth Supplemental Indenture has been duly and validly authorized, executed and delivered by the Retiring Trustee and constitutes its legal, valid and binding obligation, enforceable in accordance with its terms.

Section 2.06<u>Representations and Warranties of the Successor Trustee to the Company and the Retiring Trustee</u>. The Successor Trustee represents and warrants to the Company and the Retiring Trustee that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)The Successor Trustee is qualified and eligible under the provisions of Article VII of the Base Indenture to accept its appointment as successor Trustee with respect to all Debt Securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)The Successor Trustee has full power and authority to execute and deliver this Eighth Supplemental Indenture and to perform its obligations hereunder; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)The Eighth Supplemental Indenture has been duly and validly authorized, executed and delivered by the Successor Trustee and constitutes its legal, valid and binding obligation, enforceable in accordance with its terms.

Section 2.07<u>Representations and Warranties of the Company to the Successor Trustee</u>. The Company represents and warrants to the Successor Trustee that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)The Eighth Supplemental Indenture has been duly and validly authorized, executed and delivered by the Company and constitutes its legal, valid and binding obligations, enforceable in accordance with its terms;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)No Event of Default has occurred and is continuing;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)The Retiring Trustee has been properly replaced as Trustee effective as of the Effective Date under the terms of the Indenture; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)All conditions relating to the appointment of the Successor Trustee as successor Trustee under the Indenture have been met by the Company.

------

Section 2.08<u>Corporate Trust Office of the Successor Trustee</u>. For all purposes under the Indenture, including the presentation or surrender of the Securities for payment, registration, transfer or exchange and for the service of notices and demands to or upon the Company in respect of the Securities, the "Corporate Trust Office of the Trustee" or other similar terms shall thereafter be deemed to refer to the Corporate Trust Office of the Successor Trustee at (i) for purposes of surrender, registration, transfer, exchange, or presentation for payment at 111 Fillmore Avenue. St. Paul, MN 55107, Attention: Global Corporate Trust – Keurig Dr Pepper Inc., and (ii) for all other purposes, One Federal Street, Boston, MA 02110, Attention: Global Corporate Trust – Keurig Dr Pepper Inc., or such other address as the Successor Trustee may designate by notice to the Company and the Holders.

Section 2.09<u>Effect of this Eighth Supplemental Indenture</u>. On and after the Effective Date, every reference in the Indenture or in any Securities to the "Trustee" shall be deemed to be a reference to the Successor Trustee, and every right, privilege, protection, immunity, indemnity and benefit afforded to the Trustee under the Indenture shall vest in and be enjoyed by the Successor Trustee with respect to all Securities, whether issued prior to, on or after the Effective Date, *provided*, however, that the Company shall remain obligated under the Indenture to compensate, reimburse and indemnify the Retiring Trustee in connection with its prior service as Trustee, Paying Agent, and Registrar as provided in the Indenture as stated in Section 2.01 hereof.

**ARTICLE III<br>MISCELLANEOUS**

Section 3.01<u>Ratification of Indenture</u>. This Eighth Supplemental Indenture is executed and shall be construed as an indenture supplement to the Base Indenture, and as supplemented and modified hereby, the Base Indenture is in all respects ratified and confirmed, and the Base Indenture and this Eighth Supplemental Indenture shall be read, taken and construed as one and the same instrument.

Section 3.02<u>Trust Indenture Act Controls</u>. If any provision of this Eighth Supplemental Indenture limits, qualifies or conflicts with another provision that is required or deemed to be included in this Eighth Supplemental Indenture by the Trust Indenture Act the required or deemed provision shall control.

Section 3.03<u>Notices</u>**.** All notices and other communications shall be given as provided in the Base Indenture; *provided* that any notice or communication mailed to the Company, the Resigning Trustee or the Successor Trustee shall be addressed as follows:

if to the Company:

Keurig Dr Pepper Inc.

6425 Hall of Fame Lane

Frisco, Texas 75034

Attention: Chief Legal Officer and General Counsel

------

if to the Resigning Trustee:

Computershare Trust Company, N.A.

1505 Energy Park Drive

St. Paul, MN 55108

Attention: CCT Administrator for Keurig Dr. Pepper Inc.

if to the Successor Trustee:

U.S. Bank Trust Company, National Association

One Federal Street

Boston, MA 02110

Attention: Global Corporate Trust

Section 3.04<u>Governing Law; Waiver of Jury Trial</u>. THIS EIGHTH SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE.

Section 3.05<u>Successors</u>. All agreements of the Company, the Retiring Trustee and the Successor Trustee in this Eighth Supplemental Indenture shall bind their respective successors. All agreements of Retiring Trustee and the Successor Trustee in this Eighth Supplemental Indenture shall bind each of its successors.

Section 3.06<u>Multiple Originals</u>. The parties may sign any number of copies of this Eighth Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. One signed copy is enough to prove this Eighth Supplemental Indenture.

Section 3.07<u>Headings</u>. The headings of the Articles and Sections of this Eighth Supplemental Indenture have been inserted for convenience of reference only, are not intended to be considered a part hereof and shall not modify or restrict any of the terms or provisions hereof.

Section 3.08<u>Trustee Not Responsible for Recitals</u>. The recitals contained herein shall be taken as statements of the Company, and the Retiring Trustee and the Successor Trustee do not assume any responsibility for their correctness. The Resigning Trustee and the Successor Trustee make no representations as to the validity or sufficiency of this Eighth Supplemental Indenture, except that each of the Resigning Trustee and the Successor Trustee represents that it is duly authorized to execute and deliver this Eighth Supplemental Indenture and perform its obligations hereunder. Except as otherwise expressly provided herein, no duties, responsibilities or liabilities are assumed, or shall be construed to be assumed, by the Resigning Trustee or the Successor Trustee by reason of this Eighth Supplemental Indenture. In acting hereunder, all of the rights, privileges, protections, indemnities, immunities and benefits afforded

------

to the Resigning Trustee and the Successor Trustee under the Base Indenture are deemed to be incorporated herein and shall be enforceable by the Resigning Trustee and the Successor Trustee hereunder as if set forth herein in full.

Section 3.09<u>Force Majeure</u>. In no event shall the Resigning Trustee or the Successor Trustee be responsible or liable for any failure or delay in the performance of its obligations arising out of or caused by, directly or indirectly, forces beyond its control, including, without limitation, (i) any act or provision of present or future law or regulation or governmental authority, (ii) labor disputes, strikes or work stoppages, (iii) accidents, (iv) acts of war or terrorism, (v) civil or military disturbances or unrest, (vi) nuclear or natural catastrophes or acts of God, (vii) epidemics or pandemics, (viii) disease, (ix) national emergency, (x) interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services, (xi) communications system failure, (xii) malware or ransomware, (xiii) the unavailability of the Federal Reserve Bank wire, telex or other communication or wire facility or (xiv) unavailability of any securities clearing system; it being understood that the Resigning Trustee and the Successor Trustee, as applicable, shall undertake commercially reasonable efforts to resume performance as soon as practicable under the circumstances.

Section 3.10<u>Damages</u>. In no event shall the Resigning Trustee or the Successor Trustee be liable to any Person for special, punitive, indirect, consequential or incidental loss or damage of any kind whatsoever (including, but not limited to, lost profits), even if the Resigning Trustee or the Successor Trustee, as applicable, has been advised of the likelihood of such loss or damage and regardless of the form of action.

Section 3.11<u>USA PATRIOT Act</u>. The Company acknowledges that in accordance with Section 326 of the U.S.A. PATRIOT Act, the Successor Trustee, like all financial institutions and in order to help fight the funding of terrorism and money laundering, is required to obtain, verify, and record information that identifies each person or legal entity that establishes a relationship or opens an account with the Successor Trustee. The Company and the Guarantors agree that they will provide the Successor Trustee with such information as it may request in order for the Successor Trustee to satisfy the requirements of the USA PATRIOT Act.

Section 3.12<u>Electronic Signatures</u>. This Eighth Supplemental Indenture and any certificate, agreement or other document to be signed in connection with this Eighth Supplemental Indenture and the transactions contemplated hereby shall be valid, binding, and enforceable against a party only when executed and delivered by an authorized individual on behalf of the party by means of (i) an original manual signature, (ii) a faxed, scanned, or photocopied manual signature, or (iii) in the case of this Eighth Supplemental Indenture and any certificate, agreement or other document to be signed in connection with this Eighth Supplemental Indenture and the transactions contemplated hereby, any electronic signature permitted by the federal Electronic Signatures in Global and National Commerce Act, state enactments of the Uniform Electronic Transactions Act, and/or any other relevant electronic signatures law, including relevant provisions of the Uniform Commercial Code (collectively, "<u>Signature Law</u>"). Each electronic signature or faxed, scanned, or photocopied manual signature shall for all purposes have the same validity, legal effect, and admissibility in evidence as an

------

original manual signature. Each party hereto shall be entitled to conclusively rely upon, and shall have no liability with respect to, any faxed, scanned, or photocopied manual signature, or other electronic signature of any party and shall have no duty to investigate, confirm or otherwise verify the validity or authenticity thereof. For avoidance of doubt, original manual signatures shall be used for execution or indorsement of writings when required under the Uniform Commercial Code or other Signature Law due to the character or intended character of the writings. For the avoidance of doubt, all notices, approvals, consents, requests and any communications hereunder must be in writing (provided that any communication sent to Trustee hereunder must be in the form of a document that is signed manually or by way of a digital signature provided by DocuSign or Adobe (or such other digital signature provider as specified in writing to Trustee by the authorized representative)), in English. The Company agrees to assume all risks arising out of the use of using digital signatures and electronic methods to submit communications to the Resigning Trustee and the Successor Trustee, as applicable, including without limitation the risk of the Resigning Trustee and the Successor Trustee, as applicable, acting on unauthorized instructions, and the risk of interception and misuse by third parties.

Section 3.13<u>Effectiveness</u>. This Eighth Supplemental Indenture shall become effective as of the Effective Date upon execution and delivery hereof by each of the parties hereto.

[Signature page follows]

------

IN WITNESS WHEREOF, the parties have caused this Eighth Supplemental Indenture to be duly executed as of the date first written above.

**COMPANY:<br>**<br> KEURIG DR PEPPER INC.

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Dan Morrell&nbsp;&nbsp;&nbsp;&nbsp;</u><br>Name: Dan Morrell<br>Title: Vice President and Treasurer

*[Signature Page to the Eighth Supplemental Indenture]*

------

**GUARANTORS:**<br>234DP AVIATION, LLC<br>A & W CONCENTRATE COMPANY<br>BAI BRANDS LLC<br>BEVERAGES DELAWARE INC.<br>DP BEVERAGES INC.<br>DPS AMERICAS BEVERAGES, LLC<br>DPS BEVERAGES, INC.<br>DPS HOLDINGS INC.<br>DR PEPPER/SEVEN-UP BEVERAGE SALES COMPANY<br>DR PEPPER/SEVEN UP MANUFACTURING COMPANY<br>DR PEPPER/SEVEN UP, INC.<br>MOTT'S DELAWARE LLC<br>MOTT'S LLP<br>NANTUCKET ALLSERVE, LLC<br>SNAPPLE BEVERAGE CORP.<br>SPLASH TRANSPORT, INC.<br>THE AMERICAN BOTTLING COMPANY<br>

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Dan Morrell&nbsp;&nbsp;&nbsp;&nbsp;</u><br>Name: Dan Morrell<br>Title: Vice President and Treasurer

*[Signature Page to the Eighth Supplemental Indenture]*

------

**RESIGNING TRUSTEE:**

COMPUTERSHARE TRUST COMPANY, N.A., as Resigning Trustee

By: <u>/s/ Eric Schlemmer&nbsp;&nbsp;&nbsp;&nbsp;</u> <br> Name: Eric Schlemmer<br> Title: Vice President

**SUCCESSOR TRUSTEE:**

U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Successor Trustee

By: <u>/s/ David J. Ganss&nbsp;&nbsp;&nbsp;&nbsp;</u> <br> Name: David J. Ganss<br> Title: Vice President

*[Signature Page to the Eighth Supplemental Indenture]*

------

**SCHEDULE I**

**<u>LIST OF GUARANTORS</u>**

---

| |
|:---|
| 234DP Aviation, LLC |
| A & W Concentrate Company |
| Bai Brands LLC |
| Beverages Delaware Inc. |
| DP Beverages Inc. |
| DPS Americas Beverages, LLC |
| DPS Beverages, Inc. |
| DPS Holdings Inc. |
| Dr Pepper/Seven-Up Beverage Sales Company |
| Dr Pepper/Seven Up Manufacturing Company |
| Dr Pepper/Seven Up, Inc. |
| Mott's Delaware LLC |
| Mott's LLP |
| Nantucket Allserve LLC |
| Snapple Beverage Corp. |
| Splash Transport, Inc. |
| The American Bottling Company |

---

Schedule I-1

------

**SCHEDULE II**

**<u>LIST OF THE DEBT SECURITIES</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Title of Notes** | **CUSIP Numbers** | **ISIN Numbers** | **Reg S CUSIP Numbers** | **Reg S ISIN Numbers** |
| 4.597% Senior Notes due 2028 | 49271VAF7 | US49271VAF76 |  |  |
| 4.985% Senior Notes due 2038 | 49271VAC4 | US49271VAC46 |  |  |
| 5.085% Senior Notes due 2048 | 49271VAD2<br>565122AG3 | US49271VAD29<br>US565122AG31 | U56495AF8 | USU56495AF83 |

---

Schedule II-1

## Exhibit 4.29

**EXHIBIT 4.29**

This THIRTEENTH SUPPLEMENTAL INDENTURE (this "<u>Thirteenth Supplemental Indenture</u>"), dated as of August 15, 2025, among KEURIG DR PEPPER INC., a Delaware corporation (the "<u>Company</u>"), the Guarantors listed in <u>Schedule I</u> (the "<u>Guarantors</u>"), COMPUTERSHARE TRUST COMPANY, N.A., successor in interest to WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking corporation (the "<u>Retiring Trustee</u>"), and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, a national banking corporation (the "<u>Successor Trustee</u>").

**RECITALS**

WHEREAS, the Company and the Retiring Trustee have heretofore executed and delivered an indenture, dated as of December 15, 2009 (the "<u>Base Indenture</u>"), providing for the issuance by the Company from time to time of its debt securities to be issued in one or more series;

WHEREAS, Section 9.1 of the Base Indenture provides, among other things, that the Company, any Guarantors and the Retiring Trustee may, without the consent of Holders, enter into indentures supplemental to the Base Indenture to evidence and provide for the acceptance under the Base Indenture of a successor trustee;

WHEREAS, Section 7.8 of the Base Indenture provides, among other things, that the Retiring Trustee may resign at any time by so notifying the Company;

WHEREAS, the Company desires to appoint U.S. Bank Trust Company, National Association to serve as the Successor Trustee under the Base Indenture and with respect to the debt securities of any series issued and authenticated under the terms of the supplemental indentures to the Base Indenture listed on <u>Schedule II</u> hereto (the "<u>Debt Securities</u>");

WHEREAS, the Successor Trustee is willing to and by its execution of this Thirteenth Supplemental Indenture does hereby accept the appointment as trustee for all Debt Securities;

&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Section 9.1(5) of the Base Indenture permits the Company, the Guarantors, and the Trustee, without notice to or consent of any Holder, to amend or supplement the Indenture to make any change that does not adversely affect the legal rights of any Holders under the Indenture; and

&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, each of the Company, the Guarantors, the Retiring Trustee and the Successor Trustee have agreed to amend Section 7.7 of the Base Indenture as provided for herein and the Company and the Guarantors have determined that such amendment does not adversely affect the legal rights of any Holder under the Indenture.

NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration, the sufficiency and adequacy of which are hereby acknowledged, the parties hereto hereby agree as follows:

------

**ARTICLE I<br>DEFINITIONS AND INCORPORATION BY REFERENCE**

Section 1.01<u>Definitions</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All capitalized terms used herein and not otherwise defined below shall have the meanings ascribed thereto in the Base Indenture.

**ARTICLE II<br>APPLICATION OF SUPPLEMENTAL INDENTURE** 

Section 2.01<u>Resignation of the Retiring Trustee</u>. Pursuant to Section 7.8 of the Base Indenture, the Retiring Trustee hereby acknowledges its replacement as Trustee, Registrar and Paying Agent under the Base Indenture and under each indenture supplemental thereto (collectively, the "<u>Indenture</u>") with respect to all Debt Securities. The Retiring Trustee hereby assigns, transfers, delivers and confirms to the Successor Trustee all right, title, and interest of the Retiring Trustee in and to the trust under the Indenture with respect to all Debt Securities, all funds and other assets held in trust under the Indenture and all rights, powers, privileges, responsibilities, trusts, obligations, immunities, indemnities and duties of the Retiring Trustee, the Registrar and the Paying Agent under the Indenture. Notwithstanding the resignation of the Retiring Trustee as Trustee, Paying Agent, and Registrar under the Indenture, the Company shall remain obligated under the Indenture to compensate, reimburse and indemnify the Retiring Trustee in connection with its prior service as Trustee, Paying Agent, and Registrar as provided in the Indenture. The Company acknowledges its obligations set forth under the Indenture, including without limitation, to pay all amounts owing and payable to the Retiring Trustee pursuant to Section 7.7 of the Base Indenture (the "<u>Resigning Trustee Amounts</u>"). The Successor Trustee hereby agrees that any exercise of the charging lien of the Successor Trustee, including in connection with any bankruptcy proceeding and/or from any proceeds of collateral, shall include the payment of any and all outstanding Resigning Trustee Amounts.

Section 2.02<u>Appointment of the Successor Trustee</u>. Effective as of the date first written above (the "<u>Effective Date</u>"), the Company hereby appoints the Successor Trustee as Trustee under the Indenture with respect to all Debt Securities. The Successor Trustee is hereby vested with all rights, powers, privileges, responsibilities, trusts, obligations, immunities, protections, indemnities and duties of the Trustee, Registrar and Paying Agent under the Indenture with respect to each series of Debt Securities.

Section 2.03<u>Acceptance by the Successor Trustee</u>. The Successor Trustee hereby: (a) accepts its appointment as Trustee, Registrar and Paying Agent under the Indenture with respect to all Debt Securities; (b) agrees to perform and shall be bound by every provision of the Indenture applicable to the "Trustee" thereunder, as fully and effectually as if originally named therein as Trustee; and (c) represents and warrants that it is qualified and eligible under the provisions of Article VII of the Base Indenture and applicable law to act as Trustee with respect to the Securities.

------

Section 2.04&nbsp;&nbsp;&nbsp;&nbsp;<u>Amendment.</u> The Company, the Guarantors, the Retiring Trustee and the Successor Trustee hereby agree to amend the first paragraph of Section 7.7 of the Base Indenture as follows:

"The Company and any Guarantor, jointly and severally, shall pay to the Trustee from time to time compensation for its acceptance of this Indenture and services hereunder as the Company and the Trustee shall from time to time agree in writing. The Trustee's compensation shall not be limited by any law on compensation of a trustee of an express trust. The Company shall reimburse the Trustee promptly upon request for all reasonable out-of-pocket expenses incurred or made by it, including costs of collection, costs of preparing and reviewing reports, certificates and other documents, costs of preparation and mailing of notices to Holders, in addition to the compensation for its services. Such expenses shall include the reasonable compensation and expenses, disbursements and advances of the Trustee's agents, counsel, accountants and experts. The Company and any Guarantor, jointly and severally, shall indemnify the Trustee against any and all losses, liabilities, damages, claims, penalties, fines or expenses (including reasonable attorneys' fees and expenses) (for purposes of this Section 7.7, "losses") incurred by it in connection with the administration of this trust and the performance of its duties hereunder, including the costs and expenses of enforcing this Indenture (including this Section 7.7) and of defending itself against any claims (whether asserted by any Holder, the Company or otherwise), except to the extent such losses may be attributable to its gross negligence or willful misconduct (as determined by a court of competent jurisdiction in a final and non-appealable decision). The Trustee shall notify the Company promptly of any claim for which it may seek indemnity. Failure by the Trustee to so notify the Company shall not relieve the Company of its obligations hereunder. The Company shall defend the claim with counsel reasonably satisfactory to the Trustee and the Trustee shall provide reasonable cooperation at the Company's and/or the Guarantors' expense in the defense. The Trustee may have separate counsel and the Company shall pay the fees and expenses of such counsel provided that the Company and the Guarantors shall not be required to pay such fees and expenses if it assumes the Trustee's defense, and, in the reasonable judgment of outside counsel to the Trustee, there is no conflict of interest between the Company and the Trustee in connection with such defense. Any settlement which affects the Trustee may not be entered into without the written consent of the Trustee, which consent shall not be unreasonably delayed, conditioned or withheld, unless the Trustee is given a full and unconditional release from liability with respect to the claims covered thereby and such settlement does not include a statement or admission of fault, culpability or failure to act by or on behalf of the Trustee. The Company and the Guarantors shall not be under any obligation to pay for any written settlement without its consent, which consent shall not be unreasonably delayed, conditioned or withheld. The Company and the Guarantors need not reimburse any expense incurred by the Trustee through the Trustee's own willful misconduct or gross negligence."

------

Section 2.05<u>Representations and Warranties of the Retiring Trustee to the Company and the Successor Trustee</u>. The Retiring Trustee represents and warrants to the Company and the Successor Trustee that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)The Retiring Trustee understands that all of the rights, powers, privileges, responsibilities, trusts, obligations, immunities, protections, indemnities and duties of the Trustee outlined in the Indenture are hereby assigned, delivered and conveyed to the Successor Trustee (except as stated in Section 2.01 hereof);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)The Retiring Trustee has full power and authority to execute and deliver this Thirteenth Supplemental Indenture and to perform its obligations hereunder; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)The Thirteenth Supplemental Indenture has been duly and validly authorized, executed and delivered by the Retiring Trustee and constitutes its legal, valid and binding obligation, enforceable in accordance with its terms.

Section 2.06<u>Representations and Warranties of the Successor Trustee to the Company and the Retiring Trustee</u>. The Successor Trustee represents and warrants to the Company and the Retiring Trustee that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)The Successor Trustee is qualified and eligible under the provisions of Article VII of the Base Indenture to accept its appointment as successor Trustee with respect to all Debt Securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)The Successor Trustee has full power and authority to execute and deliver this Thirteenth Supplemental Indenture and to perform its obligations hereunder; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)The Thirteenth Supplemental Indenture has been duly and validly authorized, executed and delivered by the Successor Trustee and constitutes its legal, valid and binding obligation, enforceable in accordance with its terms.

Section 2.07<u>Representations and Warranties of the Company to the Successor Trustee</u>. The Company represents and warrants to the Successor Trustee that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)The Thirteenth Supplemental Indenture has been duly and validly authorized, executed and delivered by the Company and constitutes its legal, valid and binding obligations, enforceable in accordance with its terms;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)No Event of Default has occurred and is continuing;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)The Retiring Trustee has been properly replaced as Trustee effective as of the Effective Date under the terms of the Indenture; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)All conditions relating to the appointment of the Successor Trustee as successor Trustee under the Indenture have been met by the Company.

------

Section 2.08<u>Corporate Trust Office of the Successor Trustee</u>. For all purposes under the Indenture, including the presentation or surrender of the Securities for payment, registration, transfer or exchange and for the service of notices and demands to or upon the Company in respect of the Securities, the "Corporate Trust Office of the Trustee" or other similar terms shall thereafter be deemed to refer to the Corporate Trust Office of the Successor Trustee at (i) for purposes of surrender, registration, transfer, exchange, or presentation for payment at 111 Fillmore Avenue. St. Paul, MN 55107, Attention: Global Corporate Trust – Keurig Dr Pepper Inc., and (ii) for all other purposes, One Federal Street, Boston, MA 02110, Attention: Global Corporate Trust – Keurig Dr Pepper Inc., or such other address as the Successor Trustee may designate by notice to the Company and the Holders.

Section 2.09<u>Effect of this Thirteenth Supplemental Indenture</u>. On and after the Effective Date, every reference in the Indenture or in any Securities to the "Trustee" shall be deemed to be a reference to the Successor Trustee, and every right, privilege, protection, immunity, indemnity and benefit afforded to the Trustee under the Indenture shall vest in and be enjoyed by the Successor Trustee with respect to all Securities, whether issued prior to, on or after the Effective Date, *provided*, however, that the Company shall remain obligated under the Indenture to compensate, reimburse and indemnify the Retiring Trustee in connection with its prior service as Trustee, Paying Agent, and Registrar as provided in the Indenture as stated in Section 2.01 hereof.

**ARTICLE III<br>MISCELLANEOUS**

Section 3.01<u>Ratification of Indenture</u>. This Thirteenth Supplemental Indenture is executed and shall be construed as an indenture supplement to the Base Indenture, and as supplemented and modified hereby, the Base Indenture is in all respects ratified and confirmed, and the Base Indenture and this Thirteenth Supplemental Indenture shall be read, taken and construed as one and the same instrument.

Section 3.02<u>Trust Indenture Act Controls</u>. If any provision of this Thirteenth Supplemental Indenture limits, qualifies or conflicts with another provision that is required or deemed to be included in this Thirteenth Supplemental Indenture by the Trust Indenture Act the required or deemed provision shall control.

Section 3.03<u>Notices</u>**.** All notices and other communications shall be given as provided in the Base Indenture; *provided* that any notice or communication mailed to the Company, the Resigning Trustee or the Successor Trustee shall be addressed as follows:

if to the Company:

Keurig Dr Pepper Inc.

6425 Hall of Fame Lane

Frisco, Texas 75034

Attention: Chief Legal Officer and General Counsel

------

if to the Resigning Trustee:

Computershare Trust Company, N.A.

1505 Energy Park Drive

St. Paul, MN 55108

Attention: CCT Administrator for Keurig Dr. Pepper Inc.

if to the Successor Trustee:

U.S. Bank Trust Company, National Association

One Federal Street

Boston, MA 02110

Attention: Global Corporate Trust

Section 3.04<u>Governing Law; Waiver of Jury Trial</u>. THIS THIRTEENTH SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE.

Section 3.05<u>Successors</u>. All agreements of the Company, the Retiring Trustee and the Successor Trustee in this Thirteenth Supplemental Indenture shall bind their respective successors. All agreements of Retiring Trustee and the Successor Trustee in this Thirteenth Supplemental Indenture shall bind each of its successors.

Section 3.06<u>Multiple Originals</u>. The parties may sign any number of copies of this Thirteenth Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. One signed copy is enough to prove this Thirteenth Supplemental Indenture.

Section 3.07<u>Headings</u>. The headings of the Articles and Sections of this Thirteenth Supplemental Indenture have been inserted for convenience of reference only, are not intended to be considered a part hereof and shall not modify or restrict any of the terms or provisions hereof.

Section 3.08<u>Trustee Not Responsible for Recitals</u>. The recitals contained herein shall be taken as statements of the Company, and the Retiring Trustee and the Successor Trustee do not assume any responsibility for their correctness. The Resigning Trustee and the Successor Trustee make no representations as to the validity or sufficiency of this Thirteenth Supplemental Indenture, except that each of the Resigning Trustee and the Successor Trustee represents that it is duly authorized to execute and deliver this Thirteenth Supplemental Indenture and perform its obligations hereunder. Except as otherwise expressly provided herein, no duties, responsibilities or liabilities are assumed, or shall be construed to be assumed, by the Resigning Trustee or the Successor Trustee by reason of this Thirteenth Supplemental Indenture. In acting

------

hereunder, all of the rights, privileges, protections, indemnities, immunities and benefits afforded to the Resigning Trustee and the Successor Trustee under the Base Indenture are deemed to be incorporated herein and shall be enforceable by the Resigning Trustee and the Successor Trustee hereunder as if set forth herein in full.

Section 3.09<u>Force Majeure</u>. In no event shall the Resigning Trustee or the Successor Trustee be responsible or liable for any failure or delay in the performance of its obligations arising out of or caused by, directly or indirectly, forces beyond its control, including, without limitation, (i) any act or provision of present or future law or regulation or governmental authority, (ii) labor disputes, strikes or work stoppages, (iii) accidents, (iv) acts of war or terrorism, (v) civil or military disturbances or unrest, (vi) nuclear or natural catastrophes or acts of God, (vii) epidemics or pandemics, (viii) disease, (ix) national emergency, (x) interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services, (xi) communications system failure, (xii) malware or ransomware, (xiii) the unavailability of the Federal Reserve Bank wire, telex or other communication or wire facility or (xiv) unavailability of any securities clearing system; it being understood that the Resigning Trustee and the Successor Trustee, as applicable, shall undertake commercially reasonable efforts to resume performance as soon as practicable under the circumstances.

Section 3.10<u>Damages</u>. In no event shall the Resigning Trustee or the Successor Trustee be liable to any Person for special, punitive, indirect, consequential or incidental loss or damage of any kind whatsoever (including, but not limited to, lost profits), even if the Resigning Trustee or the Successor Trustee, as applicable, has been advised of the likelihood of such loss or damage and regardless of the form of action.

Section 3.11<u>USA PATRIOT Act</u>. The Company acknowledges that in accordance with Section 326 of the U.S.A. PATRIOT Act, the Successor Trustee, like all financial institutions and in order to help fight the funding of terrorism and money laundering, is required to obtain, verify, and record information that identifies each person or legal entity that establishes a relationship or opens an account with the Successor Trustee. The Company and the Guarantors agree that they will provide the Successor Trustee with such information as it may request in order for the Successor Trustee to satisfy the requirements of the USA PATRIOT Act.

Section 3.12<u>Electronic Signatures</u>. This Thirteenth Supplemental Indenture and any certificate, agreement or other document to be signed in connection with this Thirteenth Supplemental Indenture and the transactions contemplated hereby shall be valid, binding, and enforceable against a party only when executed and delivered by an authorized individual on behalf of the party by means of (i) an original manual signature, (ii) a faxed, scanned, or photocopied manual signature, or (iii) in the case of this Thirteenth Supplemental Indenture and any certificate, agreement or other document to be signed in connection with this Thirteenth Supplemental Indenture and the transactions contemplated hereby, any electronic signature permitted by the federal Electronic Signatures in Global and National Commerce Act, state enactments of the Uniform Electronic Transactions Act, and/or any other relevant electronic signatures law, including relevant provisions of the Uniform Commercial Code (collectively, "<u>Signature Law</u>"). Each electronic signature or faxed, scanned, or photocopied manual signature

------

shall for all purposes have the same validity, legal effect, and admissibility in evidence as an original manual signature. Each party hereto shall be entitled to conclusively rely upon, and shall have no liability with respect to, any faxed, scanned, or photocopied manual signature, or other electronic signature of any party and shall have no duty to investigate, confirm or otherwise verify the validity or authenticity thereof. For avoidance of doubt, original manual signatures shall be used for execution or indorsement of writings when required under the Uniform Commercial Code or other Signature Law due to the character or intended character of the writings. For the avoidance of doubt, all notices, approvals, consents, requests and any communications hereunder must be in writing (provided that any communication sent to Trustee hereunder must be in the form of a document that is signed manually or by way of a digital signature provided by DocuSign or Adobe (or such other digital signature provider as specified in writing to Trustee by the authorized representative)), in English. The Company agrees to assume all risks arising out of the use of using digital signatures and electronic methods to submit communications to the Resigning Trustee and the Successor Trustee, as applicable, including without limitation the risk of the Resigning Trustee and the Successor Trustee, as applicable, acting on unauthorized instructions, and the risk of interception and misuse by third parties.

Section 3.13<u>Effectiveness</u>. This Thirteenth Supplemental Indenture shall become effective as of the Effective Date upon execution and delivery hereof by each of the parties hereto.

[Signature page follows]

------

IN WITNESS WHEREOF, the parties have caused this Thirteenth Supplemental Indenture to be duly executed as of the date first written above.

**COMPANY:<br>**<br> KEURIG DR PEPPER INC.

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Dan Morrell&nbsp;&nbsp;&nbsp;&nbsp;</u><br>Name: Dan Morrell<br>Title: Vice President and Treasurer

*[Signature Page to the Thirteenth Supplemental Indenture]*

------

**GUARANTORS:**<br>234DP AVIATION, LLC<br>A & W CONCENTRATE COMPANY<br>BAI BRANDS LLC<br>BEVERAGES DELAWARE INC.<br>DP BEVERAGES INC.<br>DPS AMERICAS BEVERAGES, LLC<br>DPS BEVERAGES, INC.<br>DPS HOLDINGS INC.<br>DR PEPPER/SEVEN-UP BEVERAGE SALES COMPANY<br>DR PEPPER/SEVEN UP MANUFACTURING COMPANY<br>DR PEPPER/SEVEN UP, INC.<br>MOTT'S DELAWARE LLC<br>MOTT'S LLP<br>NANTUCKET ALLSERVE, LLC<br>SNAPPLE BEVERAGE CORP.<br>SPLASH TRANSPORT, INC.<br>THE AMERICAN BOTTLING COMPANY<br>

By:&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Dan Morrell&nbsp;&nbsp;&nbsp;&nbsp;</u><br>Name: Dan Morrell<br>Title: Vice President and Treasurer

*[Signature Page to the Thirteenth Supplemental Indenture]*

------

**RESIGNING TRUSTEE:**

COMPUTERSHARE TRUST COMPANY, N.A., as Resigning Trustee

By: <u>/s/ Eric Schlemmer&nbsp;&nbsp;&nbsp;&nbsp;</u> <br> Name: Eric Schlemmer<br> Title: Vice President

**SUCCESSOR TRUSTEE:**

U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Successor Trustee

By: <u>/s/ David J. Ganss&nbsp;&nbsp;&nbsp;&nbsp;</u> <br> Name: David J. Ganss<br> Title: Vice President

*[Signature Page to the Thirteenth Supplemental Indenture]*

------

**SCHEDULE I**

**<u>LIST OF GUARANTORS</u>**

---

| |
|:---|
| 234DP Aviation, LLC |
| A & W Concentrate Company |
| Bai Brands LLC |
| Beverages Delaware Inc. |
| DP Beverages Inc. |
| DPS Americas Beverages, LLC |
| DPS Beverages, Inc. |
| DPS Holdings Inc. |
| Dr Pepper/Seven-Up Beverage Sales Company |
| Dr Pepper/Seven Up Manufacturing Company |
| Dr Pepper/Seven Up, Inc. |
| Mott's Delaware LLC |
| Mott's LLP |
| Nantucket Allserve LLC |
| Snapple Beverage Corp. |
| Splash Transport, Inc. |
| The American Bottling Company |

---

Schedule I-1

------

**SCHEDULE II**

**<u>LIST OF THE DEBT SECURITIES</u>**

---

| | | |
|:---|:---|:---|
| **Title of Notes** | **CUSIP Numbers** | **ISIN Numbers** |
| 3.400% Senior Notes due 2025 | 26138E AS8 | US26138EAS81 |
| 2.550% Senior Notes due 2026 | 26138EAU3 | US26138EAU38 |
| 3.430% Senior Notes due 2027 | 26138E AX7<br>U2645FAD2 | US26138EAX76<br>USU2645FAD25 |
| 3.950% Senior Notes due 2029 | 49271VAP5 | US49271VAP58 |
| 3.200% Senior Notes due 2030 | 49271V AJ9 | US49271VAJ98 |
| 2.250% Senior Notes due 2031 | 49271V AN0 | US49271VAN01 |
| 4.050% Senior Notes due 2032 | 49271VAQ3 | US49271VAQ32 |
| 4.500% Senior Notes due 2045 | 26138E AT6 | US 26138EAT64 |
| 4.420% Senior Notes due 2046 | 26138E AY5 | US26138EAY59 |
| 3.800% Senior Notes due 2050 | 49271V AK6 | US49271VAK61 |
| 3.350% Senior Notes due 2051 | 49271V AM2 | US49271VAM28 |
| 4.500% Senior Notes due 2052 | 49271VAR1 | US49271VAR15 |

---

Schedule II-1

## Exhibit 4.30

**Exhibit 4.30**

**Description of Securities**

**Registered Pursuant to Section 12 of the**

**Securities Exchange Act of 1934**

Except as otherwise indicated or unless the context requires otherwise, all references herein to the "Company," "KDP", "we," "us," "our" and similar terms refer to Keurig Dr Pepper Inc.

**DESCRIPTION OF CAPITAL STOCK**

The following description of the material terms of our capital stock is based upon our Amended and Restated Certificate of Incorporation (as amended and/or restated from time to time, the "Certificate of Incorporation"), our Amended and Restated By-Laws (as amended and/or restated from time to time, the "Bylaws") and applicable provisions of law. We have summarized certain portions of the Certificate of Incorporation and Bylaws below. The summary is not complete. The Certificate of Incorporation and Bylaws are incorporated by reference as exhibits to the Annual Report on Form 10-K to which this exhibit is a part. You should read the Certificate of Incorporation and Bylaws for the provisions that are important to you.

**GENERAL**

Our authorized capital stock consists of 2,000,000,000 shares of common stock, par value $0.01 per share, and 15,000,000 shares of preferred stock, par value $0.01 per share. Our board of directors may establish the rights and preferences of the preferred stock from time to time.

**COMMON STOCK**

Each holder of our common stock is entitled to one vote for each share on all matters to be voted upon by the common stockholders and there are no cumulative voting rights. Subject to any preferential rights of any outstanding preferred stock, holders of our common stock are entitled to receive ratably the dividends, if any, as may be declared from time to time by our board of directors out of funds legally available. If there is a liquidation, dissolution or winding up of our company, holders of our common stock will be entitled to share in our assets remaining after the payment of liabilities and any preferential rights of any outstanding preferred stock. Holders of our common stock have no preemptive or conversion rights or other subscription rights and there are no redemption or sinking fund provisions applicable to the common stock. All outstanding shares of our common stock are fully paid and non-assessable. The rights, preferences and privileges of the holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock which we may designate and issue in the future.

**PREFERRED STOCK**

Under the terms of our Certificate of Incorporation, our board of directors is authorized, subject to limitations prescribed by the Delaware General Corporation Law ("DGCL"), and by our Certificate of Incorporation, to issue preferred stock in one or more series without stockholder approval. Our board of directors has the discretion, subject to limitations prescribed by the DGCL and by our Certificate of Incorporation, to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, of each series of preferred stock.

------

**ANTI-TAKEOVER EFFECTS OF VARIOUS PROVISIONS OF DELAWARE LAW AND OUR CERTIFICATE OF INCORPORATION AND BYLAWS**

Provisions of the DGCL and our Certificate of Incorporation and Bylaws could make it more difficult to acquire us by means of a tender offer, a proxy contest or otherwise or to remove incumbent officers and directors. These provisions, summarized below, would be expected to discourage certain types of coercive takeover practices and takeover bids our board of directors may consider inadequate and to encourage persons seeking to acquire control of us to first negotiate with us. We believe that the benefits of increased protection of our ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us will outweigh the disadvantages of discouraging takeover or acquisition proposals because, among other things, negotiation of these proposals could result in an improvement of their terms.

***Board Vacancies to be Filled by Remaining Directors and Not Stockholders***

Our Certificate of Incorporation and Bylaws provide that the entire board of directors will be elected annually; however, any vacancies, including any newly created directorships, on the board of directors will be filled by the affirmative vote of the majority of the remaining directors then in office, even if such directors constitute less than a quorum, or by the sole remaining director. Any director so chosen will hold office until the next election of directors and until his or her successor shall have been duly elected and qualified or until such director's earlier death, resignation, retirement or removal. No decrease in authorized number of directors will shorten the term of any incumbent director.

***Stockholder Action***

Our Certificate of Incorporation and Bylaws preclude stockholders from calling special meetings and taking action or passing resolutions by written consent.

***Advance Notice of Director Nominations and Stockholder Proposals***

Our Bylaws contain advance notice procedures for stockholders to make nominations of candidates for election as directors or to bring other business before the annual meeting of stockholders. As specified in our Bylaws, director nominations and the proposal of business to be considered by stockholders may be made only pursuant to a notice of meeting, at the direction of the board of directors or by a stockholder who is entitled to vote at the meeting and who has complied with the advance notice procedures, requirements and disclosures that are set forth in our Bylaws. To be timely, a nomination of a director by a stockholder or notice for business to be brought before an annual meeting by a stockholder must be delivered to the secretary at our principal executive offices not later than the close of business on the 90th day nor earlier than the close of business on the 120th day prior to the anniversary date of the immediately preceding year's annual meeting; provided, however, that in the event that the date of an annual meeting is advanced by more than 30 days or delayed by more than 60 days from such anniversary date, for notice by the stockholder to be timely, it must be delivered not earlier than the 120th day prior to such annual meeting and not later than the close of business on the later of (i) the 90th day prior to such annual meeting and (ii) the 10th day following the day on which notice of such annual meeting was mailed or public announcement of the date of such meeting is first made, whichever first occurs. In the event a special meeting of stockholders is called for the purpose of electing one or more directors, any stockholder entitled to vote may nominate a person or persons as specified in our Bylaws, but only if the stockholder notice is delivered to the secretary at our principal executive offices not earlier than the 120th day prior to such special meeting and not later than the close of business on the later of (i) the 90th day prior to such special meeting and (ii) the 10th day following the day on which notice of the date of such special meeting was mailed or public disclosure of the date of such special meeting was made, whichever first occurs.

------

***Amendments to the Certificate of Incorporation and Bylaws***

Our Certificate of Incorporation and Bylaws require an affirmative vote of two-thirds of the voting power of the outstanding shares to amend certain provisions of our Certificate of Incorporation or Bylaws, including the provisions relating to the ability of stockholders to call special meetings or act by written consent, the size of the board, filling vacancies on the board, indemnification of directors and officers, advance notice provisions and supermajority voting requirements.

***Delaware Anti-Takeover Statute***

We are subject to Section 203 of the DGCL, an anti-takeover statute. In general, Section 203 of the DGCL prohibits a publicly-held Delaware corporation from engaging in a "business combination" with an "interested stockholder" during the period of three years following the time the person becomes an interested stockholder, unless (with certain exceptions) the business combination or the transaction in which the person became an interested stockholder is approved in a prescribed manner. Generally, a "business combination" includes a merger, asset or stock sale or other transaction resulting in a financial benefit to the interested stockholder. Generally, an "interested stockholder" is a person who, together with affiliates and associates, owns (or within three years prior to the determination of interested stockholder status did own) 15% or more of a corporation's voting stock. The existence of this provision would be expected to have an anti-takeover effect with respect to transactions not approved in advance by the board of directors, including discouraging attempts that might result in a premium over the market price for the shares of common stock held by stockholders.

***No Cumulative Voting***

The DGCL provides that stockholders are denied the right to cumulate votes in the election of directors unless our Certificate of Incorporation provides otherwise. Our Certificate of Incorporation does not provide for cumulative voting.

***Limitations on Liability and Indemnification of Officers and Directors***

The DGCL authorizes corporations to limit or eliminate the personal liability of directors to corporations and their stockholders for monetary damages for breaches of directors' fiduciary duties as directors. Our Certificate of Incorporation contains such exculpation provisions for directors and includes provisions that indemnify, to the fullest extent allowable under the DGCL, the personal liability of directors or officers for monetary damages for actions taken as a director or officer of our company, or for serving at our request as a director or officer or another position at another corporation or enterprise, as the case may be. Our Certificate of Incorporation also provides that we must indemnify and advance reasonable expenses to our directors and officers, subject to our receipt of an undertaking from the indemnified party as may be required under the DGCL. We are also expressly authorized to carry directors' and officers' insurance to protect our company, our directors, officers and certain employees for some liabilities. The limitation of liability and indemnification provisions in our Certificate of Incorporation may discourage stockholders from bringing a lawsuit against directors for breach of their fiduciary duty. These provisions may also have the effect of reducing the likelihood of derivative litigation against directors and officers, even though such an action, if successful, might otherwise benefit us and our stockholders. However, these provisions do not limit or eliminate our rights, or those of any stockholder, to seek non-monetary relief such as injunction or rescission in the event of a breach of a director's duty of care. Moreover, the provisions do not alter the liability of directors under the federal securities laws.

------

***Authorized but Unissued Shares***

Our authorized but unissued shares of common stock and preferred stock are generally available for future issuance without stockholder approval. We may use additional shares for a variety of purposes, including future public offerings to raise additional capital, to fund acquisitions and as employee compensation. The existence of authorized but unissued shares of common stock and preferred stock could render more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.

***Exclusive Forum Provision***

Our Bylaws provide that unless we select or consent in writing to an alternative forum, to the fullest extent permitted by law, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for any derivative action or proceeding brought on behalf of us, any action asserting a claim of breach of a fiduciary duty owed by any current or former director, officer or other employee of KDP to us or our stockholders, any action arising pursuant to any provision of the DGCL, or any action asserting a claim governed by the internal affairs doctrine; provided, however, that, in the event that the Court of Chancery of the State of Delaware lacks subject matter jurisdiction over any such action or proceeding, the sole exclusive forum for such action or proceeding shall be another state or federal court located in the State of Delaware, unless the Court of Chancery (or such other state or federal court located within the State of Delaware, as applicable) has dismissed a prior action by the same plaintiff asserting the same claims because such court lacked personal jurisdiction over an indispensable party named as a defendant therein. In addition, our Bylaws further provide that, unless we, in writing, select or consent to the selection of an alternative forum, the sole and exclusive forum for any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, to the fullest extent permitted by law, shall be the federal district courts of the United States of America. Any person or entity purchasing or otherwise acquiring or holding any interest in shares of stock of KDP shall be deemed to have notice of and consented to the provisions of our forum selection provisions.

**STOCK EXCHANGE LISTING**

Our common stock is listed on The Nasdaq Stock Market LLC under the ticker symbol "KDP."

**TRANSFER AGENT AND REGISTRAR**

Computershare Trust Company, N.A. ("Computershare") is the transfer agent and registrar for our common stock.

**DIRECT REGISTRATION SYSTEM**

Our common stock is registered in book-entry form through the direct registration system. Under this system, ownership of our common stock is reflected in account statements periodically distributed to stockholders by Computershare, our transfer agent, who holds the book-entry shares on behalf of our common stockholders.

## Exhibit 10.8

**EXHIBIT 10.8**

November 18, 2025

Anthony DiSilvestro

Via email: [\*\*\*]

Dear Anthony:

Congratulations, we are pleased to extend you this offer of employment to join Keurig Dr Pepper ("the Company")! You will be joining our company at an exciting time. We are recognized as an industry leader for our award-winning beverages, innovative brewing technology and socially responsible business practices. We are also excited about the planned transformational acquisition of JDE Peet's and subsequent separation into two new companies: Global Coffee Co and Beverage Co. We are glad that you are joining us to add your skills, experiences and creative ideas to the team.

We hope you will accept our offer to join the organization in the role of **Chief Financial Officer** reporting to Tim Cofer, CEO.

The details of this offer are outlined below, and we ask that all compensation matters be kept confidential until subject to public disclosure.

**Base Salary:** Your base salary of $1,000,000 will be paid in bi-weekly installments, consistent with the payroll schedule in place for all active employees. Any merit increase will be based upon evaluation of overall performance against your position accountabilities and objectives. Please note that by stating your salary as an annual amount, the Company does not intend to create a contract of employment or otherwise alter the "at-will" status of your employment.

**Short Term Incentive Program:** You are eligible to participate in the Company's Short Term Incentive Program (STIP) in accordance with the terms in effect at the time of a payout. The target award is 100% of your base salary. Payments will be pro-rated during the first year based on your actual start date and in your last year based on your termination date, and payable at a date consistent with other plan participants. The program's annual performance metrics will be based on achievement of specific financial targets set by the Company, as determined by the Company in its sole discretion. The Company may modify and/or eliminate the Short Term Incentive Program or any other incentive program at any time in its sole discretion.

------

**One-Time Long Term Incentive (LTI) Award:** You will receive a one-time LTI award of $8,000,000. The award will be granted within thirty days of your start date. This award will be issued as Restricted Stock Units (RSUs), the number of which will be calculated by dividing the grant value by the closing stock price on the grant date. The award will vest 67% on the two year anniversary of the grant date, and the remaining 33% on the three year anniversary of the grant date, and the vesting of both portions of the award will continue in the event of your termination of service without cause (including in connection with the separation of Beverage Co and Global Coffee Co) or your resignation for good reason. The award will be subject to terms and conditions set forth in the grant agreement.

**Annual Long Term Incentive (LTI) Program:** You will not be eligible to participate in the Company's annual LTI program.

**Waiver of Severance Benefits:** Your employment is anticipated to be terminated at a date to be agreed at or around the full separation of Beverage Co and Global Coffee Co (anticipated by late 2026/ early 2027). Upon your termination, regardless of the reason, you will not be eligible for any severance benefits under the Executive Severance Plan and your signature below waives any rights you might have otherwise had under the Plan.

**Benefits:** You will be eligible to participate in the Company's Benefit Plans for Salaried Employees including medical, dental and vision plans, short-term and long-term disability programs, life insurance, savings and retirement plans. Details of our various plans will be provided to you in your new hire packet and during your orientation. The Company reviews its benefits and incentive plans and programs periodically, and those plans and programs are subject to change at the Company's sole discretion.

**Work Location:** You will be expected to have a primary office location in the Burlington, MA headquarters location. You will be expected to travel to other locations as required for business purposes and will be reimbursed per Company policy for business-related travel expenses.

**Start Date:** We anticipate your start date to be on or around November 24, 2025.

**Other Terms and Conditions:**

The Company requires its employees to honor their valid legal obligations to their prior employers (just as we expect you will honor your ongoing legal obligations to the Company should you leave our employ). Therefore, as a condition of your employment by the Company, you must not bring with you from your current or former employer(s) any confidential or proprietary business information or copies of such information; you must not reveal to the Company or any of our employees or use on the Company's behalf any such information; and you must comply with any other valid contractual obligations owed to previous employers.

This offer is contingent upon satisfactory completion of a background investigation, which has been completed.

As a condition of employment, the Company is required under current federal regulations to certify the legal status of all employees. Your employment at the Company is contingent upon presenting and

------

maintaining authorization to work in the United States. Therefore, on your first day of employment, you must provide documentation proving both your identity and authorization to work in the United States.

Your employment with the Company is on an "at will" basis, meaning that, just as you are free to resign at any time, with or without any reason, and with or without prior notice, the Company is free to end your employment at any time, with or without cause or any reason, and with or without prior notice. Although your employment will be at-will, it is our hope that your acceptance of this offer will be just the beginning of a mutually beneficial relationship with the Company.

This offer should be confirmed by November 21, 2025 by signing below.

<br>We look forward to you joining our team!

<u>/s/ Tim Cofer</u>**_______________________________**

Tim Cofer

Chief Executive Officer

<u>/s/ Anthony DiSilvestro</u>**________________________&nbsp;&nbsp;&nbsp;&nbsp;**<u>11/21/25</u>**___________**

Anthony DiSilvestro&nbsp;&nbsp;&nbsp;&nbsp;Date

## Exhibit 10.9

**EXHIBIT 10.9**

**<u>Transition, Separation and Release Agreement</u>**

This Transition, Separation and Release Agreement ("Agreement") is entered into by and between Sudhanshu Priyadarshi (hereinafter "you") and Keurig Dr Pepper Inc. and its subsidiaries (the "Company"), in order to set out their agreement on the terms and conditions under which your employment will end. To assist you with your transition to new employment and to otherwise resolve any and all disputes that you may have regarding your employment with the Company, including without limitation those related to any complaints or reports you may have made to the Company and the separation of your employment therewith, you and the Company agree to enter into this Agreement under the terms and conditions set forth below and in accordance with the Keurig Dr Pepper Inc. Executive Severance Plan (the "Plan"). Capitalized terms used in this Agreement and not otherwise defined herein shall have the meaning given to such terms in the Plan.

1.<u>Transition; Termination of Employment</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Effective as of November 25, 2025 (the "Transition Date"), you shall no longer serve as Chief Financial Officer and President, International of the Company and you hereby resign as an officer of the Company and its affiliates. Between the Transition Date and the Termination Date (as defined below) (the "Transition Period"), you will (i) remain employed by the Company as a Senior Advisor to the Company, (ii) receive the same Base Salary and be eligible for the same annual bonus opportunity (on a pro-rata basis) and benefits as in effect on the date hereof, (iii) continue to vest in your outstanding equity awards in accordance with the terms thereof, and (iv) provide any transition services as reasonably requested by the Company's Chief Executive Officer and Chief Financial Officer. After the Transition Date, you will have no power or authority to incur any debt, liability, or obligation on behalf of the Company, and except as approved by a member of the Executive Leadership Team of the Company, no right to incur any expenses on behalf of the Company or be reimbursed by the Company for such expenses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Unless earlier terminated as provided in Section 1(c) below, your employment with the Company will be terminated on April 7, 2026 (such actual date of termination, the "Termination Date"). In order to receive any benefits under this Agreement, in addition to complying with all its terms, you must have fully cooperated with the Company in the transition of your responsibilities during the Transition Period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Your employment with the Company may end prior to April 7, 2026 as a result of (i) your unilateral resignation; (ii) your resignation following December 31, 2025 with the consent of the Company (such consent not to be unreasonably withheld); (iii) the Company's termination of your employment for Cause; or (iv) your death or Disability. In the event of such earlier termination of employment, the Termination Date will be the actual date of such termination; provided, however, that if such earlier termination occurs as a result of <u>clauses (i)</u> or <u>(iii)</u>, you will no longer be eligible to receive the payments and benefits set forth in <u>Section 2</u>.

2.<u>Severance Payments and Benefits</u>. Provided you (x) timely execute and return this Agreement by no later than 5:00 pm PT on the Return Date (as defined below); (y) as set forth in Section 18, timely execute and return to the Company a copy of the Confirming Release Agreement that is attached as <u>Exhibit A</u> (the "Confirming Release") and do not revoke the Confirming Release pursuant to the terms of the Confirming Release; and (z) remain in compliance with the other terms and conditions set forth in this Agreement, you will be provided with the following separation payments and benefits:

<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

**Transition, Separation and Release Agreement&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 1**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Severance Pay</u>. You will receive an amount equal to 1.5 times your Base Salary (as defined in the Plan); plus (ii) your Target Bonus (as defined in the Plan), for a gross amount of $3,000,000.00, referred to herein as "Severance Pay."

Your Severance Pay will be paid in substantially equal installments over an 18-month period (the "Severance Period") in accordance with the Company's normal payroll practices and will be subject to statutory deductions, including all voluntary and statutory withholdings. The Severance Period will begin on the next normal pay cycle following the Effective Date of the Confirming Release (as defined therein).

Notwithstanding the foregoing, in the event the time period for you to execute, return, and consider revoking the Confirming Release spans two tax years, then no amount of Severance Pay will be paid to you until the Company's first regularly scheduled payroll date in the second tax year, and such payment shall include any portion of Severance Pay that would have otherwise been payable to you but for this provision of this Section 2(a).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>2022 Matching RSUs</u>. With respect to the 130,447 elite matching restricted stock units granted to you on November 22, 2022 (the "2022 Matching RSUs"), a pro-rated portion of the 2022 Matching RSUs will vest effective as of the Termination Date determined by multiplying (i) the total number of 2022 Matching RSUs by (ii) a fraction, the numerator of which is the number of complete months elapsed from November 22, 2022 to the Termination Date and the denominator of which is 60. The remaining 2022 Matching RSUs shall be forfeited as of the Termination Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Pro-Rata STIP; Prior Year STIP</u>. You will be eligible for a pro-rata annual bonus for the fiscal year in which the Termination Date occurs under the Keurig Dr Pepper Short-Term Incentive Plan (the "STIP"), in an amount based on your Target Percentage (as defined in the STIP) and your bonus design, as determined after the conclusion of such fiscal year, which will be multiplied by a fraction, the numerator of which is the number of days of your employment in such fiscal year prior to the Termination Date, and the denominator of which is the total number of days in such fiscal year. To the extent that these calculations result in your being eligible for a bonus payment, this payment will be made at the same time as other recipients receive their bonus payment under the STIP for such fiscal year. In addition, to the extent unpaid as of the Termination Date, you shall also receive any annual bonus under the STIP for any fiscal year completed prior to the Termination Date based on actual performance for such year. Your short-term incentive eligibility will be administered consistent with the terms and conditions of the STIP.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Outplacement</u>. The Company will provide you with outplacement services. You must begin using the outplacement services within 90 days of your Termination Date. Contact information for the outplacement services will be provided to you by HR.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)<u>Advisory Services Fee</u>. In recognition of your cooperation and support in transitioning your duties and responsibilities to your designated successor, you will receive an additional cash payment of $500,000 (the "Advisory Fee") assuming that you continue to provide transition services through April 7, 2026, payable in a lump sum within 60 days following April 7, 2026. In the event that the Termination Date occurs prior to April 7, 2026, you shall receive a pro-rata portion of the Advisory Fee (based on your days of service from the Transition Date through the Termination Date over 133).

<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

**Transition, Separation and Release Agreement&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 2**

------

If you apply for and accept a position with the Company while receiving Severance Pay, you understand and agree all severance and other payments described herein shall cease effective on your rehire date without otherwise affecting the validity of any other terms in this Agreement, including without limitation the release of claims.

3.<u>Equity Awards</u>. Except as set forth in Section 2(b), equity awards are treated as described in the applicable plan documents and award agreements, including the Keurig Dr Pepper Inc. Omnibus Stock Incentive Plan of 2019 documents, your Restricted Stock Unit Award Terms and Conditions agreements, and your Matching Restricted Stock Unit Award Terms and Conditions. You can obtain a copy by logging onto Morgan Stanley Benefit Access at https://www.stockplanconnect.com or your Workday profile, as applicable.

4.<u>Benefit Plans</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Except for group medical, dental, and vision plans, the Termination Date shall be your termination date for purposes of all Company benefit plans. Your benefits will be administered consistent with the benefit plan documents and based on your Termination Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)For any group medical, dental, and vision plan you are enrolled in immediately prior to your Termination Date, the last day of the calendar month in which the Termination Date occurs will be your termination date for purposes of coverage under such plans. Your benefits will be administered consistent with plan documents and based on the date of termination of such coverage. Subject to your having timely elected under the federal law known as "COBRA" to continue participation in the Company's group medical, dental and vision plans for yourself and those individuals who were your eligible dependents immediately prior to your Termination Date, and regardless of whether you sign this Agreement, you are able to continue your current benefits coverage for the period of time permitted under COBRA by paying the full monthly COBRA premiums.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Employee Assistance Program. You will have access to the Company's Employee Assistance Program until the end of the month following the month of your Termination Date.

5.<u>Termination for Cause; Material Breach</u>. The Company represents that it is not currently aware of information that would have constituted grounds for your termination for Cause. After you execute, return, and do not revoke the Confirming Release, if the Company discovers information that would have constituted grounds for your termination for Cause or that you have materially breached this Agreement, the Company's obligation to pay or continue to pay the Severance Pay or provide benefits pursuant to Section 2 of this Agreement shall terminate immediately and, where appropriate, such obligations shall terminate on the date of the act or failure to act which would have constituted grounds for termination for cause. Alternatively, if you have already received all or a portion of the Severance Pay or benefits identified in Section 2 of this Agreement, to the fullest extent permissible by law, you agree to reimburse the Company all but $500.00 of the Severance Pay and benefits you received within seven days of the Company's request, and you further agree that the $500.00 identified in this Agreement is adequate consideration in support of this Agreement. In addition, the Company shall be entitled, upon application to any court of competent jurisdiction, to specific performance or injunction or other relief against you. Nothing in this Agreement shall be construed as prohibiting the Company from pursuing other remedies available to it for such breach or threatened breach including the recovery of damages and attorneys' fees from you.

<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

**Transition, Separation and Release Agreement&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 3**

------

6.<u>Confidentiality; Cooperation</u>. By accepting the benefits, payments, and other items described in this Agreement, you agree that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All documents (including this Agreement), records, techniques, business secrets, and other information which have come into your possession from time to time during your employment with the Company ("Confidential Information and Business Secrets") are and shall remain confidential and proprietary to the Company and/or its affiliates, and you will keep confidential and not divulge to any other party any of the Company's and/or its affiliates' Confidential Information and Business Secrets, including, but not limited to, Confidential Information and Business Secrets relating to such matters as the Company's finances (including financial results, budgets, forecast, and long-range plans), operations, materials, processes, plans, designs, models, new products, apparatus, equipment, or formulas used in the Company's operations, and the names of the Company's customers and suppliers. You also agree that, if you are ever asked to disclose any Confidential Information and Business Secrets pursuant to legal process or otherwise, you will immediately (and in any event within five days) provide notice to the Company pursuant to Section 15 herein to seek the Company's express written consent to such disclosure prior to such disclosure.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)All of the Company's and/or its affiliates' and related companies' Confidential Information and Business Secrets are and shall remain the sole and exclusive property of the Company and/or its affiliates and related companies.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Pursuant to the Defend Trade Secrets Act of 2016, you are hereby advised that an individual may not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (a) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. Further, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the employer's trade secrets to the attorney and use the trade secret information in the court proceeding if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)You agree to cooperate with reasonable requests for cooperation from the Company with respect to any legal issue regarding any matter of which you had knowledge during your employment with the Company. Such cooperation may include appearance at depositions, assistance in responding to discovery, preparation for hearings or trial, and appearance at trial. The Company will reimburse you for all reasonable expenses incurred by you in providing such assistance and undertake reasonable efforts to prevent such cooperation from interfering with your new employment, provided the Company can control the timing of such cooperation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)You have been paid all earned wages and salary through the date you sign this Agreement, and will be paid all accrued unused vacation pay.

7.<u>Non-Disparagement and Waiver of Related Rights</u>. Except as requested by the Company or any of the Releasees (defined below), as permitted above or by law that may supersede the terms of this Agreement, or as compelled by valid legal process, you shall not before or after the Termination Date make (or encourage or cause anyone else to make), including through a third party, to any

<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

**Transition, Separation and Release Agreement&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 4**

------

other parties any statement, oral or written, which directly or indirectly impugns (or would reasonably be expected to impugn) the quality or integrity of the Company's or any of the other Releasees' business or employment practices, or any other disparaging or derogatory remarks about the Company or any of the Releasees, their officers, directors, equity holders, managerial personnel, or other employees, or take any other action (or encourage or cause anyone else to take any other action) that seeks to (or would reasonably be expected to) influence, disrupt or change the management, policies or affairs of the Company. Similarly, the Company will instruct its officers and directors to not make any disparaging or derogatory remarks, whether oral or written, regarding you. The conduct prohibited by this Section 7 includes, without limitation, comments or statements to any person or entity, including but not limited to the press and/or media, or any entity with whom the Company or any of the Releasees has a business relationship, which would adversely affect in any manner (a) the conduct of the Company's business or (b) the reputation of the Company and the Releasees, in any format, forum, or medium, including without limitation statements to individuals or groups, the media, the press, websites, blog posts, and social media.

9.<u>Release of Claims</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)In exchange for the good and valuable consideration set forth in this Agreement, to which you are not otherwise entitled, and the sufficiency of which you hereby acknowledge, you hereby, on behalf of yourself, your descendants, ancestors, dependents, heirs, representatives, executors, administrators, successors, and assigns:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)Fully and forever release and discharge Keurig Dr Pepper Inc. and all of its subsidiaries, affiliates, and related entities and all of their respective past and present agents, employees, officers, directors, shareholders, members, managers, insurers, attorneys, divisions, successors, and assigns (collectively the "Releasees"), from any and all claims, demands, rights, liens, agreements, contracts, covenants, actions, suits, causes of action, obligations, debts, costs, expenses, attorneys' fees, damages, judgments, orders, or liabilities of whatsoever kind or nature in law, equity, or otherwise, whether known or unknown, which you now own or hold or have or may have at any time heretofore or hereafter owned or held as against the Company and/or any of the Releasees, arising out of or in any way connected with:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)your employment with the Company and/or any of its past or present subsidiaries or parent or affiliated companies or entities (except any claims for pension or retirement benefits);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)your separation from the Company and/or any of its past or present subsidiaries or parent or affiliated companies or entities; and

<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

**Transition, Separation and Release Agreement&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 5**

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)any and all other transactions, occurrences, acts, or omissions and any loss, damage, or injury whatsoever, known or unknown, resulting from any act or omission by or on the part of the Company and/or any of the Releasees arising, committed, or omitted before the date of this Agreement or at any time during your employment with the Company or with any of the Releasees, including, but not limited to claims under Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Worker Adjustment and Retraining Notification Act, the Equal Pay Act of 1963, the Americans with Disabilities Act, the Family and Medical Leave Act, the Uniformed Services Employment and Reemployment Rights Act, the California Family Rights Act, the Unruh Civil Rights Act, the California Pregnancy Disability Leave Law, the California Equal Pay Act, the California Civil Code, the California Labor Code, the California Constitution, the California Occupational Health and Safety Acts, the California Business and Professions Code, the California Ban the Box Law, any Wage Order promulgated by the California Industrial Welfare Commission, and any other federal, state, or local law, rule, ordinance, or regulation or common law or constitutional provision that applies, or is asserted to apply, directly or indirectly, to the formation, continuation, or termination of your employment relationship with the Company or with any of the Releasees, any and all claims for breach of contract, tort, and personal injury of any kind, including but not limited to any claims for severance pay, bonus, sick leave, holiday pay, life insurance, health or medical insurance, or any other fringe benefit, worker's compensation or disability, and/or any claims under any other federal, state, local, or other governmental statute, regulation and/or common law, as well as claims in equity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>California Civil Code Section 1542 Waiver</u>. You agree that this Agreement and the releases contained herein shall and do apply to all unknown or unanticipated results of any and all matters caused by or connected with your employment or the separation therefrom, as well as those currently known or anticipated. Accordingly, you acknowledge that you have read the provisions of California Civil Code Section 1542, which provides as follows:

**"A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release and that, if known by him or her, would have materially affected his or her settlement with the debtor or released party."**

You expressly waive, relinquish and forfeit all rights and benefits accorded by the provisions of Section 1542, and furthermore waive any rights that you might have to invoke said provisions now or in the future with respect to any claims released in this Agreement.

10.<u>Covenant Not To Sue</u>. A "covenant not to sue" is a legal term for a promise not to file lawsuit in court. It is different from Section 9 above. In addition to waiving and releasing the claims covered in this Agreement, you agree never to sue any Releasee in any forum for any reason arising out of your employment with the Company, including but not limited to the claims covered in this Agreement; provided, however, that you may bring a claim against the Company to enforce this Agreement. You agree and acknowledge that if you break this promise not to sue, then you will pay for all costs, including reasonable attorneys' fees, incurred by the Company or any Releasee in defending any matter or proceeding covered by the promise not to sue. Alternatively, if you break your promise not to sue, you may, at the Company's option, be required to return all but $500.00 of the Severance Pay you received pursuant to the Agreement to the fullest extent permissible by

<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

**Transition, Separation and Release Agreement&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 6**

------

law, and you further agree that the $500.00 identified in this Agreement is adequate consideration in support of this Agreement.

11.<u>Rights And Claims Excluded From Release of Claims</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)This Agreement does not waive or apply to (a) any claims for breach or enforcement of this Agreement, (b) any claims that may not be waived or released by applicable law, (c) any vested rights under the Company's ERISA-covered employee benefit plans as applicable on the date you sign this Agreement, (d) any claims or rights that may arise after the date that you sign this Agreement, (e) any right to reimbursement for reasonable business expenses in accordance with the Company's expense reimbursement policies, and (f) any administrative claims for unemployment compensation or workers' compensation benefits.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Nothing in this Agreement (including but not limited to the acknowledgements, release of claims, the covenant not to sue, the confidentiality obligations, and the company property provision):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)prevents you from communicating with, filing a charge or complaint with, providing documents or information voluntarily or in response to a subpoena or other information request to, or from participating in an investigation or proceeding conducted by the Equal Employment Opportunity Commission, National Labor Relations Board, the Securities and Exchange Commission, law enforcement, or any other any federal, state, or local agency charged with the enforcement of any laws; or from testifying, providing evidence, or responding to a subpoena or discovery request in court litigation or arbitration;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)precludes you from exercising your rights under Section 7 of the National Labor Relations Act or similar state law to engage in protected, concerted activity (including, but not limited to discussions concerning compensation and other terms and conditions of employment), although by signing this Agreement you are waiving your right to recover any individual relief (including any back pay, front pay, reinstatement, or other legal or equitable relief) in any charge, complaint, or lawsuit or other proceeding brought by you or on your behalf by any third party, except for any right you may have to receive a payment or award from a government agency (and not the Company) for information provided to the government agency or where otherwise prohibited);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)prevents you from discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that you have reason to believe is unlawful; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)waives your right to testify in an administrative, legislative, or judicial proceeding concerning alleged criminal conduct or alleged sexual harassment on the part of the Company, or on the part of the agents or employees of the Company, when you have been required or requested to attend such a proceeding pursuant to a court order, subpoena, or written request from an administrative agency or the legislature.

12.<u>No Violations</u>. By signing this Agreement, you represent and warrant that you have no knowledge that the Company or any of the Releasees have committed or are suspected of committing any act

<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

**Transition, Separation and Release Agreement&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 7**

------

which is or may be in violation of any federal or state law or regulation or has acted in a manner which requires corrective action of any kind. You further represent and warrant that you have not informed the Company or any of the other Releasees of, and that you are unaware of, any alleged violations of the Company's standards of business conduct or personnel policies, of the Company's integrity or ethics policies, or other misconduct by the Company or any of the other Releasees, that have not been resolved satisfactorily by the Company or the other Releasees.

13.<u>Non-Liability</u>. You agree that neither this Agreement, the Confirming Release nor the furnishing of the consideration for this Agreement shall be deemed or construed as an admission by the Company or by any of the Releasees of any liability or wrongful or unlawful conduct of any kind whatsoever.

14.<u>Company Property</u>. On or before the Termination Date, you agree to return all Company property (including, but not limited to, sales materials, documents or other company records, access cards, keys, mobile phones, smart phones, credit cards, gas cards, computers, or any other equipment) that you have or may have in your possession or control, except as expressly permitted in writing by an authorized officer of the Company. By signing below, you hereby consent to permitting the Company to remove (either directly or via remote wiping) all confidential information and other property belonging to the Company from any electronic device owned or controlled by you. Your obligations under this paragraph supplement, rather than supplant, your obligations under the common law. Your obligations under this paragraph shall not apply to, and you may retain copies of, personnel, benefit, or payroll documents concerning only yourself. If you do not return Company property in your possession or control by the Termination Date, the Company may, in addition to the rights and remedies it may have under this Agreement or otherwise, withhold any and all payments under this Agreement. You further agree to submit all outstanding expenses on Company credit accounts on or before the Termination Date whenever possible, and in any event no later than 30 days following the Termination Date. Your Severance Pay will be offset by any personal or undocumented expenses.

15.<u>Notices</u>. All notices, requests, demands and other communications hereunder or under the Confirming Release must be in writing and shall be deemed to have been given if delivered by hand or mailed within the continental United States by first class, registered or certified mail, return receipt requested, postage and registry fees prepaid and addressed as follows:

<u>If to the Company</u>:

Keurig Dr Pepper

6425 Hall of Fame Lane

Frisco, TX 75034

Attention: Chief Legal Officer & General Counsel

<u>If to you</u>:

At the last home address on file with the Company

Either party by notice in writing to the other may change the address to which notices, requests, demands, or other communications to it shall be mailed.

16.<u>Offer</u>. This offer shall remain in effect only through 5:00 pm PT on the Return Date identified in this Agreement, after which this offer shall be automatically withdrawn.

<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

**Transition, Separation and Release Agreement&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 8**

------

17.<u>Employee Acknowledgments and Representations</u>. You hereby acknowledge and represent that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)You have had an adequate opportunity to seek legal counsel of your own choosing, and you have been or are represented by counsel in connection with this Agreement and all negotiations related thereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)The Company and you agree that the parties have relied upon the advice of their respective attorneys, who are attorneys of their own choice, or they have knowingly and willingly not sought the advice of such attorneys.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)You understand and acknowledge the significance and consequence of this Agreement and represent that the terms of this Agreement are fully understood and voluntarily accepted by you.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)This Agreement is intended to include in its effect and does include, without limitation, all claims which you do not know or suspect to exist in your favor at the time of execution of this release, and that the terms agreed upon contemplate and extinguish any and all such claims.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)You will have at least five days to consider and accept or reject this Agreement, though you may elect to sign it sooner.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)This Agreement will become null and void and of no further force or effect if the Company does not receive a fully executed copy from you **<u>ON OR BEFORE</u>** 5:00 pm PT on the Return Date (defined below).

18.<u>Reaffirmation of Release</u>. On or within 21 days following the Termination Date, you shall execute the Confirming Release and return it to the Company as provided therein.

19.<u>Dispute Resolution</u>. The parties agree that any future disputes between the parties, including but not limited to disputes arising out of or related to your employment or this Agreement, the Confirming Release or any of the matters discussed herein, to the maximum extent permitted by law, shall be subject to confidential and binding individual arbitration in COLLIN COUNTY, Texas, or another location mutually agreed by the parties, before the Judicial Arbitration and Mediation Service ("JAMS") under its Employment Arbitration Rules and Procedures then in-effect. The JAMS rules are available at the following address: https://www.jamsadr.com/rules-employment-arbitration. For the avoidance of doubt, the question of whether a particular dispute is subject to arbitration shall be decided by the arbitrator. The arbitrator selected shall have the authority to grant either party or both all remedies otherwise available at law or in equity, including injunctions. The arbitrator shall render a final decision in writing, setting forth the reasons for the arbitration award. The decision of the arbitrator shall be final, conclusive, and binding on the parties to the arbitration. The parties agree that the prevailing party in any arbitration shall be entitled to injunctive relief in any court of competent jurisdiction to enforce the arbitration award. If you initiate arbitration, you shall be responsible for any filing fee up to the amount of the filing fee, if any, that would have been incurred had such claims been filed in federal court, and the Company shall be responsible for all additional arbitration filing fees and forum fees and costs. Each party shall separately pay for its respective counsel fees and expenses, except the arbitrator may award costs and attorneys' fees to the prevailing party to the extent permitted by law. The parties hereby agree to waive their right to have any dispute between them resolved in a court of law by a judge or jury, and you specifically waive your right to participate in any class, collective, or representative action, whether in a court of law or in arbitration, to the fullest extent permitted by law. Notwithstanding the foregoing, this paragraph will not prevent

<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

**Transition, Separation and Release Agreement&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 9**

------

either party from seeking injunctive relief (or any other provisional remedy) from any court having jurisdiction over the parties and the subject matter of their dispute. The parties agree that the Company is engaged in interstate commerce and that, except as otherwise provided in this Agreement, the Federal Arbitration Act ("FAA") shall govern any arbitration pursuant to this paragraph and the enforceability of this paragraph.

20.<u>Miscellaneous</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Assignment</u>. You shall not assign, pledge, or transfer this Agreement or the Confirming Release without the Company's prior written consent.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Prior Agreement and Modification</u>. This Agreement, including the Confirming Release, is the entire understanding between you and the Company concerning the termination of your employment, and no change, alteration, or modification of this Agreement may be made except in writing signed by both parties. You previously signed an Employee Confidentiality Agreement and/or an Employee Confidentiality and Non-Compete Agreement(s). All terms and conditions of the Employee Confidentiality and/or Employee Confidentiality and Non-Compete Agreement(s) shall remain in effect after the Termination Date pursuant to the terms of such agreements to the fullest extent permissible by law. To the extent there is any conflict between or among the terms of this Agreement and the Employee Confidentiality Agreement and/or an Employee Confidentiality and Non-Compete Agreement(s), you agree that the provision that provides the greatest protection or benefit to the Company shall control to the fullest extent permissible by law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Headings</u>. The headings in this Agreement and the Confirming Release are for convenience of reference only and shall not limit the enforceability of this Agreement or the Confirming Release.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Severability</u>. Should any provision of this Agreement or the Confirming Release be declared illegal or unenforceable by any court of competent jurisdiction, a provision that most closely resembles the parties' intent, but which is legally enforceable, shall be deemed to have been automatically substituted in the place of such provision. If a legal provision which would carry out the parties' intent cannot, as a practical matter, be substituted in the place of such unenforceable provision (other than the general release language), then such provision shall immediately become null and void, but leaving the remainder of this Agreement fully enforceable. If, however, a court deems any portion of Section 9 above or the Confirming Release unenforceable for any reason, then you agree to promptly return to the Company all of the consideration that has been paid to you under this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)<u>Waiver of Breach; Rights and Remedies Cumulative</u>. The waiver by either party of a breach of a provision of this Agreement or the Confirming Release shall not operate or be construed as a waiver of a subsequent breach by either party. No right or remedy provided in this Agreement or the Confirming Release is intended to be exclusive of any other right or remedy available by law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)<u>All Commitments</u>. The amounts and benefits payable to you under this Agreement constitute all payments or benefits which the Company shall be obligated to provide for you, and you agree that, except as provided herein, neither you nor your estate will have any rights under any bonus plan, incentive compensation plan, health plan, or any other benefit or compensation plan whatsoever. Any rights under Company benefit & reward plans are subject to the terms and conditions of such plans.

<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

**Transition, Separation and Release Agreement&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 10**

------

21.<u>Governing Law and Venue</u>. Except as otherwise provided in Section 19, the terms and provisions of this Agreement and the Confirming Release shall be governed by and construed in accordance with the laws of the STATE OF TEXAS, exclusive of any conflict of law provisions, and venue for all purposes of this Agreement and release shall be in a court of competent jurisdiction sitting in COLLIN COUNTY, TEXAS or the applicable federal district or appellate court having jurisdiction over actions filed in such county and state. You have been represented by counsel in the negotiation of this Agreement and, notwithstanding California Labor Code Section 925, you and the Company acknowledge and agree that (a) this Agreement will be construed and enforced under and be governed in all respects by the laws of the STATE OF TEXAS, without regard to the conflict of laws principles thereof, and (b) venue for any dispute arising hereunder shall be in the federal or state district courts sitting in COLLIN COUNTY, TEXAS.

22.<u>Section 409A; Six Month Delay</u>. Notwithstanding anything herein to the contrary, if and to the extent any portion of any payment, compensation or other benefit provided to you in connection with this Agreement is determined to constitute "nonqualified deferred compensation" within the meaning of Code Section 409A and you are a "specified employee" as defined in Code Section 409A(a)(2)(B)(i), as determined by the Company in accordance with its procedures, by which determination you hereby agree that you are bound, such portion of the payment, compensation or other benefit shall not be paid until the earlier of (i) the date that is six months and two days after your Termination Date or (y) the date of your death.

**THE COMPANY HEREBY ADVISES YOU IN WRITING TO CONSULT WITH AN ATTORNEY PRIOR TO SIGNING THE AGREEMENT.** The Agreement must be signed electronically and returned to **Keurig Dr Pepper Inc. no later than November 21, 2025** (the "Return Date"). This Agreement will take effect as a legally binding document upon your execution (the "Effective Date").

**BY SIGNING BELOW, YOU ACKNOWLEDGE THAT YOU HAVE READ THE ENTIRE AGREEMENT, HAVE HAD THE OPPORTUNITY TO CONSULT WITH AN ATTORNEY OF YOUR CHOICE, UNDERSTAND IT, AND ARE VOLUNTARILY ENTERING INTO IT. READ THE ENTIRE AGREEMENT CAREFULLY, AS IT CONTAINS A RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS.**

By: <u>/s/ Sudhanshu Priyadarshi&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

**&nbsp;&nbsp;&nbsp;&nbsp;Sudhanshu Priyadarshi**

Date: <u>11/21/2025&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

**Keurig Dr Pepper Inc.**

By: <u>/s/ Mary Beth DeNooyer&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

**Mary Beth DeNooyer**

**Chief Human Resources Officer** &nbsp;&nbsp;&nbsp;&nbsp;

<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

**Transition, Separation and Release Agreement&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 11**

## Exhibit 10.22

**EXHIBIT 10.22**

**<u>Restricted Stock Unit Award<br>Terms and Conditions</u><br> Under the<br>KEURIG DR PEPPER INC. OMNIBUS STOCK INCENTIVE PLAN OF 2019**

This instrument (this "**Agreement**") evidences the grant effective on __________ (the "**Grant Date**") of an award of restricted stock units (the "**Restricted Stock Units**") by Keurig Dr Pepper Inc., a Delaware corporation (the "**Company**"), under the Keurig Dr Pepper Inc. Omnibus Stock Incentive Plan of 2019, as the same may be amended from time to time (the "**Plan**"). Any term capitalized but not defined in this Agreement will have the meaning set forth in the Plan.

1.**Restricted Stock Unit Grant.** In accordance with the terms of the Plan and subject to this Agreement, as of the Grant Date you are hereby granted the number of Restricted Stock Units, each of which represents the right to receive one share of Common Stock of the Company (each, a "**Share**"), set forth in your award notice (the "**Award**"). The Restricted Stock Units, and any Shares acquired upon settlement thereof, are subject to the following terms and conditions and to the provisions of the Plan, the terms of which are incorporated by reference herein. 

2.**Vesting Period.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>In General</u>. The Restricted Stock Units shall vest on the following vesting schedule, provided that you have remained in continuous Service through each such date: 25% of the Restricted Stock Units subject to the Award shall vest on each of the first, second, third and fourth anniversaries of the Grant Date. If a vesting date falls on a weekend or any other day when the national stock exchange on which the Shares are then listed is not open for trading, affected Restricted Stock Units shall vest on the next following trading day. Except as otherwise provided in Section 2(b), 2(c), 2(d), or 2(e) below, in the event your Service terminates for any reason, all Restricted Stock Units that are unvested as of your termination of Service shall automatically terminate without consideration as of the date of such termination and your right to receive further Shares under this Award shall also terminate as of the date of such termination.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Involuntary Termination</u>. If, before all of the Restricted Stock Units have otherwise become vested, your Service terminates as a result of a Qualifying Termination, then your Restricted Stock Units shall vest as of the date of such termination in a number of Restricted Stock Units determined by (i) multiplying the total number of Restricted Stock Units subject to the Award by a fraction, the numerator of which is the number of complete months elapsed from the Grant Date of this Award to the date of your Qualifying Termination and the denominator of which is 48, and (ii) subtracting from that product the number of Restricted Stock Units subject to the Award that have already become vested, if any. The remaining Restricted Stock Units shall be immediately forfeited and canceled as of the date of such Qualifying Termination. For purposes of this Agreement, "**Qualifying Termination**" shall have the meaning set forth in the Keurig Dr Pepper Inc. Executive Severance Plan, as such plan may be amended in the future (the "**Severance Plan**").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Death or Disability</u>. If, before all of the Restricted Stock Units have otherwise become vested, your Service terminates due to death or Disability, then the Restricted Stock Units shall vest in full on the date of your termination from Service.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Retirement.</u> If, before all of the Restricted Stock Units subject to the Award have otherwise become vested, your Service terminates due to Retirement, then your Restricted Stock Units shall vest as of the date of such Retirement in a number of

------

Restricted Stock Units determined by (i) multiplying the total number of Restricted Stock Units subject to the Award by a fraction, the numerator of which is the number of complete months elapsed from the Grant Date of this Award to the date of your Retirement and the denominator of which is 48, and (ii) subtracting from that product the number of Restricted Stock Units subject to the Award that have already become vested, if any. The remaining Restricted Stock Units shall be immediately forfeited and canceled as of the date of such Retirement. For purposes of this Agreement, "**Retirement**" means your termination of Service (other than a termination of Service for Cause) after attaining age 60 and having completed at least 5 years of continuous service with the Company and its Subsidiaries or any of their respective affiliates. For purposes of this Agreement, "**Cause**" shall have the meaning set forth in the Severance Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)<u>Change in Control.</u> In the event of a Change in Control, any Restricted Stock Units then outstanding shall continue in effect or shall become vested and payable, in either case, as provided in, and subject to the conditions of, Section 4. For purposes of this Agreement, "Change in Control" means the occurrence of any of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)any person or "group" (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the "**Exchange Act**")) is or becomes the "beneficial owner" (as defined below), directly or indirectly, of securities representing more than 50% of the combined voting power of the Company's then outstanding securities. For purposes of this clause (i), "beneficial owner" has the meaning given to such term in Rule 13d-3 under the Exchange Act, except that a person shall be deemed to be the "beneficial owner" of all shares that any such person has the right to acquire pursuant to any agreement or arrangement or upon exercise of conversion rights, warrants, options or otherwise, without regard to the 60-day period referred to in such Rule; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)the consummation of a plan or agreement approved by the Company's shareholders, providing (x) for a merger or consolidation of the Company, other than with a wholly owned subsidiary of such entity and other than a merger or consolidation that would result in the voting securities of such entity outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 50% of the combined voting power of the voting securities of such entity or such surviving entity outstanding immediately after such merger or consolidation or (y) for a sale, exchange or other disposition of all or substantially all of the business or assets of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)<u>Service</u>. For purposes of this Agreement, **"Service**" means the provision of services in the capacity of an employee or Director. For purposes of this Agreement, "**Director**" means any person who is not an employee and who is serving as a member of the Board or the board of directors or equivalent governing body of any of the Company's Subsidiaries or affiliates. If, upon termination of employment with the Company, any Subsidiary or any of their respective affiliates, you become or continue to serve as a member of the Board or the board of directors of such an affiliate you shall not be deemed to have had an interruption in Service, unless, to the extent necessary to avoid any additional taxes or penalties that may be imposed under Section 409A of the Code, such termination of service constitutes a "separation from service" within the meaning of Section 409A of the Code. For this purpose, years of service shall be based on the period of time elapsed from your commencement of services (whether as an employee or Director) with the Company, any of its Subsidiaries or any of their respective affiliates to the date such services terminate, whether due to Retirement, death, Disability or for any

&nbsp;&nbsp;&nbsp;&nbsp;2

------

other reason. A transfer of Service from the Company to a Subsidiary or an affiliate or from an affiliate of the Company to the Company, a Subsidiary or another affiliate of the Company shall not constitute a termination of Service. All determinations regarding Service, including whether any leave of absence is a termination of Service, shall be made by the Committee.

3.**Settlement of Restricted Stock Units.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Timing of Settlement</u>. The Shares underlying vested Restricted Stock Units shall be delivered promptly (and in all events within 60 days) following the date such Restricted Stock Units vest pursuant to Section 2 hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Withholding Obligation</u>. Prior to or upon settlement of any Restricted Stock Units, all federal, state, and local taxes, domestic or foreign, required by law or regulation to be withheld (each, a "**Withholding Tax**") must be satisfied. In the Company's sole discretion, you may satisfy the Withholding Tax by either (i) paying the amount of required Withholding Tax to the Company in cash, (ii) electing to have the Company sell that number of whole Shares that you have acquired through the vesting of Restricted Stock Units having a Fair Market Value at least equal to the amount of the required Withholding Tax, (iii) electing to have the Company withhold Shares otherwise issuable in respect of the Restricted Stock Units having a Fair Market Value at least equal to the amount of the required Withholding Tax, or (iv) a combination of the foregoing; <u>provided</u>, <u>however</u>, <u>that</u> if and to the extent that the Withholding Tax is satisfied using Shares issuable in settlement of the Restricted Stock Units, the applicable Withholding Tax shall be based on no more than the statutory maximum amount for the applicable jurisdictions.

4.**Change in Control.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Double Trigger Protection Upon a Change in Control</u>. In the event of a Change in Control, unless otherwise determined by the Committee prior to the occurrence of a Change in Control, the Company shall take all actions necessary or appropriate to assure that each Award outstanding under the Plan shall be honored or assumed, or new rights substituted therefor (such honored, assumed or substituted award hereinafter called an "**Alternative Award**") by the entity for which you will be performing Service immediately following the Change in Control (or the parent or a subsidiary of such entity); provided that any such Alternative Award must provide that if your Service is terminated upon or following such Change in Control (<u>x</u>) by the Company other than for Cause or (<u>y</u>) by you for Good Reason (as defined below), in either case, within 24 months following the Change in Control, your rights under each such Alternative Award shall become fully vested and exercisable or payable, whichever is applicable, in accordance with its otherwise applicable terms (including, without limitation, provisions similar to Section 4(d) hereof). In addition, any such Alternative Award granted to you must

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) &nbsp;&nbsp;&nbsp;&nbsp;provide you with rights and entitlements substantially equivalent to or better than the rights and entitlements applicable under the corresponding Award, including, but not limited to, an identical or better exercise or vesting schedule and identical or better timing and methods of payment (including all provisions applicable in respect of such Award that provide for accelerated vesting); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) &nbsp;&nbsp;&nbsp;&nbsp;have substantially equivalent economic value to such Award (as determined by the Committee as constituted immediately prior to the Change in Control).

&nbsp;&nbsp;&nbsp;&nbsp;3

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Accelerated Vesting and Payment</u>. Notwithstanding the provisions of Section 4(a), the Committee may otherwise determine that, upon the occurrence of a Change in Control, all or any portion of the Restricted Stock Units that are then still outstanding shall become vested and shall be immediately payable in Shares (or, if so directed by the Committee, cash in an amount equal to the Fair Market Value of the Shares that would otherwise have been deliverable to you).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Good Reason</u>. For purposes of this Section 4, "**Good Reason**" shall have the meaning set forth in the Severance Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Deferred Compensation Subject to Section 409A.</u> Notwithstanding the foregoing provisions of this Section 4, if you are or will become eligible for Retirement prior to the date that the Restricted Stock Units would otherwise vest in accordance with the terms of this Section 4 ("**Retirement Eligible Units**"), such Restricted Stock Units shall not become payable at the time specified under the provisions of Section 4(a) or 4(b). Instead, to the extent that any such Retirement Eligible Units become vested in accordance with the terms of the Plan or this Agreement (including Section 4(a) or 4(b)), such Restricted Stock Units shall be payable at the time that they would otherwise have been payable without regard to the occurrence of a Change in Control but only to the extent necessary to avoid any additional taxes and penalties that may be imposed under Section 409A of the Code.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)<u>Provisions Related to Golden Parachute Excise Tax.</u> Notwithstanding anything to the contrary contained in this Agreement, to the extent that any of the payments and benefits provided for under the Plan, any Award or any other agreement or arrangement between the Company, any Subsidiary or any of their respective affiliates and you (collectively, the "**Payments**") would constitute a "parachute payment" within the meaning of section 280G of the Code (a "**Parachute Payment**"), then, if and solely to the extent that reducing the benefits payable hereunder would result in your receiving a greater amount, on an after-tax basis, taking into account any Excise Tax and all applicable income, employment and other taxes payable on such amounts, the amount of such Payments shall be reduced to the amount (the "**Safe Harbor Amount**") that would result in no portion of the Payments being treated as an excess parachute payment pursuant to section 280G of the Code (the "**Excise Tax**"). Any reduction in the amount of compensation or benefits effected pursuant to this Section 4 shall first come, in order and, in each case, solely to the extent necessary, from any cash severance benefits payable to you, then ratably from any other payments which are treated in their entirety as Parachute Payments and then ratably from any other Parachute Payments payable to you.

5.**Nontransferability of Restricted Stock Units**; **Transferability of Shares.** The Restricted Stock Units granted hereby may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent or distribution or, to the extent approved by the Committee, to a trust for estate planning purposes, and all rights with respect to the Restricted Stock Units shall be available during your lifetime only to you, a trustee approved by the Committee, or your guardian or legal representative. The Committee may, in its sole discretion, require your guardian or legal representative to supply it with evidence the Committee deems necessary to establish the authority of the guardian or legal representative to act on behalf of you.

6.**No Limitation on Rights of the Company.** The grant of the Restricted Stock Units does not and will not in any way affect the right or power of the Company to make adjustments, reclassifications or changes in its capital or business structure, or to merge, consolidate, dissolve, liquidate, sell or transfer all or any part of its business or assets.

&nbsp;&nbsp;&nbsp;&nbsp;4

------

7.**Plan and Agreement Not a Contract of Employment or Service**. Neither the Plan nor this Agreement are a contract of employment or Service, and no terms of your employment or Service will be affected in any way by the Plan, this Agreement or related instruments, except to the extent specifically expressed therein. Neither the Plan nor this Agreement will be construed as conferring any legal rights on you to continue to be employed or remain in Service with the Company, nor will it interfere with any right of the Company, any Subsidiary or any of their respective affiliates to discharge you or to deal with you regardless of the existence of the Plan, this Agreement or the Restricted Stock Units.

8.**Employee Confidentiality and Non-Competition Obligations.&nbsp;&nbsp;&nbsp;&nbsp;**As a condition to your eligibility to receive an Award under the Plan and the vesting of any Shares granted thereunder, you must execute and comply fully with the Employee Confidentiality and Non-Competition Agreement that is attached as Exhibit A to this Agreement, which is incorporated herein by reference.

9.**Clawback/Recoupment; Other Company Policies**. The Restricted Stock Units granted under this Agreement, and any Shares issued or other payments made in respect thereof, shall be subject to the Company's share ownership policies and any recoupment policy that the Company may adopt from time to time, to the extent any such policy is applicable to you and to such compensation including, but not limited to, the Company's Ownership Guidelines for Senior Vice Presidents & Vice Presidents, the Company's Rule 10D-1 Clawback Policy, designed to comply with the requirements of Rule 10D-1 promulgated under the U.S. Securities Exchange Act of 1934, as amended, and the Company's Senior Leadership Clawback Policy, as well as any recoupment provisions required under applicable law. By accepting the grant of Restricted Stock Units under this Agreement, you acknowledge, agree and consent to the Company's application, implementation and enforcement of both (i) such policies with respect to all covered compensation received or to be received by you, to the extent applicable, and (ii) any provision of applicable law relating to cancellation, recoupment, rescission or payback of compensation, and, further, expressly agree that the Company may take such actions as are necessary to effectuate such policies (as applicable to you) or such applicable law without further consent or action being required by you. For purposes of the foregoing, you expressly and explicitly authorize (<u>x</u>) the Company to issue instructions, on your behalf, to any brokerage firm and/or third party administrator engaged by the Company to hold your Shares and other amounts acquired under the Plan to re-convey, transfer or otherwise return such Shares and/or other amounts to the Company and (<u>y</u>) the Company's recovery of any covered compensation through any method of recovery that the Company deems appropriate, including without limitation by reducing any amount that is or may become payable to you. You further agree to comply with any request or demand for repayment by any Subsidiary or affiliate of the Company in order to comply with such policies or applicable law. To the extent that the terms of this Agreement and any Company policy conflict, the terms of the policy shall prevail.

10.**No Rights as a Shareholder.** Before the date as of which you are recorded on the books of the Company as the holder of any Shares related to the Restricted Stock Units, you will have no rights as a shareholder by reason of this Restricted Stock Units Award (including voting rights or any right to dividends or dividend equivalents).

11.**Continued Effect of Award Agreement**. To the extent that the Plan or this Agreement contain provisions that are intended to have effect after the date(s) as of which your rights in respect to the Restricted Stock Units have become vested (including, but not limited to, following the date of your termination of Service), the Restricted Stock Units and any Shares issued in respect of such Restricted Stock Units shall continue to be subject to the terms of the Plan and this Agreement.

12.**Securities Law Requirements.** If at any time the Committee determines that issuing Shares would violate applicable securities laws, the Company will not be required to issue such Shares.

&nbsp;&nbsp;&nbsp;&nbsp;5

------

The Committee may declare any provision of this Agreement or action of its own null and void, if it determines the provision or action fails to comply with the short-swing trading rules. As a condition to issuance, the Company may require you to make written representations it deems necessary or desirable to comply with applicable securities laws. No person who acquires Shares under this Agreement may sell the Shares, unless they make the offer and sale pursuant to an effective registration statement under the Securities Act of 1933, as amended (the "**Securities Act**"), which is current and includes the Shares to be sold, or an exemption from the registration requirements of the Securities Act.

13.**Notice.** Any notice or other communication required or permitted under this Agreement must be in writing and must be delivered personally, sent by certified, registered or express mail or by email, or sent by overnight courier, at the sender's expense. Notice will be deemed given when delivered personally, on the date sent by email or, if mailed, three (3) days after the date of deposit in the United States mail or, if sent by overnight courier, on the regular business day following the date sent. Notice to the Company should be sent to:

Keurig Dr Pepper Inc.

6425 Hall of Fame Lane

Frisco, TX 75034

Attention: Chief Legal Officer, Corporate General Counsel and Secretary

Email: anthony.shoemaker@kdrp.com

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.Notice to you should be sent to the address on file with the Company. Either party may change the Person and/or address to which the other party must give notice under this Section 13 by giving such other party written notice of such change, in accordance with the procedures described above.

15.**Successors.** All obligations of the Company under this Agreement will be binding on any successor to the Company, whether the existence of the successor results from a direct or indirect purchase of all or substantially all of the business of the Company, or a merger, consolidation, or otherwise.

16.**Governing Law.** To the extent not preempted by federal law, this Agreement, except as otherwise provided in <u>Exhibit A</u>, will be construed and enforced in accordance with, and governed by, the laws of the State of Delaware, without giving effect to its conflicts of law principles that would require the application of the law of any other jurisdiction.

17.**Plan Document Controls.** The rights granted under this Agreement are in all respects subject to the provisions set forth in the Plan to the same extent and with the same effect as if set forth fully in this Agreement. If the terms of this Agreement conflict with the terms of the Plan document, the Plan document will control.

18.**Amendment.** This Agreement may be amended unilaterally by the Company to the extent determined by the Committee and permitted under the Plan, or by a written instrument signed by both parties.

19.**Entire Agreement.** This Agreement, including <u>Exhibit A</u>, together with the Plan, constitute the entire obligation of the parties with respect to the subject matter of this Agreement and supersede any prior written or oral expressions of intent or understanding with respect to such subject matter.

&nbsp;&nbsp;&nbsp;&nbsp;6

------

20.**Administration.** The Committee administers the Plan and this Agreement. Your rights under this Agreement are expressly subject to the terms and conditions of the Plan, including any guidelines the Committee adopts from time to time. You hereby acknowledge receipt of a copy of the Plan.

21.**Section 409A.** The Restricted Stock Units awarded pursuant to this Agreement are intended to comply with or, in the alternative, be exempt from Section 409A. Any reference to a termination of Service shall be construed as a "separation from service" for purposes of Section 409A. In the event that you are a "specified employee" within the meaning of Section 409A and the Shares are to be delivered in connection with the termination of your Service, the delivery of the Shares under Section 3 shall be delayed until the date that is six months and one day following the date of your termination of Service if required to avoid the imposition of additional taxes under Section 409A.

22.**Consent to Electronic Delivery; Electronic Signature**. In lieu of receiving documents in paper format, you hereby agree, to the fullest extent permitted by law, to accept electronic delivery of any documents that the Company may be required to deliver (including, but not limited to, prospectuses, prospectus supplements, grant or award notifications and agreements, account statements, annual and quarterly reports and all other forms of communications) in connection with this and any other award made or offered by the Company. Electronic delivery may be via a Company electronic mail system or by reference to a location on a Company intranet to which you have access. You hereby consent to any and all procedures the Company has established or may establish for an electronic signature system for delivery and acceptance of any such documents that the Company may be required to deliver, and agree that your electronic signature is the same as, and shall have the same force and effect as, your manual signature.

23.**Acceptance of Award**. You acknowledge and agree that you will have 90 days following the Grant Date to accept this Award, which Award will be delivered to you electronically in accordance with Section 21 of this Agreement and which acceptance must also be delivered electronically. If you do not accept the Award within 90 days following the Grant Date, the Award shall automatically terminate and cease to be acceptable by you as of 12:01 a.m. on the day following the expiration of such 90-day period without any further action by the Company or notice required to you.

24.**Personal Data.** The Company, its Subsidiaries and each of their respective affiliates, and the Company's authorized third-party service providers will process your personal information, including financial information, (collectively, "**Personal Data**") for the purpose of implementing, administering, and managing the Plan and in accordance with the Company's employee privacy notice(s). For more information about the collection, use, sharing, and processing of your Personal Data, and your rights with respect to your Personal Data, please see our employee privacy notice accessible on the Company's Corporate Policy portal.

**EMPLOYEE**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**KEURIG DR PEPPER INC.**

By: <u>&nbsp;&nbsp;&nbsp;&nbsp;</u>&nbsp;&nbsp;&nbsp;&nbsp;By:&nbsp;&nbsp;&nbsp;&nbsp;

Name: <u>&nbsp;&nbsp;&nbsp;&nbsp;</u>&nbsp;&nbsp;&nbsp;&nbsp;Name: Mary Beth DeNooyer

Date: <u>&nbsp;&nbsp;&nbsp;&nbsp;</u>&nbsp;&nbsp;&nbsp;&nbsp;Title: Chief Human Resources Officer

&nbsp;&nbsp;&nbsp;&nbsp;7

## Exhibit 10.23

**EXHIBIT 10.23**

**<u>Matching Restricted Stock Unit Award<br>Terms and Conditions</u><br> Under<br>KEURIG DR PEPPER INC. OMNIBUS STOCK INCENTIVE PLAN OF 2019**

This instrument (this "**Agreement**") evidences the grant effective on _________ (the "**Grant Date**") of an award of restricted stock units (the **"Restricted Stock Units"**) by Keurig Dr Pepper Inc., a Delaware corporation (the "**Company**"), under the Keurig Dr Pepper Inc. Omnibus Stock Incentive Plan of 2019, as the same may be amended from time to time (the "**Plan**"). Any term capitalized but not defined in this Agreement will have the meaning set forth in the Plan. The Restricted Stock Units granted hereby are granted as a matching award on the condition that you hold Shares (as hereinafter defined) (whether you shall have purchased such Shares through open market transactions consistent with the Company's applicable securities trading policies or otherwise received or acquired such Shares) in your Morgan Stanley Smith Barney LLC ("**Morgan Stanley**") account established by the Company (such account, your "**Measurement Account**") on the Share Ownership Determination Date (as defined below), and on the Share Ownership Determination Date such number of Shares in your Measurement Account equals or exceeds the number of shares you elected to purchase in your Investment Election (the "**Target Number of Shares**" and, such condition, the "**Minimum Share Ownership Condition**").

1.**Restricted Stock Unit Grant.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)In accordance with the terms of the Plan and subject to this Agreement, as of the Grant Date you are hereby granted the number of Restricted Stock Units, each of which represents the right to receive one share of Common Stock of the Company (each, a "**Share**"), set forth in your award notice (the "**Award**"). The Restricted Stock Units, and any Shares acquired upon settlement thereof, are subject to the following terms and conditions and to the provisions of the Plan, the terms of which are incorporated by reference herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Share Ownership Condition.</u> Notwithstanding anything else contained herein to the contrary, you shall forfeit the Specified Portion (as defined below) of the Restricted Stock Units on the Share Ownership Determination Date if on such date you have not satisfied the Minimum Share Ownership Condition. If on the Share Ownership Determination Date, you hold Shares in your Measurement Account (the "**Owned Shares**") representing at least the number of Shares required to satisfy the minimum investment required under the Elite Investment Plan (such minimum number of Shares required to participate in the Elite Investment Plan, the "**Baseline Number of Shares**") but do not hold at least the Target Number of Shares, the "**Specified Portion**" shall mean a percentage determined by dividing (i) the remainder of (A) the Target Number of Shares <u>minus</u> (B) the Owned Shares by (ii) the Target Number of Shares. If on the Share Ownership Determination Date, your Owned Shares are less than the Baseline Number of Shares, the "Specified Percentage" shall be 100%. The "**Share Ownership Determination Date**" shall mean the earlier to occur of (i) the first anniversary of the Grant Date or (ii) the date on which a Change in Control (as defined below) occurs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Risk of Forfeiture</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)You acknowledge and agree that the Restricted Stock Units granted in accordance with this Agreement were granted to you because you agreed to hold, on the Share Ownership Determination Date and in your Measurement Account, the Target Number of Shares (or the remainder of the Target Number of Shares after forfeiture of the Specified Portion thereof, if applicable) (the "**Matching Shares**").

1004280792v1

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)If you do not own and continue to hold the Baseline Number of Shares on the Share Ownership Determination Date and at all times after the Share Ownership Determination Date and prior to the Vesting Date, you shall forfeit this Award in its entirety.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)Except as provided in the next sentence, if you transfer any Matching Shares outside of your Measurement Account prior to the Vesting Date you shall forfeit a corresponding number of Restricted Stock Units for each Matching Share you transfer outside of your Measurement Account. However, no forfeiture shall occur under the immediately preceding sentence upon a transfer of Matching Shares to an immediate family member or a trust, partnership or other collective ownership vehicle solely for the benefit of you and your immediate family members, so long as following such transfer all of the transfer and forfeiture restrictions otherwise applicable in respect of your Matching Shares continue to apply to such family member or collective ownership vehicle on the same terms as applied to you immediately prior to such transfer (with vesting still tied to your continuous Service), and that you continue to provide the Company with audit rights over such holdings.

2.**Vesting Period.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>In General</u>. The Restricted Stock Units shall vest on the fifth anniversary of the Grant Date (the "**Vesting Date**"), provided that you have remained in continuous Service through such date and provided that you have not forfeited such Restricted Stock Units pursuant to Section 1(b) or 1(c) hereof. If a vesting date falls on a weekend or any other day when the national stock exchange on which the Shares are then listed is not open for trading, the Restricted Stock Units shall vest on the next following trading day. Except as otherwise provided in Section 2(b), 2(c), 2(d) or 2(e) below, in the event your Service terminates for any reason, all Restricted Stock Units that are unvested as of your termination of Service shall automatically terminate without consideration as of the date of such termination and your right to receive further Shares under this Award shall also terminate as of the date of such termination.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Involuntary Termination</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)If your Service terminates before the Share Ownership Determination Date as a result of a Qualifying Termination, then as of the date of such termination you shall vest in a number of Restricted Stock Units determined by multiplying (A) the lesser of the number of Owned Shares as of the date of such Qualifying Termination and the Target Number of Shares by (B) a fraction, the numerator of which is the number of complete months elapsed from the Grant Date to the date of your Qualifying Termination and the denominator of which is 60. The remaining Restricted Stock Units shall be immediately forfeited and canceled as of the date of such Qualifying Termination. For purposes of this Agreement, "**Qualifying Termination**" shall have the meaning set forth in the Keurig Dr Pepper Inc. Executive Severance Plan, as such plan may be amended in the future (the "**Severance Plan**").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)If your Service terminates on or after the Share Ownership Determination Date, but before all of the Restricted Stock Units have otherwise become vested, as a result of a Qualifying Termination, then you shall vest as of the date of such termination in a number of Restricted Stock Units determined by multiplying the total number of Restricted Stock Units then subject to the Award by a fraction, the numerator of which is the number of complete months elapsed from the Grant Date to the date of your Qualifying Termination and the denominator of which is

&nbsp;&nbsp;&nbsp;&nbsp;2

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;60. The remaining Restricted Stock Units shall be immediately forfeited and canceled as of the date of such Qualifying Termination.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Death or Disability</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)If your Service terminates before the Share Ownership Determination Date as a result of your death or Disability, then you shall vest as of the date of your termination from Service in a number of Restricted Stock Units equivalent to the lesser of the number of Owned Shares as of the date of such termination and the Target Number of Shares. The remaining Restricted Stock Units shall be immediately forfeited and canceled as of the date of such termination.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)If your Service terminates on or after the Share Ownership Determination Date, but before all of the Restricted Stock Units have otherwise become vested, as a result of your death or Disability, then the total number of Restricted Stock Units then subject to the Award shall vest in full as of the date of your termination from Service.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Retirement</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)If your Service terminates before the Share Ownership Determination Date as a result of your Retirement, then you shall vest as of the date of such Retirement in a number of Restricted Stock Units determined by multiplying (A) the lesser of (1) the number of Owned Shares as of the date of such termination and (2) the Target Number of Shares by (B) a fraction, the numerator of which is the number of complete months elapsed from the Grant Date to the date of your Retirement and the denominator of which is 60. The remaining Restricted Stock Units shall be immediately forfeited and canceled as of the date of such Retirement. For purposes of this Agreement, "**Retirement**" means your termination of Service (other than a termination of Service for Cause) after attaining age 60 and having completed at least 5 years of continuous service with the Company and its Subsidiaries or any of their respective affiliates. For purposes of this Agreement, "**Cause**" shall have the meaning set forth in the Severance Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)If your Service terminates on or after the Share Ownership Determination Date, but before all of the Restricted Stock Units subject to the Award have otherwise become vested, as a result of your Retirement, then you shall vest as of the date of your Retirement in a number of Restricted Stock Units determined by multiplying the total number of Restricted Stock Units then subject to the Award by a fraction, the numerator of which is the number of complete months elapsed from the Grant Date to the date of your Retirement and the denominator of which is 60. The remaining Restricted Stock Units shall be immediately forfeited and canceled as of the date of such Retirement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)<u>Change in Control.</u> In the event of a Change in Control, any Restricted Stock Units then outstanding shall continue in effect or shall become vested and payable, in either case, as provided in, and subject to the conditions of, Section 4. For purposes of this Agreement, "**Change in Control**" means the occurrence of any of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)any person or "group" (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the "**Exchange Act**")) is or becomes the "beneficial owner" (as defined below), directly or indirectly, of securities representing more than 50% of the combined voting power of the Company's then outstanding securities. For purposes of this clause (i),

&nbsp;&nbsp;&nbsp;&nbsp;3

------

"beneficial owner" has the meaning given to such term in Rule 13d-3 under the Exchange Act, except that a person shall be deemed to be the "beneficial owner" of all shares that any such person has the right to acquire pursuant to any agreement or arrangement or upon exercise of conversion rights, warrants, options or otherwise, without regard to the 60-day period referred to in such Rule; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)the consummation of a plan or agreement approved by the Company's shareholders, providing (<u>x</u>) for a merger or consolidation of the Company other than with a wholly owned subsidiary of such entity and other than a merger or consolidation that would result in the voting securities of such entity outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 50% of the combined voting power of the voting securities of such entity or such surviving entity outstanding immediately after such merger or consolidation or (<u>y</u>) for a sale, exchange or other disposition of all or substantially all of the business or assets of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)<u>Service</u>. For purposes of this Agreement, **"Service**" means the provision of services in the capacity of an employee or Director. For purposes of this Agreement, "**Director**" means any person who is not an employee and who is serving as a member of the Board or the board of directors or equivalent governing body of any of the Company's Subsidiaries or affiliates. For purposes of this Agreement, years of service shall be based on the period of time elapsed from your commencement of services (whether as an employee or Director) with the Company, any of its Subsidiaries or any of their respective affiliates to the date such services terminate, whether due to Retirement, death, Disability or for any other reason. A transfer of Service from the Company to a Subsidiary or an affiliate or from an affiliate of the Company to the Company, a Subsidiary or another affiliate of the Company shall not constitute a termination of Service. All determinations regarding Service, including whether any leave of absence is a termination of Service, shall be made by the Committee.

3.**Settlement of Restricted Stock Units.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Timing of Settlement</u>. The Shares underlying vested Restricted Stock Units shall be delivered promptly (and in all events within 60 days) following the date such Restricted Stock Units vest pursuant to Section 2 hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Withholding Obligation</u>. Prior to or upon settlement of any Restricted Stock Units, all federal, state, and local taxes, domestic or foreign, required by law or regulation to be withheld (each, a "**Withholding Tax**") must be satisfied. In the Company's sole discretion, you may satisfy the Withholding Tax by either (i) paying the amount of required Withholding Tax to the Company in cash, (ii) electing to have the Company sell that number of whole Shares that you have acquired through the vesting of Restricted Stock Units having a Fair Market Value at least equal to the amount of the required Withholding Tax, (iii) electing to have the Company withhold Shares otherwise issuable in respect of the Restricted Stock Units having a Fair Market Value at least equal to the amount of the required Withholding Tax, or (iv) a combination of the foregoing; <u>provided</u>, <u>however</u>, <u>that</u> if and to the extent that the Withholding Tax is satisfied using Shares issuable in settlement of the Restricted Stock Units, the applicable Withholding Tax shall be based on no more than the statutory maximum amount for the applicable jurisdictions.

4.**Change in Control.** 

&nbsp;&nbsp;&nbsp;&nbsp;4

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Double Trigger Protection Upon a Change in Control</u>. In the event of a Change in Control, unless otherwise determined by the Committee prior to the occurrence of a Change in Control, the Company shall take all actions necessary or appropriate to assure that each Award outstanding under the Plan shall be honored or assumed, or new rights substituted therefor (such honored, assumed or substituted award hereinafter called an "**Alternative Award**") by the entity for which you will be performing Service immediately following the Change in Control (or the parent or a subsidiary of such entity); provided that any such Alternative Award must provide that if your Service is terminated upon or following such Change in Control (<u>x</u>) by the Company other than for Cause or (<u>y</u>) by you for Good Reason (as defined below), in either case, within 24 months following the Change in Control, your rights under each such Alternative Award shall become fully vested and exercisable or payable, whichever is applicable, in accordance with its otherwise applicable terms (including, without limitation, provisions similar to Section 4(d) hereof). In addition, any such Alternative Award granted to you must:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) &nbsp;&nbsp;&nbsp;&nbsp;provide you with rights and entitlements substantially equivalent to or better than the rights and entitlements applicable under the corresponding Award, including, but not limited to, an identical or better exercise or vesting schedule and identical or better timing and methods of payment (including all provisions applicable in respect of such Award that provide for accelerated vesting); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) &nbsp;&nbsp;&nbsp;&nbsp;have substantially equivalent economic value to such Award (as determined by the Committee as constituted immediately prior to the Change in Control).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Accelerated Vesting and Payment</u>. Notwithstanding the provisions of Section 4(a), the Committee may otherwise determine that, upon the occurrence of a Change in Control, all or any portion of the Restricted Stock Units that are then still outstanding shall become vested and shall be immediately payable in Shares (or, if so directed by the Committee, cash in an amount equal to the Fair Market Value of the Shares that would otherwise have been deliverable to you).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Good Reason</u>. For purposes of this Section 4, "**Good Reason**" shall have the meaning set forth in the Severance Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Deferred Compensation Subject to Section 409A.</u> Notwithstanding the foregoing provisions of this Section 4, if you are or will become eligible for Retirement prior to the date that the Restricted Stock Units would otherwise vest in accordance with the terms of this Section 4 ("**Retirement Eligible Units**"), such Restricted Stock Units shall not become payable at the time specified under the provisions of Section 4(a) or 4(b). Instead, to the extent that any such Retirement Eligible Units become vested in accordance with the terms of the Plan or this Agreement (including Section 4(a) or 4(b)), such Restricted Stock Units shall be payable at the time that they would otherwise have been payable without regard to the occurrence of a Change in Control but only to the extent necessary to avoid any additional taxes and penalties that may be imposed under Section 409A of the Code.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)<u>Provisions Related to Golden Parachute Excise Tax.</u> Notwithstanding anything to the contrary contained in this Agreement, to the extent that any of the payments and benefits provided for under the Plan, any Award or any other agreement or arrangement between the Company, any Subsidiary or any of their respective affiliates and you (collectively, the "**Payments**") would constitute a "parachute payment" within the meaning of section 280G of the Code (a "**Parachute Payment**"), then, if and solely to the extent that reducing the benefits payable hereunder would result in your receiving a greater amount, on an after-tax basis, taking into account any Excise Tax and all applicable income, employment and other taxes payable on such amounts, the amount of such Payments shall be reduced to the amount (the "**Safe Harbor Amount**") that would result in no

&nbsp;&nbsp;&nbsp;&nbsp;5

------

portion of the Payments being treated as an excess parachute payment pursuant to section 280G of the Code (the "**Excise Tax**"). Any reduction in the amount of compensation or benefits effected pursuant to this Section 4 shall first come, in order and, in each case, solely to the extent necessary, from any cash severance benefits payable to you, then ratably from any other payments which are treated in their entirety as Parachute Payments and then ratably from any other Parachute Payments payable to you.

5.**Nontransferability of Restricted Stock Units**; **Transferability of Shares.** The Restricted Stock Units granted hereby may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent or distribution or, to the extent approved by the Committee, to a trust for estate planning purposes, and all rights with respect to the Restricted Stock Units shall be available during your lifetime only to you, a trustee approved by the Committee, or your guardian or legal representative. The Committee may, in its sole discretion, require your guardian or legal representative to supply it with evidence the Committee deems necessary to establish the authority of the guardian or legal representative to act on behalf of you.

6.**No Limitation on Rights of the Company.** The grant of the Restricted Stock Units does not and will not in any way affect the right or power of the Company to make adjustments, reclassifications or changes in its capital or business structure, or to merge, consolidate, dissolve, liquidate, sell or transfer all or any part of its business or assets.

7.**Plan and Agreement Not a Contract of Employment or Service**. Neither the Plan nor this Agreement are a contract of employment or Service, and no terms of your employment or Service will be affected in any way by the Plan, this Agreement or related instruments, except to the extent specifically expressed therein. Neither the Plan nor this Agreement will be construed as conferring any legal rights on you to continue to be employed or remain in Service with the Company, nor will it interfere with any right of the Company, any Subsidiary or any of their respective affiliates to discharge you or to deal with you regardless of the existence of the Plan, this Agreement or the Restricted Stock Units.

8.**Clawback/Recoupment; Other Company Policies**. The Restricted Stock Units granted under this Agreement, and any Shares issued or other payments made in respect thereof, shall be subject to the Company's share ownership policies and any recoupment policy that the Company may adopt from time to time, to the extent any such policy is applicable to you and to such compensation including, but not limited to, the Company's Ownership Guidelines for Senior Vice Presidents & Vice Presidents, the Company's Rule 10D-1 Clawback Policy, designed to comply with the requirements of Rule 10D-1 promulgated under the U.S. Securities Exchange Act of 1934, as amended, and the Company's Senior Leadership Clawback Policy, as well as any recoupment provisions required under applicable law. By accepting the grant of Restricted Stock Units under this Agreement, you acknowledge, agree and consent to the Company's application, implementation and enforcement of both (i) such policies with respect to all covered compensation received or to be received by you, to the extent applicable, and (ii) any provision of applicable law relating to cancellation, recoupment, rescission or payback of compensation, and, further, expressly agree that the Company may take such actions as are necessary to effectuate such policies (as applicable to you) or such applicable law without further consent or action being required by you. For purposes of the foregoing, you expressly and explicitly authorize (<u>x</u>) the Company to issue instructions, on your behalf, to any brokerage firm and/or third party administrator engaged by the Company to hold your Shares and other amounts acquired under the Plan to re-convey, transfer or otherwise return such Shares and/or other amounts to the Company and (<u>y</u>) the Company's recovery of any covered compensation through any method of recovery that the Company deems appropriate, including without limitation by reducing any amount that is or may become payable to you. You further agree to comply with any request or demand for repayment by any Subsidiary or affiliate of the Company in order to comply with such policies or applicable law. To the extent that the terms of this Agreement and any Company policy conflict, the terms of the policy shall prevail.

&nbsp;&nbsp;&nbsp;&nbsp;6

------

9.**No Rights as a Shareholder; Company Audit Rights.** Before the date as of which you are recorded on the books of the Company as the holder of any Shares related to the Restricted Stock Units, you will have no rights as a shareholder by reason of this Restricted Stock Units Award (including voting rights or any right to dividends or dividend equivalents). You acknowledge and agree that the Company may at any time and from time to time verify your Owned Shares in your Measurement Account, and that the Company may require you to provide certifications with respect to your Owned Shares in the Measurement Account or otherwise, in order to confirm that you are continuing to meet the Minimum Share Ownership Condition (or portion thereof, if applicable).

10.**Continued Effect of Award Agreement**. To the extent that the Plan or this Agreement contain provisions that are intended to have effect after the date(s) as of which your rights in respect to the Restricted Stock Units have become vested (including, but not limited to, following the date of your termination of Service), the Restricted Stock Units and any Shares issued in respect of such Restricted Stock Units shall continue to be subject to the terms of the Plan and this Agreement.

11.**Securities Law Requirements.** If at any time the Committee determines that issuing Shares would violate applicable securities laws, the Company will not be required to issue such Shares. The Committee may declare any provision of this Agreement or action of its own null and void, if it determines the provision or action fails to comply with the short-swing trading rules. As a condition to issuance, the Company may require you to make written representations it deems necessary or desirable to comply with applicable securities laws. No person who acquires Shares under this Agreement may sell the Shares, unless they make the offer and sale pursuant to an effective registration statement under the Securities Act of 1933, as amended (the "**Securities Act**"), which is current and includes the Shares to be sold, or an exemption from the registration requirements of the Securities Act.

12.**Notice.** Any notice or other communication required or permitted under this Agreement must be in writing and must be delivered personally, sent by certified, registered or express mail or by email, or sent by overnight courier, at the sender's expense. Notice will be deemed given when delivered personally, on the date sent by email or, if mailed, three (3) days after the date of deposit in the United States mail or, if sent by overnight courier, on the regular business day following the date sent. Notice to the Company should be sent to:

Keurig Dr Pepper Inc. <br> 6425 Hall of Fame Lane<br>Frisco, TX 75034<br>Attention: Chief Legal Officer, Corporate General Counsel and Secretary

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.Notice to you should be sent to the address on file with the Company. Either party may change the Person and/or address to which the other party must give notice under this Section 12 by giving such other party written notice of such change, in accordance with the procedures described above.

14.**Successors.** All obligations of the Company under this Agreement will be binding on any successor to the Company, whether the existence of the successor results from a direct or indirect purchase of all or substantially all of the business of the Company, or a merger, consolidation, or otherwise.

15.**Governing Law.** To the extent not preempted by federal law, this Agreement will be construed and enforced in accordance with, and governed by, the laws of the State of Delaware, without giving effect to its conflicts of law principles that would require the application of the law of any other jurisdiction.

&nbsp;&nbsp;&nbsp;&nbsp;7

------

16.**Plan Document Controls.** The rights granted under this Agreement are in all respects subject to the provisions set forth in the Plan to the same extent and with the same effect as if set forth fully in this Agreement. If the terms of this Agreement conflict with the terms of the Plan document, the Plan document will control.

17.**Amendment.** This Agreement may be amended unilaterally by the Company to the extent determined by the Committee and permitted under the Plan, or by a written instrument signed by both parties.

18.**Entire Agreement.** This Agreement, together with the Plan, constitutes the entire obligation of the parties with respect to the subject matter of this Agreement and supersede any prior written or oral expressions of intent or understanding with respect to such subject matter.

19.**Administration.** The Committee administers the Plan and this Agreement. Your rights under this Agreement are expressly subject to the terms and conditions of the Plan, including any guidelines the Committee adopts from time to time. You hereby acknowledge receipt of a copy of the Plan.

20.**Section 409A.** The Restricted Stock Units awarded pursuant to this Agreement are intended to comply with or, in the alternative, be exempt from Section 409A. Any reference to a termination of Service shall be construed as a "separation from service" for purposes of Section 409A. In the event that you are a "specified employee" within the meaning of Section 409A and the Shares are to be delivered in connection with the termination of your Service, the delivery of the Shares under Section 3 shall be delayed until the date that is six months and one day following the date of your termination of Service if required to avoid the imposition of additional taxes under Section 409A.

21.**Consent to Electronic Delivery; Electronic Signature**. In lieu of receiving documents in paper format, you hereby agree, to the fullest extent permitted by law, to accept electronic delivery of any documents that the Company may be required to deliver (including, but not limited to, prospectuses, prospectus supplements, grant or award notifications and agreements, account statements, annual and quarterly reports and all other forms of communications) in connection with this and any other award made or offered by the Company. Electronic delivery may be via a Company electronic mail system or by reference to a location on a Company intranet to which you have access. You hereby consent to any and all procedures the Company has established or may establish for an electronic signature system for delivery and acceptance of any such documents that the Company may be required to deliver, and agree that your electronic signature is the same as, and shall have the same force and effect as, your manual signature.

22.**Acceptance of Award**. You acknowledge and agree that you will have 90 days following the Grant Date to accept this Award, which Award will be delivered to you electronically in accordance with Section 20 of this Agreement and which acceptance must also be delivered electronically. If you do not accept the Award within 90 days following the Grant Date, the Award shall automatically terminate and cease to be acceptable by you as of 12:01 a.m. on the day following the expiration of such 90-day period without any further action by the Company or notice required to you.

23.**Personal Data.** The Company, its Subsidiaries and each of their respective affiliates, and the Company's authorized third-party service providers will process your personal information, including financial information, (collectively, "**Personal Data**") for the purpose of implementing, administering, and managing the Plan and in accordance with the Company's employee privacy notice(s). For more information about the collection, use, sharing, and processing of your Personal Data, and your rights with respect to your Personal Data, please see our employee privacy notice accessible on the Company's Corporate Policy portal.

&nbsp;&nbsp;&nbsp;&nbsp;8

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**KEURIG DR PEPPER INC.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By:&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: &nbsp;&nbsp;&nbsp;&nbsp;Mary Beth DeNooyer

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: &nbsp;&nbsp;&nbsp;&nbsp;Chief Human Resources Officer

Acknowledged and agreed:<br>By: <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

Name: <br>Date:

&nbsp;&nbsp;&nbsp;&nbsp;9

## Exhibit 10.24

**EXHIBIT 10.24**

**NOTICE OF GRANT OF AWARD OF** 

**PERFORMANCE STOCK UNITS**

**under the<br>KEURIG DR PEPPER INC. OMNIBUS STOCK INCENTIVE PLAN OF 2019**

**<u>Notice of Grant</u>**

Keurig Dr Pepper Inc., a Delaware corporation (the "**Company**"), hereby grants to the Employee named below a target number of performance-based Restricted Stock Units (the "**Performance Stock Units**" or "**PSUs**") as a performance-based Stock Award (the "**Award**") under the Keurig Dr Pepper Inc. Omnibus Stock Incentive Plan of 2019, as the same may be amended from time to time (the "**Plan**"). Each PSU represents the right to receive one share of Common Stock of the Company (each, a "**Share**"), upon the terms and conditions set forth in this Notice of Grant and the Performance Stock Unit Award Terms and Conditions attached hereto (collectively, the "**Award Agreement**") and the Plan.

**Employee**:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

**Grant Date:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**&nbsp;&nbsp;&nbsp;&nbsp;<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><br> ("**Grant Date**")

**Target Number of PSUs**:&nbsp;&nbsp;&nbsp;&nbsp;<u>the number of PSUs set forth in your award notice email&nbsp;&nbsp;&nbsp;&nbsp;</u><br>("**Target PSUs**")

**Performance Period:**&nbsp;&nbsp;&nbsp;&nbsp;The "**Performance Period**" is set forth on Exhibit A to <u>the Award Agreement.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

**Performance Goals:**&nbsp;&nbsp;&nbsp;&nbsp;The "**Performance Goals**" are set forth on Exhibit A to <u>the Award Agreement.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

**<u>Employee's Acknowledgments and Agreements</u>**

By your acceptance of this Award, you agree that this Award is granted under and governed by the terms of the Plan and the Award Agreement, which have been made available to you herewith and are incorporated herein by this reference. Capitalized terms used but not defined herein shall have the meanings given to them in the Plan or the Award Agreement, as the case may be.

You further acknowledge that your rights to any Performance Stock Units will be earned and become vested only as you provide services to the Company over time, subject to the attainment of the performance-vesting provisions contained in <u>Exhibit A</u> to the Award Agreement; that the grant of this Award is not consideration for service you rendered to the Company prior to the Grant Date; and that nothing herein or in the attached documents confers upon you any right to continue your employment or other service relationship with the Company or any Subsidiary for any period of time, nor does it interfere in any way with your right or the Company's (or any Subsidiary's) right to terminate that relationship at any time, for any reason or no reason, with or without Cause, and with or without advance notice, except as may be required by the terms of any employment or service agreement, offer letter, the Keurig Dr Pepper Inc. Executive Severance Plan, or any other agreement between you and the Company or any Subsidiary or in compliance with applicable governing law.

------

**KEURIG DR PEPPER INC.**

By:

Name: Mary Beth DeNooyer

Title: Chief Human Resources Officer

&nbsp;&nbsp;&nbsp;&nbsp;2

------

**Performance Stock Unit Award<br>Terms and Conditions<br> Under the<br>KEURIG DR PEPPER INC. OMNIBUS STOCK INCENTIVE PLAN OF 2019**

This instrument sets forth the terms and conditions of the grant effective on the Grant Date set forth on the Notice of Grant of Award of Performance Stock Units attached hereto (the "**Notice**") of an award of performance-based Restricted Stock Units (the "**Performance Stock Units**" or "**PSUs**") by Keurig Dr Pepper Inc., a Delaware corporation (the "**Company**"), under the Keurig Dr Pepper Inc. Omnibus Stock Incentive Plan of 2019, as the same may be amended from time to time (the "**Plan**"). Any term capitalized but not defined in this instrument will have the meaning set forth in the Notice or the Plan, as the case may be.

1.**Performance Stock Unit Grant.** In accordance with the terms of the Plan and subject to this Award Agreement, as of the Grant Date you are hereby granted the target number of Performance Stock Units set forth in the Notice. The Performance Stock Units, and any Shares acquired upon settlement thereof, are subject to the following terms and conditions and to the provisions of the Plan, the terms of which are incorporated by reference herein. 

2.**Vesting of Award; Forfeiture.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>In General</u>. The Performance Stock Units shall become earned and vest, if at all, based upon the achievement of the Performance Goals over the Performance Period, each as set forth on Exhibit A, following the Committee's certification of the attained level of the Performance Goals following completion of the Performance Period; and <u>provided</u> that you have remained in continuous Service through the third anniversary of the Grant Date (the "**Vesting Date**"). Except as otherwise provided in Section 2(b), 2(c), 2(d), or 2(e) below, in the event your Service terminates for any reason prior to the Vesting Date, all PSUs granted hereunder shall automatically terminate without consideration as of the date of such termination and your right to receive any Shares under this Award shall also terminate as of the date of such termination.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Involuntary Termination</u>. If, prior to the Vesting Date, your Service terminates as a result of a "**Qualifying Termination**" (which, for purposes of this Award Agreement, shall have the meaning set forth in the Keurig Dr Pepper Inc. Executive Severance Plan, as such plan may be amended in the future (the "**Severance Plan**")), then a pro-rated portion of the Performance Stock Units granted hereunder, determined by multiplying the target number of Performance Stock Units subject to the Award by a fraction, the numerator of which is the number of complete months elapsed from the Grant Date to the date of your Qualifying Termination and the denominator of which is the total number of months between the Grant Date and the Vesting Date, shall remain outstanding and eligible to vest on the Vesting Date based on actual achievement of the Performance Goals and shall be settled into Shares and delivered in accordance with Section 3 below. Any remaining PSUs shall be immediately forfeited and canceled as of the date of such Qualifying Termination.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Death or Disability</u>. If, prior to the Vesting Date, your Service terminates due to death or Disability, then a pro-rated portion of the Performance Stock Units granted hereunder shall vest in accordance with Exhibit A and be settled into Shares and delivered in accordance with Section 3 below. Any remaining PSUs shall be immediately forfeited and canceled as of the date of such termination of Service.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Retirement</u>. If, prior to the Vesting Date, your Service terminates due to Retirement, then a pro-rated portion of the Performance Stock Units granted hereunder, determined by multiplying the target number of Performance Stock Units subject to the Award by a fraction, the numerator of which is the number of complete months elapsed from the Grant Date to the date of your Retirement and the denominator of which is the total number of months between the Grant Date and the Vesting Date, shall remain outstanding and eligible to vest on the Vesting Date based on actual achievement of the Performance Goals and shall be settled into Shares and delivered in accordance with Section 3 below. Any remaining PSUs shall be immediately forfeited and canceled as of the date of such Retirement. For purposes of this Award Agreement, "**Retirement**" means your termination of Service (other than a termination of Service for Cause) after attaining age 60 and having completed at least five years of continuous service with the Company and its Subsidiaries or any of their respective affiliates. For purposes of this Award Agreement, "**Cause**" shall have the meaning set forth in the Severance Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)<u>Change in Control</u>. In the event of a Change in Control prior to the Vesting Date, the Performance Stock Units granted hereunder shall continue in effect or shall become vested and payable, in either case, as provided in, and subject to the conditions of, Section 4. For purposes of this Award Agreement, "**Change in Control**" means the occurrence of any of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)any person or "group" (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the "**Exchange Act**")) is or becomes the "beneficial owner" (as defined below), directly or indirectly, of securities representing more than 50% of the combined voting power of the Company's then outstanding securities. For purposes of this clause (i), "beneficial owner" has the meaning given to such term in Rule 13d-3 under the Exchange Act, except that a person shall be deemed to be the "beneficial owner" of all shares that any such person has the right to acquire pursuant to any agreement or arrangement or upon exercise of conversion rights, warrants, options or otherwise, without regard to the 60-day period referred to in such Rule; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)the consummation of a plan or agreement approved by the Company's shareholders, providing (<u>x</u>) for a merger or consolidation of the Company, other than with a wholly owned subsidiary of such entity and other than a merger or consolidation that would result in the voting securities of such entity outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 50% of the combined voting power of the voting securities of such entity or such surviving entity outstanding immediately after such merger or consolidation or (<u>y</u>) for a sale, exchange or other disposition of all or substantially all of the business or assets of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)<u>Service</u>. For purposes of this Award Agreement, **"Service**" means the provision of services in the capacity of an employee or Director. For purposes of this Award Agreement, "**Director**" means any person who is not an employee and who is serving as a member of the Board or the board of directors or equivalent governing body of any of the Company's Subsidiaries or affiliates. For purposes of this Award Agreement, years of service shall be based on the period of time elapsed from your commencement of services (whether as an employee or Director) with the Company, any of its Subsidiaries or any of their respective affiliates to the date such services terminate, whether due to Retirement, death, Disability or for any other reason. A transfer of Service from the Company to a Subsidiary or an affiliate or from an affiliate of the Company to the

&nbsp;&nbsp;&nbsp;&nbsp;4

------

Company, a Subsidiary or another affiliate of the Company shall not constitute a termination of Service. All determinations regarding Service, including whether any leave of absence is a termination of Service, shall be made by the Committee.

3.**Settlement of Performance Stock Units.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Timing of Settlement</u>. Except as provided in Section 4 below, the Shares underlying vested Performance Stock Units shall be delivered promptly (and in all events within 60 days) following the earlier of (i) the Vesting Date or (ii) the date of your termination of Service due to death or Disability. Prior to the delivery of Shares in respect of any Performance Stock Unit, such Performance Stock Unit will represent an unsecured obligation of the Company, for which you have no rights as a stockholder and there is no trust and no obligation other than to issue Shares as contemplated by this Award Agreement and the Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Withholding Obligation</u>. Prior to or upon settlement of any Performance Stock Units, all federal, state, and local taxes, domestic or foreign, required by law or regulation to be withheld (each, a "**Withholding Tax**") must be satisfied. In the Company's sole discretion, you may satisfy the Withholding Tax by either (i) paying the amount of required Withholding Tax to the Company in cash, (ii) electing to have the Company sell that number of whole Shares that you have acquired through the vesting of Performance Stock Units having a Fair Market Value at least equal to the amount of the required Withholding Tax, (iii) electing to have the Company withhold Shares otherwise issuable in respect of the Performance Stock Units having a Fair Market Value at least equal to the amount of the required Withholding Tax, or (iv) a combination of the foregoing; <u>provided</u>, <u>however</u>, <u>that</u> if and to the extent that the Withholding Tax is satisfied using Shares issuable in settlement of the Performance Stock Units, the applicable Withholding Tax shall be based on no more than the statutory maximum amount for the applicable jurisdictions.

4.**Change in Control.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Treatment of Performance Goals upon Change in Control</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)In the event of a Change in Control prior to the last day of the Performance Period, the Performance Goals shall be deemed achieved at the greater of (x) the target performance level and (y) the level at which the Performance Goals were actually attained and certified by the Committee, treating the date of the Change in Control (or, as determined by the Committee, the last day of the most recently completed calendar month or fiscal quarter immediately preceding the Change in Control) as the last day of the Performance Period and annualizing any performance as determined in the sole discretion of the Committee. Such earned PSUs shall remain outstanding and eligible to vest subject to your continued Service through the Vesting Date or as otherwise provided in this Section 4 or Section 2 above (if such provides you with more favorable vesting).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)In the event of a Change in Control upon or following the last day of the Performance Period but prior to the Vesting Date, the Performance Goals shall be assessed and certified by the Committee immediately prior to such Change in Control, and the resulting earned PSUs shall remain outstanding and eligible to vest subject to your continued Service through the Vesting Date or as otherwise provided in this Section 4 or Section 2 above (if such provides you with more favorable vesting).

&nbsp;&nbsp;&nbsp;&nbsp;5

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Double Trigger Protection Upon a Change in Control</u>. In the event of a Change in Control, unless otherwise determined by the Committee prior to the occurrence of a Change in Control, the Company shall take all actions necessary or appropriate to assure that each Award outstanding under the Plan shall be honored or assumed, or new rights substituted therefor (such honored, assumed or substituted award hereinafter called an "**Alternative Award**") by the entity for which you will be performing Service immediately following the Change in Control (or the parent or a subsidiary of such entity); provided that any such Alternative Award must provide that if your Service is terminated upon or following such Change in Control (<u>x</u>) by the Company other than for Cause or (<u>y</u>) by you for Good Reason (as defined below), in either case, within 24 months following the Change in Control, your rights under each such Alternative Award shall become fully vested and exercisable or payable, whichever is applicable, in accordance with its otherwise applicable terms (including, without limitation, provisions similar to Section 4(e) hereof). In addition, any such Alternative Award granted to you must

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) &nbsp;&nbsp;&nbsp;&nbsp;provide you with rights and entitlements substantially equivalent to or better than the rights and entitlements applicable under the corresponding Award, including, but not limited to, an identical or better exercise or vesting schedule and identical or better timing and methods of payment (including all provisions applicable in respect of such Award that provide for accelerated vesting); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) &nbsp;&nbsp;&nbsp;&nbsp;have substantially equivalent economic value to such Award (as determined by the Committee as constituted immediately prior to the Change in Control and after giving effect to Section 4(a) hereof).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Accelerated Vesting and Payment</u>. Notwithstanding the foregoing, the Committee may otherwise determine that, upon the occurrence of a Change in Control, the Performance Stock Units that are then outstanding (after giving effect to Section 4(a)) shall become vested and shall be immediately payable in Shares (or, if so directed by the Committee, in cash in an amount equal to the Fair Market Value of the Shares that would otherwise have been deliverable to you).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Good Reason</u>. For purposes of this Section 4, "**Good Reason**" shall have the meaning set forth in the Severance Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)<u>Provisions Related to Golden Parachute Excise Tax.</u> Notwithstanding anything to the contrary contained in this Award Agreement, to the extent that any of the payments and benefits provided for under the Plan, any Award or any other agreement or arrangement between the Company, any Subsidiary or any of their respective affiliates and you (collectively, the "**Payments**") would constitute a "parachute payment" within the meaning of section 280G of the Code (a "**Parachute Payment**"), then, if and solely to the extent that reducing the benefits payable hereunder would result in your receiving a greater amount, on an after-tax basis, taking into account any Excise Tax and all applicable income, employment and other taxes payable on such amounts, the amount of such Payments shall be reduced to the amount (the "**Safe Harbor Amount**") that would result in no portion of the Payments being treated as an excess parachute payment pursuant to section 280G of the Code (the "**Excise Tax**"). Any reduction in the amount of compensation or benefits effected pursuant to this Section 4 shall first come, in order and, in each case, solely to the extent necessary, from any cash severance benefits payable to you, then ratably from any other payments which are treated in their entirety as Parachute Payments and then ratably from any other Parachute Payments payable to you.

&nbsp;&nbsp;&nbsp;&nbsp;6

------

5.**Nontransferability of Performance Stock Units**; **Transferability of Shares.** The Performance Stock Units granted hereby may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent or distribution or, to the extent approved by the Committee, to a trust for estate planning purposes, and all rights with respect to the Performance Stock Units shall be available during your lifetime only to you, a trustee approved by the Committee, or your guardian or legal representative. The Committee may, in its sole discretion, require your guardian or legal representative to supply it with evidence the Committee deems necessary to establish the authority of the guardian or legal representative to act on behalf of you.

6.**No Limitation on Rights of the Company.** The grant of the Performance Stock Units does not and will not in any way affect the right or power of the Company to make adjustments, reclassifications or changes in its capital or business structure, or to merge, consolidate, dissolve, liquidate, sell or transfer all or any part of its business or assets.

7.**Plan and Award Agreement Not a Contract of Employment or Service**. Neither the Plan nor this Award Agreement are a contract of employment or Service, and no terms of your employment or Service will be affected in any way by the Plan, this Award Agreement or related instruments, except to the extent specifically expressed therein. Neither the Plan nor this Award Agreement will be construed as conferring any legal rights on you to continue to be employed or remain in Service with the Company, nor will it interfere with any right of the Company, any Subsidiary or any of their respective affiliates to discharge you or to deal with you regardless of the existence of the Plan, this Award Agreement or the Performance Stock Units.

8.**Employee Confidentiality and Non-Competition Obligations.** You acknowledge and agree that as a condition to your eligibility to receive this Award of PSUs under the Plan and the vesting of any Shares granted hereunder, you remain bound by and must comply fully with that certain Employee Confidentiality and Non-Competition Agreement dated on or about the Grant Date (the "Employee Confidentiality and Non-Competition Agreement"), which is incorporated herein by reference.

9.**Clawback/Recoupment; Other Company Policies**. The Performance Stock Units granted under this Award Agreement, and any Shares issued or other payments made in respect thereof, shall be subject to the Company's share ownership policies and any recoupment policy that the Company may adopt from time to time, to the extent any such policy is applicable to you and to such compensation including, but not limited to, the Company's Ownership Guidelines for Senior Vice Presidents & Vice Presidents, the Company's Rule 10D-1 Clawback Policy, designed to comply with the requirements of Rule 10D-1 promulgated under the U.S. Securities Exchange Act of 1934, as amended, and the Company's Senior Leadership Clawback Policy, as well as any recoupment provisions required under applicable law. By accepting the grant of Performance Stock Units under this Award Agreement, you acknowledge, agree and consent to the Company's application, implementation and enforcement of both (i) such policies with respect to all covered compensation received or to be received by you, to the extent applicable, and (ii) any provision of applicable law relating to cancellation, recoupment, rescission or payback of compensation, and, further, expressly agree that the Company may take such actions as are necessary to effectuate such policies (as applicable to you) or such applicable law without further consent or action being required by you. For purposes of the foregoing, you expressly and explicitly authorize (<u>x</u>) the Company to issue instructions, on your behalf, to any brokerage firm and/or third party administrator engaged by the Company to hold your Shares and other amounts acquired under the Plan to re-convey, transfer or otherwise return such Shares and/or other amounts to the Company and (<u>y</u>) the Company's recovery of any covered compensation through any method of recovery that the Company deems appropriate, including without limitation by reducing any amount that is or may become payable to you. You further agree to comply with any request or demand for repayment by any Subsidiary or affiliate of the Company in order to comply with such policies or

&nbsp;&nbsp;&nbsp;&nbsp;7

------

applicable law. To the extent that the terms of this Award Agreement and any Company policy conflict, the terms of the policy shall prevail.

10.**No Rights as a Shareholder.** Before the date as of which you are recorded on the books of the Company as the holder of any Shares related to the Performance Stock Units, you will have no rights as a shareholder by reason of this Award (including voting rights or any right to dividends or dividend equivalents).

11.**Continued Effect of Award Agreement**. To the extent that the Plan or this Award Agreement contain provisions that are intended to have effect after the date(s) as of which your rights in respect to the Performance Stock Units have become vested (including, but not limited to, following the date of your termination of Service), the Performance Stock Units and any Shares issued in respect of such Performance Stock Units shall continue to be subject to the terms of the Plan and this Award Agreement.

12.**Securities Law Requirements.** If at any time the Committee determines that issuing Shares would violate applicable securities laws, the Company will not be required to issue such Shares. The Committee may declare any provision of this Award Agreement or action of its own null and void, if it determines the provision or action fails to comply with the short-swing trading rules. As a condition to issuance, the Company may require you to make written representations it deems necessary or desirable to comply with applicable securities laws. No person who acquires Shares under this Award Agreement may sell the Shares, unless they make the offer and sale pursuant to an effective registration statement under the Securities Act of 1933, as amended (the "**Securities Act**"), which is current and includes the Shares to be sold, or an exemption from the registration requirements of the Securities Act.

13.**Notice.** Any notice or other communication required or permitted under this Award Agreement must be in writing and must be delivered personally, sent by certified, registered or express mail or by email, or sent by overnight courier, at the sender's expense. Notice will be deemed given when delivered personally, on the date sent by email or, if mailed, three (3) days after the date of deposit in the United States mail or, if sent by overnight courier, on the regular business day following the date sent. Notice to the Company should be sent to:

Keurig Dr Pepper Inc.

6425 Hall of Fame Lane

Frisco, TX 75034

Attention: Chief Legal Officer, Corporate General Counsel and Secretary

Email: anthony.shoemaker@kdrp.com

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.Notice to you should be sent to the address on file with the Company. Either party may change the Person and/or address to which the other party must give notice under this Section 13 by giving such other party written notice of such change, in accordance with the procedures described above.

15.**Successors.** All obligations of the Company under this Award Agreement will be binding on any successor to the Company, whether the existence of the successor results from a direct or indirect purchase of all or substantially all of the business of the Company, or a merger, consolidation, or otherwise.

16.**Governing Law.** To the extent not preempted by federal law, this Award Agreement will be construed and enforced in accordance with, and governed by, the laws of the State of Delaware,

&nbsp;&nbsp;&nbsp;&nbsp;8

------

without giving effect to its conflicts of law principles that would require the application of the law of any other jurisdiction.

17.**Plan Document Controls.** The rights granted under this Award Agreement are in all respects subject to the provisions set forth in the Plan to the same extent and with the same effect as if set forth fully in this Award Agreement. If the terms of this Award Agreement conflict with the terms of the Plan document, the Plan document will control.

18.**Amendment.** This Award Agreement may be amended unilaterally by the Company to the extent determined by the Committee and permitted under the Plan, or by a written instrument signed by both parties.

19.**Entire Agreement.** This Award Agreement, including <u>Exhibit A</u>, together with the Plan and the Employee Confidentiality and Non-Competition Agreement, constitutes the entire obligation of the parties with respect to the subject matter of this Award Agreement and supersede any prior written or oral expressions of intent or understanding with respect to such subject matter.

20.**Administration.** The Committee administers the Plan and this Award Agreement. Your rights under this Award Agreement are expressly subject to the terms and conditions of the Plan, including any guidelines the Committee adopts from time to time. You hereby acknowledge receipt of a copy of the Plan.

21.**Section 409A.** The Performance Stock Units awarded pursuant to this Award Agreement are intended to comply with or, in the alternative, be exempt from Section 409A. Any reference to a termination of Service shall be construed as a "separation from service" for purposes of Section 409A. In the event that you are a "specified employee" within the meaning of Section 409A and the Shares are to be delivered in connection with the termination of your Service, the delivery of the Shares under Section 3 shall be delayed until the date that is six months and one day following the date of your termination of Service if required to avoid the imposition of additional taxes under Section 409A.

22.**Consent to Electronic Delivery; Electronic Signature**. In lieu of receiving documents in paper format, you hereby agree, to the fullest extent permitted by law, to accept electronic delivery of any documents that the Company may be required to deliver (including, but not limited to, prospectuses, prospectus supplements, grant or award notifications and agreements, account statements, annual and quarterly reports and all other forms of communications) in connection with this and any other award made or offered by the Company. Electronic delivery may be via a Company electronic mail system or by reference to a location on a Company intranet to which you have access. You hereby consent to any and all procedures the Company has established or may establish for an electronic signature system for delivery and acceptance of any such documents that the Company may be required to deliver and agree that your electronic signature is the same as, and shall have the same force and effect as, your manual signature.

23.**Acceptance of Award**. You acknowledge and agree that you will have 90 days following the Grant Date to accept the Award, which Award will be delivered to you electronically in accordance with Section 21 of this Award Agreement and which acceptance must also be delivered electronically. If you do not accept the Award within 90 days following the Grant Date, the Award shall automatically terminate and cease to be acceptable by you as of 12:01 a.m. on the day following the expiration of such 90-day period without any further action by the Company or notice required to you.

24.**Personal Data.** The Company, its Subsidiaries and each of their respective affiliates, and the Company's authorized third-party service providers will process your personal information, including financial information, (collectively, "**Personal Data**") for the purpose of implementing,

&nbsp;&nbsp;&nbsp;&nbsp;9

------

administering, and managing the Plan and in accordance with the Company's employee privacy notice(s). For more information about the collection, use, sharing, and processing of your Personal Data, and your rights with respect to your Personal Data, please see our employee privacy notice accessible on the Company's Corporate Policy portal.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;25. <br>

**EMPLOYEE**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**KEURIG DR PEPPER INC.**

By: <u>&nbsp;&nbsp;&nbsp;&nbsp;</u>&nbsp;&nbsp;&nbsp;&nbsp;By:&nbsp;&nbsp;&nbsp;&nbsp;

Name: <u>&nbsp;&nbsp;&nbsp;&nbsp;</u>&nbsp;&nbsp;&nbsp;&nbsp;Name: Mary Beth DeNooyer

Date: <u>&nbsp;&nbsp;&nbsp;&nbsp;</u>&nbsp;&nbsp;&nbsp;&nbsp;Title: Chief Human Resources Officer

&nbsp;&nbsp;&nbsp;&nbsp;10

------

**<u>Exhibit A</u>**

**Performance Goals and Performance Period** 

[●]

&nbsp;&nbsp;&nbsp;&nbsp;[***Exhibit A to Performance Stock Unit Award Agreement***]

## Exhibit 10.25

**EXHIBIT 10.25**

**For Directors**

**<u>Restricted Stock Unit Award<br>Terms and Conditions</u><br> Under the<br>KEURIG DR PEPPER INC. OMNIBUS STOCK INCENTIVE PLAN OF 2019**

This instrument (this "**Agreement**") evidences the grant effective on __________ (the "**Grant Date**") of an award (the "**Award**") of restricted stock units (the **"Restricted Stock Units"**) by Keurig Dr Pepper Inc., a Delaware corporation (the "**Company**"), under the Keurig Dr Pepper Inc. Omnibus Stock Incentive Plan of 2019, as the same may be amended from time to time (the "**Plan**"). Any term capitalized but not defined in this Agreement will have the meaning set forth in the Plan.

1.**Restricted Stock Unit Grant.** In accordance with the terms of the Plan and subject to this Agreement, as of the Grant Date you are hereby granted __________ Restricted Stock Units, each of which represents the right to receive one share of Common Stock of the Company (each, a "**Share**"). The Restricted Stock Units, and any Shares acquired upon settlement thereof, are subject to the following terms and conditions and to the provisions of the Plan, the terms of which are incorporated by reference herein. 

2.**Vesting Period.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>In General</u>. The Restricted Stock Units shall vest on the fifth anniversary of the Grant Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Death or Disability</u>. If, before all of the Restricted Stock Units have otherwise become vested, your Service terminates due to death or Disability, then the Restricted Stock Units shall vest in full on the date of your termination from Service.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Termination for Service for Reasons Other than Death or Disability.</u> If, before all of the Restricted Stock Units have otherwise become vested, your Service terminates other than due to death or Disability, then notwithstanding any provision in the Plan or this Agreement to the contrary, the Restricted Stock Units granted to you shall become fully vested immediately, except that all Restricted Stock Units granted within one year prior to the date of termination of your Service shall become fully vested with respect to the Applicable Fraction of the Restricted Stock Units and shall be immediately forfeited and canceled with respect to the remaining Restricted Stock Units. The "**Applicable Fraction**" means a fraction, the numerator of which is the number of days elapsed since the Grant Date and the denominator of which is 365.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Change in Control.</u> In the event of a Change in Control, any Restricted Stock Units then outstanding shall become fully vested and payable. For purposes of this Agreement, "**Change in Control**" means the occurrence of any of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)any person or "group" (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the "**Exchange Act**")) is or becomes the "beneficial owner" (as defined below), directly or indirectly, of securities representing more than 50% of the combined voting power of the Company's then outstanding securities. For purposes of this clause (i), "beneficial owner" has the meaning given to such term in Rule 13d-3 under the Exchange Act, except that a person shall be deemed to be the "beneficial owner" of all shares that any such person has the right to acquire pursuant to any agreement or arrangement or upon exercise of conversion rights, warrants,

------

options or otherwise, without regard to the 60-day period referred to in such Rule; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)the consummation of a plan or agreement approved by the Company's shareholders, providing (x) for a merger or consolidation of the Company (other than with a wholly owned subsidiary of such entity and other than a merger or consolidation that would result in the voting securities of such entity outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 50% of the combined voting power of the voting securities of such entity or such surviving entity outstanding immediately after such merger or consolidation) or (y) for a sale, exchange or other disposition of all or substantially all of the business or assets of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)<u>Service</u>. For purposes of this Agreement, "**Service**" means the provision of services in the capacity of an employee or Director. For purposes of this Agreement, "**Director**" means any person who is not an employee and who is serving as a member of the Board or the board of directors or equivalent governing body of any of the Company's subsidiaries or affiliates. For purposes of this Agreement, years of service shall be based on the period of time elapsed from your commencement of services (whether as an employee or Director) with the Company, any of its Subsidiaries or any of their respective affiliates to the date such services terminate, whether due to retirement, death, Disability or for any other reason. A transfer of Service from the Company to a Subsidiary or an affiliate or from an affiliate of the Company to the Company, a Subsidiary or another affiliate of the Company shall not constitute a termination of Service. All determinations regarding Service, including whether any leave of absence is a termination of Service, shall be made by the Committee.

3.**Settlement of Restricted Stock Units.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Timing of Settlement</u>. The Shares underlying such vested Restricted Stock Units shall be delivered promptly (and in all events within 60 days) following the date such Restricted Stock Units vest pursuant to Section 2 hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Withholding Obligation</u>. Prior to or upon settlement of any Restricted Stock Units, all federal, state, and local taxes, domestic or foreign, required by law or regulation to be withheld (each, a "**Withholding Tax**") must be satisfied. In the Company's sole discretion, you may satisfy the Withholding Tax by either (i) paying the amount of required Withholding Tax to the Company in cash, (ii) electing to have the Company sell that number of whole Shares that you have acquired through the vesting of Restricted Stock Units having a Fair Market Value at least equal to the amount of the required Withholding Tax, (iii) electing to have the Company withhold Shares otherwise issuable in respect of the Restricted Stock Units having a Fair Market Value at least equal to the amount of the required Withholding Tax, or (iv) a combination of the foregoing; <u>provided</u>, <u>however</u>, <u>that</u> if and to the extent that the Withholding Tax is satisfied using Shares issuable in settlement of the Restricted Stock Units and if necessary to avoid an adverse financial accounting consequence for the Company, the applicable Withholding Tax shall be based on no more than the statutory maximum amount for the applicable jurisdictions.

4.**Nontransferability of Restricted Stock Units**; **Transferability of Shares.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Except as provided in Section 4(b), the Restricted Stock Units granted hereby may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent or distribution and all rights with respect to the Restricted Stock Units shall be available during your lifetime only to you, or your guardian or legal representative. The Committee may, in its sole discretion, require your guardian or legal

&nbsp;&nbsp;&nbsp;&nbsp;2

------

representative to supply it with evidence the Committee deems necessary to establish the authority of the guardian or legal representative to act on behalf of you.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Subject to applicable law, Restricted Stock Units may be transferred to a Successor. Such transferred Restricted Stock Units may only be further sold, transferred, pledged, assigned or otherwise alienated by the Successor in accordance with the terms of this Section 4, and shall be subject in all respects to the terms of this Agreement and the Plan. For a transfer to be effective, the Successor shall promptly furnish the Company with written notice thereof and a copy of such other evidence as the Committee may deem necessary to establish the validity of the transfer and the acceptance of the Successor of the terms and conditions of the Plan. "**Successor**" means your spouse, your lineal descendants, any trust the beneficiaries of which consist only of you, your spouse and/or your lineal descendants, or a corporation in which the you, your spouse and/or your lineal descendants own 100% of the economic interest and have the unfettered right to prevent further transfer or disposition of the Restricted Stock Unit. The Committee may, in its discretion, deem other parties to qualify as a Successor for purposes of this Plan.

5.**No Limitation on Rights of the Company.** The grant of the Restricted Stock Units does not and will not in any way affect the right or power of the Company to make adjustments, reclassifications or changes in its capital or business structure, or to merge, consolidate, dissolve, liquidate, sell or transfer all or any part of its business or assets.

6.**No Rights as a Shareholder.** Before the date as of which you are recorded on the books of the Company as the holder of any Shares related to the Restricted Stock Units, you will have no rights as a shareholder by reason of this Restricted Stock Units Award (including voting rights or any right to dividends or dividend equivalents).

7.**Continued Effect of Award Agreement**. To the extent that the Plan or this Agreement contain provisions that are intended to have effect after the date(s) as of which your rights in respect to the Restricted Stock Units have become vested (including, but not limited to, following the date of your termination of Service), the Restricted Stock Units and any Shares issued in respect of such Restricted Stock Units shall continue to be subject to the terms of the Plan and this Agreement.

8.**Securities Law Requirements.** If at any time the Committee determines that issuing Shares would violate applicable securities laws, the Company will not be required to issue such Shares. The Committee may declare any provision of this Agreement or action of its own null and void, if it determines the provision or action fails to comply with the short-swing trading rules. As a condition to issuance, the Company may require you to make written representations it deems necessary or desirable to comply with applicable securities laws. No person who acquires Shares under this Agreement may sell the Shares, unless they make the offer and sale pursuant to an effective registration statement under the Securities Act of 1933, as amended (the "**Securities Act**"), which is current and includes the Shares to be sold, or an exemption from the registration requirements of the Securities Act.

9.**Notice.** Any notice or other communication required or permitted under this Agreement must be in writing and must be delivered personally, sent by certified, registered or express mail or by email, or sent by overnight courier, at the sender's expense. Notice will be deemed given when delivered personally, on the date sent by email or, if mailed, three (3) days after the date of deposit in the United States mail or, if sent by overnight courier, on the regular business day following the date sent. Notice to the Company should be sent to:

Keurig Dr Pepper Inc. <br>6425 Hall of Fame Lane<br>Frisco, TX 75034<br>Attention: Chief Legal Officer, Corporate General Counsel and Secretary<br>Email: anthony.shoemaker@kdrp.com

&nbsp;&nbsp;&nbsp;&nbsp;3

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.Notice to you should be sent to the address on file with the Company. Either party may change the Person and/or address to which the other party must give notice under this Section 9 by giving such other party written notice of such change, in accordance with the procedures described above.

11.**Successors.** All obligations of the Company under this Agreement will be binding on any successor to the Company, whether the existence of the successor results from a direct or indirect purchase of all or substantially all of the business of the Company, or a merger, consolidation, or otherwise.

12.**Governing Law.** To the extent not preempted by federal law, this Agreement will be construed and enforced in accordance with, and governed by, the laws of the State of Delaware, without giving effect to its conflicts of law principles that would require the application of the law of any other jurisdiction.

13.**Plan Document Controls.** The rights granted under this Agreement are in all respects subject to the provisions set forth in the Plan to the same extent and with the same effect as if set forth fully in this Agreement. If the terms of this Agreement conflict with the terms of the Plan document, the Plan document will control.

14.**Amendment.** This Agreement may be amended unilaterally by the Company to the extent determined by the Committee and permitted under the Plan, or by a written instrument signed by both parties.

15.**Entire Agreement.** This Agreement, together with the Plan, constitute the entire obligation of the parties with respect to the subject matter of this Agreement and supersede any prior written or oral expressions of intent or understanding with respect to such subject matter.

16.**Administration.** The Committee administers the Plan and this Agreement. Your rights under this Agreement are expressly subject to the terms and conditions of the Plan, including any guidelines the Committee adopts from time to time. You hereby acknowledge receipt of a copy of the Plan.

17.**Section 409A.** The Restricted Stock Units awarded pursuant to this Agreement are intended to comply with or, in the alternative, be exempt from Section 409A. Any reference to a termination of Service shall be construed as a "separation from service" for purposes of Section 409A.

18.**Consent to Electronic Delivery; Electronic Signature**. In lieu of receiving documents in paper format, you hereby agree, to the fullest extent permitted by law, to accept electronic delivery of any documents that the Company may be required to deliver (including, but not limited to, prospectuses, prospectus supplements, grant or award notifications and agreements, account statements, annual and quarterly reports and all other forms of communications) in connection with this and any other award made or offered by the Company. Electronic delivery may be via a Company electronic mail system or by reference to a location on a Company intranet to which you have access. You hereby consent to any and all procedures the Company has established or may establish for an electronic signature system for delivery and acceptance of any such documents that the Company may be required to deliver, and agree that your electronic signature is the same as, and shall have the same force and effect as, your manual signature.

19.**Personal Data.** The Company, its Subsidiaries and each of their respective affiliates, and the Company's authorized third-party service providers will process your personal information, including financial information, (collectively, "**Personal Data**") for the purpose of implementing, administering, and managing the Plan and in accordance with the Company's employee privacy notice(s)..

&nbsp;&nbsp;&nbsp;&nbsp;4

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**KEURIG DR PEPPER INC.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By:&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: &nbsp;&nbsp;&nbsp;&nbsp;Mary Beth DeNooyer

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: &nbsp;&nbsp;&nbsp;&nbsp;Chief Human Resources Officer

&nbsp;&nbsp;&nbsp;&nbsp;5

## Exhibit 21.1

**Exhibit 21.1**

**<u>Subsidiaries of Keurig Dr Pepper Inc.</u>**

As of December 31, 2025

---

| | | |
|:---|:---|:---|
| **Name of Subsidiary** | **Name of Subsidiary** | **Jurisdiction of Formation** |
| 1 | 234DP Aviation, LLC | Delaware |
| 2 | A&W Concentrate Company | Delaware |
| 3 | All Sport, LLC | Delaware |
| 4 | All Sport Distributing, Inc. | Delaware |
| 5 | Altitude Beverages LLC | Delaware |
| 6 | Bai Brands LLC | New Jersey |
| 7 | Beverages Delaware Inc. | Delaware |
| 8 | Big Red, LLC | Texas |
| 9 | BR HyDrive LLC | Texas |
| 10 | Core Nutrition, LLC | Delaware |
| 11 | DP Beverages Inc. | Delaware |
| 12 | DPS Americas Beverages, LLC | Delaware |
| 13 | DPS Beverages, Inc. | Delaware |
| 14 | DPS Holdings Inc. | Delaware |
| 15 | Dr Pepper/Seven Up Beverage Sales Company | Texas |
| 16 | Dr Pepper/Seven Up Manufacturing Company | Delaware |
| 17 | Dr Pepper/Seven Up, Inc. | Delaware |
| 18 | Dyla LLC | Delaware |
| 19 | Force Holdings, LLC | Delaware |
| 20 | G Pure, Inc. | Texas |
| 21 | Ghost LLC | Nevada |
| 22 | Ghost 3P LLC | Nevada |
| 23 | Ghost Aggregator LLC | Delaware |
| 24 | Ghost Beverages, LLC | Delaware |
| 25 | Ghost Beverages 3P LLC | Delaware |
| 26 | Ghost Lifestyle LLC | Delaware |
| 27 | Hydration Ventures LLC | Delaware |
| 28 | KDP Procurement Services, Inc. | Texas |
| 29 | Keurig Corporation Inc. | Delaware |
| 30 | Keurig Green Mountain, Inc. | Delaware |
| 31 | Keurig JV GP, LLC | Delaware |
| 32 | Keurig JV, LP | Delaware |
| 33 | Keurig Manufacturing Inc. | Delaware |
| 34 | Keurig Production Holding, LLC | Delaware |
| 35 | Keurig Production SubCo LLC | Delaware |
| 36 | KGM Manufacturing LLC | Delaware |
| 37 | Kodiak NewCo Inc. | Delaware |
| 38 | Maple Parent Holdings Corp. | Delaware |
| 39 | Mott's Delaware LLC | Delaware |
| 40 | Mott's LLP | Delaware |
| 41 | Nantucket Allserve, LLC | Delaware |
| 42 | North American Beverages, LLC | Texas |
| 43 | Revive Brands | California |
| 44 | Snapple Beverage Corp. | Delaware |
| 45 | Splash Transport, Inc. | Delaware |
| 46 | The American Bottling Company | Delaware |

---

------

---

| | | |
|:---|:---|:---|
| 47 | Thomas Kemper Acquisition Co. Inc. | Texas |
| 48 | Xyience Beverage Company, LLC | Texas |
| 49 | Xyience Contracts Company, LLC | Texas |
| 50 | Xyience Supplements Company, LLC | Texas |
| 51 | Canada Dry Mott's Inc. | Canada |
| 52 | Keurig Canada Inc. | Canada |
| 53 | Van Houtte Coffee Services Inc. | Canada |
| 54 | Alder Basswood Clover LP | Ireland |
| 55 | Alder Clover Limited | Ireland |
| 56 | Basswood Clover Limited | Ireland |
| 57 | Ghost Lifestyle Ireland Limited | Ireland |
| 58 | KDP Beverage Concentrate Operations Limited | Ireland |
| 59 | KDP Beverage Enterprises Limited | Ireland |
| 60 | KDP Global Sourcing Limited | Ireland |
| 61 | Keurig International Sàrl | Luxembourg |
| 62 | Bebidas Americas Investments B.V. | Netherlands |
| 63 | Kodiak BidCo B.V. | Netherlands |
| 64 | Keurig Switzerland GmbH | Switzerland |
| 65 | Keurig Trading GmbH | Switzerland |
| 66 | Ghost Lifestyle UK Limited | United Kingdom |
| 67 | Big Red Mexico S de RL de CV | Mexico |
| 68 | Comercializadora de Bebidas, SA de CV | Mexico |
| 69 | Peñafiel Aguas Minerales SA de CV | Mexico |
| 70 | Peñafiel Bebidas SA de CV | Mexico |
| 71 | Manantiales Peñafiel, S.A. de C.V. | Mexico |
| 72 | Servicios Logisticos Peñafiel, S.A. de C.V. | Mexico |
| 73 | Snapple Beverage de Mexico, S.A. de C.V. | Mexico |
| 74 | KDP Brasil Global Sourcing LTDA | Brazil |
| 75 | Green Mountain Electrical Appliances Technical Consulting (Shenzhen) Company Limited | China |
| 76 | Green Mountain Hong Kong Limited | Hong Kong |
| 77 | Keurig Malaysia Sdn. Bhd. | Malaysia |
| 78 | Keurig Singapore Pte. Ltd. | Singapore |

---

## Exhibit 22.1

**Exhibit 22.1**

**<u>Guarantor Subsidiaries of Keurig Dr Pepper Inc.</u>**

As of December 31, 2025

The following subsidiaries of Keurig Dr Pepper Inc. (the "Company") were guarantors of the Company's senior unsecured notes as of December 31, 2025:

---

| | | |
|:---|:---|:---|
| **Name of Guarantor Subsidiary** | **Name of Guarantor Subsidiary** | **Jurisdiction of Formation** |
| 1 | 234DP Aviation, LLC | Delaware |
| 2 | A&W Concentrate Company | Delaware |
| 3 | Bai Brands LLC | New Jersey |
| 4 | Beverages Delaware Inc. | Delaware |
| 5 | DP Beverages Inc. | Delaware |
| 6 | DPS Americas Beverages, LLC | Delaware |
| 7 | DPS Beverages, Inc. | Delaware |
| 8 | DPS Holdings Inc. | Delaware |
| 9 | Dr Pepper/Seven Up Beverage Sales Company | Texas |
| 10 | Dr Pepper/Seven Up Manufacturing Company | Delaware |
| 11 | Dr Pepper/Seven Up, Inc. | Delaware |
| 12 | Mott's Delaware LLC | Delaware |
| 13 | Mott's LLP | Delaware |
| 14 | Nantucket Allserve, LLC | Delaware |
| 15 | Snapple Beverage Corp. | Delaware |
| 16 | Splash Transport, Inc. | Delaware |
| 17 | The American Bottling Company | Delaware |

---

## Exhibit 23.1

**Exhibit 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We consent to the incorporation by reference in Registration Statement No. 333-289652 on Form S-3 and Registration Statement No. 333-233481 on Form S-8 of our reports dated February 24, 2026, relating to the financial statements of Keurig Dr Pepper Inc. and the effectiveness of Keurig Dr Pepper Inc.'s internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2025.

/s/ DELOITTE & TOUCHE LLP

Dallas, Texas

February 24, 2026

## Exhibit 31.1

**Exhibit 31.1**

**Principal Executive Officer's Certification**

**Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002** 

I, Timothy Cofer, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Annual Report on Form 10-K of Keurig Dr Pepper Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: February 24, 2026 | /s/ Timothy Cofer |
| | Timothy Cofer |
| | Chief Executive Officer |

---

## Exhibit 31.2

**Exhibit 31.2** 

**Principal Financial Officer's Certification**

**Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002** 

I, Anthony DiSilvestro, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Annual Report on Form 10-K of Keurig Dr Pepper Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: February 24, 2026 | /s/ Anthony DiSilvestro |
| | Anthony DiSilvestro |
| | Chief Financial Officer |

---

## Exhibit 32.1

**Exhibit 32.1**

**Certification Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To**

**Section 906 of the Sarbanes-Oxley Act of 2002** 

I, Timothy Cofer, Chief Executive Officer of Keurig Dr Pepper Inc. (the "Company"), certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)the Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2025, as filed with the Securities and Exchange Commission (the "Report"), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| Date: February 24, 2026 | /s/ Timothy Cofer |
| | Timothy Cofer |
| | Chief Executive Officer |

---

## Exhibit 32.2

**Exhibit 32.2** 

**Certification Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To**

**Section 906 of the Sarbanes-Oxley Act of 2002** 

I, Anthony DiSilvestro, Chief Financial Officer of Keurig Dr Pepper Inc. (the "Company"), certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)the Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2025, as filed with the Securities and Exchange Commission (the "Report"), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| Date: February 24, 2026 | /s/ Anthony DiSilvestro |
| | Anthony DiSilvestro |
| | Chief Financial Officer |

---

<br>